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Summary 
 The non-ribosomal peptide gliotoxin, is a toxic fungal secondary metabolite 
produced by the filamentous fungus Aspergillus fumigatus. Previous work has 
implicated its potent anti-fungal properties and importance as a virulence factor in 
human infection. Availability of the A. fumigatus genome has allowed for the 
characterisation of the gliotoxin biosynthetic cluster gli, with previous work illustrating 
the importance of the thioredoxin reductase gliT in self protection against gliotoxin, 
regulation of which has been shown to be independent of the transcriptional role of gliZ 
in regulating the cluster. The work presented here characterises the creation of a double 
gene deletion strain lacking both gliT and gliZ (ΔgliTΔgliZ) ultimately silencing the gli 
cluster. Phenotypic characterisation revealed that ΔgliTΔgliZ is more sensitive to 
gliotoxin challenge when compared with ΔgliZ, yet is more resistant when compared 
with ΔgliT, highlighting the importance of gliT in protection against gliotoxin, 
especially when the cluster is still expressed.     
 An anti-oxidant role for gliotoxin is highlighted, with co-addition of gliotoxin 
and hydrogen peroxide resulting in a reduction in the production of reactive oxygen 
species in A. fumigatus, when compared with hydrogen peroxide only treated cells. 
 Additionally, proteomic and transcriptomic data indicate gliotoxin exposure 
dysregulates S-adenosyl-L-methionine biosynthesis with key enzymes of this pathway, 
i.e., S-adenosyl-L-homocysteinase and cobalmin-independent L-methionine synthase, 
eliciting significant changes in their respective expression in response to gliotoxin in A. 
fumigatus an also in Saccharomyces cerevisiae. Using a gene candidate approach, S. 
cerevisiae Δsod1 and Δyap1 sensitivity to exogenous gliotoxin suggest gliotoxin 
induces some form of oxidative stress on the cell. Furthermore, low to null levels of 
glutathione were seen to be advantageous to the S. cerevisiae mutant strain Δgsh1, 
eliciting resistance to gliotoxin challenge. Similarly, glutathione levels were found to 
significantly altered in A. fumigatus gliT and gliZ mutant lysates and may be a factor in 
their respective gliotoxin sensitivity. 
 Overall this work highlights key factors which may contribute to gliotoxin 
toxicity. Highlighting the importance of gliotoxin biosynthetic genes and the pathways 
involved in the response to gliotoxin exposure.
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Introduction 
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1.1 Aspergillus fumigatus 
 The genus Aspergillus consists of approximately 200 species, 20 of which have 
been associated with some form of disease (Tomee & Werf 2001). The most pathogenic 
species A. fumigatus, was first described in 1863 after being isolated from avian lung 
tissue and is responsible for approximately 90 % of all invasive aspergillosis cases 
(Dagenais & Keller 2009). A. fumigatus is an omnipresent saprophytic fungus which 
naturally occupies niches within soil environments or decaying organic matter where it 
plays an important role in carbon and nitrogen recycling (Latge 2001).  
 The fungus produces thousands of airborne hydrophobic conidia which are 
released into the surrounding environment facilitated by their small size (2.5-3 µm) and 
aerodynamic nature (Dagenais & Keller 2009). A. fumigatus life cycle entails the 
asexual production of haploid conidia in chains known as conidiophores, release of 
conidia into the environment, conidia germination and hyphal growth from which the 
new conidiophores and haploid conidia will be produced (Latgé 1999). The 
identification of sexual reproduction and development genes in A. fumigatus suggested 
it held the potential to reproduce both asexually and sexually (Galagan et al., 2005). 
This was later confirmed with the identification of a functional sexual cycle in certain A. 
fumigatus isolates of different mating types. 
 
1.2 Aspergillus fumigatus, a pathogenic fungus 
 A. fumigatus is an opportunistic human pathogen whose small spore size allows 
for easy access into the alveoli of the lungs of mammals (Latgé 1999). It is estimated 
that the average human breathes up to 200 conidia, rarely resulting in any adverse 
affects due to the efficient elimination via the host immune system (Philippe et al., 
2003). However, in the case of immuno-compromised individuals, this is not always the 
case and in these situations, patients are vulnerable to the onset of Invasive 
Aspergillosis (IA) (Dagenais & Keller 2009). A. fumigatus infections are classed into 
three categories which affect patients who are severely immuno-compromised (Daly & 
Kavanagh 2001; Thomson & Patterson 2008; Tomee & Werf 2001). Allergic broncho-
pulmonary aspergillosis (ABPA) is caused by a poorly controlled inflammatory 
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response primarily, but not limited to, patients who have already been suffering from 
some type of pulmonary disease such as cystic fibrosis or prolonged asthma (Daly & 
Kavanagh 2001; Sherif & Segal 2012). It can be differentiated from other types of IA 
by the elevated levels of IgE in the sera of patients (Moss 2002). The second category 
consists of the formation of masses of A. fumigatus hyphae and mucous known as 
Aspergillomas or fungal balls first described by Deve (1938). These masses form in pre-
existing pulmonary cavities, usually caused by TB, pneumonia or carcinoma (Thomson 
& Patterson 2008) and can continue to grow in mass without invading any pulmonary 
tissue for months or even years (Daly & Kavanagh 2001).  
 IA is the most prevalent form of A. fumigatus infection, affecting 
immunocompromised individuals, and is particularly dangerous in recipients of solid 
organ and hematopoietic transplants, HIV patients and leukaemia patients (Pagano et 
al., 2001; Post et al., 2007; Holding et al., 2000). In these cases a mortality rate of ~80 
%, is not un-common and greatly depends on the point of entry, immune status of the 
patient, and time of diagnosis (S.-jane Lin et al., 2001). A. fumigatus can produce an 
array of secondary metabolites which contribute to its pathogenicity as well as its anti-
fungal activity such as fumagillin, fumitremorgin, helvolic acid and gliotoxin (Nierman 
et al., 2005; Kamei & Watanabe 2005; Dhingra et al., 2013)  
 
1.3 A. fumigatus genome 
 The genome sequence of A. fumigatus strain AF293 was fully sequenced in 2005 
(Nierman et al., 2005). From this the total size of the genome was found to possess a 
total of 9,926 predicted genes in 8 chromosomes totalling 29.4 Mb in size (Nierman et 
al., 2005). Only 451 (4.61 %) of the open reading frames (ORFs) have been 
characterised to date out of a total number of 9,783 ORFs (Arnaud et al., 2011). The 
availability of this genome sequence data has facilitated large scale studies into further 
understanding the response of this fungus to various stimuli. These include the 
transcriptional response to anti-fungal drugs like amphotericin B (Gautam et al., 2008) 
and voricanazole (Ferreira et al., 2006; Zhao et al., 2012); transcriptional response to 
hosts’ cells including neutrophils (Sugui et al., 2008) and epithelial cells (Oosthuizen et 
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al., 2011); and response to environmental factors including hypoxia (Barker et al., 
2012) and heat shock (Albrecht et al., 2010). It has also allowed for direct comparison 
with the different genomes of other strains and Aspergillus spp. For example Fedorova 
et al, (2008) showed that a great translocation event had taken place between 
chromosomes 1 and 6 of AF293 when compared with the genome of A. fumigatus 
A1163, with 99.8 % similarity seen in core related genes at the nucleotide level. 
Similarly, when the size of the A. fumigatus genome is compared to the genome of A. 
oryzae it was found to be 34 % smaller, yet shares ~ 77 % identity with A. oryzae 
(Machida et al., 2005; Galagan et al., 2005). Additionally, when compared to A. 
nidulans, the A. fumigatus genome is 7% smaller and only shares ~66 % identity 
(Galagan et al., 2005). Interestingly, > 70 % of each genome could be mapped onto 
conserved syntenic blocks of genes, even though they show re-arrangement (Galagan et 
al., 2005). The regions where there is a loss of synteny occur near or within sub-
telomeric regions, known for rapid re-arrangement and possible species-specific 
evolution of genes and is also where many secondary metabolite clusters have been 
shown to be located in A. fumigatus (Galagan et al., 2005; Perrin et al, 2007a). This can 
be seen when the genes of A. fumigatus, A. niger and A. nidulans are compared, 
whereby there are 500 specific genes in A. fumigatus which share no homology with the 
other two species (Nierman et al., 2005). Many of these are involved in secondary 
metabolite biosynthesis which will be discussed in more detail in the next section. 
 
1.4 Secondary metabolite clusters and biosynthesis 
 Keller defines secondary metabolites as low molecular mass, bioactive 
molecules associated with secondary metabolism usually produced at specific 
morphological stages in the life cycle of the fungus but which are not essential for 
growth (Keller et al., 2005). Secondary metabolism may refer to any process which is 
not directly linked to the primary growth of the organism. Secondary metabolites can be 
grouped into four broad categories: Alkaloids which include fumigclavines and 
fumitremorgins; terpenes which include gibberellin and asristolochene; polyketides 
which include fusarin C and aflatoxin and non-ribosomal peptides which include 
gliotoxin (Keller et al., 2005; Fox & Howlett 2008)  
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The purpose of these secondary metabolites is to enable the fungus to adapt to its 
surroundings, improving its chance of survival by decreasing the fitness of competing 
microbes in their environment (Losada et al., 2009). The effectiveness of these 
secondary metabolites and their uses against other microbes is exemplified in the use of 
the antibiotic penicillin or the cholesterol-reducing compound, lovastatin a.k.a. 
mevinolin (Demain & Elander 1999; Alberts et al., 1980). However some secondary 
metabolites, known as mycotoxins, are quite toxic, and include aflatoxin which has been 
associated as a major risk factor for liver cancer in humans when it is ingested from 
certain contaminated food-stuff, and gliotoxin which will be discussed in more detail 
later (Groopman et al., 1988; Jones & Hancock 1988).  
 Due to the many benefits secondary metabolites can have, much research has 
gone into the identification of new metabolites and fungi (Schulz et al., 2002; Rateb & 
Ebel 2011). However, the production of many other secondary metabolites remain 
silenced under normal laboratory growth conditions, requiring specific conditions and 
stimuli in order for them to be expressed (Brakhage et al., 2008; Hertweck 2009; 
Brakhage & Schroeckh 2011).  
 The biosynthesis of these secondary metabolites requires the presence of 
different ‘backbone’ enzymes which catalyse the initial biosynthetic step. These include 
non-ribosomal peptide syntethases (NRPS), polketide synthases (PKS), prenyl-
transferases (DMATS) and terpene cyclises (Khaldi et al., 2011). In the case of the 
NRPS and PKS enzymes, there exists particular domains which facilitate their function 
in the cell. In the A. fumigatus NRPS GliP (Figure 1.1), there exists two adenylation 
domains which are involved in amino acid activation, three thiolation domains which 
are involved in anchoring the growing polypeptide chain during biosynthesis and two 
condensation domains which help catalyse the formation of peptide bonds (Balibar & 
Walsh 2006; Brakhage & Schroeckh 2011). Other domains, also known as ‘decorating’ 
domains, can exist which further modify the metabolite, include methyltransferases and 
epimerisation domains which may also be present (Walsh et al., 2001). PKS modules 
use slightly different domains such as an acyltransferase domain, acyl carrier protein 
and ketoacyl synthase (Brakhage & Schroeckh 2011). The final metabolite can then be 
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transported from the cell via a specific transporter which can be found within the cluster 
also (Khaldi et al., 2011). 
 
 
 
Figure 1.1 Schematic of the non-ribosomal synthetase GliP adapted from Balibar 
& Walsh 2006. Adenylation domain (A), Thiolation domain (T) and Condensation 
domain (C) are depicted in their respective positions along the NRPS 
 
 Certain clusters can be regulated by transcription factors which are encoded 
within their cluster such as GliZ of the gliotoxin biosynthetic cluster and ChaZ of the 
chaeotocin biosynthetic cluster (Gardiner & Howlett 2005; Gerken & Walsh 2013). Not 
all gene clusters are regulated by transcription factors encoded within the same cluster. 
Some are regulated by other external regulators such as the secondary metabolite global 
transcriptional regulators LaeA and VeA (Perrin et al., 2007; Fox & Howlett 2008; 
Dhingra et al., 2013). LaeA is a highly conserved, nuclear protein found to have global 
effects on the regulation of a plethora of different genes and pathways including 
secondary metabolite clusters in A. fumigatus (Bok & Keller 2004). LaeA was first 
characterised by Bok et al., (2004) identifying its role as a global regulator of secondary 
metabolism with loss of LaeA in an A. fumigatus ΔlaeA strain resulting in the 
abrogation of gene expression of several metabolic gene clusters. Additionally, Bok et 
al., (2005) demonstrated that loss of A. fumigatus laeA resulted in abolition of gliotoxin 
biosynthesis and subsequent attenuation in virulence of mice hosts, further supporting 
gliotoxin as a virulence factor in IA. Additionally, Perrin et al., (2007) highlighted that 
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loss of laeA in A. fumigatus resulted in 13 of 22 characterised secondary metabolite 
gene clusters to have significantly lower gene expression when compared to A. 
fumigatus wild-type. Furthermore, they identified that LaeA positively regulated 20-40 
% of the major secondary metabolite biosynthesis classes. LaeA regulation of secondary 
metabolite gene clusters is facilitated by its SAM binding site and subsequent 
manipulation of chromatin re-modelling in the nucleus thus affecting expression (Bok et 
al., 2006; Shwab et al., 2007) 
 Similar to LaeA, VeA is a global regulator of gene expression effecting genes 
involved in sexual and asexual development in Aspergillus spp. Loss of VeA in A. 
fumigatus ΔveA strains resulted in conidiation being impaired (Krappmann & Braus 
2005). Dhingra et al., (2012) demonstrated that gliotoxin production in A. fumigatus 
ΔveA strains was significantly reduced highlighting VeA regulation of secondary 
metabolism. Interestingly, in A. fumigatus ΔveA there was a corresponding decrease in 
the expression of gliZ and gliP, both of which have been shown previously to be 
necessary for gliotoxin biosynthesis (Dhingra et al., 2012; Bok et al., 2006; Cramer et 
al., 2006). Yet, loss of VeA in A. fumigatus does not affect virulence in mice, indicating 
that unlike LaeA, VeA is dispensable for virulence (Dhingra et al., 2012). 
 Both LaeA and VeA are part of the velvet regulatory proteins which primarily 
regulate fungal development across the Aspergillus spp. (Bayram et al., 2008). These 
proteins are involved in the regulation of the light response in A. nidulans whereby VeA 
expression, in the dark, interacts with VelB, another velvet associated regulatory protein 
primarily involved in sexual development, this interaction results in the bridging of 
VelB to LaeA and subsequent regulation of gene expression (Bayram et al., 2008). In a 
recent study by Park et al., (2012), the velvet proteins LaeA, VeA, VelB,VosB and BrlA 
of A. fumigatus were characterised. ΔveA, ΔvosB and ΔvelB A. fumigatus strains all 
displayed dysregulation of asexual development, with a significant increase in the 
production of conidiophores (Park et al., 2012). This study highlighted a similar 
regulatory role for these proteins which may prove to regulate important secondary 
metabolite gene clusters in A. fumigatus also. 
 Since the full genome sequencing of A. fumigatus a total of 26 gene clusters 
have been identified based on the presence of a PKS, NRPS or DMAT gene (Nierman 
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et al., 2005). One such cluster responsible for the biosynthesis of secondary metabolite 
gliotoxin will be discussed in more detail in the next section. 
 
1.5 Gliotoxin biosynthesis 
 As mentioned, gliotoxin is a secondary metabolite produced by the filamentous 
fungus A. fumigatus which possesses a role as a virulence factor during IA (Sutton et 
al., 1994). Gliotoxin is also produced in a number of other biologically and industrially 
relevant strains such as certain Trichoderma and Penicillium spp (Kamei & Watanabe 
2005). It belongs to the epipolythiodioxopiperazine class of organic molecules, 
possessing an indicative piperazine ring and trans-molecular disulphide bridge as seen 
in figure 1.2 (Gross et al., 2010). Presence of this disulphide bridge results in gliotoxin 
existing in either an oxidised disulphide form or reduced dithiol form (Waring et al., 
1995; Sutton & Waring 1996). 
 
 
Figure 1.2 Chemical structure of the non-ribosomal peptide gliotoxin. Note the 
trans-molecular disulphide bridge shown here in its closed oxidised form. Source: 
http://www.abcam.com/ps/datasheet/images/142/ab142437/Gliotoxin-ab142437-
ChemicalStructure-1.jpg 
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 The gliotoxin biosynthetic cluster, gli, consists of a 13 gene cluster (figure 1.3) 
spanning 28 kb on chromosome six of A. fumigatus which is responsible for the 
biosynthesis of gliotoxin (Gardiner et al., 2004; Gardiner & Howlett 2005). The 
functions of many of the genes of the gli cluster, have yet to be elucidated however 
some have been characterised. GliZ encodes a Zn2Cys6 transcription factor which 
regulates the gli cluster (Bok et al., 2006). Loss of gliZ results in the subsequent 
abolition of gliotoxin biosynthesis (Bok et al., 2006). It also results in the loss of gliZ 
dependant intermediates absent from ΔgliZ (Forseth et al., 2011).  
 
 
Figure 1.3 Gliotoxin biosynthetic cluster gli from A. fumigatus. Diagram modified 
from Gardiner et al, (2005) including the recent addition of the thirteenth gli cluster 
gene gliH (Schrettl et al., 2010). 
 
A later study which created a ΔgliT strain, illustrated that similar to ΔgliZ 
gliotoxin biosynthesis was abolished with no detectable gliotoxin levels found in culture 
supernatants (Schrettl et al., 2010). Unlike ΔgliZ, A. fumigatus ΔgliT exhibited a 
hypersensitive phenotype to gliotoxin, demonstrating the role of gliT in self-protection 
against gliotoxin (Schrettl et al., 2010). This same study also demonstrated that gliT was 
still expressed in ΔgliZ in the presence of gliotoxin, depicting gliT regulation is 
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independent of gliZ and that gliotoxin presence could induce expression of its own 
biosynthetic cluster (Schrettl et al., 2010). GliT is an oxido-reductase responsible for the 
closure of the disulphide bridge of gliotoxin (Scharf et al., 2013) 
 As mentioned, gliP encodes a non-ribosomal peptide synthetase which consists 
of two condensation, two adenylation and three thiolation domains (Balibar & Walsh 
2006). It’s responsible for the formation of the diketopiperazine backbone of gliotoxin 
from the amino acids L-serine and L-phenylalanine (Balibar & Walsh 2006). Loss of 
gliP results in loss of gliotoxin biosynthesis and subsequent attenuation of infection in 
an immunocompromised murine infection model (Cramer et al., 2006; Kupfahl et al., 
2006). gliG encodes a glutathione S-transferase and has been shown to catalyse the 
incorporation of two glutathione molecules in the latter stages of gliotoxin biosynthesis 
which act as the sulphur sources required for the formation of its disulphide bridge 
(Davis et al., 2011). In A. fumigatus ΔgliG, a subsequent loss in gliotoxin biosynthesis 
was seen as well as the accumulation of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione, believed to be a shunt metabolite produced in the 
absence of GliG enzymatic activity (Davis et al., 2011). GliK has been previously 
shown to be involved in gliotoxin biosynthesis with an A. fumigatus ΔgliK strain unable 
to produce gliotoxin and possessed elevated intermediates lacking disulfide or thiol 
groups (Gallagher et al., 2012). This gliotoxin biosynthetic activity of GliK was later 
confirmed and identified as a γ-glutamate cyclotransferase (Scharf et al., 2013). 
Similarly, a homologue in the chaeotocin A ETP cluster of Chaetomium virescens, 
chaK, was found to be have γ-glutamylcyclotransferase activity, which may be involved 
in processing a biosynthetic intermediate diketopiperazine-glutathione adduct (Gerken 
& Walsh 2013). Creation of a ΔgliK strain has illustrated that it may also play a role in 
the oxidative stress response, with loss of gliK eliciting increased sensitivity to the 
presence of H2O2, which was subsequently alleviated upon exogenous gliotoxin 
addition highlighting an anti-oxidant potential for gliotoxin (Gallagher et al., 2012). gliI 
has been demonstrated to be involved in the cleaving the C-S bond resulting in the 
formation of the epidithiol moiety of gliotoxin formed via gliKs’ putative γ-
glutamylcyclotransferase activity. ΔgliI strains are unable to produce gliotoxin, 
highlighting it’s essential for gliotoxin biosynthesis (Scharf et al., 2012). A model of 
gliotoxin biosynthesis is show in Figure 1.4. 
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Figure 1.4 Gliotoxin biosynthesis enzymatic pathway. Taken from Scharf et 
al., 2013. 1= gliotoxin biochemical structure; 2 = biscysteine adduct; 3 = dithiol 
intermediate; 4 = oxidised disulphide intermediate; 5 = bisglutathione intermediate 
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Although no functional characterisation of gliA has been carried out, a similar 
transporter, sirA, located with the biosynthetic cluster of another ETP molecule, 
sirodesmin, from Leptosphaeria maculans has highlighted its role in gliotoxin 
detoxification (Gardiner et al, 2005). ΔsirA sensitivity to exogenous gliotoxin was 
attenuated upon transformation of L. maculans ΔsirA with A. fumigatus gliA, however 
no alteration of the phenotype was seen to exogenous sirodesmin, illustrating GliA-
mediated attenuation of gliotoxin toxicity to be gliotoxin specific (Gardiner et al, 2005). 
  
1.6 Gliotoxins affect on host immune cells 
 As stated, gliotoxin is an important causative factor in IA. It achieves this 
through the biological activity of its indispensible disulphide bridge which facilitates 
potential conjugation to the thiol residues within proteins, subsequently leading to 
protein inactivation (Mullbacher et al., 1986; Waring et al., 1995; Pahl et al., 1996; 
Hurne et al., 2000). Gliotoxin has been shown to inhibit the formation of the respiratory 
burst NADPH oxidase complex, used by polymorphonuclear leukocytes in the 
superoxide killing of invading pathogens (Tsunawaki et al., 2004). Additionally, a study 
using the insect model Galleria mellonella found that gliotoxin specifically repressed 
the translocation of p47
phox
 and p67
phox
 homologues which resulted in basal levels of 
superoxide generation (Renwick et al., 2006).  
Through this ability, gliotoxin is also able to undergo redox cycling resulting in the 
production of reactive oxygen species (ROS), which can cause oxidative stress and 
damage to the cell (Waring, et al., 2005). The role of gliotoxin as an 
immunosuppressant was first demonstrated in 1988 where it was found to induce 
apoptosis in macrophages (Waring et al., 1988). It has also been demonstrated to 
repress macrophage function as well as target antigen presenting cells (e.g., dendritic 
cells), thus repressing the antigen-presenting response and maturation of A. fumigatus 
specific T-cells (Stanzani et al., 2005). Furthermore gliotoxin has deleterious affects on 
other cell types such as hepatic, endothelial, and anthrocyte cells (DeWitte-Orr & Bols 
2005; Kweon et al., 2003; Caprariello et al., 2013) 
  
12 
 Alongside this, gliotoxin has also been shown to promote inflammation with low 
levels of the toxin eliciting an induction in the pro-inflammatory cytokine TNF-α, while 
simultaneously reducing the expression of the anti-inflammatory Il-10 (Johannessen et 
al., 2005). 
 
1.7 Gliotoxin as an anti- fungal, bacterial and viral agent 
 Much of the original interest in gliotoxin was focused around its potent anti-
fungal properties in which “toxic compounds” from Trichoderma viride which were 
later isolated and named gliotoxin, were noted to inhibit the growth of the soil fungus 
Rhizoctonia solani (Weindling and Emerson 1936). Gliotoxin has been demonstrated to 
inhibit the growth of an array of different fungal species including A. nidulans, A. 
terreus, A. niger and Saccharomyces cerevisiae, and has been utilised as an antifungal 
antibiotic, most notably in the treatment of soil borne fungi (Chamilos et al., 2008; 
Carberry et al., 2012; Howell & Stipanovic 1995; Aliaa 2008; Losada et al., 2009) .  
 Similarly, gliotoxin has been demonstrated to possess anti-bacterial properties 
inhibiting proteasomal activity in certain bacterial strains and ultimately growth 
(Paugam et al., 2002; Hatabu et al., 2006) as well as inhibiting viral RNA replication, 
affecting many types of viruses such as poliovirus types I-III, Nipah, Hendra, and 
Influenza A viruses (Larin et al., 1965; Aljofan et al., 2009). 
 
 
1.8 Gliotoxin detoxification 
 As mentioned previously, gliotoxin is a potent anti-fungal agent and elicits 
inhibition of growth of other Aspergilli spp. (Schrettl et al., 2010). To prevent auto- 
toxicity, A. fumigatus would require the presence of gliotoxin detoxification 
mechanisms. One such mechanism mentioned earlier is GliT, which can alter the redox 
state of gliotoxin via enzymatic manipulation of its disulphide bridge from its toxic 
oxidised form, to its non-toxic reduced form as seen in figure 1.5. Many other 
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mechanisms have been put forward as being potential detoxification mechanisms. The 
putative MFS transporter protein GliA has been previously demonstrated to attenuate 
gliotoxin sensitivity of L. maculans exposed to exogenous gliotoxin (Gardiner et al., 
2005) and may be involved in detoxification of gliotoxin via its efflux from the cell 
thereby preventing accumulation and subsequent toxicity. GliG was also hypothesised 
to be involved in gliotoxin toxicity, however a ΔgliG strain educed no sensitivity when 
exposed to gliotoxin suggesting gliG alone at least, is not involved in gliotoxin 
detoxification (Davis et al., 2011). 
 
 
Figure 1.5 Proposed model of GliT mediated protection against gliotoxin GliT 
protects the cell by acting as an oxido-reductase altering the trans-molecular disulphide 
bridge from the reduced form of gliotoxin (GT-SH-SH) to the oxidised form (GT-S-S) 
facilitating its efflux. Image taken from Schrettl et al., (2010) 
 
 Gliotoxin can also be found in an alternative form, other than the reduced and 
oxidised forms discussed earlier. Bis-methylated gliotoxin (Bm-GT), has an m/z of 357 
by LC-MS can be found in equimolar and sometimes 100 fold more concentrated in 
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tissue samples from patients suffering from A. fumigatus infection (Amitani et al., 1995; 
Bernardo et al., 2003). This form of gliotoxin would require the disulphide gliotoxin to 
be reduced, exposing the two thiol groups, onto which two methyl groups can be 
transferred in the presence of a methyl donor as seen in figure 1.6. Bm-GT shows no 
toxic effects to cells, indicating it’s unlikely to be an active mycotoxin. Because of this, 
its relatively stable chemical nature and the fact it was found to not be concentrated in 
fungal cells, Bm-GT has been hypothesised as being the product of gliotoxin 
detoxification and is currently being used as a biomarker for A. fumigatus infection 
from patient serum (Bernardo et al., 2003; Domingo et al., 2012). 
 
 
Figure 1.6 Diagram of bismethyl-gliotoxin production in A. fumigatus 
 
 
 
1.8.1 Oxidative stress response in fungi 
 Fungal cells are exposed to an environment which is in a constant flux, requiring 
the fungus to continually adapt to its surroundings in order to survive (Schimel et al., 
2007). Many common variables exist which can greatly affect the growth of fungi, as 
well as other organisms, including pH, temperature, nutrient type and availability and 
the presence of reactive oxygen species (ROS) (Arst Jr & Penalva 2003; Bellí et al., 
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2004; Narasimha et al., 2006; Angelova et al., 2005). ROS are reactive molecules such 
as the super oxide radical, and hydroxyl radical, which are produced both endogenously 
as by-products of metabolism, oxidative phosphorylation through reduction of 
molecular oxygen and by external factors in the environment such as the production of 
secondary metabolites like gliotoxin, or as part of a host immune response such as the 
superoxide burst seen in human neutrophils (Jamieson 1998; Montibus et al., 2013; 
Izawa et al., 1995). The fungus employs various enzymatic and non-enzymatic methods 
to attenuate the levels of the various ROS, in a response known as the oxidative stress 
(OS) response, preventing intracellular damage of important macromolecules (Sato et 
al., 2013). ROS are non-specific and can induce oxidation of organic molecules, sulphur 
containing amino acids and functional iron clusters. The efficiency of the OS response 
has been attributed to the pathogenicity of certain fungi, allowing for dismantling of 
host immune systems as mentioned in the case of gliotoxin and IA (Moye-rowley 2003; 
Montibus et al., 2013). Some of the mechanisms utilised by the OS response include the 
redox thiol glutathione, superoxide dismutases, and catalases which will be discussed in 
more detail in the following sections. 
 
1.8.2 Glutathione, role and biosynthesis 
 Glutathione (γ-glutamyl-cysteinyl-glycine) is a ubiquitous low molecular mass 
tripeptide which possesses a redox active free thiol group (Meister & Anderson 1983). 
It acts as a redox buffer and radical scavenger of ROS and xenobiotics which cause 
oxidative damage to proteins and other macromolecules (Schafer & Buettner 2001; 
Grant 2001). It achieves this through the interaction of its free thiol moiety, which is 
essential for its function, with ROS and xenobiotics present in the cell resulting in the 
oxidation of GSH to its oxidised from GSSG (Alton Meister 1988; Pompella et al., 
2003). The GSH:GSSG ratio is maintained in favour of the reduced from, with 
dysregulation of the GSH:GSSG ratio indicative of a cell under OS due to increased 
GSH oxidation via peroxide detoxification (Schafer & Buettner 2001; Ostergaard et al., 
2004). GSH regeneration requires the FAD-dependant enzyme glutathione reductase 
(GR) using NADPH as an electron donor to reduce GSSG to GSH and maintain the 
redox balance of the cell (Grant et al., 1996; Sato et al., 2013).  
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In addition to its radical scavenging role in the OS response, glutathione has also 
been demonstrated to possess a role as a cofactor in the reactions of other OS response 
mediators and as a means of protein modification (Grant 2001). Glutathione presence is 
necessary for the disulphide reductase activity of certain glutaredoxins, helping to 
reduce protein disulphide formation created by the presence of ROS (Holmgren 1989). 
Similarly, GSH acts as an electron donor to glutathione peroxidases in the reduction of 
H2O2 to H2O (Draculic et al., 2000). 
Glutathione s-transferases (GSTs) are cytosolic enzymes which also contain a 
redox active sulphydral group (Hayes et al., 2005). This group of enzymes mediate the 
transfer and conjugation of GSH to xenobiotics and other ROS agents. GSH-conjugates 
are then transported to vesicles in which they are detoxified (Coleman & Randall 1997; 
Klein et al., 2007). GSTs also possess a role in disulphide reduction via GSH and 
glutathionylation modification as seen in gliotoxin biosynthesis with the gli cluster GST 
GliG (Davis et al., 2011). Glutathione can also modify proteins via its s-
glutathionylation mechanism, interacting with the free thiol groups of proteins 
(Cotgreave & Gerdes 1998; Jacob et al., 2003; Yang et al., 2010). This helps protect 
proteins from irreversible oxidative damage induced by ROS thus reducing OS stress.  
Information of glutathione biosynthesis in filamentous fungi is sparse, but is 
well documented in the yeast S. cerevisiae (Izawa et al., 1995; Pompella et al., 2003; 
Schafer & Buettner 2001). Glutathione is made as product of the sulphur amino acid 
biosynthesis pathway in yeast by the combination of three amino acids L-glutamate, L-
glycine and L-cysteine. The latter is a product of the sulphur amino acid pathway 
produced from L-homocysteine which is catalysed via cystahionine β-synthase (Cys4) 
and L-cystathionine which is catalysed by cystathionine γ-lyase (Cys3) (Ono et al., 
1988). Both are found to be up-regulated under sulphur starvation due to the ability of S. 
cerevisiae to use L-methionine, L-homocysteine, glutathione or L-cysteine as a sulphur 
source required for nominal growth (Hiraishi & Miyake 2008).  
Two key enzymes catalyse the formation of GSH. γ-glutamylcysteine synthetase 
1 (Gsh1) and glutathione synthetase (Gsh2) (Lee et al., 2001). Gsh1 catalyses the 
formation of the dipeptide γ-glutamylcysteine, and has been demonstrated to be the rate 
limiting step in GSH biosynthesis (Ohtake et al., 1990). Loss of GSH1 in yeast results 
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in the abrogation of glutathione biosynthesis and subsequent sensitivity to ROS (Lee et 
al., 2001). Gsh2 catalyses the final step producing GSH with subsequent loss of GSH2 
resulting in GSH biosynthesis being abolished, yet this does not elicit sensitivity to the 
ROS agent H2O2 due to an accumulation of the Gsh1 intermediate γ-glutamylcysteine 
(Lee et al., 2001).  
 Previous work has demonstrated a relationship between GSH and gliotoxin. 
Gliotoxin was found to be reversibly taken up by cells in a GSH dependant manner, as 
well as forming gliotoxin-GSH conjugates (Bernardo et al., 2001, 2003). Similarly, 
addition of gliotoxin to A. fumigatus cells was found to reduce the GSH pool and also 
stimulate the levels of GSH1 (Carberry et al., 2012; Axelsson et al., 2006) In a study 
using a human neuroblastoma cell line, artificially reducing the GSH levels attenuated 
gliotoxin toxicity highlighting the potential of GSH to facilitate gliotoxin toxicity in 
cells and how these two redox active molecules interact (Axelsson et al., 2006). 
 
1.8.3 Superoxide dismutase 
 Superoxide dismutases (SOD) are metalloenzymes which act on the dismutation 
of the superoxide radical O2
-
 to molecular oxygen and the less toxic H2O2 (Mccord & 
Fridovich 1969; Bannister et al., 1987). In cells, there is an array of different types of 
SOD enzymes which vary on the metal cofactor attached. These include the copper-zinc 
SOD (CuZnSOD), manganese SOD (MnSOD), nickel SOD (NiSOD) and iron SOD 
(FeSOD) (Mccord & Fridovich 1969; Youn et al., 1996; Yost & Fridovich 1973). In A. 
fumigatus there are four genes encoding putative superoxide dismutases (SOD1-4) 
based on orthologs in other organisms (Lamarre et al., 2001; Hwang et al., 2002). In S. 
cerevisiae, there are two SOD genes, SOD1 and SOD2 which encode a CuZnSOD and 
MnSOD respectively (Bermingham-mcdonogh et al., 1988; Van Loon et al., 1986). 
These two enzymes have been demonstrated to be homologous to Sod1p and Sod2p in 
A. fumigatus. Sod1p is located in the cytosol of the cell while Sod2p is based in the 
mitochondrion with loss of either resulting in sensitivity to subsequent ROS. There is 
some evidence which illustrates a role for different SODs in the pathogenesis of 
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different fungi, helping to attenuate the superoxide burst of human neutrophils (Lambou 
et al., 2010) 
 
1.8.4 Catalase 
 Catalases react with H2O2, breaking it down to water and molecular oxygen 
(Cross & Ruis 1987). H2O2 can be produced in vivo as a result of redox cycling 
reactions as described previously, or as a by-product of other OS responses, namely 
SOD dismutaion of O2
- 
(Waring et al., 1995; Jamieson 1998). There are two catalases in 
yeast, cytoplasmic catalase T (Ctt1) and the peroxisomal catalase A (Cta1). Loss of 
either elicits increased sensitivity to OS stress (Todorova et al., 2009; Delaney et al., 
2013) . In A. fumigatus there are a total of three catalases, one conidial catalase (CatA) 
and two mycelia catalases (Cat1 and Cat2). Interestingly, Cat2 was found to be bi-
functional acting as a catalase-peroxidase in the cell (Paris et al., 2003).  
 Similar to SOD, the presence of certain catalases have been attributed to 
virulence and the ability to counteract the host immune response. In an A. fumigatus 
Δcat1Δcat2 strain, only slight sensitivity is seen to H2O2, yet a significant delay in 
infection time was seen in Δcat1Δcat2 infected murine hosts (Paris et al., 2003) 
 
1.9 S-adenosyl-L-methionine cycle 
 S-adenosyl L-methionine (SAM) is the principle methyl source for a myriad of 
biological reactions (Chiang et al., 1996). Its structure was first elucidated in 1951 and 
since then has been demonstrated to be vital in many cellular processes including 
polyamine biosynthesis, gene expression and as a source of L-cysteine for the 
production of glutathione (Cantoni 1951; Eloranta & Kajander 1984; Finkelstein & 
Martin 1990). Altered SAM levels have been attributed to many diseases in humans and 
it has been employed as a therapeutic, treating liver problems as well as neurological 
ailments including depression (Friedal et al., 1989; Papakostas et al., 2010). SAM has 
two main roles in the cell, as an s-methyl donor through its methyl donor activity or as 
an enzymatic inducer, and is produced via the SAM cycle (Chiang et al., 1996). SAM 
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biosynthesis occurs in the cytosol in all cells as seen in Figure 1.7. L-homocysteine, 
which is produced as part of the sulphur amino acid biosynthetic pathway from L-
cysteine, is methylated by a methionine synthase to form L-methionine (Mato et al., 
1997; Kacprzak et al., 2003). An adenosyl group is attached to this via the s-
adenosylmethionine synthases, Sam1 and Sam2, to form s-adenosly-L-methionine. 
After donating its methyl group as part of some biological reaction, s-adenosyl-L-
homocysteine is produced from s-adenosyl-L-methionine, which is later hydrated and 
converted back to L-homocysteine via s-adenosyl-homocysteinase (i.e., s-adenosyL-
homocysteine hydrolase) in yeast (Kredich & Hershfield 1979; Tehlivets et al., 2004). 
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Figure 1.7 S-adeonosyl-L-methionine biosynthesis cycle Enzymes involved in 
catalysing the biosynthesis of key components of the SAM cycle are depicted in red. 
The chemical structure of L-homocysteine, L-methionine, S-adenosyl-L-methionine, S-
adenosylhomocysteine are given for each.  
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 SAMs methyl donor activity is facilitated by the addition of an ATP molecule 
during its biosynthesis. ATP is transferred to L-methionine via SAM synthase resulting 
in the formation of a high energy sulfonium ion which readily donates its methyl groups 
to suitable methyl acceptors (Chiang et al., 1996; Cosper et al., 2003).  
Prior to polyamine biosynthesis, SAM is decarboxylated via SAM decarboxylase and 
the subsequent aminopropyl group is transferred to putrescine via spermidine synthase 
to form spermidine (Finkelstein & Martin 1990). Polyamines have a multitude of roles 
in the cell possessing the ability to interact with nucleic acid due to their highly 
protonated nature which can affect gene regulation, as well as protecting the cell from 
oxidative damage and ROS, highlighting a role for SAM in the OS response of cells 
(Chattopadhyay et al., 2002).  
S-adenosyL-homocysteine (SAH) is produced after every SAM reaction (Deguchi & 
Barchas 1971). SAH has been demonstrated to inhibit certain methyltransferase 
reactions in the cell including SAM methyl donor reactions via competition of the SAM 
binding domain. It has also been linked to adenosine toxicity in humans suffering from 
the immune deficiency disease ADA, with increasing levels of SAH resulting in a 
simultaneous increase in adenosine through its catabolism by SAH hydrolase (Kredich 
& Hershfield 1979). Similarly, L-homocysteine accumulation has been linked to 
adverse affects on the cell causing a subsequent defect in purine biosynthesis, (Fujita et 
al., 2006) and sterol biosynthesis (Mccammon & Parks 1981). Importantly, an alteration 
to the levels of either of these two compounds, particularly uncontrolled elevation, 
would have deleterious effects on the cell. 
 
1.10 Proteomic analysis in A. fumigatus 
 With the increasing number of sequenced genomes and rising availability of 
next generation sequencing tools, there has been a subsequent rise in the importance for 
proteome analysis in these organisms (Bhadauria et al., 2007). Proteome analysis allows 
for the specific location and identification of certain proteins depending on the sample 
origin, as well as analysis of any post-translational modifications which would not be 
described in genome or transcriptome studies (Lu et al., 2010; Wartenberg et al., 2011). 
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Similarly, genomic studies cannot predict the number of proteins a single gene may 
encode meaning the predicted protein coding sequence number given in these studies 
may not be a true representative of the total number of proteins which can be expressed 
(Griffin et al., 2002). Of particular importance, is the analysis of the A. fumigatus 
proteome response. 
Previous proteomic studies in A. fumigatus have helped further elucidate the 
cellular response of this fungus under different conditions identifying proteins which are 
vital to the response to adverse conditions analogous to a human host such as hypoxia 
(Vodisch et al., 2011), as well as the response of conidia upon initial contact with 
human cells (Teutschbein et al., 2010). Additionally, these studies can also be used for 
the identification of diagnostic markers which can be employed for the detection of A. 
fumigatus via a bioassay (Kniemeyer et al., 2009).  
 This approach has helped identify some of the major intracellular proteins found 
in A. fumigatus as well as key enzymes involved in secondary metabolism, oxidative 
stress response, cell wall biosynthesis and the enzymes which are secreted as part of the 
secretome of the fungus which facilitates its saprophytic niche as well as its ability to 
infect immuno-compromised individuals and evade their immune response (Carberry et 
al., 2006; Reeves et al., 2006; Bruneau et al., 2001; Wartenberg et al., 2011). 
 From this, identified proteins can be either isolated from the fungus or expressed 
via recombinant mechanisms in order to characterise their function in vitro. One such 
example is the characterisation of GliT activity on gliotoxin. In a neat experiment, 
Schrettl et al., were able to identify thart native GliT catalysed the NADPH dependant 
reduction of oxidised gliotoxin, confirming its gliotoxin reductase activity (Schrettl et 
al., 2010).  
 
1.11 Transcriptome analysis in filamentous fungi 
Transcriptomics is the global study of gene expression taken at the RNA level 
(Feder & Walser 2005). The availability of the A .fumigatus genome allows for the 
mapping of gene sequences from a given sample to the reference genome allowing for it 
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to be identified and most importantly, quantified (Groot et al., 2007). Although the 
protein and mRNA levels have been shown to not correlate well in previous studies in 
yeast, it does give a wider look at what is happening in the cell at a given time point and 
response (Griffin et al., 2002). Figure 1.8 depicts the general process of transcriptomics 
from sample to data analysis which can be summarised into RNA extraction, library 
construction, sequencing and data analysis (Barker et al., 2012) 
 
Figure 1.8 Transcriptomic sequencing work flow 
 
 There are many different methods which can be utilised to deduce the 
transcriptome profile of a given sample. Microarrays are a popular method of 
identification of target cDNA sequences creating from extracted RNA, identified 
utilising a corresponding unique cDNA probe which is attached to a glass plate (Hegde 
et al., 2000). Detection is measured by the use of fluorescently labelled RNA probes, 
whereby the amount of fluorescence is proportional to the amount of that specific 
transcript present and therefore its expression. This method requires prior amplification 
of cDNA of target genes either from extracted RNA or from a previously constructed 
cDNA plasmid library. Due to the limited number of targets it can detect, it’s not useful 
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for whole transcriptome analysis nor will it detect any change in other highly expressed 
transcripts if there is not a corresponding probe present (Hegde et al., 2000).  
Gel based methods like Differential display (DD) and cDNA-amplified fragment 
length polymorphism (AFLP) involve PCR mediated amplification of different cDNA 
fragments separated on a poly-acrylamide gel, subsequent excision of the band(s) of 
interest and sequencing which can be laborious and time consuming (Liang & Pardee 
1992; Bachem et al., 1996). 
Tag based systems like Sequence Analysis of Gene Expression (SAGE), Cap 
Analysis of Gene Expression (CAGE) or Massively Parallel Signature Sequencing 
(MPSS) are a high through-put sequencing method yielding precise gene expression 
levels with a digital output (Velculescu et al., 1995; Kodzius et al., 2006; Brenner et al., 
2000). SAGE relies on the principle that 10-30 bp of a specific cDNA fragment is 
sufficient to uniquely identify that particular fragment when the relative location is also 
known (Velculescu et al., 1995). The second principle involves synthesis of cDNA 
fragments using biotinylated oligo dT primer and cleaving the fragment using restriction 
enzymes with 4 base pair recognition sites. The biotin located at the 3’ ends are then 
attached to streptavidin allowing for isolation of bound fragments and separated into 
two fractions which are ligated to two different linkers which contained a 20 bp 
endonuclease site (Velculescu et al., 1995). These linker sequences serve two purposes, 
firstly they facilitate release of the linker and a short cDNA fragment and secondly 
serve as primer sites for the amplification of cDNA-linker fragments after they have 
been ligated together which can then be cloned and sequenced. Unlike gel based 
methods, this method allows for quantitative analysis of cDNA fragments.  
 Similarly, CAGE and MPSS utilise this tag based method of cDNA 
identification and measurement. Unlike SAGE, CAGE uses tags which target the 5’ end 
or ‘cap’ of the extracted mRNA prior cDNA synthesis, but is similar to SAGE in the use 
of linker molecules and restriction endonucleases (Kodzius et al., 2006). MPSS 
involves the cloning of template cDNA onto individual micro-beads (Brenner et al., 
2000). The main principle of MPSS is the serial ligation of target fragments with 
adaptor fragments which attach onto a micro-bead and can be subsequently measured 
photometrically.  
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 Although these tag based systems, also known as expressed sequence tags 
(EST), allow for quantification of gene expression, the generation of cDNA clone 
libraries is a major drawback as it doesn’t allow for the identitification of unique 
transcripts. Also, the use of short fragment lengths for detection of fragments can 
become an issue when trying to identify short mRNA molecules (Wang et al., 2009). 
 The recent breakthrough in being able to map genes and quantify them using 
RNA sequence technology (RNA Seq), has become the pinnacle of transcriptome 
profiling in science. This technology uses similar EST principles described earlier, with 
cDNA libraries being attached to adaptor sequences and the creation of an EST library 
with adaptors attached to either one or both ends of the cDNA fragment. Sequences 
undergo high through put sequencing, resulting in short sequences obtained from either 
one end, known as pair-end sequencing, or both ends, known as pair end sequencing 
(Wang et al., 2009). 
Some of the major RNA Seq systems available for transcriptome analysis include: 
Sanger automated sequencing Illumina IG, 454 pyro sequencing by Roche; SOLiD by 
Applied Biosystems and Heliscope by Helicos (Wang et al., 2009). This method does 
not require a reference genome, allowing for the sequencing of non-model organisms 
(Vera et al., 2008). It also has low background due to the mapping of genes to unique 
regions of the genome and the high detection rate of amplification of specific genes 
(Nagalakshmi et al., 2008). As the costs for this kind of analysis become more 
affordable the potential in furthering our understanding of the inner workings of an 
organism and how it responds to specific stimuli will increase dramatically.  
 
1.12 Omics analysis in organisms 
 Advancement and availability of different scientific techniques involved in 
global characterisation such as phenomics, transcriptomics, proteomics, secretomics, 
metabolimics collectively termed as ‘omics’ research, allow for the quantitative, high 
through put analysis between different biological molecules at a given state (Kandpal et 
al., 2009). Although each omics technique has its own advantages with the potential in 
yielding a plethora of results, one single technique is insufficient in elucidating the 
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complexity of an organisms’ response and so the use of multiple types is becoming 
more prevalent in the literature (Kniemeyer et al., 2009; Schrettl et al., 2010; 
Teutschbein et al., 2010; Vodisch et al., 2011). Multi-layer omics approaches have 
become more popular due to the increasing availability of sequenced genomes, online 
databases and advancing bioinformatic analytic tools (Nierman et al., 2005; Machida et 
al., 2005; Arnaud et al., 2011; Goujon et al., 2010).  
 With the increasing usage of these types of techniques, we begin to see the 
interaction between certain responses at different levels, gene to protein, and ultimately 
the molecules produced as the end product, a branch of research aptly named 
‘Interactomics’ (Kandpal et al., 2009). Gautam et al., used this approach investigating 
the proteomic and transcriptomic response of A. fumigatus to the polyene anti-fungal 
amphotericin B identifying ergosterol biosynthesis, cell stress and cell wall proteins and 
genes dysregulated in response to this drug (Gautam et al., 2008). Similarly, 
Teutschbein et al., (2010) coupled their proteomic study of A. fumigatus conidia 
proteome with the conidia transcriptome of Lamarre et al., allowing for the 
identification of 25 similar hits highlighting a correlation of these results from the 
transcript to the protein level (Lamarre et al., 2008; Teutschbein et al., 2010). 
 The use of genomic tools, particularly functional genomics, has highlighted the 
importance of particular genes and subsequent proteins when used in conjunction with 
other omic techniques. For example, a number of gene knockout studies, most notably 
in the opportunistic pathogen A. fumigatus have been studied in conjunction with 
phenomic and metabolomic analysis to help elucidate key components of gliotoxin self 
protection, gliotoxin biosynthesis and characterisation of previously un-annotated genes 
(Schrettl et al., 2010; Davis et al., 2011; Gallagher et al., 2012; Scharf et al., 2013).  
 
Combining omic technologies allows for a deeper understanding of the response of an 
organism to a particular stimulus, and should be employed further when trying to 
elucidate the mode of action of the many mechanisms which still eludes us in the field 
of microbiology such as the biosynthesis and response to secondary metabolites of 
certain fungi. 
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1.13 S. cerevisiae, a model organism  
 S. cerevisiae is a tractable eukaryotic model organism and since being the first 
eukaryotic organism to have its genome sequenced, S. cerevisiae has been at the 
forefront of other key areas of eukaryotic research. The ability to use ‘simpler’ 
organisms like S. cerevisiae has many advantages such as cost, pliable nature and 
genetic similarity to other higher eukaryotes including filamentous fungi and human 
cells. For example, Botstein et al., calculated 31 % of yeast genes had homologs in 
humans, highlighting the comparability of yeast to other eukaryotes (Botstein et al., 
2011). 
 S. cerevisiae has been employed to investigate the anti-fungal activity of various 
chemicals and secondary metabolites, most notably gliotoxin. In a study by Chamilos et 
al., a yeast gene deletion library consisting of a total of 4,787 haploid strains were 
screened for sensitivity to gliotoxin. From this study, 56 strains (44 which were 
sensitive to gliotoxin and 12 which were resistant) were identified to have an altered 
phenotype to gliotoxin exposure (Chamilos et al., 2008). This inspired a follow up study 
by Carberry et al., which helped identify other resistant and sensitive strains which were 
originally overlooked in the Chamilos study (Carberry et al., 2012). Utilising this model 
organism, Schrettl et al., further confirmed the protective function of GliT by 
expressing this fungal protein in yeast eliciting increased resistance to gliotoxin 
exposure (Schrettl et al., 2010).  
With a high proportion of conserved gene regions and homology to certain 
genes and pathways in S. cerevisiae and other filamentous fungi, comparison of yeast to 
other fungi is possible and may help highlight key cellular pathways which may remain 
elusive in more complex models. Also, due to the availability of mutant strains in S. 
cerevisiae, the identification of key genes and biological pathways in response to anti-
fungal agents like gliotoxin is relatively easier than creating a homologous gene 
deletion in A. fumigatus.  
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1.14 Transformation and gene replacement in A. fumigatus 
 With the sequencing of the A. fumigatus genome, there is a necessity to confirm 
and characterise the function of the many putative and uncharacterised genes in this 
organism (Nierman et al., 2005). Advancements in gene targeting systems, gene 
deletion construct creation and the creation of non-homologous end joining (NHEJ) A. 
fumigatus strains have improved the success rate of gene replacement in this organism 
(Nielsen et al., 2006; Krappmann et al., 2006). Protoplast transformation is the most 
commonly used means of gene targeting used in A. fumigatus gene deletion studies 
however there are others such as electroporation, and Agrobacterium tumefaciens 
mediated transformation (Meyer 2008) This method involves the temporary degradation 
of the cell wall using lytic enzymes. Once this is ready, transforming DNA constructs 
are taken up by the cell which is facilitated either by heat shock or by the addition of 
chemicals such as PEG and CaCl2 (Brookman & Denning 2000). Variations to this type 
of transformation exist, whereby the membrane of the protoplasts is sonicated causing 
reversible permeabilisation facilitating uptake of the transforming constructs (Ruiz-Díez 
2002).  
 Transforming DNA constructs consist of regions homologous to flanking the 
gene of interest which are amplified via PCR amplification using specific primers that 
are subsequently ligated to a selection marker as seen in Figure 1.9 (Brakhage & 
Langfelder 2002). These are than transformed into the protoplasts of the fungus. There 
are a range of methods for gene replacement in A. fumigatus such as plasmid 
integration, single construct insertion, double joint method and the bi-partite technique 
(Kubodera et al., 2000; Kuwayama et al., 2002; Yu et al., 2004; Nielsen et al., 2006). 
This last method involves the formation of transforming constructs as described before, 
however it involves a second round of PCR which utilises a nested primer located 
within each flanking region and another located within the region of the selection 
marker that amplifies a select part of the selection marker for each construct with a 
shared region which can homologously recombine (Figure 1.10) (Nielsen et al., 2006). 
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Figure 1.9 Schematic of transformation of A. fumigatus (A) Flanking regions are 
amplified using primers 5’ and 3’ of each. Each set of primers will have a restriction site 
included which will allow for ligation to the selection marker. (B) Flanking regions 
from A and the selection marker are digested with restriction enzymes and subsequently 
ligated together forming transformation constructs. (C) Transformation constructs from 
B are transformed into A. fumigatus protoplasts and flanking regions will attach to 
homologous flanking regions via homologous recombination. Arrows represent primer 
sites used for the amplification of flanking regions. Crosses represent homologous 
recombination of the nucleotide regions. 
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Figure 1.10 Bi-partite transformation of A. fumigatus. Image illustrates the two 
homologous reactions which take place between the two flanking regions and the 
selection marker fragments which recombine to form the full selection marker cassette. 
Arrows represent primer sites used to amplify the flanking region and part of the 
selection marker. Crosses represent sites of recombination. 
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 There are many different types of selection markers which can be used in this 
process. The most commonly used are anti-fungal resistance cassettes which elicit 
resistance in transformants to a specific anti-fungal agent, such as pyrathiamine or 
gliotoxin (Kubodera et al., 2000; Schrettl et al., 2010) This last method involves the use 
of gliT resistance to gliotoxin as a selection marker of potential transformants (Schrettl 
et al., 2010). 
There has also been some success with the use of auxotrophic strains, most notably in 
the deletion of the uracil/uridine biosynthesis gene orotine 5’-monphosphate (pyrG) (De 
Enfert 1996). Genes in these auxotrophic strains can be deleted using pyrG isolated 
from A. niger, with subsequent selection on media lacking uracil or uridine (De Enfert 
1996). This particular cassette has a bacterial transposon repeating sequence on either 
side of the pyrG gene, allowing for removal of the pyrG gene on FOA media which 
facilitates recombination of these transposon sequences and pyrg removal. (De Enfert 
1996) 
 
1.15 Infection models in research of fungal pathogens 
 The rise in fungal infections in recent years has brought with it a need to 
broaden our understanding of fungal disease (Zilberberg et al., 2008; Low & Rotstein 
2011). This entails the use of infection models, organisms which are purposefully 
injected with a pathogenic organism in order to study its progression, virulence and the 
factors which enable its infection. Traditionally mouse models have been used to study 
filamentous fungal infection due to the similarity of its immune response to humans’, as 
well as analogous organs which can be targeted in a similar fashion (Arvanitis et al., 
2013). Many types of mouse models have been used to investigate IA infection 
including intravenous and, the more reproducible, inhalation models (Fordi & Friedman 
1967; Sheppard et al., 2004). In Verweij et al., the susceptibility of an amphotereicin-B 
resistant A. fumigatus strain was assessed using a novel echinocandin, identifying it 
elicited significantly greater survival rates in IA infected mice (Verweij et al., 1998). 
Bozza et al., demonstrated that pre-exposure of mice to A. fumigatus allergens induced 
CD4
+
 Th1 cell activation and subsequent resistance to A. fumigatus (Bozza et al., 2002). 
  
31 
 Similarly mouse models have been used to examine the importance of particular 
genes during in A. fumigatus infection. This is achieved using gene deletion strains and 
measuring the survival rate of the infected immuno-compromised mice. For example, 
loss of gliotoxin biosynthesis due to the deletion of gliP reduced virulence of ΔgliP A. 
fumigatus strains in mice (Sugui et al., 2007), while loss of the NRPS pes3 was found to 
augment virulence of Δpes3 A. fumigatus strains in mice (O’Hanlon et al., 2011). 
 Although there are many clear advantages in using mouse models there are also 
some disadvantages. Firstly, a response found in one organism may not be common to 
all organisms. This particularly found in clinical trials where a lot of trials rarely pass 
the in vitro to in vivo transition (Johnson et al., 2001). Secondly, relative cost and 
ethical concerns have created a demand for new types of infection models and the use of 
invertebrate models has been on the rise (Heemskerk et al., 2002). Invertebrate models 
are a low cost model which addresses other concerns associated with more complex 
models, with most invertebrates having relatively short life spans and ideal candidates 
for large scale studies (Arvanitis et al., 2013). Three of the main invertebrate models 
used are the fruit fly Drosophila melanogaster which has been used to identify the 
importance of the dorso-ventral regulatory cassette ‘Toll’ in A. fumigatus pathogenesis; 
Caenorhabditis elegans which has been shown to express proteins comparable to those 
of the human innate immune response when exposed to different fungi and G. 
mellonella which will be discussed in more detail in the next section (Lemaitre et al., 
1996; Couillault et al., 2012)  
 
1.16 Galleria mellonella 
 The larvae of the greater wax moth (Figure 1.11), G. mellonella, has emerged as 
a popular insect model. G. mellonella has been employed to assess new therapeutic 
agents and as a model for virulence of different bacterial and fungal strains (Rowan et 
al., 2009). Traditionally used for fishing bait, G. mellonella is a low cost model 
allowing for increased test sample size, and has been previously demonstrated to 
survive temperatures of 37 ⁰ C making it a prime candidate as a model organism of 
human pathogens (Cotter et al., 2000).  
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Figure 1.11 Larva of the greater wax moth G. mellonella Picture taken from the 
journal of American Microbiology  http://jb.asm.org/content/186/3.cover-expansion 
 
Importantly, G. mellonella was found to elicit similar responses when exposed 
to different pathogens when compared with previous results seen in mammalian models 
(Cotter et al., 2000; Brennan et al., 2002; Reeves, et al., 2006). The most crucial result 
was the identification of an immune system present in these larvae closely resembling 
the innate immune response of mammals. It is an immediate response which consists of 
both a humoral response and a cellular response (Angrgaeni & Ratcliffe 1991). The 
humoral response involves two key responses, the first is a signalling cascade known as 
the propphenoloxiase system which results in melanisation through the activity of serine 
proteases on zymogenic molecules (Brookman et al., 1989). This helps augment the 
humoral response of the insect larvae by inducing sequestration of the foreign body and 
also facilitating different host defence mechanisms such as the production of quinones 
which help in the ROS killing of foreign cells (Slepneva et al., 1999). The second 
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involves anti-microbial peptides (AMPs) which are effector molecules produced in the 
fat body of the larvae which are then secreted into the haemolymph where they will 
come into contact with invading pathogens (Hoffmann 1995). There are a range of 
AMPs in insects which respond to particular types of cells and cell markers; lysozyme 
breaks down the peptidoglycan wall of bacterial cells further enhancing immune 
response; defensins which have been found to specifically attack the cell walls of gram 
positive bacteria and apolipophorin 3 which has been demonstrated to bind 
lipopolysaccharide molecules found on bacterial cell walls (Kavanagh & Reeves 2004). 
Other responses include the production of transferrins which limit the iron availability 
of the larvae subsequently limiting bacterial growth in vivo (Yoshiga et al., 1999; 
Mowlds & Kavanagh 2008). 
 The cellular response is made up of different sub-types of immune cells known 
as haemocytes. These cells can recognise foreign bodies through specific signalling 
cascades which in turn increases the production of haemocytes, a trend that can be used 
as a marker of the infection of a pathogen in a given test sample (Mowlds et al., 2010). 
The principle roles of haemocytes are the encapsulation, nodulation and phagocytosis of 
pathogens (Mowlds et al., 2010). 
Survival time of G. mellonella over a given time period can be measured to 
assess the pathogenicity of particular strains. This has been used assessing the virulence 
of different bacterial strains like Listeria monocytogenes, Pseudomonas aeruginosa and 
Staphylococcus aureus (Mukherjee et al., 2010; Seed & Dennis 2008; Gibreel & Upton 
2013). Similarly, this has also been used for the study of fungal infections, most notably 
A. fumigatus. Reeves et al., illustrated the correlation between gliotoxin biosynthesis 
and virulence, implicating higher gliotoxin levels resulted in an increase in G. 
mellonella death (Reeves et al., 2004). Renwick et al., (2006) showed that A. fumigatus 
infection in this model varied depending on the germination stage of the injected 
conidia, highlighting the importance of conidia age and size which can result in 
increased larval death (Daly, et al., 2006). Exposure of G. mellonella larvae to A. 
fumigatus gene deletion strains by Slater et al., implicated that loss of genes involved in 
siderophore biosynthesis resulted in attenuation of A. fumigatus virulence, thus 
highlighting a role of this pathway in A. fumigatus pathogenesis (Slater et al., 2011).  
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 The similarities of these responses to components of the mammalian immune 
response, makes G. mellonella a suitable and efficient model for the study of virulence 
of bacterial and fungal infections in vivo. 
 
Aims of study 
 The characterisation and elucidation of the A. fumigatus response to the fungal 
secondary metabolite gliotoxin has been elusive to date. The components of gliotoxin 
biosynthesis and their importance in this response have also been equally elusive.  
To this end, the aims of this study are: 
 
1) Create a double gene deletion in A. fumigatus lacking the two key gliotoxin 
biosynthetic genes ΔgliT and ΔgliZ, using a targeted gene deletion approach, and 
subsequent phenotypic characterisation. 
 
2) Investigate the A. fumigatus proteome response to gliotoxin using gliT and gliZ 
deletion strains using 2D-PAGE 
 
3)  Investigate the A. fumigatus transcriptome response to gliotoxin by comparative 
transcript profiling between wild-type and ΔgliT strains.  
 
4)  Exploit the yeast based system S. cerevisiae to further elucidate the anti-fungal 
activity of gliotoxin and identify key genes and cellular pathways involved in 
gliotoxin toxicity applying a gene candidate approach. 
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Chapter 2  
Materials and Methods 
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2.1.1 Materials 
2.1.1.1 Strains in this study 
 Table 2.1 lists S. cerevisiae and bacterial strains used in this study, Table 2.2 
lists the A. fumigatus strains used in this study.. 
Table 2.1 S. cerevisiae and bacterial strains used 
Strain Genotype Source 
BY4741 MATa his3Δ 1, leu2Δ, met15Δ 0, ura3Δ 0 Euroscarf 
BY4742 MATα his3Δ 1; leu2Δ 0; lys2Δ 0; ura3Δ 0 Euroscarf 
BY4741 Δgsh1 MAT a; his3Δ1; leu2Δ0; met15Δ0; 
ura3Δ0; gsh1::kanMX4  
Euroscarf 
BY4742 Δgsh1 MATα his3Δ 1; leu2Δ 0; lys2Δ 0; ura3Δ 0 
gsh1::kanMX4 
Euroscarf 
BY4741 Δgsh2 MAT a; his3Δ1; leu2Δ0; met15Δ0; 
ura3Δ0; gsh2::kanMX4 
Euroscarf 
BY4741 Δcys3 MAT a; his3Δ1; leu2Δ0; met15Δ0; 
ura3Δ0; cys3::kanMX4 
Euroscarf 
BY4742 Δcys3 MATα his3Δ 1; leu2Δ 0; lys2Δ 0; ura3Δ 0 
cys3::kanMX4 
Euroscarf 
BY4741 Δcys4 MAT a; his3Δ1; leu2Δ0; met15Δ0; 
ura3Δ0; cys4::kanMX4 
Euroscarf 
BY4742 Δcys4 MATα his3Δ 1; leu2Δ 0; lys2Δ 0; ura3Δ 0 
cys4::kanMX4 
Euroscarf 
BY4741 Δsod1 MAT a; his3Δ1; leu2Δ0; met15Δ0; 
ura3Δ0; sod1::kanMX4 
Euroscarf 
BY4742 Δsod1 MATα his3Δ 1; leu2Δ 0; lys2Δ 0; ura3Δ 0 
sod1::kanMX4 
Euroscarf 
BY4741 Δyap1 MAT a; his3Δ1; leu2Δ0; met15Δ0; 
ura3Δ0; yap1::kanMX4 
Euroscarf 
BY4742 Δyap1 MATα his3Δ 1; leu2Δ 0; lys2Δ 0; ura3Δ 0 
yap1::kanMX4 
Euroscarf 
BY4741 Δctt1 
 
MAT a; his3Δ1; leu2Δ0; met15Δ0; 
ura3Δ0; ctt1::kanMX4 
Euroscarf 
BY4742 Δctt1 MATα his3Δ 1; leu2Δ 0; lys2Δ 0; ura3Δ 0 
ctt1::kanMX4 
Euroscarf 
BY4741 Δskn7 MAT a; his3Δ1; leu2Δ0; met15Δ0; 
ura3Δ0; skn7::kanMX4 
Euroscarf 
BY4741 Δku70 MAT a; his3Δ1; leu2Δ0; met15Δ0; 
ura3Δ0; ku70::kanMX4 
Euroscarf 
BY4741 Δku80 MAT a; his3Δ1; leu2Δ0; met15Δ0; 
ura3Δ0; ku80::kanMX4 
Euroscarf 
BY4741 Δapt1 MAT a; his3Δ1; leu2Δ0; met15Δ0; Euroscarf 
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ura3Δ0; apt1::kanMX4 
BY4741 Δstr2 MAT a; his3Δ1; leu2Δ0; met15Δ0; 
ura3Δ0; str2::kanMX4 
Euroscarf 
BY4741 Δmet6 MAT a; his3Δ1; leu2Δ0; met15Δ0; 
ura3Δ0; met6::kanMX4 
Euroscarf 
DH5α E. coli Ampicillin resistance cassette Life 
Technologies 
 
Table 2.2 Aspergillus fumigatus strains used 
Strain Genoptype Source 
A. fumigatus 
ATCC46645 
Wild-type ATCC collection 
A. fumigatus AF 293 
Wild-type 
Gift from Dr. 
Markus Schrettl 
ATCC26933 Wild-type ATCC collection 
A. fumigatus ΔgliT ATCC46645 and ATCC26933 with 
AFUA_6G09740 coding region 
disrupted with pyrithiamine resistance 
gene from A. oryzae 
Dr. Markus 
Schrettl, NUI 
Maynooth 
A. fumigatus ΔgliZ AF293 with AFUA_6G09630 coding 
region disrupted with pyrG marker 
from A. parasiticus 
Gift from Dr. 
Nancy Keller 
A. fumigatus ΔgliTΔgliZ ΔgliZ strain with coding region 
AFUA_6G09740 disrupted with 
pyrithiamine resistance gene from A. 
oryzae 
This study 
 
2.1.1.2 Plasmids used in this study 
 Table 2.3 lists the plasmid vectors used in this study for both S. cerevisiae and 
Aspergillus fumigatus experimental work. 
Table 2.3 Plasmids vectors used 
Plasmid Name Description Source 
pRS315 Centromeric S. cerevisiae shuttle vector 
LEU2 marker 
Sikorski and Hieter 
1989 
pC210-gliT Vector containg Aspergillus fumigatus 
thioredoxin reductase gliT cDNA under 
the SSA2 promoter and a LEU2 marker 
Schrettl et al., 2010 
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pSK275 Vector containing the ptrA pyrithiamine 
resistance cassette originating from A. 
oryzae 
Kind gift from Dr. S. 
Krappmann 
 
2.1.1.3 Primers used in this study 
Table 2.4 shows primer sequences used in this study. 
Primer Name Sequence 5’- 3’ 
ogliT-4 GGACTAGTTATGCGCGAGAGTAGTGG 
ogliT-5 GCGCTTCTTGATCGG 
OptrA1 GACCTGGACAAGTAC 
OptrA2 CGTGACCAGTGGTAC 
GliJ_F AGACGGATCTCCAGCGTCTA 
GliJ_R CGATCAGTCTGTGGATCACG 
AFUA_2G11120_F TCCAGCGTACTCAACCACAC 
AFUA_2G11120_R CGTCTGGAAAGCTCTGGAAG 
LaeA_F AGGCCGCTCAAGAAACAAC 
LaeA_R TCGTCCGTTCTCCTGATAGC 
GliM_F AAGCTTCAACTGCAGCTCGT 
GliM_R AGACCGAGCGTTGATACAGG 
CatB_F TCAACGACAATGATGCCTTC 
CatB_R AAGAAGCCGCAGTGATGTTC 
gliZcomp_F TGCACTGCGATAGAAGGTTAAA 
gliZcomp_R GTTACATGGTCCATACTGTGAT 
 
2.1.2 Chemicals and reagents used in this study 
 All chemicals and reagents were ordered from Sigma-Aldrich ltd. unless 
otherwise stated. 
 
2.1.2.1 Gliotoxin (GT) 
 Gliotoxin was prepared by the addition of 25 ml methanol (MeOH) to 25 mg 
neat Gliotoxin. Once fully dissolved, this was aliquoted into 5x5 ml working stocks in 
glass containers and stored at -20   C. 
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2.1.2.2 Cystathionine 
 L-cystathionine (4.5 mg) was added to 20 ml sterile distilled dH2O creating a 1 
mM stock. This was filter sterilised and stored at -20  C until required. 
 
2.1.2.3 Diamide 
 A 0.0125 M working stock was made by adding 100 mg of diamide to 50 ml 
sterile distilled water. This was then filter sterilised and kept at – 20  C until required. 
 
2.1.2.4 1-Chloro-2, 4-dinitrobenzene (CDNB) 
 CDNB (0.101 g) was dissolved in 10 ml of 100   (v/v) ethanol and stored at -
20  C C until required. 
 
2.1.2.5 H2DCFDA 
 H2DCFDA dessicate (100 mg) (Invitrogen Molecular Probes Ltd.) was re-
suspended in 2 ml DMSO creating a 50 mg/ml stock which was stored at -20  C. 
 
2.1.2.6 Hydrogen Peroxide 
 A 30 % v/v stock of hydrogen peroxide, 11.8 M, (H2O2) was ordered and kept at 
4  C. This was diluted in molten agar to the desired molarity. 
 
2.1.2.7 Ampicillin 
 Ampicillin salt was added to 100 ml dH20 to create a 50 mg/ml stock, which was 
filtered sterilised and stored at -20  C until required. 
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2.1.2.8 Pyrithiamine 
 Pyrathiamine stocks of 0.1 mg/ml (w/v) were made using dH2O and stored at -
20  C. 
2.1.3 Microbiological Media and Reagents 
2.1.3.1 Yeast Peptone Dextrose (YPD) 
 Bacto-yeast extract (10 g, BD& Co.), bacto-peptone (20 g, BD &Co.) and D-
glucose (20 g) were added to 800 ml dH2O and dissolved. The solution was made up to 
1 L with dH2O subsequently autoclaved and stored at room temperature (RT). 
 
2.1.3.2 YPD Agar 
 Bacto-agar (20 g, BD & Co.) was added to liquid YPD prior to being made up to 
1 L with dH2O. This was then autoclaved, allowed to cool and poured into sterile petri 
dishes under sterile conditions till it had solidified. Subsequent agar plates were stored 
at 4  C until required. 
 
2.1.3.3 Dropout Mix 
 Two grams of the following amino acids (Table 2.5) were added to a sterile 
pestle and mortar where they were ground and mixed and stored at RT: 
 
Table 2.5 Amino acids required for dropout mix 
Amino Acid 
alanine, arginine, aspartic acid, cysteine, glutamic acid, glutamine, isoleucine, 
phenylalanine, proline, serine, threonine, tyrosine, valine, inositol, para-
aminobenzoic, methionine*, lysine 
*= For assays which required the absence of one or more of the marked amino acids, 
alternative dropout mixes were made lacking the respective amino acid. 
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2.1.3.4 Amino acid supplemental stocks 
 Strains used in this study are auxotrophic for particular amino acids depending 
on their genotypic background (Table 2.1). Working stocks were made as described in 
Table 2.4, in dH2O, autoclaved and stored at 4  C until required. Stock concentrations: 
Table 2.6 Amino acid stock concentrations and final concentration when added to 
SC media 
Amino acid Working Stock 
Conc. 
Volume added to 
1 L SC media 
Final amino acid 
conc. (µg/ml) 
L-leucine 1 g/100 ml 10 ml 100 
L-histidine 1 g/100 ml 2 ml 20 
L-uracil 0.2 g/100 ml 10 ml 20 
L-methionine 1 g/100 ml 2 ml 20 
L-lysine 1 g/100 ml 2 ml 20 
L-adenine 0.2 g/100 ml 10 ml 20 
 
2.1.3.5 Synthetic Complete (SC) 
 Yeast nitrogen base (YNB) without amino acids (6.7 g, BD &Co.), D-glucose 
(20 g) and dropout mix (1.5 g) were added to 800 ml dH2O and dissolved. This was 
supplemented, as required, with the necessary amino acids using stocks as described in 
section 2.1.3.4. This was topped up to 1 L using dH2O, autoclaved and stored at room 
temperature. 
 
2.1.3.6 SC Agar  
 Bacto-agar (20 g) was added to liquid SC prior to being topped up to 1 L using 
dH2O. This was autoclaved and then allowed to cool. SC agar plates were stored at 4  C. 
 
2.1.3.7 SC+Gliotoxin 
 SC agar was made as described previously (2.1.5.6). 25 ml was added to a sterile 
50 ml Falcon tube. To this, gliotoxin stock solution was added to bring it to the desired 
concentration (Table 2.6). The SC   gliotoxin molten agar was mixed by inversion then 
  
41 
poured into sterile petri-dishes. This was carried out in duplicate for each concentration 
desired. SC-gliotoxin agar plates were stored at 4  C for a maximum of one week. 
Table 2.7 Volumes of 1 mg/ml gliotoxin stock added to 25 ml molten SC agar 
Desired gliotoxin concentration (µM) Volume added from 1 mg/ml gliotoxin 
stock (µl) 
12.5 100 
25 200 
37.5 300 
50 400 
 
2.1.3.8 SC + L-cystathionine 
 SC agar was made as described previously (2.1.5.6). Once cool, 25 ml was 
added to a sterile 50 ml Falcon under sterile conditions. To this, L-cystathionine stock 
solution was added to bring it to the desired concentration (Table 2.8). The SC+L-
cystathionine molten agar was mixed by inversion then poured into sterile petri dishes 
under sterile conditions. This was carried out in duplicate for each concentration. SC L-
cystathoinine agar plates were stored at 4  C until required. 
Table 2.8 Volumes of 1 mM L-cystathionine stock added to 25 ml molten SC agar 
Desired L-cystathionine concentration 
(µM) 
Volume added from 1 mM L-
cystathionine stock (ml) 
50 2.5 
100 5 
250 12.5 
350 17.5 
 
2.1.3.9 SC + H2O2  
 SC agar was made as described previously (2.1.5.6). Once cool, 25 ml was 
added to a sterile 50 ml Falcon under sterile conditions. H2O2 stock solution was added 
to the desired concentration (Table 2.9). The SC+H2O2 molten agar was mixed by 
inversion then poured into sterile petri dishes under sterile conditions. This was carried 
out in duplicate for each concentration. SC+H2O2 agar plates were stored at 4  C until 
required. 
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Table 2.9 Volume of 11.8 M H2O2 stock added to 25 ml molten SC agar 
Desired H2O2 concentration (mM) Volume added from 11 M H2O2 stock 
(µl) 
1 2.2 
2 4.4 
2.5 5.5 
3 6.6 
 
2.1.3.10 Aspergillus Trace Elements 
 Na2B4O7 (0.04 g), CuSO4.5H20 (0.5 g), FeSO.7H20 (1.2 g), MnSO4 (0.7 g), 
Na2MoO.2H20 (0.8 g) and ZnSO4.7H2O (10 g) were added to 800 ml dH20 and once 
dissolved was made up to 1 L and autoclaved.  
 
2.1.3.11 Aspergillus Salt Solution 
 KCL (26 g), MgSO4.7H20 (26 g), KH2PO4 (76 g) and Aspergillus trace elements 
(2.1.6.1.; 50 ml) were added to 800 ml dH20 and once dissolved was made up to 1 L and 
autoclaved. Solution was stored at room temperature. 
 
2.1.3.12 100x Ammonium Tartrate 
 Ammonium tartrate (92 g) was dissolved in 800 ml dH2O; subsequently topped 
up to 1 L and autoclaved. Solution was stored at room temperature. 
 
2.1.3.13 Malt Extract Agar 
 Malt extract agar (25 g; Difco, Maryland, USA) was added to a total 500 ml 
dH2O and subsequently autoclaved. Once cool, 25 ml was poured into petri dishes, 
under sterile conditions. Once set plates were stored at 4  C until required. 
 
 
  
43 
2.1.3.14 Aspergillus Minimal Media (AMM) 
 Ammonium tartrate (10 ml; section 2.1.3.13), Aspergillus salt solution (20 ml; 
section 2.1.3.12) and D-glucose (20 g) were added to 800 ml dH20 until they were fully 
dissolved. Solution was pH adjusted to pH 6.8, made up to 1 L using dH2O and 
autoclaved. AMM was stored at 4 ⁰ C until required. 
 
2.1.3.15 Aspergillus Minimal Media (AMM) Agar 
 AMM was made as described previously (section 2.1.3.15). Once pH adjusted 
agar (20 g; Scharlau Chemie S.A., Barcelona, Spain) was added and then made up to 1 
L using dH2O. AMM agar was autoclaved and allowed to cool before being poured 
under sterile conditions into petri dishes 
 
2.1.3.16 Sabouraud-Dextrose (SB) Media  
 Sabouraud-Dextrose media (30.12 g; Oxoid Ltd., Basingstoke, Hampshire, 
England) was added to 800 ml dH2O and dissolved. Solution was made up to 1 L and 
autoclaved. SB media was stored at 4 ⁰ C until required. 
 
2.1.3.17 Sabouraud-Dextrose (SB) Agar 
 Sabouraud-Dextrose media was made as previously described (section 2.1.3.17). 
Agar (20 g) was added and the solution was made up to 1 L. SB agar was autoclaved 
and allowed to cool before being poured, under sterile conditions, into petri dishes. 
 
2.1.3.18 Phosphate Buffered Saline (PBS) 
 PBS (1 x tablet; Oxoid Ltd., Basingstoke, Hampshire, England) was added to 
200 ml dH2O and autoclaved. PBS was stored at room temperature until required. 
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2.1.3.19 Phosphate Buffered Saline-Tween-20 (PBST) 
 Tween-20 (0.1 ml) was added to 200 ml PBS (section 2.1.3.19). This was 
filtered sterilised through a 45 µm filter to create 50 ml aliquots which were stored at 
room temperature. 
 
2.1.3.20 Luria-Bertani (LB) Broth 
 LB broth (25 g Difco, Maryland, USA) was added to 1 L dH2O and dissolved 
with the aid of a magnetic stirring rod. LB solution was autoclaved and stored at 4 ⁰ C 
until required. 
 
2.1.3.21 Luria-Bertani (LB) Agar 
 LB agar (40 g; Difco, Maryland, USA) was added to 1 L dH2O and dissolved 
with the aid of a magnetic stirring rod. LB agar was autoclaved and once cool, was 
poured (25 ml) under sterile conditions into petri dishes. Solidified LB agar plates were 
stored at 4 ⁰ C until required. 
 
2.1.3.22 Luria-Bertani (LB) Broth + Ampicillin 
 LB broth was made as previously described (section 2.1.3.21). Before 
inoculation, using a 50 mg/ml ampicillin stock, ampicillin (0.1 mg/ml) was added to 5 
ml LB broth. 
 
2.1.3.23 Luria-Bertani (LB) Agar + Ampicillin 
 LB agar was made as previously described (section 2.1.3.21). Using a 50 mg/ml 
ampicillin stock, ampicillin (0.1 mg/ml) was added and LB-agar-ampicillin was poured 
(25 ml) under sterile conditions into petri dishes. 
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2.1.3.24 40 % (v/v) Glycerol 
 Glycerol (40 ml) was dissolved in 60 ml dH2O. Solution was autoclaved and 
stored at room temperature. 
 
2.1.3.25 80 % (v/v) Glycerol 
 Glycerol (80 ml) was added to 20 ml dH2O and dissolved by heating and with 
the aid of a magnetic stirrer. Solution was autoclaved and stored at room temperature. 
 
2.1.4 S. cerevisiae Genomic DNA Isolation Reagents 
2.1.4.1 1 M Sorbitol/100 mM EDTA 
 Sorbitol (18.2 g) was dissolved in 20 ml dH2O by heating on a heat block. Once 
dissolved, 2.92 g of EDTA was added and the solution was topped up to a total volume 
of 100 ml with dH2O. Solution was autoclaved and stored at room temperature 
 
2.1.4.2 5 mg/ml Zymolase 
 Zymolase (500 mg) was dissolved in a total volume of 100 ml dH2O creating a 5 
mg/ml working stock. This was then filter sterilised, aliquoted into 1 ml fractions in 1.5 
ml microfuge tubes and stored at -20 ⁰ C until required. 
 
2.1.4.3 1 M Tris/100 mM EDTA 
 EDTA (2.92 g) was dissolved in 20 ml dH2O. Next 12.1 g of Tris was added and 
once dissolved the solution was topped up to a final volume of 100 ml using dH2O. 
Solution was autoclaved and stored at -20 ⁰ C. 
 
2.1.4.4 5 M Potassium Acetate (KAc) 
 KAc (49 g) was dissolved in 20 ml dH2O before adjusting the volume to 100 ml 
using dH2O. This was then autoclaved and stored at room temperature. 
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2.1.5 Agarose Gel Electrophoresis Reagents 
2.1.5.1 50 X Tris-Acetate (TAE) 
 Trizma base (342 g) was added to 57.1 ml glacial acetic acid and 100 ml of 
EDTA (0.5 M). This was pH adjusted to pH 8.0 and made up to 1 L with dH2O and 
stored at room temperature. 
 
2.1.5.2 1 X Tris-Acetate (TAE) 
 50 X TAE (20 ml) (section 2.1.5.1) was added to 980 ml dH2O. 1 X TAE was 
mixed and subsequently stored at room temperature until required. 
 
2.1.5.3 0.8 % (w/v) Agarose Gel 
 Agarose (0.4 g) was dissolved in 50 ml 1 X TAE (section 2.1.5.2). This was 
brought to boil until all the agarose had been dissolved then allowed to cool until ‘hand 
hot’ before being poured into a gel casting tray. Before being allowed to set, 4 µl 
ethidium bromide was added and mixed into the molten agar by using a gel comb until 
all the ethidium bromide was dissolved. Gel was then allowed to set for at least 20 min. 
 
2.1.5.4 100 % (v/v) Ice Cold Ethanol 
 Molecular grade ethanol (100 %, v/v; Merck Ltd.) was aliquoted into 50 ml 
sterile Falcon tubes and stored at – 20 ⁰ C until required. 
 
2.1.5.5 70 % (v/v) Ice Cold Ethanol 
 Ice cold ethanol (35 ml 100 % (v/v))  (section 2.1.5.4) was added to 15 ml 
molecular grade H2O in a sterile 50 ml Falcon tube and stored at – 20 ⁰ C until 
required. 
 
2.1.5.6 3 M Sodium Acetate 
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 Sodium acetate (12.3 g) was dissolved in 50 ml molecular grade H2O in a sterile 
50 ml Falcon tube. This was then pH adjusted to pH 5.2 and stored at room temperature. 
2.1.5.7 10 mg /ml Ethidium Bromide 
 1 µl of a 10 mg/ml ethidium bromide stock was added to 50 ml molten agar for 
DNA visualisation under U.V. 
 
2.1.6 Yeast Transformation Buffers 
2.1.6.1 50 % (w/v) Polyethylene Glycol (PEG) 
 PEG (50 g) was dissolved in 100 ml dH2O, autoclaved and stored at 4 ⁰ C. 
 
2.1.6.2 1 M Lithium Acetate 
 Lithium acetate (6.59 g) was dissolved in a 100 ml dH2O, autoclaved and stored 
at room temperature. 
 
2.1.6.3 100 mM Lithium Acetate 
 Lithium acetate (1 M, 10 ml) was added to 90 ml dH2O, autoclaved and stored at 
room temperature. 
 
2.1.7 E. coli Transformation Buffers 
2.1.7.1 RF1 Buffer 
 Potassium acetate (1.47 g), 0.75 g CaCl2.2H2O and 70 g glycerol were dissolved 
in 450 ml dH2O. Solution was pH adjusted to pH 5.92 after which 6 g rubidium chloride 
and 4.95 g manganese chloride were added. Volume was topped up to 500 ml using 
dH2O and was filter sterilised and stored at 4 ⁰ C. 
 
2.1.7.2 RF 2 
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 Rubidium chloride (0.6 g), 5.5 g calcium chloride, 1.05 g of 3-(N-
morpholinopropaesulfonic acid (MOPS) and 75 g glycerol were dissolved in 450 ml 
dH2O. Solution was pH adjusted to pH 6.8 before being topped up to 500 ml using 
dH2O. This was filter sterilised and stored at 4 ⁰ C. 
2.1.8 Aspergillus Transformation Buffers 
2.1.8.1 Buffer L1 
 KH2PO4 (1.7 g) was dissolved in 500 ml dH2O to yield 50 mM KH2PO4 stock. 
 
2.1.8.2 Buffer L2 
 K2HPO4 (0.87 g) was dissolved in 200 ml dH2O to yield a 50 mM K2HPO4 
stock. 
 
2.1.8.3 Lysis Buffer 
 A 0.8 M KCL solution was prepared by dissolving 26.1 g of KCL in 350 ml 
buffer L1 ( 2.1.8.1). This was pH adjusted to pH 5.8 using buffers L1 and L2 (sections 
2.1.8.1 & 2.1.8.2 respectively). This was brought to a final volume of 500 ml using 
dH2O, autoclaved and stored at room temperature. 
 
2.1.8.4 Mycelium Lysing Solution 
 Trichoderma harzianum Lytic enzymes (0.9 g) were dissolved in 30 ml Lysis 
buffer (section 2.1.8.3) and filtered through a 0.45 µm filter. 
 
2.1.8.5 0.7 M KCl 
 KCl (26.1 g) was dissolved in 500 ml dH2O, autoclaved and stored at room 
temperature. 
 
2.1.8.6 L6 Buffer 
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 1 M sorbitol (72.88 g), 10 mM Tris-HCL (0.484 g) and 10 mM CaCl2.6H2O 
(0.876 g) were dissolved in 300 ml dH2O. The pH was then adjusted to pH 7.5 and 
brought to a final volume of 400 ml with dH2O. L6 buffer was autoclaved and stored at 
room temperature. 
 
2.1.8.7 L7 Buffer 
 PEG 6000 (60 g) was dissolved in 40 ml dH2O. 10 mM Tris-HCL (0.157 g) was 
added to this and dissolved. The solution was pH adjusted to pH 7.5, autoclaved and 
stored at room temperature. 
 
2.1.8.8 Aspergillus Regeneration Media 
 Ammonium tartrate (10 ml) (section 2.1.3.13), 20 ml Aspergillus salt solution 
(section 2.1.3.12), 10 g glucose and 342 g sucrose were dissolved in 800 ml dH2O. The 
solution was pH adjusted to pH 6.8 and topped up to a total volume of 1 L with dH2O 
prior to the addition of 18 g agar (Scharlau Chemie S.A., Barcelona, Spain). Solution 
was autoclaved and allowed cool before being poured into petri-dishes. 
 
2.1.8.9 Aspergillus Transformation Soft Agar 
 Ammonium tartrate (10 ml, section 2.1.3.13), 20 ml Aspergillus salt solution 
(section 2.1.8.3.12), 10 g glucose and 342 g sucrose were dissolved in 800 ml dH2O. 
The solution was pH adjusted to pH 6.8 and topped up to a total volume of 1 L with 
dH2O prior to the addition of 7 g agar. Solution was autoclaved and allowed cool before 
being poured into petri-dishes. 
 
2.1.9 Southern Blotting Reagents 
2.1.9.1 Southern Transfer Buffer 
 NaOH (16 g) and 0.6 M NaCl (35.06 g) were dissolved in 1 L dH2O. This was 
made up just before carrying out the Southern blot. 
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2.1.9.2 20 X SSC Buffer 
 NaCl (175.3 g) and sodium citrate (88.2 g) were dissolved in 800 ml dH2O. This 
was then pH adjusted to pH 7 and brought to a final volume of 1 L with dH2O. Solution 
was autoclaved and stored at room temperature. 
 
2.1.9.3 10 X SSC Buffer 
 500 ml of 20 X SSC buffer (section 2.1.9.2) was to 500 ml dH2O and stirred to 
ensure it was homogenous. This was autoclaved and stored at room temperature. 
 
2.1.9.4 2 X SSC Buffer 
 100 ml of 20 X SSC buffer (section 2.1.9.2) was added to 900 ml dH2O and 
stirred to ensure it was homogenous. This was autoclaved and stored at room 
temperature. 
 
2.1.9.5 10 % (w/v) Sodium Dodecyl Sulphate (SDS) 
 SDS (100 g) was dissolved in 1 L dH2O with the aid of a magnetic stirrer and a 
heat block to help get it into solution. The solution was autoclaved and stored at room 
temperature. 
 
2.1.9.6 0.1 % (w/v) SDS/1 X SSC Buffer 
SDS (10 ml of 10 % (w/v), section 2.1.9.5) and 50 ml of 20 X SSC (section 
2.1.9.2) were dissolved in a total volume of 1 L dH2O. This was  made on the day it was 
required and stored at room temperature before use. 
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2.1.10 Digoxigenin (DIG) Detection Buffers 
2.1.10.1 10 % Blocking reagent 
 Blocking reagent (20 g) was dissolved in 200 ml dH2O with the aid of a 
magnetic stirrer and hot plate. Solution was stored at 4 ⁰ C. 
2.1.10.2 Membrane Pre-hybridisation Buffer 
 SDS (35 g), 250 ml de-ionised formamide, 100 ml 10 % (w/v) blocking reagent 
(section 2.1.10.1) and 5 ml (w/v) laurylsarcosine were dissolved in a total 500 ml dH2O 
with the aid of a magnetic stirrer and hot plate. The solution was stored at 4 ⁰ C. 
 
2.1.10.3 DIG Buffer 1 
 Maleic acid (1.1.61 g) and NaCl (0.876 g) were dissolved in 80 ml dH2O. This 
was then pH adjusted to pH 7.5 and brought to a final volume of 100 ml using dH2O. 
This was filter sterilised using a 0.45µm filter and stored at room temperature. 
 
2.1.10.4 DIG Buffer 2/Antibody Blocking Buffer 
 Blocking reagent (0.4 g) was dissolved at 50 ⁰ C in 40 ml DIG buffer 1 (section 
2.1.10.3) just before use. 
 
2.1.10.5 DIG Buffer 3 
 Tris-HCl (1.57 g), NaCl (0.58 g) and MgCl2.6H2O (1.01 g) were dissolved in 80 
ml dH2O. This was pH adjusted to pH 9.5 and brought to a final volume of 100 ml using 
dH2O. Solution was filter sterilised using a 0.45 µm filter and stored at room 
temperature. 
 
2.1.10.6 DIG Wash Buffer 
 Tween-20 (0.15 g) was dissolved in 50 ml DIG Buffer 1 (section 2.1.10.3) and 
stored at room temperature. 
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2.1.10.7 Anti-DIG FaB Fragments-alkaline phosphatase 
 Anti-DIG FaB fragments (1 µl, Roche), was added to 10 ml antibody blocking 
buffer (section 2.1.10.4) just before usage in a 50 ml Falcon tube. 
2.1.10.8 CSPD Chemi-luminescent substrate 
 CSPD (50 µl, Roche) was added to 4.95 ml DIG Buffer 3 (section 2.1.10.5) just 
before use in a 50 ml Falcon tube. 
 
2.1.10.9 DIG-labelled Deoxynucleotide Triphosphates (dNTP’s) 
 Pre-mixed DIG-labelled dNTP’s (Roche) were used as per suppliers instructions 
for the generation of Southern blot probes. 
 
2.1.11 Blot Development Solutions 
2.1.11.1 Kodak Developing Solution 
 Developing solution (200 ml, Kodak) was added to 400 ml dH2O in a Duran 
bottle covered in tin foil. Developer was stored in the dark at room temperature. 
 
2.1.11.2 Kodak Fixing Solution 
 Fixing solution (150 ml, Kodak) was added to 350 ml dH2O in a Duran bottle 
covered in tin foil. Fixer was stored in the dark at room temperature. 
 
2.1.12 LC-MS Stocks and Buffer 
2.1.12.1 Bovine Serum Albumin (BSA) 
 BSA (1 g) was added to 10 ml dH2O to create a 100 mg/ml stock. 100 µl of this 
was then transferred to 1.5 ml microfuge tubes and stored at -20 ⁰ C until required.  
 
2.1.12.2 Iso-electric Focussing Buffer 
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 Urea (24.02 g), 7.61 g thio-urea, 2 g 3-[(3-Cholamidopropyl)dimethylamoonio]-
1-propanesulfonate (CHAPS), 500 µl Triton X-100 and 0.06 g tris-base were dissolved 
sequentially in dH2O and brought to a total volume of 50ml using dH2O. This was 
stored at -20 ⁰ C until required. 
2.1.12.3 Rehydration Buffer  
 Urea (24.02 g), 0.25 g CHAPS, 0.1 g dithiothreitol (DTT) and 100 µl 
ampholytes (GE Healthcare) were dissolved sequentially in dH2O and brought to a total 
volume of 50 ml using dH2O. 
 
2.1.12.4 Reduction Buffer 
 Glycerol (150 ml), 10 g SDS, 180 g urea and 3.03 g tris were dissolved 
sequentially in 300 ml dH2O and brought to pH 6.8. This was brought to a total volume 
of 500 ml using dH2O. 50 ml fractions were transferred to 50 ml Falcon tubes and 
stored at -20 ⁰ C until required. Prior to use DTT (0.02g/ml) was added. 
 
2.1.12.5 Alkylation Buffer 
 Glycerol (150 ml), 10 g SDS, 180 g urea and 3.03 g tris were dissolved 
sequentially in 300 ml dH2O and brought to pH 6.8. This was brought to a total volume 
of 500 ml using dH2O. 50 ml fractions were transferred to 50 ml Falcon tubes and 
stored at -20 ⁰ C until required. Prior to use, iodoacetamide (0.025g/ml) was added, 
along with 100 µl 1% bromophenol blue solution. 
 
2.1.12.6 10 X Running Buffer 
 Trizma base (30 g), 144 g glycine and 10 g SDS were dissolved in 800 ml dH2O 
with the aid of a heat block and magnetic stirrer. Once fully dissolved the solution was 
brought to a total volume of 1 L using dH2O and stored at room temperature. 
 
2.1.12.7 1 X Running Buffer 
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 10 X running buffer (100 ml, section 2.1.12.6) was added to 900 ml dH2O and 
stored at room temperature. 
 
 
2.1.12.8 10% Ampholytes 
 Ampholytes (500 µl, APS) (GE Healthcare) was added to 4.5 ml dH2O creating 
a 10 % APS stock. 1 ml aliquots were transferred to fresh 1.5 ml microfuge tubes and 
stored at -20 ⁰ C until required. 
 
2.1.12.9 Agarose Sealing Solution 
 Trizma base (1.5 g), 7.2 g glycine, 0.5 g SDS, and 1.5 g agarose (Electran) were 
added to 80 ml sequentially. A pinch of bromophenol blue was added prior to the 
solution being topped up to 100 ml with dH2O  and was kept molten in a water bath 
prior to use. 
 
2.1.13 Coomassie Staining Reagents (Colloidal Method) 
2.1.13.1 Fixing Solution 
 Ethanol (500 ml), 30 ml phosphoric acid were topped up to 1 L with dH2O, 
solution was made on day of usage. 
 
2.1.13.2 Incubation Buffer 
 Methanol (340 ml), 30 ml phosphoric acid and 170 g ammonium sulphate were 
brought up to 1 L using dH2O. This was made on day of usage. 
 
2.1.13.3 Stain Solution 
 Methanol (340 ml), 30 ml phosphoric acid, 170 g ammonium sulphate and 0.35 
g Colloidal Coomassie Blue G-250 (Serva) were brought to 1 L using dH2O. 
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2.1.13.4 Neutralisation Buffer  
 Tris base (12.11 g) was dissolved in 900 ml dH2O. This was pH adjusted to pH 
6.5 using phosphoric acid after which it was brought to a total volume of 1 L using 
dH2O 
2.1.14 Mass Spectrometry Reagents 
2.1.14.1 Destaining Buffer 
 Ammonium bicarbonate (0.79 g) was dissolved in 100 ml HPLC-grade dH2O 
and diluted 1:1 HPLC grade aceto-nitrile. This was made fresh on the day. 
 
2.1.14.2 Trypsin Reconstitution Buffer 
 Ammonium bicarbonate (10 mM) and 10 % (v/v) acetonitrile were brought to a 
final volume of 10 ml using HPLC-grade dH2O. This was made fresh on the day 
 
2.1.14.3 Trypsin Digestion Buffer 
 Trypsin (20 µg) was diluted in 1.5 ml reconstitution buffer giving a 13 ng/µl 
working stock. Surplus trypsin digestion buffer was stored at -20 ⁰ C. 
 
2.1.14.4 50 mM Ammonium bicarbonate 
 200 mg ammonium bicarbonate was dissolved in 50 ml HPLC-grade dH2O, on 
day of usage. 
 
2.1.14.5 Extraction Buffer 
 5 % (v/v) formic acid and HPLC-grade acetonitrile were mixed 1:2 (v/v). This 
was made fresh on day of use. 
 
2.1.14.6 0.1 % Formic Acid 
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 0.1 % (v/v) was added to a total 10 ml HPLC-grade dH2O, fresh on the day of 
use. 
 
 
2.1.15 Glutathione Assay Buffers 
2.1.15.1 1 M NaCl 
 NaCl (5.844 g) was dissolved to in 100 ml dH2O, autoclaved and stored at room 
temperature. 
 
2.1.15.2 Pepstatin A 1 mg/ml 
 Pepstatin A (10 mg) was added to 10 ml dH2O to give a 1 mg/ml pepstatin A 
stock. This was filter sterilised using a 0.45 µm filter and 500 µl fractions were 
aliquoted into 1.5 ml microfuge tubes and stored at -20 ⁰ C. 
 
2.1.15.3 Phenylmethylsulfonyl fluoride (PMSF) 
 PMSF (0.435 g) was dissolved in 5 ml dH2O to yield a 500 mM PMSF stock. 1 
ml fractions were aliquoted into 1.5 ml microfuge tubes and stored at -20 ⁰ C. 
 
2.1.15.4 Lysis Buffer 
 Tris-HCl (1.576 g), 5 ml of 1 M NaCl (section 2.1.15.1), EDTA (0.745 g), 
Glycerol (10 ml) were dissolved in 80 ml dH2O. Solution was pH adjusted to pH 7.5 
and brought to a final volume of 100 ml with dH2O, autoclaved and stored at 4 ⁰ C. 30 
mM DTT (0.4627 g), 100 µl of 1 mg/ml pepstatin A stock (section 2.1.15.2) and 200 µl 
of 500 mM PMSF stock (section 2.1.15.3) were later added just before use. 
 
2.1.15.5 GSH Assay Buffer 
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 Sodium phosphate (1.5 g) was dissolved in 80 ml dH2O. Solution was pH 
adjusted to pH 7.5. EDTA (0.2345 g) was then dissolved and the solution was brought 
to a final volume of 100 ml using dH2O. 
 
 
 
2.1.15.6 5 % (w/v) Sulfo-salicyclic Acid (5 % SSA) 
 SSA (0.5 g) was dissolved in 10 ml GSH assay buffer (section 2.1.15.5) fresh 
and kept on ice until required. 
 
2.1.15.7 Triethanolamine 
 Triethanolamine was diluted 1:2 (v/v) using GSH assay buffer (section 
2.1.15.5), and kept on ice. 
 
2.1.15.8 2-vinylpyridine 
 2-vinylpyridine was diluted 1:5 (v/v) in GSH assay buffer (section 2.1.15.5) 
under a fume hood and kept on ice. 
 
2.1.15.9 5,5′-Dithiobis(2-nitrobenzoic acid) (DTNB) + Glutathione Reductase 
 DTNB (11.89 mg) and 157.1 µl glutathione reductase were added to 3 ml GSH 
assay buffer in a 15 ml Falcon wrapped in tin foil and stored on ice. 
 
2.1.15.10 NADPH 
 A 25 mg/ml NADPH stock solution was made by adding 1 ml GSH assay buffer 
(section 2.1.15.5) to 25 mg NADPH. 200 µl aliquots were added to 1.5 ml microfuge 
tubes wrapped in tin foil and stored at -20 ⁰ C until required. 
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2.2 Methods 
2.2.1 Microbiological Methods 
2.2.1.1 S. cerevisiae growth, maintenance and storage 
 S. cerevisiae strains were grown on YPD agar plates (section 2.1.3.2) at 30 ⁰ C 
in a static incubator for ~48 h in the dark. For liquid cultures, S. cerevisiae strains were 
inoculated in liquid YPD (section 2.1.3.1) at 200 rpm (Innova 4000 Orbital Shaker, 
New Brunswick Scietnific, UK) at 30 ⁰ C. Growth and maintenance of those strains 
which contained plasmids was carried out using SC media (section 2.1.3.5) or SC agar 
(section 2.1.3.6) lacking an appropriate amino acid to maintain selection for that 
particular plasmid. Working stocks of strains were kept at 4 ⁰ C for short term use and 
were re-inoculated every few weeks. Long term stocks were generated using 500 µl of 
freshly grown cells, mixed with 40 % (v/v) glycerol (section 2.1.3.25) in a 1.5 ml 
microfuge tube. This was then ‘flash-frozen’ using liquid Nitrogen and stored at -70 
⁰ C until required.  
 
2.2.1.2 E. coli growth, maintenance and storage 
 E. coli cells were grown on LB-ampicillin agar plates (section 2.1.3.24) and 
grown at 37 ⁰ C, or in LB-amp broth (section 2.1.3.23) at 37 ⁰ C shaking at 200 rpm. 
Working stocks were kept at 4 ⁰ C for short term use. Long term stocks were generated 
using 500 µl of freshly grown cells (in appropriate selective media) and mixed with 40 
  (v/v) glycerol (section 2.1.3.25). This was then ‘flash-frozen’ using liquid Nitrogen 
and stored at -70 ⁰ C until required. 
 
2.2.1.3 Aspergillus fumigatus growth, maintenance and storage 
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 A. fumigatus strains were stored on either AMM (section 2.1.3.16) or MEA 
(section 2.1.3.14) agar plates at 4 ⁰ C. To culture strains, a loop of spores from a stock 
spore solution was spread around an appropriate culture plate under sterile conditions 
and incubated at 37 ⁰ C for 3-4 days depending on growth rate of that particular strain. 
Conidia were then harvested by adding 10 ml sterile PBST (section 2.1.3.20) to the 
plate while rubbing the surface with a sterile inoculation loop to get the conidia into 
solution. The conidial-PBST solution was aliquoted from the plate into a sterile 50 ml 
Falcon tube using a sterile Pasteur pipette, sealed with parafilm and stored at 4 ⁰ C 
until required. From this, liquid cultures were inoculated (usually at a concentration of 5 
X 10
6
 spores/ml) for relevant experiments. These were then incubated for the 
appropriate length of time, depending on the experiment, at 37 ⁰ C shaking at 200 rpm. 
Resulting mycelia could be harvested by filtering the culture through sterile 
Mira-cloth and washed using sterile water to remove residual media. Washed mycelia 
were removed from the Mira-cloth and were either immediately used or wrapped in tin 
foil and flash frozen in liquid nitrogen. Mycelia could then be used for the relevant 
experiment or stored at -70 ⁰ C until required. Long term conidial stocks were prepared 
by aliquoting 800 µl of a conidial-PBST suspension to 200 µl 80 % (v/v) glycerol 
solution (section 2.1.3.26). Tubes were mixed by vortexing and stored at -70 ⁰ C. 
 
2.2.1.4 Measuring S. cerevisiae cell density 
 Overnight cultures were diluted 1/50 by adding 100 µl of culture to 4.9 ml fresh 
media. The OD600nm was then measured using a spectrophotometer (Eppendorf). 
Depending on the OD600nm required, more culture would be added to increase the OD or 
removed and more media added in its place to lower the OD until at the desired 
concentration. This was carried out under sterile conditions. 
 
2.2.1.5 Dot assay/Comparative growth analysis 
 5 ml overnight cultures were diluted the next morning to an OD600nm=0.15 in 5 
ml fresh media. Diluted cultures were incubated at 30 ⁰ C at 200 rpm until at a 
concentration of 3 x 10
6 
cells/ml. Cultures were pelleted by centrifugation at 1677 g 
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(Centrifuge 5810R, Eppendorf) for 5 min and re-suspended to a concentration of 5 x 10
6
 
cells/ml. Using a 96 well plate (Sarstedt), 200 µl neat culture was added to wells in 
column ‘1’. In the wells of columns 2-6 inclusive, 160 µl fresh media was added. Using 
a multi-channel pipette, a 1/5 serial dilution was carried out by removing and adding 40 
µl from well A1 through to well A6. With a sterilised 96 well replicator (Sigma), cells 
transferred agar plates under sterile conditions. Cells were allowed to dry before being 
incubated at 30 ⁰ C static for 48 h. 
 
2.2.1.6 A. fumigatus Plate Assays 
 A. fumigatus strains were spotted onto AMM agar plates (section 2.1.3.16) with 
or without the added experimental variable. 5 X 10
6
 conidia/20 µl spot was incubated at 
37 ⁰ C static for 72 h after which mycelia radii were measured as an indicator of 
growth. Significance was measured by a two way ANOVA using two replicates for 
each strain. 
 
2.2.1.7 Galleria mellonella Virulence Testing 
 G. mellonella testing was carried out as described by Reeves et al., (2004). Sixth 
instar G. mellonella larvae (Lepitdoptera: Pyralidae, the Greater Wax Moth) (Mealworm 
company, Sheffield, England) were stored in the dark at 15 ⁰ C in wood shavings. 
Larvae weighing 0.2 and 0.4 g were used in this study. All A. fumigatus conidial 
suspensions used were prepared in sterile PBS (section 2.1.3.19). 5 X 10
6
 conidia per 20 
µl inoculum was injected into the last left proleg of G. mellonella hosts (n=10). All 
injections were carried out using sterile syringes (1ml, 27 g). Un-injected G. mellonella 
and injections using 20 µl PBS served as negative controls. Two sets of injections were 
carried out for each replicate and each data set was repeated in triplicate on three 
independent occasions. Mortality rates and melanisation rates were measured over a 72 
h period with a positive death being confirmed by lack of movement from larvae in 
response to stimulation and a discolouration of its cuticle. 
 
2.2.2 Molecular Biological Methods 
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2.2.2.1 Isolation of Genomic DNA from S. cerevisiae 
 S. cerevisiae strain(s) were inoculated in 2 ml YPD (section 2.1.3.1) and 
incubated overnight at 30 ⁰ C shaking at 200 rpm. Cells were pelleted at 1077 g for 5 
min. and resulting pellets were re-suspended in 150 µl 1 M sorbitol/100 mM EDTA 
(section 2.1.4.1) and aliquoted into a sterile 1.5 ml microfuge tube. 12 µl of 5 mg/ml 
zymolase (section 2.1.4.2) was added to the cell mixes and incubated for 1 h at 37 ⁰ C 
static. Samples were spun at 13000 rpm for 5 s and re-suspended in 150 µl 1 M Tris/100 
mM EDTA (section 2.1.4.3). 10 µl of 10 % SDS solution (section 2.1.9.5) was added to 
each sample and mixed. Solutions were then incubated at 65 ⁰ C for 30 min after which 
60 µl of 5 M KAc (section 2.1.4.4) was added to each sample and subsequently cooled 
on ice for 1 h. Samples were centrifuged at 18894 g for 5 min and resulting supernatants 
were transferred to new microfuge tubes. To this, 195 µl of iso-propanol was added and 
left to incubate at room temperature for 5 min permitting DNA precipitation. Samples 
were centrifuged briefly at 18894 g for 10 s to form a DNA pellet. Supernatant was 
removed and the pellets were air dried and subsequently re-suspended in 30-50 µl 
dH2O. DNA samples were stored at -20 ⁰ C until required. 
 
2.2.2.2 Isolation of Genomic DNA from A. fumigatus 
 50 ml SB media (Section 2.1.3.17) were inoculated using an A. fumigatus 
conidial suspension (usually at a concentration of 5 x 10
6
 conidia/ml). These cultures 
were incubated overnight at 37 ⁰ C shaking at 200 rpm after which mycelia was 
harvested by filtering through sterile Mira cloth. Media were washed from the 
mycelium using sterile dH2O and scraped from the Mira cloth using a sterile spatula. 
This was then wrapped in the Mira cloth and dried using tissue paper ensuring none of 
the mycelium was exposed to the tissue. Once dry, the mycelium was wrapped in tinfoil 
and flash frozen in liquid nitrogen. Samples could be stored at this point at -70 ⁰ C until 
required. Prior to DNA isolation, frozen mycelium was crushed using a sterile pestle 
and mortar until a powdery consistency was formed. To prevent the mycelium from 
thawing during this process, more liquid nitrogen would be added. 100 mg of ground 
mycelia was then added to a ZR BashingBead
TM. 
Using the ZR Fungal/Bacterial DNA 
Kit
TM
 (Zymo Research U.S.A) DNA was isolated using reagents and materials as 
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instructed by the manufacturers guidelines. To elute the DNA, 50 µl sterile water was 
added to the centre of the spin column and centrifuged at 11180 g for 1 min and 
collected in a sterile 1.5 ml microfuge tube and stored at -20 ⁰ C. 
 
 
2.2.2.3 Genomic DNA Precipitation in A. fumigatus 
 DNA samples from section 2.2.2.2 were topped up to a total volume of 100 µl 
using sterile dH2O. 10 µl 3 M sodium acetate (section 2.1.5.6) and 250 µl ice-cold 
100% ethanol (v/v) (section 2.1.5.4) were added and mixed by inversion. Samples were 
then incubated at -20 ⁰ C for at least an hour and subsequently centrifuged at 18894 g 
for 10 min at 4 ⁰ C. Supernatants were carefully removed ensuring not to disturb the 
pellet and 100 µl 70 % (v/v) ethanol was added to the tube. Samples were centrifuged at 
18894x g  for 10 min at 4 ⁰ C after which the supernatants were removed and samples 
were centrifuged again at 11180 g for 15 secs. Residual ethanol was removed and the 
pellet was air dried and re-suspended in 16 µl sterile dH2O. 
 
2.2.2.4 Polymerase Chain Reaction (PCR) 
 PCR was employed to amplify fragments of DNA for cloning into plasmids, 
generation of gene disruption cassettes, DIG-labelled probes, and knockout qualification 
of transformants. For the production of DIG-labelled probes and gene disruption 
cassettes, a high fidelity, high proof read Taq polymerase was used, either Platinum 
Taq
TM 
(Invitrogen)
 
or AccuTaq LA polymerase. All other PCR reactions were carried 
out using NEB Taq polymerase. 
PCR using Platinum Taq polymerase 
10X High fidelity reaction buffer 5 µl 
dNTP mix (10 µM)   2 µl 
Forward primer (100 pmol/µl) 2 µl 
Reverse primer (100 pmol/µl) 2 µl 
MgSO4    2 µl 
Template DNA   (10-100 ng) 
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Platinum High Fidelity Taq
TM
 0.5 µl 
Sterile dH2O    to a total volume of 20 µl 
 
PCR using AccuTaq LA polymerase 
10X Reaction buffer   2 µl 
dNTP mix (10 µM)   2 µl 
Forward primer (100 pmol/µl) 1 µl 
Reverse primer (100 pmol/µl) 1 µl 
DMSO     0.8 µl 
Template DNA    (10-100 ng) 
AccuTaq LA polymerase
TM
  0.25 µl 
Sterile dH2O    to a total volume of 20 µl 
PCR using NEB Taq polymerase 
10X reaction buffer   2 µl 
dNTP mix (10 µM)   1 µl 
Forward primer (100 pmol/µl) 1 µl 
Reverse primer (100 pmol/µl) 1 µl 
MgCl2     1 µl 
Template DNA   (50-100 ng) 
Taq polymerase   0.5 µl 
Steril dH2O    to a total volume of 20 µl 
 
PCR Reaction Cycle 
The following reaction cycle is a typical example of  what was used unless otherwise 
stated: Step 1: 95 ⁰ C (denaturing) 5 min; Step 2: 95 ⁰ C (denaturing) 1 min; Step 3: 
55 ⁰ C*(annealing) 1 min 30 secs; Step 4: 72 ⁰ C (extension) 1 min+; repeat X30 
cycles from step 2; Step 5: 72 ⁰ C (extending) 10 min. 
 *Annealing temperatures were calculated by setting them 4 ⁰ C below the 
lowest melting temperature (Tm) of the primers being used. 
 Extension times were chosen as 1 min/kb of target DNA to be amplified. When 
either AccuTaq or Platinum Taq were being used the extension time was reduced to 68 
⁰ C as per suppliers recommendations. 
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 For difficult to amplify targets Fusion PCR was carried out using a high fidelity 
Taq. Protocol was followed as described in Szewczyk et al., (2006). 
 
 
2.2.3 DNA Gel electrophoresis 
2.2.3.1 Preparation of a 0.8 % agarose gel 
 Gels were cast in a Biorad casting tray by adding 0.4 g electrophoresis agarose 
(Biorad) into 50 ml (0.8 % w/v) 1X TAE buffer (section 2.1.5.2 ) and heated to boiling 
using a microwave set at maximum power for 1 min. This was allowed to cool till hand 
hot and was poured into the casting mould. To this 1 µl of a 10 mg/ml ethidium bromide 
solution was added and mixed into the agar solution by stirring gently. A well comb 
was then secured in place to create wells for the addition of samples, and allowed to set 
for 30 min.   
 
2.2.3.2 Loading and running of samples 
 Before loading onto a gel, DNA samples must first be mixed with a 6X loading 
dye (Promega). To estimate sample size, a molecular weight marker was also added to 
one lane. Marker VII (DIG-labelled)(Roche), 1 kb DNA ladder (New England Biolabs) 
and 50 bp DNA ladder (New England Biolabs) were used throughout this study. Each 
was subsequently loaded into respective wells and run at 90 V for 45 min depending on 
the size of the expected sample. 
 
2.2.3.3 DNA Gel extraction 
 For the extraction of sample products separated on an agarose gel, bands were 
excised using a sterile scalpel and transferred to a sterile, pre-weighed, 1.5 ml microfuge 
tube. The weight of the gel slice was then weighed and treated using the QIA quick gel 
extraction kit (Qiagen) and the reagents and columns provided as per the manufacturers 
guidelines. 
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DNA was eluted using 30 µl sterile dH2O added directly to the centre of the spin 
column, leaving to stand for 2 min. This was centrifuged at 16099 g for 1 min and the 
eluted DNA was stored at -20 ⁰ C until required. 
 
 
2.2.3.4 DNA Restriction digest 
 DNA restriction digest was used for the digestion of genomic DNA used in 
Southern blotting, release of target regions contained within a plasmid, linearising a 
plasmid, to enable the subsequent ligation of gene disruption cassettes and insertion of 
genes of interest into plasmid vectors. Restriction-digest enzymes and buffers were 
supplied from New England Biolabs and reactions were carried out as per their 
instructions e.g.: DNA 1-5 µg; enzyme 1 1 µl; enzyme 2 1 µl; 10 X buffer 2.5 µl; 10X 
BSA 2.5 µl; sterile dH2O to a total volume of 25 µl. Reactions were usually carried out 
at 37 ⁰ C for three hours, however due to different requirements this could be altered as 
per manufacturers’ guidelines. 
 
2.2.3.5 DNA ligation 
 Gene disruption cassettes and genes required to be cloned via vectors were 
created by restriction digest with specific enzymes and DNA ligation. After the creation 
of compatible fragments (section 2.2.3.4) digested DNA samples were separated via gel 
electrophoresis (section 2.2.3.2) and correctly sized bands were excised from the gel 
(section 2.2.3.3). DNA fragments were ligated using T4 DNA ligase (Promega) as per 
manufacturers’ guidelines. After digestion, double stranded DNA will have a single 
stranded overhang if they are cohesive ends or none as is the case in blunt ended 
molecules. All digested DNA samples used in this study possessed cohesive ends. 
Ligation reactions were carried using this formula: 
(ng of vector)*(kb size of insert) * 3 = ng of insert 
 kb size of vector   1 
2.2.4 Aspergillus fumigatus mutant strain generation 
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2.2.4.1 Gene disruption cassette generation 
 A. fumigatus genes were disrupted by employing a bi-partite strategy. This 
employs PCR (section 2.2.2.4) to amplify the gene cassettes ligated to a selectable 
marker facilitating relatively quick generation when compared to methods which enlist 
bacterial sub-cloning practices (Nielson et al., 2006). This technique amplifies regions 
outside the gene of interest (GOI) flanking the gene on its 5’ side and 3’ side (usually 
between 1200-1500 bp in size). The primers used to amplify these regions will contain 
two restriction sites not normally found in this ORF. The incorporation of these 
restriction sites facilitates the next step of ligating each flanking region to the selectable 
marker. In this study, the pyrithiamine resistance gene (ptrA) from Aspergillus oryzae 
(Kubodera et al., 2000; 2002) was used. This was liberated from a plasmid vector 
pSK275 using the restriction enzymes which correspond to the restriction sites found on 
the flanking regions. Following subsequent digestion of the flanking regions (section 
2.2.3.4) to create combatable ends to ptrA, they were then respectively ligated (section 
2.2.3.5) to the ptrA gene.  
 Subsequent ligation reactions were then used as DNA template for another 
round of PCR using a nested primer within the flanking region and an internal ptrA 
(optra) primer amplifying only a portion of the ptrA gene. All PCR reactions were 
carried out using a high fidelity Taq to ensure no loss of homology. PCR products were 
separated by gel electrophoresis (section 2.2.3.2) and purified using a Qiagen gel 
extraction kit (section 2.2.3.3). Upon transformation the flanking regions should 
homologously recombine with the corresponding flanking regions within the organism, 
while the ptrA partially amplified regions will homologously recombine along the 
portion which is common in both (Figure 2.1 ) 
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Figure 2.1 Bi-partite strategy for gene disruption in A. fumigatus using a ptrA 
selectable marker. Using specific primers (1-4), two regions from the 5’ and 3’ regions 
flanking a gene of interest are amplified (A), using suitable restriction enzymes 
engineered for ptrA (B). Using primer 5F-oPtrA-2R and 6R-oPtrA-1F respectively 
another round of PCR generates two new constructs which consists of only two thirds of 
the ptrA gene. Three sites will then homologously recombine with their corresponding 
regions: 5’flanking region, 3’ flanking region and ptrA. 
 
2.2.4.2 A. fumigatus Protoplast Production 
 A. fumigatus conidial suspensions were used to inoculate 2X 200 ml AMM 
media (section 2.1.3.15) cultures and were incubated at 37 ⁰ C overnight shaking at 11 
g. Mycelia were harvested through sterile Mira-cloth and excess media was rinsed off 
using sterile dH2O. Harvested mycelia was dried using sterile tissue paper and 
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subsequently 1.5 g dried mycelia was transferred to a sterile 50 ml Falcon tube in 
duplicate. To each, 15 ml mycelium lysing solution (section 2.1.8.4) was added and 
each was incubated for 20 min at 30 ⁰ C shaking at 3 g with each tube set lying down. 
After this, the tubes were removed and homogenised using a Gilson pipette and a 1000 
µl tip. Each sample was aliquoted up and down to break up the cells and remove 
clumps. Next a 200 µl pipette tip was placed onto the other tip and the samples were 
once again aliquoted up and down. Once each sample was completely homogenised 
they were placed back into the incubator at 30 ⁰ C shaking at 3 g for another 2 h and 40 
min. Samples were placed on ice for at least 5 min afterwards to stop the lysing 
reaction. They were centrifuged with the brake off, preventing protoplast disruption, at 
1073 g for 18 min to collect cellular debris. Supernatant was filtered through sterile 
Mira-cloth into fresh 50 ml Falcon tubes and the volume was brought to 40 ml using 0.7 
M KCl solution (section 2.1.8.5). Protoplasts solutions were centrifuged at 4293 g for 
18 min. Supernatant was removed carefully ensuring not to disturb the pellet. Pellets 
were re-suspended in 10 ml 0.7 M KCl and centrifuged at 4293 g for 12 min. Again, 
supernatant was immediately removed and tubes were left to dry upside down over 
sterile tissue paper for 1 min. Pellets were re-suspended using 70 µl L6 buffer (section 
2.1.8.6) by gently swirling. Samples were briefly centrifuged at 604 g and duplicate 
samples were combined and left on ice for no longer than 20 min prior to use. At this 
point protoplasts could be checked for integrity and number by aliquoting 5 µl onto an 
haemocytometer and visualising using a light microscope and a high power lens. 
 
2.2.4.3 A. fumigatus Protoplast Transformation 
 For each strain to be transformed, 10 µg of the DNA to be transformed was 
used. DNA was placed in a 50 ml Falcon tube and was brought to a total volume of 50 
µl using buffer L6 solution (section 2.1.8.6). 150 µl protoplast solution (section 2.2.4.2) 
was added to the DNA-L6 buffer and mixed by gently swirling. A negative control was 
made by adding 15 µl protoplast solution to 185 µl buffer L6 in a separate 50 ml Falcon 
tube and mixed by gently swirling. 50 µl buffer L7 (section 2.1.8.7) was added to both 
tubes, shaking gently to mix and left to incubate on ice for 20 min. Buffer L7 (1ml) was 
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added to each tube and samples were left at room temperature for 5 min. Following this, 
samples were ready to be plated. 
 
 
2.2.4.4 Transformed A. Fumigatus Protoplasts Plating and Selection on 
pyrithiamine agar plates 
 A. fumigatus protoplasts were plated onto Aspergillus regeneration media 
(section 2.1.8.8) with or without pyrithiamine where appropriate. Plates were made 
prior to the transformation typically during the lysing incubation step (section 2.2.4.2). 
Before being poured into petri dishes, pyrithiamine (section 2.1.2.8) was added to yield 
a concentration of 0.1 µg/ml and was added to six plates. Two positive control plates 
were poured containing no pyrithiamine. 
For plating the negative controls (section 2.2.4.3) 1.25 ml of the negative control 
protoplasts was added to a fresh 50 ml Falcon tube and was brought to a final volume of 
6 ml with Aspergillus transformation soft agar (section 2.1.8.9) and poured onto a plate 
containing pyrithiamine. For the positive controls/protoplast viability plates, two 
concentrations were prepared in two separate 50 ml Falcon tubes. 12.5 µl and 1.25 µl of 
transformed protoplasts were added to a respective tube with the final volume of each 
brought to 6 ml using Aspergillus transformation soft agar before being poured onto 
agar plates containing no pyrithiamine. Lastly, the remaining transformed protoplasts 
solution was topped up to a final volume of 30 ml using soft agar and 6 ml was poured 
onto each of the 5 remaining pyrithiamine plates ensuring the agar spread completely 
before setting. 
 Plates were left on the bench overnight to allow for the protoplasts to re-grow 
their cell wall (removed via the lysing step in section 2.2.4.2). The next day, negative 
control and transformed experimental plates were overlaid with another 6 ml soft agar 
containing 0.1 µg/ml pyrithiamine (section 2.1.2.8). Once the agar had set, all plates 
were incubated at 37 ⁰ C static for 4-5 days depending on growth rate. 
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2.2.4.5 Isolation of A. fumigatus Transformants 
 Growth of transformed protoplasts on agar plates containing pyrithiamine 
identified potential successfully transformed A. fumigatus strains. Number of potential 
transformants can range from 5-30 colonies from each transformation. Using a sterile 
1000 µl pipette tip, plugs of potential transformants were taken under sterile conditions 
and added to a 1.5 ml microfuge tube, to which 1 ml PBS-T (section 2.1.3.20) was 
added. Potential transformant plugged samples were vortexed to release the conidia into 
solution and were re-aliquoted onto fresh AMM agar plates (section 2.1.3.16) 
containing pyrithiamine to ensure resistance to the marker. 500 µl conidial suspension 
of plugged samples which proved resistant to pyrithaimine were used to inoculate 50 ml 
SB media (section 2.1.3.17) and were incubated at 37 ⁰ C at 200 rpm. From these, 
genomic DNA was extracted as described in section 2.2.2.2, for further analysis via 
Southern Blotting. 
 
2.2.4.6 A. fumigatus Single Spore Isolation 
 Samples were serially diluted, typically 1:10, 1:100, 1:1000 & 1:2000. The 
resulting single colonies were isolated as described previously (section 2.2.4.5) and 
analysed by a second round of Southern blotting. 
 
2.2.5 Southern Blotting 
2.2.5.1 gDNA Preparation and Subsequent Nucleic Acid Transfer 
 Southern blotting was used to detect specific gene fragments at desired loci to 
help identify successful gene loss in transformants. gDNA was isolated from 
transformants and wild-type strains as described (section 2.2.2.2), and was restriction 
digested using an appropriate restriction enzyme. The enzyme used should result in 
differential cutting between wild-type and knockout strain at the region of interest. 
Restriction digests was carried out as described (section 2.2.3.4) and were subsequently 
ran on a 0.8 % (w/v) agarose gel (section 2.2.3.2). Once completed gels were visualised 
using an ultraviolet light and GelDoc Camera to ensure complete digestion had 
occurred. Gels were then placed in a UV cross-linking machine and subjected to a 800 
µJ pulse creating nicks in the DNA aiding transfer onto a nylon membrane. 
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 Following this the Southern transfer tower was set up. Using a large BioRad gel 
tank, 1 L of transfer buffer (section 2.1.9.1) was added equally to each side. To this, two 
sheets of Whatman filter paper (about 1 inch wider than the width of the gel on each 
side and slightly longer than the width of the gel tray) was added to the transfer buffer 
and laid across the tank. On top of this the gel(s) (two gels are needed to balance the 
tower but both don’t need to contain sample) were placed with the wells facing down 
and one piece of Hybond nylon membrane (slightly larger than the gel) was added 
carefully and directly to the gel which contained DNA. To this, three gel sized pieces of 
Whatmann filter paper was added on top of which three packs of pocket tissues were 
taken out of their wrappers and added to each side to ensure the tower stayed balanced. 
Lastly a glass plate was balanced on top of the two resulting stacks of tissue, Whatmann 
filter paper, H
+ 
Nylon Membrane and agarose gels; topped off with a weight in the form 
of a Duran bottle filled with 500 ml H2O. Southern blotting was carried out at room 
temperature, overnight. 
 
2.2.5.2 Disassembly of Southern Transfer Tower 
 After the overnight blot transfer step in section 2.2.5.1, the Duran bottle and 
glass plate were taken off. The stacks of tissue were then carefully removed and 
discarded. The agarose gel was turned over carefully with the Hybond nylon membrane 
and gel sized Whatmann filter paper still attached and now on the underside of the gel 
with the wells facing up. Using a sharpened pencil, lines were marked using the wells as 
a guide in order to see the orientation of the membrane. The agarose gel was then taken 
off and left to one side while the membrane was carefully placed into a clean container 
where it was washed twice for 5 min using ~ 10 mls 0.1 % (w/v) SDS/ 1 X SSC Buffer 
(section 2.1.9.6) rocking. During this step the agarose gel was visualised under a U.V. 
light to ensure all the DNA was transferred and subsequently discarded. Washed blots 
were placed into a U.V. cross-linking machine and subjected to a 1200 µJ pulse to 
prevent any DNA to be washed off in the subsequent steps. 
 
2.2.6 Digoxigenin (DIG) Detection of Hybridised DNA fragments 
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2.2.6.1 Generation of DIG-labelled DNA probes  
 DIG-labelled probes were amplified using primers specific to the region of 
interest. Also DIG-labelled dNTP’s (section 2.1.10.9) were used in order to DIG-label 
the probe itself. PCR amplicons were visualised on agarose gels (section 2.2.3.2) and 
purified using a Qiagen gel extraction kit (section 2.2.3.3). Prior to being used in the 
DIG-detection step of Southern blotting, the probe was denatured at 95 ⁰ C for 8 min 
using a dry bath. DIG probe was the placed on ice and quantified using a Nanodrop 
spectrophotometer. 400 ng was then added to 5 ml membrane pre-hybridisation buffer 
(section 2.1.10.2) pre-heated to 65 ⁰ C for at least 30 min. The probe could stored at -
20 ⁰ C and re-used for subsequent experiments where it was re-heated to 65 ⁰ C for 30 
min prior to use. 
 
2.2.6.2 Pre-hybridisation of Southern Blot Membrane 
 After U.V. crosslinking (section 2.2.5.2), the blot(s) were added to a Hybaid 
tube, ensuring to only hold the corners of the membrane i.e. not where the DNA would 
have transferred to, using a sterile forceps. 10 ml pre-hybridisation buffer, which had 
been pre-heated at 65 ⁰ C, was poured in down the side of the Hybaid tube and not 
directly onto the membrane. This was then added to a pre-heated (42 ⁰ C) Hybaid oven 
and left rotating for 4-5 h to block the blots. 
 
2.2.6.3 Addition of DIG-labelled probe 
 Pre-hybridisation buffer from section 2.2.6.2 was poured from the Hybaid tube. 
400 ng of the denatured DIG-labelled probe solution (section 2.2.6.1) was poured down 
the side of the Hybaid tube and not directly onto the membrane. This was then placed 
back into the Hybaid oven and incubated at 42 ⁰ C rotating overnight. 
 
2.2.6.4 DIG Detection 
 Following overnight incubation of the DIG-labelled probe solution in section 
2.2.6.3, the solution was poured into a 50 ml Falcon and stored at -20 ⁰ C for re-use. 
The blot(s) was taken from the Hybaid tube and placed into a clean container and was 
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washed 2 X 5 min, rocking in 10 ml 0.1% (w/v) SDS/1 X SSC buffer (section 2.1.9.6). 
The blot(s) were then placed into a clean Hybaid tube, which was pre-heated in a 
Hybaid oven now set to 65 ⁰ C. The tube(s) were filled halfway with 0.1 % (w/v) 
SDS/1 X SSC (section 2.1.9.6) buffer and incubated for 15 min rotating at 65 ⁰ C. This 
was repeated and each time the buffer was poured off and the Hybaid tube was placed 
upside down on clean tissue paper to remove excess buffer. 
 10 ml DIG wash buffer (section 2.1.10.6) was next added to the Hybaid tube and 
left rotating at 25 ⁰ C for 5 min. Subsequently, the buffer was poured off and in its 
place 10 ml Antibody Blocking buffer (section 2.1.10.4) was added and left rotating at 
25 ⁰ C for 30 min. This was poured off and the Anti-DIG Fab Fragments – alkaline 
phosphatase (10 ml) was added (section 2.1.10.7). This was left rotating at 25 ⁰ C for 
30 min after which the blot(s) was washed 2 X in 10 ml DIG wash buffer at 25 ⁰ C 
rotating for 10 min. 5 ml DIG buffer 3 (section 2.1.10.5) was next added to the blot(s) 
which were then left rotating at 25 ⁰ C for 5min. Buffer was then poured off and the 
CSPD chemi-luminescent substrate buffer (5 ml) (section 2.1.10.8) was added. Blot(s) 
were left for a further 5 min rotating at 25 ⁰ C and subsequently the CSPD buffer was 
collected into a fresh 50 ml Falcon tube wrapped in tin foil (CSPD buffer if kept in the 
dark can be re-used within a week) and stored at 4 ⁰ C. The blot(s) was carefully 
removed from the Hybaid tube and wrapped in clingfilm making sure that there were no 
air bubbles which might obstruct Southern blot development (section 2.2.7). Blots were 
incubated at 37 ⁰ C static in the dark for 15 min to help intensify the signal emitted 
from Anti-DIG fab-alkaline phosphatase processing CSPD. 
 
2.2.7 Southern Blot Development 
 At the end of section 2.2.6.4, blots were placed into a film exposure cassette. 
Kodak film was then cut to shape, in the dark, and placed on top of the blot and the 
cassette was shut. Blots were then left to expose at room temperature, usually for 3 h 
depending on strength of signal and background noise. After being exposed the Kodak 
film was developed by submerging it in Kodak developing solution (section 2.1.11.1) 
until bands begin to appear, then rinsing in water and fixing the image in Kodak fixing 
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solution (section 2.1.11.2). If the signal was very weak, exposure time could be 
extended using new Kodak film and exposing overnight. 
 
 
 
2.2.8 Generation and Transformation of Competent Saccharomyces cerevisiae and 
Escherichia coli cells 
2.2.8.1 Competent S. cerevisiae cells 
 S. cerevisiae cells were inoculated in 5 ml YPD (section 2.1.3.1) at 30 ⁰ C 
shaking at 200 rpm . The next morning the cultures were added to 50 ml fresh media in 
a 250 ml sterile conical flask at an OD600nm=0.4 and incubated at 30 ⁰ C for 3 h until at 
a concentration of 1 x 10
7
 cells/ml. The culture was then split into two 25 ml fractions 
in two 50 ml Falcon tubes. Cells were centrifuged at 1677 g for 5 min, subsequently 
washed with 25 ml dH2O then centrifuged again at 1677 g for another 5 min. 
Supernatants were removed from each respective tube, and the cell pellets were re-
suspended in 1 ml 100 mM lithium acetate (section 2.1.6.3). Re-suspended cells were 
transferred to microfuge tubes and centrifuged at 18894 g for 5 secs (Centrifuge 5415D, 
Eppendorf AG, Hamburg). Resulting pellets were re-suspended in 500 µl 100 mM 
lithium acetate and stored at 4 ⁰ C. 
 
2.2.8.2 S. cerevisiae transformation of competent yeast 
 50 µl of competent yeast (section 2.2.8.1) were centrifuged for 5 secs at 
maximum speed and any residual lithium acetate was aliquoted out. To the cell pellet 
the following was added in order without mixing: 240 µl 50 % (w/v) PEG (section 
2.1.6.1); 36 µl 1 M lithium acetate (section 2.1.6.2); 25 µl single stranded carrier DNA 
(2 mg/ml stock) and 50 µl DNA/dH2O mix to be transformed  
Once all components were added they were mixed and incubated at 30 ⁰ C for 
30 min. This was then treated to a 42 ⁰ C heat-shock (Accublock Digital Dry Bath, 
Labnet International Inc.) for 20 min. Mixtures were subsequently centrifuged at 18894 
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g for 15 secs and supernatants were removed. Resulting pellets were re-suspended in 
200 µl dH2O, plated onto selective agar plates and incubated for 48 hrs at 30 ⁰ C static. 
 
 
2.2.8.3 Competent E. coli cells 
 E. coli DH5α cells were inoculated in 10 ml LB broth (section 2.1.3.21) and 
incubated at 37 ⁰ C at 250 rpm overnight. This 10 ml culture was then added to 1 L LB 
broth and incubated again at 37 ⁰ C for 2 h at 200 rpm. This was subsequently split into 
4 x 250 ml centrifugation tubes and chilled on ice for 10 min. Cells were pelleted in a 
GSA rotor at 4293 g at 4 ⁰ C. Cells were re-suspended in RF1 buffer (section 2.1.7.1) 
and kept on ice for a further 30 min. Cells were next centrifuged at 5000 rpm for 10 min 
at 4 ⁰ C and each subsequent pellet was re-suspended in 3.2 ml RF2 buffer (section 
2.1.7.2). Samples were kept on ice for 15 min, after which 100 µl aliquots were 
transferred to pre-cooled 1.5 ml microfuge tubes and stored at -70 ⁰ C until required. 
 
2.2.8.4 E. coli transformation 
 Plasmid DNA (~1 µg) was added to 100 µl competent E. coli cells (section 
2.2.8.3) and incubated on ice for 30 min. Cells underwent a 42 ⁰ C heat shock 
treatment for 1 min in a digital dry bath followed by a recovery period whereby 1 ml 
liquid LB (section 2.1.3.21) was added. Transformed cells were incubated for 1 hr at 37 
⁰ C and plated onto LB-Amp-agar plates (section 2.1.3.24) and incubated overnight at 
37 ⁰ C.  
 
2.2.8.5 “Lazy Bones” E. coli transformation 
 LB-Amp-agar plates were pre-warmed at 37 ⁰ C for 1 hr prior to 
transformation. 1-5 µl plasmid DNA was added to 50 µl pre-thawed competent E. coli 
(section 2.2.8.3). These were incubated on ice for 5 min then plated onto the pre-
warmed LB-amp-agar plates and incubated overnight at 37 ⁰ C. 
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2.2.9 Plasmid Isolation in S. cerevisiae and E. coli 
2.2.9.1 Plasmid Isolation and Purification from S. cerevisiae 
 Plasmid isolation and subsequent purification was carried out according to the 
Qiagen plasmid purification manual using all buffers, reagents and materials provided 
in the QIA prep miniprep kit as per manufacturers’ instructions. 5 ml selective SC 
medium (section 2.1.3.5) was inoculated with the appropriate S. cerevisiae strain and 
incubated at 30 ⁰ C shaking at 200 rpm overnight. This was centrifuged the following 
morning at 1073 g for 5 min and treated as described in the QIA prep miniprep kit 
instructions. To elute the plasmid DNA 30 µl of dH2O was added directly to the centre 
of the spin column and let stand for 1 min at room temperature. Plasmid DNA was 
collected by centrifuged at 18894 g for 1 min and stored at -20 ⁰ C until required. 
 
2.2.9.2 Plasmid Isolation and Purification from E. coli 
 A single colony from a transformed E. coli LB-amp-agar plate (section 2.1.3.24) 
was inoculated in 5 ml LB broth + AMP (section 2.1.3.23) and incubated at 250 rpm at 
37 ⁰ C overnight. Cells were pelleted via centrifugation for 5 min at 4000 rpm. To elute 
the plasmid DNA 30 µl of dH2O was added directly to the centre of the spin column and 
let stand for 1 min at room temperature. Plasmid DNA was collected by centrifugation 
at 18894 g for 1 min and stored at -20 ⁰ C until required. 
 
2.2.10 RNA Methodological Analysis 
2.2.10.1 RNA Extraction 
 RNA was extracted from A. fumigatus strains using the QIAGEN RNeasy plant 
mini kit as per manufacturers’ guidelines. All buffers and filter columns were supplied 
with the kit as well as the constituents of the buffers used. All other materials used were 
double autoclaved and treated with RNase Zap
TM
 (Invitrogen) prior to use to remove 
any un-wanted RNases. All workspaces were thoroughly washed with 70 % (v/v) 
ethanol and RNaseZap for the same reason. 50 ml SB media (section 2.1.3.17) was 
inoculated with 500 µl conidial suspension and incubated overnight at 37 ⁰ C shaking 
at 200 rpm. Mycelia were harvested through sterile Mira-cloth and excess medium was 
washed off using dH2O. Mycelia were then dried using sterile tissue paper, wrapped in 
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tin foil and flash frozen in liquid nitrogen. Samples could be stored from this point at -
70 ⁰ C until required. Frozen mycelia were placed in respective pestle and grinded till 
at a powdery consistency. Powdered tissue (100 mg) was added to a sterile 2 ml 
microfuge tube and kept in an ice bucket containing liquid N2 until ready to proceed to 
the next step. To this 450 µl of RLC buffer (containing β-mercaptoethanol which has to 
be added the first time the buffer is used) and the tube was vortexed vigourously until 
homogenous. The lysate was then treated as per manufacturers’ instructions carrying out 
any optional steps which are suggested to increase yield and purity. 
 RNA was eluted by adding 30 µl RNase free water directly to the centre of the 
column and letting it stand for 1 min. Column was then centrifuged at 11180 g for 1 min 
and resulting elute was aliquoted back up using a sterile tip and passed through the 
column again to help concentrate the RNA. RNA was stored at -70 ⁰ C until required. 
 
2.2.10.2 DNase Treatment of RNA Samples 
 RNA samples extracted from A. fumigatus (section 2.2.10.1) were DNase treated 
using a DNase kit purchased from Sigma-Aldrich Ltd. 500 ng A. fumigatus was brought 
to a final volume of 8 µl using DEPC treated distilled water in a RNase free, sterile 500 
µl microfuge tube. To this, 1 µl 10 X reaction buffer and 1 µl DNase were added and 
were incubated at room temperature for 15 min. Afterwards, 1 µl stop solution (part of 
kit) was added and subsequently incubated at 70 ⁰ C for 10 min. Samples were placed 
on ice for at least 1 min, and stored at -70 ⁰ C until required. 
 
2.2.10.3 cDNA Synthesis 
 cDNA was synthesised using the qScript
TM
 cDNA Supermix (Quanta 
Biosciences). All reagents and buffers are contained a single reagent supplied in the kit. 
cDNA was synthesised as per manufacturers’ instructions. 500 ng of RNA (section 
2.2.10.1) was added to a RNase and DNase free 500 µl microfuge tube. To this 4 µl of 
the qScript cDNA Supermix 5 X was added and topped up to a final volume of 20 µl 
using diethyl-pyrocarbonate (DEPC) treated dH2O. 
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Samples were vortexed briefly and centrifuged for a few seconds to collect all of the 
reaction mix. They were then incubated using a PCR cycler using the following 
incubation protocol: 5 min at 25 ⁰ C; 30 min at 42 ⁰ C; 5 min at 85 ⁰ C; hold at 4 ⁰ C. 
Once completed the cDNA is now ready for use in RT-PCR reactions or alternatively 
can be stored at -20 ⁰ C until required. 
 
2.2.10.4 Semi-quantitive RT-PCR 
 Before carrying out qRT-PCR (section 2.2.10.5), genes of interest were 
amplified using PCR (section 2.2.2.4) along with the household gene Calmodulin 
control. As all primer sets used in this study for genes of interest and calmodulin, span 
an intron any gDNA contamination would be clearly visible when resolved on an 
agarose gel (section 2.2.3.2) as it would be slightly larger than an amplicon derived 
from cDNA alone. Once a positive single signal was observed, qRT-PCR could be 
carried out on that sample. 
 
2.2.10.5 Real-time PCR 
 A. fumigatus strains were inoculated in 50 ml SB media (2.1.3.17) and incubated 
for 21 h at 37 ⁰ C shaking at 200 rpm. At the 21 h time point, cultures were exposed to 
either a solvent control (MeOH) or 5 µg/ml gliotoxin (section 2.1.2.1) for three hours at 
37 ⁰ C shaking at 200 rpm. RNA was extracted as described in section 2.2.10.1 and 
cDNA was synthesised as in section 2.2.10.2. RT-PCR was carried out using the 
LightCycler® 480 Real-Time PCR System and KAPA Biosystems SybrFast Mix. 
Relative quantification analysis of differences in gene expression between different 
growth conditions and between different A. fumigatus strains was carried out using the 
Relative Quantification module allowing for differences in gene expression levels 
between samples to be calculated. Standard curves for the gene calm (internal control) 
and other genes of interest were created to measure PCR efficiency. 
 Standard curves were prepared for calm and each of the genes of interest by 
creating 5 orders of 10 fold serial dilutions of control cDNA in DEPC treated molecular 
H2O using 5 experimental replicates for each dilution series and for each PCR reaction 
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with their respective specific primer pairs. Cycling conditions were carried out as per 
manufacturers’ guidelines having 45 cycles per cycle being performed. Standard curves 
were calculated using the Relative Quantification Module which yielded a specific 
efficiency figure based on the reaction. An efficiency of 2 +/- 0.2 meant the PCR was 
successful and was saved for reference during experiments using these same cycling 
requirements for subsequent RT-PCR. 
 For this cDNA was diluted 1:2 in order for it to fit within the standard curve, and 
was done in quintuplicate for each sample and for each gene of interest being amplified. 
Relative program 2-(Delta Delta C(T)) method (Livak & Schmittgen, 2001) with results 
being given as a bar chart and table depicting the mean values for all genes and the 
relative ratio of a particular gene of interest:calm expression. 
 
2.2.11 mRNA Isolation and Preparation for Transcriptomic Analysis 
2.2.11.1 mRNA Isolation and Purification 
 A. fumigatus cultures were grown for 21 h at 37 ⁰ C shaking at 200 rpm. At the 
21 h mark biological replicates for each strain and each condition, were exposed to a 
solvent control (MeOH) or 5 µg/ml gliotoxin where appropriate. Samples were then 
incubated for three hours to bring the total incubation time to 24 hrs at 37 ⁰ C shaking 
at 200 rpm. RNA was extracted as described in section 2.2.10.1. For mRNA isolation 
and purification from these RNA samples were treated using Ambion® MicroPoly(A) 
Purist
TM
 (Life technologies) which enriches mRNA found in a given RNA sample. It 
achieves this by using an oligo (dT ) binding to the poly A tail of mRNA and different 
wash steps which removes any non-mRNA. Samples were treated as per manufacturers’ 
guidelines using all reagents and buffers contained within the kit as instructed. 
 A total amount of 10 µg RNA (section 2.2.10.1) was topped up to a volume of 
250 µl using RNase free water and treated as per kits protocol. mRNA purification can 
be carried out twice for increased purity and removal of other unwanted RNA’s 
however this greatly reduced mRNA yield. Samples were dissolved in 50 µl RNA 
storage solution (provided in kit) and stored at -70 ⁰ C until required. 
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2.2.11.2 Preparation of mRNA Samples for 2100 Agilent Bioanalyzer Analysis 
 To check mRNA samples (section 2.2.10.6) for integrity, they were analysed 
using an Agilent 2100 Bioanalyzer
TM
 and an Agilent RNA 6000 Nano Kit (Agilent). 
This system analyses both total RNA and mRNA using a chip system consisting of 
micro-fluidic channels which help separate RNA fragments based on their size as they 
are moved electrophoretically via an electrode chip insert. The day before use, the 
electrode chip insert was treated using RNase Zap (Agilent) to remove any un-wanted 
RNases which may be present, then placed in a petri dish filled with DEPC treated 
water (Sigma-Aldrich) and left in a dessicator overnight. The following morning this 
was placed back into the Agilent 2100 Bioanalyzer. Where appropriate, mRNA samples 
were diluted in RNase free water to a concentration of 250 ng/µl, in order for them to 
stay within range of the chip system. All reagents were allowed to equilibrate to room 
temperature for at least 30 min before being used.  
 550 µL RNA gel matrix was added to a RNase free sterile spin column (supplied 
in kit) and was centrifuged at 1370 g for 10 min. 65 µl of the filtrate was added to a 
sterile 0.5 ml microfuge tube. To this 1 µl RNA dye concentrate was added and the tube 
was vortexed for at least 10 secs to mix properly. RNA gel matrix-dye mix was then 
centrifuged at 13000 rpm for 10 min and kept at room temperature until use. 
 Using a cleansing chip, 350 µl of RNase Zap was added and placed into the 
Bioanalyzer for 1 min to further clean the electrode. After this the cleansing chip was 
washed using DEPC treated water until clean of residual RNase Zap. Next 350 µl DEPC 
treated water was added to the cleansing chip and placed into the Bioanalyzer for 1 min 
to remove any RNase Zap which could degrade any sample loaded later. The entire 
plate surface was then washed using RNase Zap. All samples and RNA ladder 
(provided in kit) were heated for 2 min at 70 ⁰ C.  
 A new RNA 6000 chip was placed in the chip priming station (Agilent). In well 
D-3, 9 µl of the gel-dye mix was added, ensuring the pipette tip was at the very bottom 
of the well and not at the side etc. Once aliquoted, the chip was primed using an 
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attached syringe which was positioned to the 1 ml mark. The syringe plunger was 
pushed down until held by the priming chip plunger and the syringe was held beneath 
the clip for 30 secs before being released slowly back to the 1 ml mark. This step allows 
for the application of defined pressure for chip priming.  
 To wells D-1&2 another 9 µl of gel-dye mix was added, any remaining gel-dye 
mix was discarded. To all 13 wells i.e. all wells except for D 1-3 inclusive, 5 µl RNA 
marker (provided with kit) was added. This RNA marker is a 25 bp marker which aids 
in standardising all sample wells to the RNA ladder. To lane D-4 1 µl RNA ladder was 
added while 1 µl of sample was added to each respective sample well, namely any wells 
apart from wells D 1-4 inclusively. For any sample well which no samples was added, 1 
µl RNA marker was added so each well contained the same volume.  
 The finished chip was then placed in an IKA vortexer for 1 min at 2400 rpm 
before being placed in the Bioanalyzer. 
 
2.2.11.3 RNA Integrity Number and Bioanalyzer Analysis of Prepared mRNA 
Samples 
 After a prepared Agilent Nano chip (section 2.2.11.2) was placed into the 2100 
Agilent Bioanlayzer, the chip loading station was closed and the ‘2100 Agilent 
Programme File was opened and the ‘Instrumental’ context was set to mRNA. As the 
chip was running sample information could then be entered. A chip run was 30-40 min 
long. Upon completion, RNA ladder was checked for a successful run. A typical run 
should yield 7 peaks: 1 marker peak and 6 separate RNA peaks each well separated 
from each other, each representing different sized RNA fragments. Successful mRNA 
samples should yield one clear marker peak and one ‘hump’ which represents mRNA. If 
more than one peak was found, sample was positive for ribosomal contamination and 
RNA (section 2.2.10.1) was treated again.  
 To measure RIN of samples, total RNA (section 2.2.10.1) was prepared for 
Bioanalyzer analysis (section 2.2.11.3) instead of mRNA samples (section 2.2.11.1). 
Here the ratio of the 18 S and 28 S ribosomal RNAs is measured and given as an 
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indicator for RNA integrity. Anything below a RIN value of 8 was discounted and new 
RNA was extracted as decribed in section 2.2.10.1. 
 
2.2.11.4 RNA Seq Analysis 
 Duplicate samples for each strain and condition were sequenced using the 
Sanger method in the Wellcome Trust. mRNA fragments were synthesised into cDNA 
by targeting of the poly(A) tail of the mRNA molecule and aligned to an Aspergillus 
fumigatus reference genome. Similar reads were assembled together using the RNA Seq 
analysis software Cuffdiff, part of the popular Cufflinks
TM 
analysis software which 
yielded a table for all reads/genes and their relative expression. This same software also 
depicts the p- and corrected q-value for all genes mapped, Significantly expressed genes 
(p < 0.05) were subsequently functionally characterised using FunCat
TM
 analysis  
 
2.2.12 Proteomic Techniques 
2.2.12.1 Protein Extraction of A. fumigatus for 2D-PAGE Analysis 
 Liquid cultures of A. fumigatus were filtered using sterile Mira-cloth and washed 
using sterile PBS. Washed mycelia was then ground in liquid nitrogen using a sterile 
pestle and mortar. Crushed mycelium (250 mg) was weighed into a 15 ml Falcon tube 
and was re-suspended in 1500 µl 10 % TCA which was pre-cooled to 4 ⁰ C. Each 
sample was then sonicated three times for 10 s at 10 % power, cooling samples on ice in 
between each sonication. Samples were incubated on ice for 30 min and then 
centrifuged for 15 min at 1677 g at 4 ⁰ C. Half the supernatant was removed and 
discarded using a Pasteur pipette while the remaining supernatant was used to re-
suspend the pellet. The re-suspended pellet was then transferred to a 2 ml microfuge 
tube and centrifuged at 11180 g at 4 ⁰ C for 10 min. Supernatant was removed and 
pellets were re-suspended in 60 µl dH2O and vortexed. To each sample, 1 ml of ice-cold 
acetone was added and mix by pipetting and vortexing to get the pellet into solution. 
Samples were stored at -20 ⁰ C and vortexed every 10 min for a total 1 h after which 
they were left at -20 ⁰ C overnight. 
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 Samples were centrifuged at 11180 g for 10 min and the supernatant was 
removed. 500 µl ice-cold acetone was added to each sample and were then centrifuged 
at 11180 g for 10 min. Supernatant was removed and samples were left to air dry for a 
maximum of 5 min. Samples were re-suspended in 500 µl IEF buffer (section 2.1.12.2) 
and left at room temperature for 1 hour. Afterwards, samples were centrifuged at 18894 
g for 1 min and the supernatants were removed to a clean microfuge tube. 
 
2.2.12.2 Bradford Protein Assay 
 Protein samples (section 2.2.12.1) were quantified using the Bradford protein 
assay. Using a BSA stock (1 mg/ml) (section 2.1.12.1) protein solutions of known 
protein concentration were created to generate a protein standard curve. Samples were 
diluted 1:10, 2 µl of which was added to a 96 well plate (Starstedt). 200 µl BioRad 
protein assay was added to each sample/standard and following a 10 min incubation at 
room temperature, absorbances were read using a spectrophotometer set at A595nm 
(Eppendorf Biophotometer). Protein concentration of samples was calculated using a 
plotted A595nm versus BSA concentration standard curve. All protein samples were 
analysed in triplicate. 
 
2.2.12.3 Iso-electric Focusing (IEF)  
 Protein samples (section 2.2.12.1) were diluted to have a final concentration of 
300 µg/250 µl using rehydration buffer (section 2.1.12.3). Into each sample, 
bromophenol blue was added and samples were then centrifuged at 16099 g for 5 min to 
remove any insoluble material. Samples were then transferred to one end of an IPG strip 
holder before an IPG strip (GE Healthcare) was placed gently, gel side facing down on 
top of the protein pushing it along the holder with the strip using a forceps to prevent 
contamination. Each strip was then overlaid with 1 ml overlay fluid (GE Healthcare) 
and subjected to iso-electric focusing on an IPGphor II IEF unit using the following 
programme: 
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Step 50 Volt 12 hours 
Step 250 Volt 0.15 hours 
Gradient 5000 Volt 2 hours 
Step 5000 Volt 5 hours 
Gradient 8000 Volt 2 hours 
Step 8000 Volt 1 hour 
 
After IEF, IPG strips were placed in 10 ml reduction buffer (section 2.1.12.4) for 20 
min, immediately followed by equilibration in 10 ml alkylation buffer (section 2.1.12.5) 
for a further 20 min. IPG strips were then rinsed in 1 X running buffer (section 2.1.12.7) 
before proceeding to 2D separation. 
 
2.2.12.4 12% SDS Gels for 2-D Poly Acrylamide Gel Electrophoresis (PAGE) 
 12% SDS gels were prepared by adding 280 ml Protogel (National 
Diagnositics), 182 ml resolving buffer (National Diagnostics), 230.3 ml sterile dH2O 
and 2.8 ml 10 % APS (section 2.1.12.8). Gel glass plates were washed with 70 % 
ethanol and placed in a gel casting system (GE Healthcare) using plastic spacers 
between each plate pair. Just before being cast, 280 µl TEMED (Sigma-Aldrich) was 
added and mixed gently. Gel was then immediately poured slowly into the caster and 
0.1 % 10X SDS buffer was sprayed on top of each gel to prevent air bubbles being 
formed. The casting cassette was sealed tightly in clingfilm and left at room temperature 
overnight to allow complete solidification of the gels. 
 Equilibrated IPG strips (section 2.2.12.3) were placed horizontally with the gel 
side facing the user and the positive end at the left hand side of the gel. Molten agarose 
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sealing solution (section 2.1.12.9) was aliquoted onto each strip sealing the gel. For 
second dimension separation, the BioRad PROTEAN
®
 Xi-II Plus Dodeca
TM
 Cell 
System was used. Gels were placed into the vertical electrophoresis cells as per 
manufacturers’ instructions. 3 L 10 X running buffer (section 2.1.12.6) was then poured 
and topped up if necessary using sterile dH2O. The Dodeca lid was secured and the gels 
were run at 1.5 W per plate at a maintained temperature of 6 ⁰ C for 20 h or until the 
bromophenol blue indication line was at the bottom of the gel. 
 
2.2.12.5 Coomassie Staining- Colloidal Method 
 Once gels had finished running (section 2.2.12.4) the glass plates were removed 
and the gels were placed in fixing solution (section 2.1.13.1) rocking for 3 h at room 
temperature followed by 2 x 30 min washes in dH2O. Next gels were placed in 
incubation buffer for 1 hour rocking at room temperature after which they were left to 
stain in stain solution (section 2.1.13.3) and were left rocking at room temperature 
overnight in the staining solution. The next day stain solution (section 2.1.13.3)  was 
removed and the gels were placed in neutralisation buffer (section 2.1.13.4) for 3 min 
after which gels were washed in 25 % methanol rocking for 1 min. After this wash step, 
gels were placed in fixing solution and incubated overnight, rocking at room 
temperature. Gels were produced in triplicate for each strain and condition used and 
were scanned using an HP Scanjet 5400C. 
 
2.2.12.6 Progenesis
TM 
 
Protein spots were analysed using Progenesis
TM
 same spot software to determine 
differential expression between different samples. Samples with a significance value 
≥0.05 were used later for LC-MS identification. 
 
2.2.13 Mass Spectrometry (LC-MS) 
2.2.13.1 Protein Spot Preparation-Shevchenko method (Shevchenko et al., 2006) 
 2D-PAGE separated spots were chosen as described in section 2.2.12.6. All 
reagents used were HPLC grade and all 1.5 ml microfuge tubes were treated with aceto-
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nitrile prior to use. Each gel was washed once using sterile water before chosen spots 
were cut out using a sterile scalpel and placed into pre-washed a 1.5 ml tube. Gel pieces 
were incubated in 100 µl de-staining buffer (section 2.1.14.1) shaking at room 
temperature for 30 min, or until all the stain was removed. Next, 500 µl acetonitrile was 
added to each of the gel pieces and was left for 10 min at room temperature causing the 
gel pieces to shrink and turn white indicating removal of the majority of the coomassie 
stain. 
 Samples were then trypsin digested with 50 µl (or enough to cover the gel piece) 
trypsin buffer (section 2.1.14.3) and incubated on ice for 30 min. More trypsin buffer 
was added if necessary. Gel pieces were incubated for a further 90 min to saturate gel 
pieces with trypsin after which 20 µl of 50 mM ammonium bicarbonate solution 
(section 2.1.14.4) was added to prevent the gel pieces becoming dehydrated during 
digestion. Gel pieces were then incubated at 37 ⁰ C static overnight to allow for 
complete trypsin digestion of sample peptides.  
 Digested peptide products were transferred to a new sterile 1.5 ml microfuge 
tube. To each digested gel piece tube, 100 µl extraction buffer (section 2.1.14.5) was 
added and each sample was incubated for 15 min at 37 ⁰ C shaking to help collect any 
residual peptide fragments. The supernatant from this was added to the trypsin digest 
supernatant and were dried overnight in a vacuum centrifuge. Dried extracts could be 
stored at this point at -20 ⁰ C for a few months.  
 Prior to LC-MS analysis, dried extracts were re-suspended in 20 µl 0.1 % formic 
acid (v/v) (section 2.1.14.6). Sample were then sonicated in a sonication bath for 5 min 
and subsequently centrifuged at 5478 g for 2 min. Samples (15 µl) were aliquoted into 
LC-MS loading vials (Agilent) and analysed using and Agilent 6340 Ion Trap Liquid 
Chromatography Mass Spectrometer. 
 
2.2.14 Glutathione Assay 
2.2.14.1 A. fumigatus Lysate Preparation 
 A. fumigatus mycelia were harvested through sterile Mira-cloth, washed with 
dH2O and dried using tissue paper, to remove as much liquid as possible. Dried mycelia 
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(250 mg) was then weighed into a 2 ml microfuge tube, to which 600 µl ice-cold 5 % 
SSA (w/v) (section 2.1.15.6) was added along with a tungsten bead. This was repeated 
using glutathione lysis buffer (section 2.1.15.4). Both sets of samples were bead beated 
at 30 Hz for 3 min and subsequently centrifuged at 11180 g at 4 ⁰ C for 10 min. 
Supernatants were removed to a clean microfuge tube wrapped in tin foil, and kept on 
ice. Glutathione lysis buffer samples were used for protein quantification as described in 
section 2.2.12.2. 5 % SSA treated samples were neutralised using tri-ethanolamine.  For 
reduced glutathione (GSH) quantification, samples were diluted 1/10 using Glutathione 
assay buffer (section 2.1.15.5), while for oxidised glutathione (GSSG) samples were 
diluted 1/5 in Glutathione assay buffer. All samples, GSH & GSSG, were then 
centrifuged at 11180 g at 4 ⁰ C for 10 min. Supernatant was removed to a clean 
microfuge tube wrapped in tin foil and kept on ice. Any excess of sample could be 
stored at -70 ⁰ C for a few months. 
 
2.2.14.2 S. cerevisiae Lysate Preparation. 
 S. cerevisiae samples were incubated in 5 ml appropriate media at 30 ⁰ C 
shaking at 200 rpm overnight. Cells were harvested via centrifugation at 1677 g. 
Resulting pellet was re-suspended in 500 µl ice-cold PBS and re-centrifuged at 11180 g 
at 4 ⁰ C for 10 min. Cells were then re-suspended in either 250 µl lysis buffer (section 
2.1.15.4) or 5 % SSA (w/v) (section 2.1.15.6) and transferred to a screw top microfuge 
tube. To this ~100 µl silica beads were added and the sample were bead beated for 1 
min 30 secs at 30 Hz. Samples were then centrifuged at 11180 g at 4 ⁰ C for 10 min 
and prepared as described in section 2.2.14.2. 
 
2.2.14.3 GSH/GSSG Standard Preparation 
 Using a 1 mg/ml solution of GSH and a 2.01 mg/ml solution of GSSG, serial 
dilutions of known glutathione molarity were made: 13.2, 6.6, 3.3, 1.65, 0.825 and 
0.4125 nmol/ml for both GSH and GSSG. 
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2.2.14.4 GSH/GSSG Assay 
 All samples/standards and reagents were kept on ice and kept from direct 
exposure from the light (all reagents were wrapped in tin foil, and ice buckets were 
covered when able. All GSSG samples/standards (100 µl) were treated with 2 µl of a 
1/5 dilution of 2-vinyl-pyridine this blocks any free GSH in these samples from giving a 
false positive result later on. They were left for 1 hour at room temperature after which 
the reaction was stopped by adding 6 µl of a 1/2 dilution of tri-ethanolamine which 
neutralises the 2-vinyl-pyridine. This was left at room temperature for at least 10 min 
prior to being used in the assay. 
 NADPH (5 mM, section 2.1.15.10) was thawed on ice making sure not to 
expose it to any unnecessary heating or light exposure. 20 µl of samples/standards and 
blanks were aliquoted to a 96 well plate. To this, 44.2 µl of 10 mM DTNB + 
Glutathione reductase mix was added. Next 42 µl of 5 mM NADPH was added to each 
well and the plate was shaken gently to mix. Reaction was left at room temperature for 
1 min and 30 secs before the absorbance was measured at 412nm. GSH levels were given 
by subtracting the absorbance values of the total GSH samples from the absorbance 
values of their respective GSSG samples. This gave the true GSH absorbance and both 
the GSH and GSSG levels could be measured directly from their respective standard 
curves. 
 
2.2.15 Oxidative Stress Assays 
2.2.15.1 Catalase Assay 
 Protein lysates from either A. fumigatus (section 2.2.13.1) or S. cerevisiae 
(section 2.2.13.2) were used to measure the redox state of samples under different 
conditions. Catalase is an enzyme which breaks down hydrogen peroxide into water and 
O2, using known concentrations of hydrogen peroxide (5 mM) and increasing units of 
catalase (0, 0.1, 0.5, 1 & 3 U/ml) the reduction in absorbance was measured indicating a 
reduction in hydrogen peroxide concentration due to increasing levels of catalase. 50 µl 
of sample lysate was added to 5 mM hydrogen peroxide which already had its initial 
absorbance measured. The reduction in absorbance was recorded over 360 s and the 
Units of catalase/ml were calculated using the formula: 
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    OD240(360 s)- OD240(0 s) = U/ml catalase 
     360 s 
 
 
2.2.15.2 Superoxide Dismutase Assay 
 Protein lysates from either A. fumigatus (section 2.2.13.1) or S. cerevisiae 
(section 2.2.13.2) were used to measure the SOD levels under different conditions. In a 
plastic cuvette, 940 µl of a 6 X 1 mM Xanthine/0.3 mM Nitrotetrazolium Blue Chloride 
(NBT) was added. To this different U/ml of SOD was added in order to generate a 
standard curve of % inhibition. Lastly 0.3 U/ml Xanthine oxidase was added to initiate 
the reaction.  
SOD activity was calculated by measuring  the λ 560nm/min for each sample/control and 
calculated by the following formula: 
λ 560nm 5min30s – λ 560nm 30s  = λ 560nm/min 
  5min 
Using this value the   inhibition was calculated by comparing the λ 560nm/min of the 
negative control (no SOD present) and the respective sample using the following 
formula: 
λ 560/min control – λ 560/min sample x 100 
 λ 560/min Control      1 
Using the % inhibition results for the standards, a standard curve was generated with % 
inhibition versus SOD concentration U/ml. From this the U/ml SOD could be calculated 
for each sample using their respective % inhibition. 
 
2.2.15.3 H2DCFDA Superoxide Detection in A. fumigatus 
 A six well plate was inoculated with with 1 X 10
6
 conidia/ml in a total volume 
of 4 ml Sabouraud media (section 2.1.3.17). To each well a sterile microscope coverslip 
was added and cultures were incubated at 37 ⁰ C static overnight. The following 
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morning any excess mycelia was removed leaving only the supernatant and lower mat 
of cells. To each well in duplicate, solvent control (MeOH), positive control (Hydrogen 
peroxide) and/or gliotoxin were added. Samples were incubated at 37 ⁰ C static for 30 
min. Afterwards supernatant was removed and cells were washed in 4 mls PBS for 5 
min. This was removed and another 3 mls SB media was added to which a 2.5 µg/ml 
H2DCFDA was added. Cells were incubated at 37 ⁰ C for 40 min before being placed 
on a microscope slide and visualised using a fluorescent microscope and a GFP filter. 
 
2.2.16 Organic Extraction of S. cerevisiae Culture Supernatant for LC-MS 
 S. cerevisiae strains were inoculated in triplicate in 5 ml YPD media (section 
2.1.3.1) and were incubated overnight at 30 ⁰ C shaking at 200 rpm. The following 
morning these cultures were used to re-inoculated another 30 ml fresh YPD in a 50 ml 
Falcon tube and let grow till at mid exponential phase. At this point cells were exposed 
to either solvent control or 5 µg/ml gliotoxin (section 2.1.2.1) for 3hours. Afterwards 
samples were centrifuged at 4293 g for 10 min transferring the supernatant to a new 
Falcon tube. To this equal volume of chloroform was added and mixed by inversion. To 
further separate the organic phase from the inorganic phase, samples were centrifuged at 
3000 rpm for 3 min. Using a sterile Pasteur pipette, the organic phase was removed to a 
fresh 50 ml Falcon tube and left in an extraction hood overnight to allow the chloroform 
to evaporate and only the organic pellet to remain. Pellet was re-suspended in 1/100
th
 its 
original volume and transferred to a glass LC-MS sampling tube (Agilent) whereby it 
was now ready to be run on the LC-MS for organic metabolite detection. 
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Chapter 3 
Phenotypic and biochemical 
characterisation of A. fumigatus gliT, gliZ 
mutants  
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3.1 Introduction 
  The fungal secondary metabolite gliotoxin, was first identified in 1936 in the 
culture filtrate of Trichoderma spp, (Weindling & Emerson 1936). It wasn’t until 
Johnson et al., (1943) isolated gliotoxin from Gliocladium fibriatum, that gliotoxin was 
named and a corrected mass of 326 Da was identified. The structure of gliotoxin, Figure 
3.1, was elucidated by Bell et al., (1958) and later confirmed by the isolation of the 
crystal structure of gliotoxin using X-ray crystallography and later, Nuclear Magnetic 
Resonance (NMR) (Beecham et al.,1966; Kauadji 1990). Gliotoxin is classed as an 
epipolythiodioxopiperazine (ETP) based on the presence on the indispensible trans-
molecular di-sulphide bridge and piperazine ring (Gross et al., 2010). 
 
 
Figure 3.1 Chemical structure of the non-ribosomal peptide gliotoxin. Note the 
trans-molecular disulphide bridge shown here in its closed oxidised form. Source: 
http://www.abcam.com/ps/datasheet/images/142/ab142437/Gliotoxin-ab142437-
ChemicalStructure-1.jpg 
 
 The key precursors utilised in the formation of gliotoxin were found via radio-
labelled amino acid studies identifying L-phenylalanine and L-serine as the main 
components utilised in the formation of the diketopiperazine structural scaffold required 
for gliotoxin biosynthesis (Suhadolnik & Chenoweth 1958). As neither, L-
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phenylalanine nor L-serine possess a sulphur moiety, labelled L-cysteine, L-methionine 
and sodium sulphate were used in order to identify the precursors of disulphide bridge 
formation in gliotoxin. These were found to act as donors of their sulphur atoms but did 
not reflect actual in vivo gliotoxin biosynthesis (Suhadolnik & Chenoweth 1958; 
Gardiner et al.,2005). The key components involved in this in vivo biosynthesis of 
gliotoxin were later identified following the discovery of the genes responsible for 
gliotoxin biosynthesis. 
 
Following the full genome sequencing of A. fumigatus, a 12 gene cluster was 
identified which closely resembled a similar ETP secondary metabolite cluster, the 
sirodesmin biosynthetic cluster, found in Leptosphaera maculans and was identified as 
the putative gliotoxin biosynthetic cluster, gli Figure 4.2 (Gardiner & Howlett 2005). 
This gli cluster was later updated to include another gene, gliH which encodes a 
hypothetical protein, bringing the total number to 13 (Schrettl et al., 2010).  
 
  
 
 
 
 
 
 
Figure 3.2 Gliotoxin biosynthetic cluster gli from A. fumigatus. Diagram modified 
from Gardiner et al, (2005) including the recent addition of the thirteenth gli cluster 
gene gliH (Schrettl et al., 2010). 
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The functions of certain gli genes have been characterised using a functional 
genomics approach. gliZ has been annotated as the transcriptional regulator of the gli 
cluster, with loss of gliZ resulting in the complete abolishment of gliotoxin biosynthesis, 
and believed to silence the entirety of this cluster (Gardiner & Howlett 2005; Bok et 
al.,2006; Forseth et al.,2011). gliZ encodes a Zn2Cys6 binuclear finger transcription 
factor responsible for the transcriptional regulation of the gli cluster (Bok et al., 2006). 
In A. fumigatus ΔgliZ, expression of gliI and gliotoxin biosynthesis was found to be 
abolished (Bok et al., 2006). Over-expression of A. fumigatus gliZ induces a 
corresponding increase in gliotoxin production (Bok et al., 2006). Additionally, Forseth 
et al., (2011) identified 9 gliZ dependent metabolites absent in ΔgliZ organic extracts 
using 2D NMR spectroscopy and are believed to be involved in gliotoxin metabolism in 
a gliZ dependant manner.   
Interestingly A. fumigatus gliT, annotated as a thioredoxin oxidoreductase, was 
found to be independent of gliZ regulation and could be induced upon exogenous 
gliotoxin addition (Schrettl et al., 2010). Furthermore, A.fumigatus ΔgliT was unable to 
produce any detectable gliotoxin and elicited a hypersensitive phenotype to exogenous 
gliotoxin highlighting its role in self-protection against gliotoxin exposure (Schrettl et 
al., 2010). GliT is involved in the oxidation of reduced gliotoxin closing the disulphide 
bridge (Figure 3.3). Only oxidised gliotoxin is actively effluxed from the cell, 
presumably facilitated by GliA, with the loss of GliT mediated oxidation and 
subsequent efflux has attributed to ΔgliT sensitivity to exogenous gliotoxin (Bernardo et 
al., 2003; Schrettl et al., 2010).  
 
 The presence of a disulphide bridge is indispensible for gliotoxin toxicity 
(Scharf et al., 2010; Scharf et al., 2011). Up until recently, no concurrent proof of the 
mechanism for the incorporation of the necessary sulphur moieties was to be found. 
GliG is annotated as a glutathione-S-transferase, an enzyme involved in the 
incorporation of glutathione molecules into different chemical structures, however what 
role it may play in gliotoxin biosynthesis was unclear (Gardiner & Howlett 2005). 
When disrupted in A. fumigatus, gliotoxin biosynthesis is abolished, indicating GliG is 
fundamental in some part of the gliotoxin biosynthesis pathway (Davis et al., 2011).  
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Figure 3.3 Proposed model of GliT mediated protection against gliotoxin GliT 
protects the cell by acting as an oxido-reductase altering the trans-molecular disulphide 
bridge from the reduced form of gliotoxin (GT-SH-SH) to the oxidised form (GT-S-S) 
facilitating its efflux. Image taken from Schrettl et al., (2010) 
 
Comparative LC-MS ToF analysis identified an accumulation of a metabolite 
specifically in A. fumigatus ΔgliG supernatant extracts which was absent form A. 
fumigatus wild-type (Davis et al., 2011). NMR spectroscopy later identified this as 6-
benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine 2,5-dione, a shunt metabolite 
involved in the latter stages of gliotoxin biosynthesis (Davis et al., 2011). Based on the 
presence of a hydroxyl group found on its C-6, this work proposed that GliG was 
involved in the incorporation of two glutathione molecules at these C-6 and C-3 
positions after hydroxylation at these sites and subsequent elimination of water creating 
a reactive acyl-imine (Davis et al., 2011). This was the first work which demonstrated 
GliG glutathione S-transferase activity, and due to A. fumigatus ΔgliG ability to grow 
equally well as A. fumigatus wild-type in the presence of exogenous gliotoxin, 
confirmed it was not involved in gliotoxin auto-protection (Davis et al., 2011). 
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 GliP encodes a non-ribosomal peptide synthetase, enabling gliotoxin to be 
produced outside of the ribosomal dependent pathway and is instead produced via 
modification of L-phenylalanine and L-serine (Gardiner & Howlett 2005; Cramer et 
al.,2006) . Loss of gliP leads to abolition of gliotoxin production, highlighting its role in 
gliotoxin biosynthesis (Cramer et al., 2006). Interestingly, mice infected with A. 
fumigatus ΔgliP conidia showed that loss of gliP attenuates Aspergillus infection when 
compared to wild-type (Sugui et al., 2007). Similarly, larvae of the greater wax moth, 
Galleria mellonella, show reduced infection when injected with conidial suspensions of 
A. fumigatus ΔgliT when compared to A. fumigatus wild-type (Schrettl et al., 2010). 
Both these results highlight gliotoxin as an important virulence factor. 
 GliK function was not characterised until relatively recently. In an A. fumigatus 
ΔgliK strain, gliotoxin biosynthesis was abolished indicating GliK was involved in 
gliotoxin biosynthesis (Gallagher et al., 2012). This biosynthetic function was later 
confirmed in vitro as γ-glutamate cyclotransferase activity (Scharf et al., 2013). 
Contrary to other gli genes, H2O2 (1 mM) was found to significantly increase expression 
of A. fumigatus gliK not gliotoxin (Gallagher et al., 2012). A. fumigauts ΔgliK also 
showed increased sensitivity to exogenous gliotoxin exposure, however it was not as 
sensitive as ΔgliT (Gallagher et al., 2012; Schrettl et al., 2010). Increased expression of 
gliK upon addition of H2O2 in A. fumigatus and corresponding sensitivity of A. 
fumigatus ΔgliK to exogenous H2O2, suggests a role in tackling with H2O2 mediated O 
S.  
Reverse phase HPLC and liquid chromatography mass spectrometry identified 
unique metabolites extracted from A. fumigatus ΔgliK culture supernatants which were 
absent in the wild-type, as well as  significantly elevated levels of ergothioneine in 
ΔgliK compared to wild-type (Gallagher et al., 2012).  Interestingly exogenously added 
gliotoxin efflux of A. fumigatus ΔgliK was significantly reduced compared with A. 
fumigatus wild-type, suggesting GliK facilitates gliotoxin efflux by some currently 
undefined mechanism (Gallagher et al., 2012). 
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 GliA is annotated as a Major Facilitator Superfamily (MFS) transporter with the 
putative function of gliotoxin efflux from the cell (Gardiner & Howlett 2005). In L. 
maculans ΔsirA lacking the sirodesmin putative ABC transporter, sensitivity to both 
gliotoxin and sirodesmin was seen (Gardiner et al., 2005). When transformed with A. 
fumigatus gliA, this sensitivity was reduced towards gliotoxin only and not sirodesmin, 
showing GliA attenuation of gliotoxin toxicity presumably through facilitating gliotoxin 
efflux (Gardiner et al., 2005; Gallagher et al., 2012). Interestingly, loss of L. maculans 
sirA elicited increased secretion of sirodesmin which may suggest that sirA is involved 
in control of secretion of sirodesmin rather than as an efflux pump (Gardiner et al., 
2005). 
 
 Although there has been much progress into the functional characterisation of 
these genes in recent years, there are a lot of questions which remain unanswered. The 
fact that gliT is still expressed in A. fumigatus ΔgliZ means that the cluster is not 
actually silent in this mutant. This means there is a need to create a strain in which the 
gli cluster is completely silenced. To this end, an A. fumigatus double knockout was 
created lacking the cluster transcriptional activator gliZ and the independently regulated 
oxido-reductase gliT with the aim of characterising the response of this strain to 
gliotoxin. 
 
3.2 Generation of ΔgliTΔgliZ293 
Bok et al., (2006) created an A. fumigatus ΔgliZ strain in a uracil/uridine 
auxotroph A. fumigatus wild-type, replacing the gliZ gene with a pyrG cassette creating 
a uracil/uridine prototroph. Using this strain, a bipartite gene disruption technique 
(Nielsen et al., 2006) was employed to knockout A. fumigatus gliT (AFUA_6G09740) 
replacing the gene with a pyrithiamine (ptrA) resistance marker. This was achieved by 
amplifying two separate genomic regions from a ΔgliT strain which was originally 
created in Schrettl et al., (2010). Constructs used for the disruption of A. fumigatus gliT 
in A. fumigatus ΔgliZ were amplified using genomic DNA isolated from A. fumigatus 
ΔgliT strain. Each construct contained sequences of homology flanking gliT (1.3 and 
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1.2 kb respectively) and two part regions coding the pyrithiamine resistance marker 
with a region of 560 bp in common (Figure. 3.4) (Schrettl et al., 2010) giving total 
construct sizes of 2.6 kb and 2.2 kb respectively. 
 
 
 
 
 
 
 
Figure 3.4 Illustration of gene disruption cassettes used to disrupt ΔgliT: 5’ and 3’ 
gene disruption cassettes were amplified using primers OgliT + OptrA2 & OptrA1 + 
OgliT6 respectively to yield constructs of 2.6 and 2.2 kb in length. 
 
 Constructs were amplified using a high fidelity taq with a high proof read ability 
to ensure sequence integrity. Resulting PCR amplified constructs were separated via gel 
electrophoresis to check for single bands and correct size (Figure. 3.5). 
 
 
 
 
 
Figure 3.5 PCR amplification of transformation constructs from ΔgliT genomic 
DNA Lane 1= 1 kb NEB ladder, lanes 2-5= 5’ construct, lanes 6-9= 3’ construct, lane 
10= negative control 
1 2 3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
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PCR products from Figure 3.5 were excised and purified prior to transformation. 
Transformants were identified by resistance to pyrithiamine on agarose plates. A total 
number of 25 transformants elicited resistance to pyrithiamine. These were isolated and 
their gDNA extracted. Potential transformants were checked by PCR qualification 
amplifying the resistance marker via an internal pyrithiamine primer and an external 
primer which was located outside the constructs used in the original transforming 
procedure for both 5’ and 3’ ends of gliT to yield an expected band size of 3.3 kb and 
2.5 kb respectively in strains lacking gliT (Figure. 3.6 A & B). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 A-B PCR qualification of pyrithiamine resistance cassette insertion in 
place of A. fumigatus gliT A= 5’ gliT region; lane 1 = 1 kb NEB ladder, lane 2= 
AF293, lane 3=  ΔgliT26933, lane 4= ΔgliZ293, lane 5= sample 11, lane 6= negative 
control. B = 3’ gliT region; lane 1- 1 kb NEB ladder, lane 2 = AF293, lane 3= 
ΔgliT26933, lane 4= ΔgliZ293, lane 5= sample 10, lane 6= sample 11, lane 7= negative 
control. 
1 2 3 4 5 6 
1 2 3 4 5 6 7 
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 Out of all the transformants screened, only one yielded the correctly sized bands 
for an A. fumigatus ΔgliTΔgliZ293 strain. This PCR qualification allowed for quick 
selection of possible candidates and meant instead of a total 25 possible transformants 
to be checked by Southern blotting, only two transformants were checked. A total 
amount of 10 µg of gDNA from AF293, ΔgliT26933, ΔgliZ293 and transformants were 
restriction digested using XbaI for 3 hours at 37 ⁰ C and separated by gel 
electrophoresis.  
 The 5’ end of the A. fumigatus gliT region was probed using a DIG-labelled 
oligo probe. The expected hybridisation pattern of A. fumigatus wild-type and ΔgliT 
were 6.4 kb and 3 kb respectively as seen in Figure 3.7 which represents the expected 
hybridisation pattern in A. fumigatus wild-type of the gliT probe (Figure. 3.7 A) and 
ΔgliT (Figure. 3.7 B). 
 
 
Figure 3.7 A-B Hybridisation of 5’ gliT probe during Southern Blotting in wild-
type (A) and ΔgliTΔgliZ. This represents the probing strategy used in the confirmation 
of disruption of gliT in ΔgliZ showing the flanking regions in blue, gliT gene in green, 
pyrithiamine resistance cassette in red (ptrA), the 5’, 1 kb DIG-labelled probe in black 
and the length of fragment after restriction digestion with XbaI 
 
 The resulting southern blot was exposed and developed as seen in Figure 3.8. 
From Figure 3.8 below, one transformant had the correct sized fragment for gliT 
replacement with ptrA which was also identical to the ΔgliT fragmentation pattern used 
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as a positive control. The A. fumigatus wild type signal identifying gliT presence, was 
still present and could be seen in AF293 (wild-type) and ΔgliZ293. The multiple 
fragments seen for the sample 10 suggest multiple integrations of the resistance cassette, 
one of which is positive for gliT presence and none of which are positive for gliT loss. 
The presence of a single KO band for sample 11 confirmed the creation of an A. 
fumigatus ΔgliTΔgliZ293. 
 
 
 
 
Figure 3.8 Southern blot confirmation of ΔgliTΔgliZ293 strain: Successful gliT 
replacement with the pyrithiamine resistance cassette confirmed using a 1 kb DIG-
labelled probe of the 5’ gliT region after previously being restriction digested with 
XbaI. A. fumigatus wild-type and ΔgliT band sizes are shown with arrows of 6.4 kb and 
3 kb respectively. Lane 1= negative control, lane 2= sample 10 , lane 3= sample 11/ 
ΔgliTΔgliZ, lane 4 = ΔgliZ293, lane 5= DIG-labelled ladder VII, lane 6= ΔgliT26933 lane 
7= AF293 wild-type 
 
3.3 Growth response of gliT, gliZ mutants in the presence of gliotoxin 
 A. fumigatus can grow in the presence of exogenous gliotoxin (< 20 µg/ml) 
showing no reduction in its growth response. Deletion of gliT elicits a highly sensitive 
response to relatively low gliotoxin concentrations (5 µg/ml) (Schrettl et al., 2010). 
Deletion of gliZ, elicits some sensitivity but nothing as dramatic as ΔgliT, presumably 
due to gliT still being expressed in this strain (Gardiner & Howlett 2005; Schrettl et al., 
2010). In an A. fumigatus ΔgliTΔgliZ strain, the cluster should now be completely silent 
and may be expected to elicit a sensitive response to gliotoxin exposure. 
 In Figure 3.9 A, A. fumigatus ΔgliTΔgliZ293 grows like AF293 wild type and 
ΔgliZ293 indicating no loss in fitness on AMM once the both genes are absent, however 
1 2 3 4 5
	
4	  
6
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7
	
4	  
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ΔgliT26933 growth is slightly altered perhaps due to a difference in its strain background 
i.e. AF293 vs. ATCC26933. When challenged with gliotoxin, the growth response of 
each strain changes dramatically (Figures. 3.9 B and C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9 A-C Phenotypic growth analysis of A. fumigatus gliT, gliZ mutants in 
the absence and presence of gliotoxin Representative  images of comparative growth 
analysis of A. fumigatus strains  ΔgliT26933 (top left),  AF293 (top right), ΔgliZ293 
(bottom left) and ΔgliTΔgliZ293 (bottom right) on AMM media (A), 5 µg/ml gliotoxin 
(B) and 10 µg/ml gliotoxin (C) repeated on three independent occassions  
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5 µg/ml gliotoxin elicits a sensitive phenotypic response in A. fumigatus 
ΔgliTΔgliZ293 when compared to A. fumigatus wild-type, which is greater than ΔgliZ 
sensitivity yet not as dramatic as ΔgliT26933. This suggests that the absence of gliT and 
gliZ is less deleterious than loss of gliT alone but more than loss of gliZ alone. 
 
These results may suggest the existence of some gliotoxin biosynthesis in ΔgliT 
which augments exogenous gliotoxin toxicity. In ΔgliT, gliotoxin can still potentially be 
produced, however without GliT it can no longer be oxidised and subsequently effluxed 
from the cell. This could lead to an accumulation of gliotoxin de novo thus potentiating 
cell stress explaining ΔgliTs sensitivity to gliotoxin.  
 ΔgliTΔgliZ293 is sensitive to gliotoxin, but more resistant than ΔgliT26933. This 
relative resistance could be attributed to the inability of this strain to produce gliotoxin 
unlike ΔgliT26933, due to complete inactivation of the gli cluster. 
 
3.4 Phenotypic response of gliT, gliZ mutants to diamide, and hydrogen peroxide 
 Comparative analysis of the phenotypic growth response of gliT and gliZ 
mutants to oxidative stress was carried using the thiol oxidising agent diamide and the 
ROS producer H2O2. The growth response of three A. fumigatus gli mutants: ΔgliT, 
ΔgliZ and ΔgliTΔgliZ, were compared to each other and the A. fumigatus AF293 wild 
type strain AF293 to a range of concentrations of diamide (1 & 2 mM) and H2O2 (0.5-2 
mM). 
Previously exposure to H2O2 was demonstrated to elicit a sensitive phenotype in 
A. fumigatus ΔgliK indicating its role in OS response (Gallagher et al., 2012). With this 
in mind, it was questioned whether sensitivity would be seen in other gli mutants which 
no longer expresse gliK. Figure 3.10 A-C illustrates the growth response of AF293, 
ΔgliT, ΔgliZ and ΔgliTΔgliZ when exposed to diamide. 2mM diamide elicited 
significant differences in the growth response of strains. A. fumigaus ΔgliT is 
significantly different from all strains i.e. AF293 (P = 0.012), ΔgliZ (P = 0.01) and 
ΔgliTΔgliZ (P = 0.015).  
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Figure 3.10 A-C Phenotypic growth analysis of A. fumigatus gliT, gliZ mutants in 
the absence and presence of diamide Representative images of comparative growth 
analysis of A. fumigatus strains ΔgliT26933 (top left),  AF293 (top right), ΔgliZ293 (bottom 
left) and ΔgliTΔgliZ293 (bottom right) on AMM media (A), 1 mM diamide (B) and 2 
mM diamide (C) repeated on three independent occassions. 
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Exposure to 2 mM diamide elicits a significant decrease (P = 0.017) in the radial 
growth ΔgliTΔgliZ when compared to AF293 wild-type. Interestingly, there is also a 
significant decrease (P= 0.019) in radial growth response between ΔgliZ and 
ΔgliTΔgliZ. AF293 is not significantly different than ΔgliZ indicating it has a wild-type 
growth response to diamide exposure and the significant decrease seen in ΔgliTΔgliZ 
compared to AF293 and ΔgliZ is due to complete silencing of the gli cluster. Diamide 
induces stress via the oxidation of glutathione to its oxidised GSSG form, with strains 
having naturally higher levels of GSH being increasingly sensitive to diamide, and cells 
with low levels of GSH being naturally resistant (Kosower et al., 1969). These results 
could suggest that ΔgliTΔgliZ may have naturally altered levels of GSH/GSSG in vivo.
 Exposure to a range of H2O2 (0.5-2 mM) does not result in any significant 
sensitivity in any of the strains Figure 3.11 A-C. This implies that loss of the gliotoxin 
self protection mechanism (GliT) and/or gliotoxin biosynthesis are not crucial in OS 
induced by exposure to H2O2.  
The sensitivity of ΔgliTΔgliZ to diamide but not H2O2 implies the glutathione 
levels may be altered when the gli cluster has been silenced. This implied alteration to 
GSH levels could be directly linked to the absence of gliT creating a subsequent greater 
demand for GSH to replace GliT activity in the cell. The reason the same phenotype is 
not seen in ΔgliT could be due to gliotoxin presence which could be redox cycling in the 
presence of diamide i.e. GliT activity is being chemically substituted by the presence of 
diamide. ΔgliZ on the other hand still has gliT expression and is thus un-perturbed to 
diamide toxicity.  
A. fumigatus ΔgliK sensitivity to H2O2 appears to be unique to this strain as 
H2O2 exposure in ΔgliZ and ΔgliTΔgliZ, which have no gliK expression, does not have 
a deleterious effect. ΔgliKs sensitivity to H2O2 could be caused by some component of 
gliotoxin biosynthesis which, in the absence of GliK, potentiates H2O2 stress e.g. a 
reactive intermediate which requires GliK to be active to prevent auto-toxicity.  
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Figure 3.11 A-C Phenotypic growth analysis of A. fumigatus gliT, gliZ mutants in 
the absence and presence of H2O2 Representative images of comparative growth 
analysis of A. fumigatus strains ΔgliT26933 (top left),  AF293 (top right), ΔgliZ293 (bottom 
left) and ΔgliTΔgliZ293 (bottom right) on AMM media (A), 1 mM H2O2 (B) and 2 mM 
H2O2 (C) repeated on three independent occassions. 
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3.5 Gliotoxin induction of oxidative stress 
 Previously in section 3.4, H2O2 exposure was found not to elicit any sensitivity 
in A. fumigatus gliT and gliZ deletion strains. However each of them possess varying 
degrees of sensitivity when challenged with gliotoxin (Figure 3.9 A-C). Gliotoxin has 
been previously demonstrated to induce OS via redox cycling between its oxidised and 
reduced form (Sutton & Waring 1996). Gliotoxin can directly interact with elements of 
the OS response, particularly the glutathione and the thioredoxin system, each key in 
maintaining redox balance inside the cell and preventing OS (Bernardo et al., 2001; 
Choi et al., 2007). To biochemically analyse the effect gliotoxin exposure had on 
enzymes involved in the OS response, two biochemical assays were set up using protein 
lysates from A. fumigatus mycelia exposed and un-exposed to 5 µg/ml gliotoxin. 
 
3.5.1 Gliotoxin induces superoxide dismutase expression 
 Superoxide dismutases (SOD) are key enzymes in the OS response, involved in 
dismutating the superoxide anion to H2O2 and oxygen (Mccord & Fridovich 1969). An 
increase in superoxide dismutase activity marks an increase in the presence of super 
oxide radicals and is a good indicator of OS. SOD activity can be measured 
spectrophotmetrically at Δ560nm by measuring SODs ability to inhibit the formation of 
the anion Nitroblue tetrazolium-formazan (NBT-formazan) from nitroblue tetrazolium 
(NBT) resulting in a lower absorbance Figure 3.12. 
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Figure 3.12 SOD inhibition assay. Xanthine is broken down into hydrogen peroxide 
and the superoxide radical via xanthine oxidase. In the absence of SOD, these 
superoxide radicals are then utilised to form the anion NBT-formazan from NBT 
creating a purple precipitate. 
 
 From Figure 3.12, the presence of SOD can inhibit the formation of NBT-
formazan which subsequently reduces the amount of precipitate that is formed and thus 
the absorbance of the sample. Approximately 1 U/ml SOD results in 50 % inhibition of 
this reaction once all components are present. Using a standard curve based on different 
U/ml of SOD, it is possible to calculate the concentration of SOD in a given sample 
based on the total % inhibition. A. fumigatus samples were treated with either 5 µg/ml 
gliotoxin or methanol (solvent control) to see if gliotoxin induces SOD expression and 
thus OS. 
Figure 3.13 illustrates the mean SOD concentration (U/ml/mg of protein) in 
ATCC26933 +/- 5 µg/ml gliotoxin. In the absence of gliotoxin, no induction of SOD 
can be detected. However, once challenged with 5 µg/ml gliotoxin, this changes 
significantly. 
 
  
108 
 
 
 
Figure 3.13 SOD concentration in A. fumigatus protein lysates in the presence and 
absence of 5 µg/ml gliotoxin The above graph represents the mean concentration of 
SOD in U/ml per mg protein from samples carried out in triplicate for each condition 
respectively. This was determined by calculating the % inhibition of the formation of 
NBT-formazan which corresponds to the concentration of SOD in that sample. 
 
 Although the levels of SOD in the control samples were too low to be 
quantified, the concentration found in samples treated with gliotoxin yielded 
significantly higher (P =0.02) levels of SOD in these samples. This highlights gliotoxin 
presence increases SOD expression in A. fumigatus cells due to the increased production 
of superoxide radicals which would augment toxicity to A. fumigatus cells. 
 
 
* 
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3.5.2 Gliotoxin induces catalase expression  
 Gliotoxin has previously been shown to alter the levels of a mycelial catalase 
(AFUA_3G02270) (Carberry et al., 2012). Catalase catalyses the breakdown of H2O2 to 
water and oxygen, and is an important part of the OS response against endogenous 
stress. Catalase activity can be quantified by measuring the breakdown of H2O2 at 
ΔA240nm. Using known amounts of catalase, a standard curve can be created to calculate 
the respective catalase levels in a given sample. Figure 3.14 illustrates the mean 
concentration of catalase (U/ml/mg protein) in A. fumigatus protein lysates treated with 
either methanol (solvent control) or 5 µg/ml gliotoxin. 
 
Figure 3.14 Catalase concentration in A. fumigatus protein lysates in the presence 
and absence of 5 µg/ml gliotoxin The above graph represents the mean concentration 
of catalase in U/ml per mg protein from samples carried out in triplicate for each 
condition respectively. This was determined by calculating the ΔA240/min for each 
sample and plotting these values on a standard curve which was created using known 
amounts of catalase. 
* 
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 Gliotoxin exposure induces a significant increase (P = 0.03) in the expression of 
catalase in A. fumigatus. Expression of a mycelia catalase (AFUA_3G02270) was found 
to decrease over 40 fold upon gliotoxin exposure (Carberry et al., 2012). Increase in 
catalase seen here could be due to an increase in other catalases found within the cell 
which weren’t detected in the 2D PAGE work carried out by Carberry et al., (2012). 
 
3.5.3 Gliotoxin induces ROS production in A. fumigatus 
 The use of biochemical assays like those described above give a picture of what 
is occurring inside the cell once challenged with a particular chemical, in this case 
gliotoxin. Being able to visualise the effects of gliotoxin in vivo holds even more 
advantages as it allows for a snap shot of any stress and location of said stress after the 
addition of the toxin. H2DCFDA is a fluorogenic dye that measures hydroxyl, peroxyl 
and other reactive oxygen species, notably the superoxide radical. It readily diffuses into 
the cell and at this point is not fluorescent. Once inside the cell it becomes de-acetylated 
via cellular esterases and later becomes oxidised by ROS to form the highly fluorescent 
7’-dichlorofluorescein. Figure 3.15 shows A. fumigatus cells treated with either 
methanol, 5 mM H2O2 or 15 µg/ml gliotoxin. All treated cells showed some degree of 
fluorescence, indicating the presence of ROS in those cells. 5 mM H2O2 yielded the 
greatest production of fluorescence. As a known OS inducer and producer of ROS this 
is not too surprising. The small fluorescence seen in methanol treated samples could be 
endogenous ROS, ROS production induced by methanol exposure or a combination of 
the two. The fact that the fluorescence seen in the 15 µg/ml gliotoxin treated samples is 
greater than the methanol treated samples, shows that this increase in fluorescence is 
gliotoxin specific and demonstrates gliotoxin induction of ROS. Although this induction 
is clear in the gliotoxin treated samples, its fluorescence is far less than that of those 
treated with 5 mM H2O2. 
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Figure 3.15 A. fumigatus cells treated with methanol, 5 mM H2O2 or 15 µg/ml 
gliotoxin as viewed under both white light and GFP at X 40 magnification: The top 
row shows treated cells under normal light, while the bottom row shows those same 
cells under a GFP filter. A bright green fluorescence is a positive result for the presence 
of ROS. 
 
3.6 Anti-oxidant potential of gliotoxin 
 Gliotoxin is a redox active molecule, cycling between an oxidised and reduced 
form, facilitated by the presence of its trans-annular di-sulphide bridge (Waring & 
Beaver 1996). Co-addition of gliotoxin to agarose plates containing H2O2 has been 
previously demonstrated to alleviate H2O2 stress in a gliotoxin dependant manner (0-10 
µg/ml) (Gallagher et al., 2012). Gliotoxin attenuation of H2O2 toxicity indicates an anti-
oxidant activity in gliotoxin through its redox cycling ability perhaps through gliotoxin 
oxidation mediated by H2O2 resulting in the formation of oxidised gliotoxin which can 
effluxed from the cell, and the degradation of H2O2 to water (Figure 3.16). 
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Figure 3.16 Proposed gliotoxin anti-oxidant mechanism in A. fumigatus: in the 
presence of excess H2O2 gliotoxin is oxidised ultimately resulting in the breakdown of 
hydrogen peroxide to water, and efflux of gliotoxin 
. 
This model indicates that increasing levels of gliotoxin should result in 
increasing attenuation of H2O2 induced toxicity, as seen in Gallagher et al., (2012). 
 Employing the flourogenic dye H2DCFDA, A. fumigatus cells were exposed to a 
combination of 5 mM H2O2 and 15 µg/ml gliotoxin, (Figure 3.17) and compared to cells 
exposed to just 5 mM H2O2 or 15 µg/ml to examine if this anti-oxidant mechanism 
could be visualised in vivo. 
 
 
 
 
  
 
 
 
  
113 
Figure 3.17 A. fumigatus cells treated with 5 mM H2O2, 15 µg/ml gliotoxin or 5 
mM H2O2 + 15 µg/ml gliotoxin,  as viewed under both white light and GFP at X 
40 magnification (A) and respective mean pixel intensity: (A) The top row shows 
representative images of treated cells under normal light, while the bottom row 
shows those same cells under a GFP filter. A bright green fluorescence is a positive 
result for the presence of ROS. Assays were repeated on three independent 
occassions. (B). Designated areas of biological replicate sample were measured for 
pixel intensity at three different locations for each strain, condition and replicate and 
the mean was plotted.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. 
B. 
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From Figure 3.17 A and B, a reduction  in fluorescence in the 5 mM H2O2 + 15 µg/ml 
gliotoxin when compared to 5 mM H2O2 or 15 µg/ml gliotoxin only treated cells, with a 
significant reduction (P = 0.004) in pixel intensity seen in gliotoxin and H2O2  
combinaiton assay compared with H2O2 only treated cells, indicating co-addition of 
gliotoxin alleviates H2O2 stress in the cell perhaps through some gliotoxin cycling 
mechanism. 
 
3.7 Gliotoxin and H2O2 plate assays 
 In section 3.6, gliotoxin was demonstrated to attenuate H2O2 induction of ROS 
indicating gliotoxin anti-oxidant activity. This led to the hypothesis that cycling of 
reduced gliotoxin to oxidised gliotoxin utilising H2O2 in the process as an electron 
donor could be occurring. This would corroborate the theory that gliotoxin is actually an 
accidental toxin and is primarily an anti-oxidant molecule in A. fumigatus (Schrettl et 
al., 2010). This can also be seen in Gallagher et al, where H2O2 sensitivity in A. 
fumigatus can be reduced by the addition of gliotoxin in a dose dependant manner 
(Gallagher et al., 2012). From this result it was hypothesised that under some conditions 
some if not all the gli mutants used in this study would show similar improvement in 
growth when grown on agarose plates with H2O2 (0.5-2 mM) and gliotoxin (1-10 
µg/ml).  
 Previously, exposure to H2O2 elicited no sensitivity in A. fumigatus gliT and gliZ 
mutants, yet exposure to gliotoxin induced a range of sensitivity in all A. fumigatus 
strains. When exposed to a combination of both H2O2 and gliotoxin, growth of all 
strains is significantly altered (Figure 3.18). 
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Figure 3.18 Comparative growth analysis of A. fumigatus gliT and gliZ mutants exposed to  H2O2 0.5-2 mM, gliotoxin 5 µg/ml and a 
combination of both AF293 (top right), ΔgliT26933 (top right), ΔgliZ293 (bottom left) and ΔgliTΔgliZ293 (bottom right).
0.5 mM H
2
O
2
 
2 mM H
2
O
2
 
1 mM H
2
O
2
 
5 μg/ml gliotoxin 
0.5 mM H
2
O
2
 + 5 μg/ml gliotoxin 
1 mM H
2
O
2
 + 5 μg/ml gliotoxin 
2 mM H
2
O
2
 + 5 μg/ml gliotoxin 
AF293 ΔgliT 
ΔgliZ 
ΔgliT 
ΔgliZ 
2 mM H
2
O
2
 + 10 μg/ml gliotoxin 
10 μg/ml gliotoxin 
  
 
116 
 In Figure 3.18, gliotoxin appears to not improve growth on H2O2. Interestingly 
the opposite is happening, with addition of H2O2 alleviating gliotoxin toxicity in a dose 
dependant manner, most notably for ΔgliT and to a lesser extent ΔgliTΔgliZ. A. 
fumigatus ΔgliT has been previously shown to be unable to produce gliotoxin, with no 
detectable gliotoxin from organic extracts from culture supernatant (Schrettl et al., 
2010). However, there could still potentially be some intracellular gliotoxin 
biosynthesis in this mutant, with gliotoxin efflux inhibited. Schrettl et al., (2010) 
identified a predicted monothiol form of gliotoxin in A. fumigatus ΔgliT, which was not 
present in the wild-type; with a mass of 279 m/z and could be an indication of some type 
of gliotoxin biosynthesis occurring de novo. GliT has been demonstrated to be involved 
in closing the disulphide bridge of gliotoxin which is required for gliotoxin transport 
from the cell, meaning that there is still the potential for gliotoxin to produced in ΔgliT, 
albeit only in the reduced form.  
 Without GliT mediating oxidation of reduced gliotoxin, efflux of gliotoxin could 
be halted as only the oxidised form of gliotoxin has been seen to be readily effluxed 
from the cell (Bernardo et al., 2003; Schrettl et al., 2010). A. fumigatus ΔgliT sensitivity 
to gliotoxin could in fact, be due to accumulation of both exogenous gliotoxin and 
endogenous gliotoxin toxicity. 
From Figure 3.18, the presence of H2O2 inside the cell could be chemically 
substituting for GliT absence, aiding in gliotoxin oxidation and subsequent efflux from 
the cell. This could explain how addition of 1 and 2 mM H2O2 respectively restores 
ΔgliT growth on 5 µg/ml gliotoxin to wild-type; with ΔgliT radial growth on 2 mM 
H2O2   5 g/ml gliotoxin significantly improves (P = 0.047) when compared with ΔgliT 
grown on 5 µg/ml gliotoxin alone. No significant difference was seen between AF293 
wild-type and ΔgliT on 2 mM H2O2 + 5 µg/ml gliotoxin highlighting addition of H2O2 
restores ΔgliT growth to wild-type levels.  
A. fumigatus ΔgliTΔgliZ293 radial growth, significantly improves (P = 0.038) on 
the 2 mM H2O2   5 µg/ml gliotoxin compared to ΔgliTΔgliZ on 5 µg/ml gliotoxin alone 
plates. ΔgliZ shows no significant difference between either treatment. Exposure to both 
H2O2 and gliotoxin, elicits a significant increase (P = 0.015) in the sensitivity of A. 
fumigatus AF293 when compared to AF293 radial growth on 5 µg/ml gliotoxin alone. 
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This suggests that the combination of 2 mM H2O2 and 5 µg/ml gliotoxin induces a 
synergistic affect augmenting each others toxic affect on A. fumigatus AF293. However, 
addition of gliotoxin significantly increases (P = 0.04) AF293 radial growth on 2 mM 
H2O2 and 5 µg/ml gliotoxin when compared with AF293 radial growth on 2 mM alone. 
This highlights that gliotoxin alleviates H2O2 stress in A. fumigatus AF293, while in the 
mutant strains the opposite is occurring.  
 A similar result can also be seen at higher gliotoxin concentrations (10 µg/ml), 
Figure 3.18. Radial growth of ΔgliT is significantly improved (P = 0.007) on 2 mM 
H2O2   10 µg/ml when compared to ΔgliT radial growth on 10 µg/ml gliotoxin alone 
 
 
 At 10 µg/ml gliotoxin, H2O2 attenuation of gliotoxin toxicity is lost in AF293 
and ΔgliTΔgliZ suggesting this higher gliotoxin concentration is overwhelming the cell 
and any benefit H2O2 presence may have is too little to compensate for increase 
gliotoxin toxicity. 
 
3.8 Quantification of GSH and GSSG in A. fumigatus strains 
Glutathione has been seen to be dysregulated in ΔgliT26933 when compared to A. 
fumigatus ATCC26933 (Carberry et al., 2012). Upon gliotoxin addition these GSH 
levels decrease significantly (P = < 0.05) when compared to basal levels (Carberry et 
al., 2012).  
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Gliotoxin has been shown to directly interact and deplete the de novo pool of the 
intracellular thiol glutathione forming gliotoxin-glutathione conjugates in vitro 
(Bernardo et al., 2001). Disrupting the intracellular levels of this thiol has grave 
consequences on the cell resulting in a reduced ability to tackle OS and tackling the 
presence of xenobiotics may be one of many factors which affect ΔgliT sensitivity to 
exogenous gliotoxin (Grant et al., 1996). 
Interestingly, addition of reduced glutathione (20 mM) was found to abolish 
gliotoxin toxicity in both A. fumigatus ATCC26933 and ΔgliT26933. Addition of reduced 
gliotoxin only (10 µg/ml), still resulted in ΔgliT being sensitive, however not to the 
same extent as non-reduced gliotoxin, suggesting that the status of the disulphide bridge 
can influence the growth response of ΔgliT to gliotoxin (Carberry et al., 2012). 
Gliotoxin transport has been previously shown to occur in a glutathione 
dependent manner (Bernardo et al., 2003). Bernardo et al., (2003) demonstrated only 
the oxidised form of gliotoxin was found to actively enter the cell. Higher than normal 
levels of this thiol could have the potential for a proportional increase in gliotoxin influx 
into the cell. This hypothesis would predict that strains with higher levels of GSH would 
have some form of sensitivity to gliotoxin due to GSH mediated influx of gliotoxin, as 
seen in Carberry et al, (2012).  
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The total GSH and GSSG levels were quantified in strains AF293, ΔgliT26933, 
ΔgliZ293 and ΔgliTΔgliZ293, with the hypothesis that strains which show sensitivity when 
grown in the presence of gliotoxin may have altered levels of glutathione (Figure 3.21). 
 
 
 
 
 
 
 
 
 
Figure 3.20 Total GSH and GSSG levels in A. fumigatus: Total GSH and GSSG 
content of strains AF293, ΔgliT26933, ΔgliZ293 and ΔgliTΔgliZ293 was quantified from 
mycelia grown in Sabouraud liquid media. 
  
 In Figure 3.20 there are clear differences in the GSH/GSSG levels amongst the 
strains. Interestingly ΔgliT has significantly lower levels of GSH than AF293 and ΔgliZ 
(P = 0.02 & 0.03, respectively). This contradicts what was seen previously in Carberry 
et al., (2012) in which ΔgliT was found to have significantly higher levels of GSH than 
ATCC26933 (Carberry et al., 2012). This could be due to a difference in the media 
which were used, Sabouraud media was used as opposed to AMM as the latter did not 
produce a high amount of mycelia. A difference in GSH content could be due to a 
higher availability of nutrients in Sabouraud and decreased stress response compared to 
AMM grown cultures. This is further supported when the growth response of these 
* 
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same strains is compared on AMM and Sabouraud media in the absence and presence of 
exogenous gliotoxin Figure 3.21. 
 
Figure 3.21 Radial growth response of A. fumigatus strains on Sabouraud and 
AMM agarose plates containing 10 µg/ml gliotoxin. 
 
 The growth of all strains on Sabouraud media was significantly different then 
their respective growth on  AMM (P = <0.05), suggesting Sabouraud may artificially 
manipulate the GSH levels in cells. Importantly, it does not alter the trend in gliotoxin 
response in these mutants. The greater growth response on Sabouraud media is 
presumably due to greater availability of nutrients facilitating improved growth. 
When the radial growth response of these strains on gliotoxin plates, seen in 
Section 3.3, Figure 3.9, is compared to their respective GSH content, there is a similar 
trend. For example, both ΔgliZ293 and AF293 show a similar growth response to 
gliotoxin with no significant difference found between them. They also have similar 
levels of GSH and GSSG suggesting a possible link between GSH levels and growth 
response to gliotoxin. This is further supported when the three gli mutants are 
compared. A. fumigatus ΔgliT has the lowest concentration of GSH, with ΔgliTΔgliZ 
having slightly higher and ΔgliZ having the highest amongst the three. This is similar to 
their growth response to gliotoxin i.e. ΔgliT is the most sensitive, with ΔgliTΔgliZ being 
more resistant than ΔgliT and ΔgliZ being the most resistant amongst the three mutants.  
* * * * 
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These results further show the importance of GliT in the response to gliotoxin 
toxicity. It was hypothesised that high levels of GSH may pre-dispose cells to being 
increasingly sensitive to gliotoxin toxicity, yet ΔgliT has been shown to possess both 
significantly higher and lower levels of glutathione on different media types, but is still 
highly sensitive when challenged with exogenous gliotoxin regardless of the media. 
This suggests that any benefit which may be seen in cells with low GSH levels of 
glutathione is insufficient to compensate for the loss of GliT. 
 
3.9 Metformin plate assay 
 Metformin is a drug which acts as an hypoglycaemic agent in treating 
type-2 diabetes and polycystic ovary syndrome and in some early cancer treatments (Li 
et al., 1999; Dowling et al., 2011; Anisimov et al., 2011). Recently it has been shown to 
influence the methionine biosynthesis cycle, by increasing the levels of S-adenosyl L-
homocysteine and S-adenosyl-L-methionine, two key components which are utilised in 
the methylation of various important components, oxidative stress response and 
methionine biosynthesis (Mato et al., 1997; Onken & Driscoll 2010; Cabreiro et al., 
2013). 
From RNA Seq. data retrieved from S. cerevisiae cells exposed to gliotoxin, the 
methionine and GSH biosynthetic pathways were significantly altered (O’Brien 2011). 
Metformin was employed to examine the phenotypic response to this compound and if 
it could alter the response to gliotoxin in gliT, gliZ strains through manipulation of the 
L-methionine biosynthesis pathway Figure 3.22 A-C. 
In Figure 3.22 A, addition of metformin has no adverse affect on cell growth. 
The combination of both 5 µg/ml gliotoxin and 100 mM metformin, Figure 3.22 B, 
significantly improves the radial growth of A. fumigatus ΔgliT (P = < 0.05) when 
compared to its respective radial growth on 8 µg/ml gliotoxin only plates Figure 3.22 C. 
This metformin meditated improvement is not seen in A. fumigatus wild-type strains 
AF293 or ATCC26933, nor ΔgliZ and ΔgliTΔgliZ, indicating that metformin is only 
advantageous in the absence of GliT, and presence of GliZ.  
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Figure 3.22 Comparative growth analysis of A. fumigatus gliT and gliZ mutants in 
the presence of metformin and/or gliotoxin Representative growth analysis of strains 
exposed to A= 100 mM metformin, B= 8 µg/ml gliotoxin, C= 100 mM metformin + 8 
µg/ml gliotoxin repeated on three independent occassions. 
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In a recent study, Cabreiro et al., (2013) demonstrated that E. coli grown on 
plates containing a range of metformin concentrations which were subsequently 
consumed by C. elegans, could influence the longevity of the C. elegans strains. They 
also found that presence of metformin induced methionine restriction in E. coli based on 
its ability to inhibit expression of methionine synthase and increase the levels of S-
adenosyl-L-methionine (SAM) and S-adenosyl-L-homocysteine (SAH) (Cabreiro et al., 
2013). An increase in the levels of 5-tetrahydrofolate and simultaneous decrease in 
tetrahydrofolate levels were also found, indicating metformin induced alteration of both 
methionine metabolism and folate biosynthesis (Cabreiro et al., 2013). The inhibition of 
methionine synthase would have a number of consequences in the cell such as reduced 
re-methylation of L-homocysteine to form L-methionine; increased 5-
methyltetrahydrofolate (THF) and reduced levels of tetrahydrofolate (Suliman et al., 
2005; Cabreiro et al., 2013).  
SAM is an important methyl donor in the cell involved in the methylation of 
proteins, purine biosynthesis and acting as a co-repressor of genes inside the cell 
(Chiang et al., 1996). An example of this co-repression activity can be seen in the 
repression of the folate cycle and inhibition of methylene-THF reductase which reduces 
5,10-methylene-THF to 5-methyl-THF resulting in an increase in 5,10-methylene-THF 
in the cell (Cabreiro et al., 2013). Accumulation of SAM, SAH, 5,10-methylene-THF 
and 5-methyl-THF results in methionine restriction in  E. coli cells which further 
induces methionine restriction in their host (C. elegans) increasing life-span (Cabreiro 
et al., 2013). 
This increase in SAM may be responsible for the improved growth of ΔgliT seen 
in Figure 3.22 C. Bis-methylated gliotoxin (Bm-GT) is a methylated form of gliotoxin 
which has been hypothesised as a product of gliotoxin detoxification (Domingo et al., 
2012). Bm-GT would require the presence of a methyl donor i.e. SAM to donate the 
two methyl groups required for its biosynthesis.  
 Addition of metformin results in a significant improvement in ΔgliT radial 
growth on 8 µg/ml gliotoxin, presumably due to an alteration in SAM levels and 
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perhaps, Bm-GT biosynthesis. However no Bm-GT was detected in ΔgliT by Schrettl et 
al., (2010) which suggests metformin may in fact help regulate the SAM cycle. 
Dysregulation of the SAM cycle can result in the accumulation of L-
homocysteine and SAH, both of which are deleterious to the cell (Kredich & Hershfield 
1979; Fujita et al., 2006). This may suggest that in the presence of exogenous gliotoxin, 
the SAM cycle is dysregulated in A. fumigatus ΔgliT resulting in L-homocysteine/SAH 
associated cytotoxicity. However, addition of metformin helps reduce this toxicity 
through L-methionine restriction.  
 In A. fumigatus AF293, ATCC26933, ΔgliZ and ΔgliTΔgliZ, metformin is not 
advantageous, showing no improvement of radial growth on metformin and gliotoxin 
plates. This may suggest that the SAM cycle is un-perturbed in these cells in the 
presence of gliotoxin and that dysregulation of this pathway only occurs in the absence 
of gliT. 
 
3.10 Galleria mellonella virulence study 
 Virulence of A. fumigatus gli mutant strains ΔgliT26933, ΔgliZ293 and 
ΔglitTΔgliZ293 were examined utilising the insect G. mellonella. Conidial inocula were 
injected into the left lowest proleg of a G. mellonella larvae weighing between 0.1 - 0.2 
g using PBS injections of the same volume and non-injected larvae (n = 10/treatment) 
as negative controls. The larvae were monitored over a 72 hour period and checked for 
the onset of melanisation which is indicative of an immune response, and death. 
 . Figure 3.23 depicts the % survival of G. mellonella injected with A. fumigatus 
strains over a period of 72 hours at 37 ⁰ C. 
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Figure 3.23 % Survival of G. mellonella infected with A. fumigatus gliT, gliZ 
mutants G. mellonella were infected with 1 x 10 
6
 conidial inoculums of A. fumigatus 
strain AF293, ATCC26933, ΔgliZ (gliZ), ΔgliT (gliT) and ΔgliTΔgliZ (gliTgliZ) 
respectively. Survival counts were taken at three separate time points (24, 48 and 72 
hours) and the mean results of three separate infection studies were plotted. 
 Post 24 hours of infection there is little difference in the virulence of the A. 
fumigatus strains. Infection with A. fumigatus ΔgliZ293 conidia results in significantly 
more (P= 0.018) death at 24 hours when compared to A. fumigatus AF293 wild type, 
and when compared with A. fumigatus ΔgliT26933 (P = 0.037) at this time point. This 
could be due to the loss of certain gli cluster related proteins which are also recognition 
markers used by the immune response of the insect larvae, allowing for ΔgliZ to 
propagate relatively un-perturbed causing increased mortality. 
 After 48 hours there is a clear change in the virulence of the A. fumigatus strains 
used. A. fumigatus ATCC26933 infection results in a significant increase in mortality 
when compared with A. fumigatus AF293 (P = 0.011); ΔgliZ (P= 0.028) and 
ΔgliTΔgliZ. This illustrates that ATCC26933 wild-type is more virulent than the second 
wild-type strain AF293, as well as the mutant strains created in this background (i.e., 
ΔgliZ293 and ΔgliTΔgliZ293). Interestingly ΔgliT infection results in significantly more 
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deaths (P= 0.037) when compared with ATCC26933; ΔgliZ (P= 0.009) and ΔgliTΔgliZ 
(P= 0.0025) indicating loss of gliT may be advantageous in A. fumigatus at this time 
point. Additionally it has been previously demonstrated that after 48 hours gliotoxin 
biosynthesis occurs in vivo and may explain ΔgliZ and ΔgliTΔgliZ are not as virulent as 
other strains, especially when their wild type background (i.e. AF293) is already not 
very virulent when compared to ATCC26933 wild-type (Gardiner & Howlett 2005). 
 
3.11 Discussion 
 Gliotoxin has been shown previously to be a highly toxic secondary metabolite 
(Kamei & Watanabe 2005; Carberry et al., 2012). In this body of work it has been 
shown that alterations to the biosynthetic cluster responsible in gliotoxin biosynthesis, 
can significantly alter the growth response of A. fumigatus to exogenous gliotoxin. 
Inability to produce gliotoxin or encode the majority of the cluster, as is the case for 
ΔgliZ which lacks the transcriptional activator of the gli cluster, shows no significant 
increase in sensitivity when challenged with exogenous gliotoxin. This has been 
attributed to the fact that gliT, an important oxido-reductase involved in gliotoxin 
modification and subsequent detoxification, is independently regulated in this cluster 
and has been shown to still be highly up-regulated in the presence of gliotoxin (Schrettl 
et al., 2010). 
 In A. fumigatus ΔgliT growth exposure to exogenous gliotoxin elicits 
hypersensitivity to concentrations as low as 5 µg/ml. This highlights GliT detoxification 
of gliotoxin and in the prevention of auto-toxicity. Interestingly, in A. fumigatus 
ΔgliTΔgliZ exposure to gliotoxin elicits a sensitive growth response which is 
significantly greater than ΔgliZ, yet significantly less than ΔgliT respective growth 
response to gliotoxin. It has been hypothesised that A. fumigatus ΔgliT still may have 
the potential for gliotoxin biosynthesis (Schrettl et al., 2010). Combined with the 
presence of exogenous gliotoxin, an accumulation of gliotoxin could be occurring 
which cannot be detoxified on account of gliT absence. Although ΔgliTΔgliZ, also lacks 
the self protection mechanism of GliT, gliotoxin biosynthesis should be abolished 
ΔgliTΔgliZ like ΔgliZ, suggesting why it’s not as sensitive as ΔgliT (Bok et al., 2006).  
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 This sensitivity appears to be limited to gliotoxin and does not pre-dispose any 
of the A. fumigatus gli mutants to being sensitive to other oxidative stress inducers such 
as H2O2 or diamide. Neither of these chemicals resulted in any significant difference in 
the growth response for any of the A. fumigatus strains with the different concentrations 
used. This could suggest that loss of gliT and gliZ is dispensable and are not vital in the 
OS response to these to compounds. When A. fumigatus cells are exposed to gliotoxin, 
there is a significant rise in the presence of OS response enzymes i.e. SOD and 
catalase.. This increase is indicative to an increase in OS inside the cell displaying 
gliotoxin induction of ROS and OS. This was further visualised in vivo using a 
fluorogenic dye for the detection of ROS and found that gliotoxin did induce greater 
production of ROS when compared to control samples, however these were 
significantly less than the H2O2 (5 mM) treated samples, exhibiting gliotoxin induced 
ROS is not as great as other known ROS inducing chemicals. This further suggests that 
gliotoxin sensitivity observed in these strains is not due to a build up of ROS but by 
some other form of toxicity e.g. gliotoxin cycling and accumulation in vivo which 
results in the formation of ROS as a by-product but not a primary means of toxicity. 
 Previous work using other gli mutants, namely ΔgliK, illustrated a protective 
role for gliotoxin, depicting a dose dependent alleviation of H2O2 induced stress on 
mycelia when grown in the presence of both H2O2 and increasing concentration of 
gliotoxin (0-10 µg/ml) on agarose plates. This was corroborated in this study whereby 
the addition of gliotoxin (5 & 10 µg/ml) alleviated H2O2 induced stress (1-2 mM) in A. 
fumigatus wild-type cells only. 
This anti-oxidant potential of gliotoxin was further investigated in vivo 
measuring the fluorescence of H2DCFDA in cells exposed to gliotoxin, H2O2 and a 
combination of both in A. fumigatus. Here it was found that the presence of gliotoxin 
and H2O2 resulted in significantly lower fluorescence than H2O2 only treated mycelia 
confirming gliotoxin can act as an anti-oxidant in the presence of OS inducing 
chemicals such as H2O2. 
 In contrast to this, ΔgliT did not show this trend. Instead, the combination of 
both H2O2 and gliotoxin (0.5 – 2 mM + 5/10 µg/ml respectively) in agarose plates 
alleviated gliotoxin induced stress in this strain resulting in wild-type like growth. 
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Unlike the previous result which showed gliotoxin as an anti-oxidant molecule, here the 
opposite is happening with H2O2 attenuating gliotoxin toxicity in this strain by some 
unknown mechanism. Interestingly this same result isn’t seen in either ΔgliZ293 or 
ΔgliTΔgliZ293which implies this H2O2 alleviation of gliotoxin toxicity is due to the 
unique phenotype of this mutant to gliotoxin exposure.  
As mentioned earlier, gliotoxin may still be produced in ΔgliT, however its 
secretion is abolished, resulting in an accumulation of reduced gliotoxin de novo. The 
main reason for this is that GliT can act as both a reducing agent and oxidizing agent on 
gliotoxin. As only the oxidized form has been shown to readily secreted from the cell, 
loss of GliT mediated oxidation of reduced gliotoxin would reduce this secretion. With 
this in mind, it is proposed that H2O2 may substitute for GliT by acting as an oxidising 
agent. Inside the cell H2O2 is readily dismutated to water and oxygen, in this model this 
dismutation could be utilized in the presence of NADPH to form oxidized gliotoxin 
which can then be secreted from the cell reducing toxicity. This would predict that as 
the concentration of H2O2 increases within the cell, so would the formation of oxidized 
gliotoxin and thus a proportional decrease in gliotoxin induced toxicity resulting in an 
improved growth response which is what is seen here. 
The GSH/GSSG levels were found to be altered in A. fumigatus ΔgliT which 
possessed significantly lower basal levels of GSH when compared with GSH 
measurements for A. fumigatus AF293 and ΔgliZ respectively. A. fumigatus ΔgliTΔgliZ 
possessed intermediate levels of GSH greater than ΔgliT but which were still similar to 
A. fumigatus AF293 wild type and ΔgliZ. The altered GSH levels in ΔgliT and 
ΔgliTΔgliZ may explain their respective sensitivity to gliotoxin exposure. This is 
supported by ΔgliZ having similar levels of GSH as AF293 as well as having a similar 
growth response to exogenous gliotoxin on agarose plates presumably due to the 
presence of GliT.  
The attenuation of gliotoxin toxicity of A.fumigatus ΔgliT growth upon addition 
of meformin, suggests alteration of the SAM and L-methionine biosynthesis pathways 
is advantageous in the presence of gliotoxin for this strain. This may be due to an 
increase in SAM biosynthesis which could in turn result in an increase in Bm-GT 
formation, a putative gliotoxin detoxification by-product. This would result in a 
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decrease in gliotoxin toxicity by modifying available gliotoxin. However, as Schrettl et 
al., (2010) detected no Bm-GT in culture supernatants, this may not be the case.  
Instead, the presence of gliotoxin may dysregulate the SAM cycle which would result in 
altered levels of L-homocysteine and SAH, both which are toxic to the cell. Addition of 
metformin could induce L-methionine restriction, as seen in Cabreiro et al., (2013) 
preventing accumulation of toxic SAM cycle intermediates and improving growth. As 
addition of metformin resulted in no significant improvement in any other A. fumigatus 
strains, it appears that this gliotoxin dysregulation is unique to ΔgliT implying GliT may 
have some role in regulating the SAM cycle, when the rest of the gli cluster is active, as 
ΔgliTΔgliZ showed no significant improvement upon metformin addition in the 
presence of gliotoxin. 
 
This body of work highlights that gliotoxin may have an alternative role in the 
cell, adding weight to the theory put forward of it being an accidental toxin. It is more 
likely gliotoxin was originally an antioxidant utilised in protecting fungus during 
competition with other organisms which employ the use of superoxides to kill off 
competitors in soil environments e.g., Pseudomonas aeruginosa. This is achieved by 
gliotoxin redox cycling which also facilitates its potent anti-fungal effects. The 
mechanisms of gliotoxin anti-oxidant activity, anti-fungal toxicity and the complex 
response of the gli cluster mutants examined here identify gliotoxin as a diverse multi-
functional secondary metabolite which requires further investigation into its 
biosynthesis and how A. fumigatus responds to it. 
 
 
 
 
  
 
 
 
 
 
 
 
Chapter 4 
Proteomic analysis of Aspergillus 
fumigatus gliT and gliZ mutants response 
to gliotoxin 
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4.1 Introduction 
Aspergillus fumigatus has been shown to be a very adaptable organism possessing the 
ability to occupy several different niches including the human body, utilising an array of 
secondary metabolites such as gliotoxin to achieve this. Since the release of the 
Aspergillus genome sequence (Mabey et al., 2004; Nierman et al., 2005), much study 
has gone into elucidating its role in pathogenesis, and as a potential anti-fungal agent 
(Sutton & Waring 1996; Mullbacher et al., 1984). 
Subsequent to the release of efficient protein extraction techniques in 
Aspergillus spp. (Scwienbacher et al., 2005), proteomic studies have identified key 
allergens and pathogenic mechanisms involved in invasive aspergillosis which may 
prove to be potential drug targets (Asif et al., 2006). Large scale proteomic studies have 
yielded large quantities of data identifying new interesting areas such as cell growth and 
development and response to the environment, which are important for the many 
Aspergilli which are used in the biotechnology sector (Lu et al., 2010; Cagas et al., 
2011).  
With the emergence of more accurate protein identification equipment and the 
availability of categorised peptide sequences on online databases, proteins are being 
identified under different conditions yielding a more complete picture of the proteome 
of this fungus. 
Proteomic analysis was employed here to further assess the response to gliotoxin 
in wild-type A. fumigatus, gliT and gliZ mutants. This study also identifies the different 
responses to gliotoxin between gliT and gliZ mutants and highlight key components in 
gliotoxin tolerance which may be the cause of their respective sensitivity.  
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4.2 A. fumigatus proteomic response to exogenous gliotoxin 
4.2.1 Proteomic response of AF293 to exogenous gliotoxin 
 AF293 mycelia were exposed to either methanol or 5 µg/ml gliotoxin for three 
hours. This concentration was chosen as it was sufficient to induce a transcriptome and 
proteome response in A. fumigatus, and is far closer to clinical levels than higher 
concentrations of gliotoxin used in other studies. Proteins extracts were separated using 
2D SDS PAGE. Both sets of samples (n=3 / treatment) were compared using 
PROGENESIS
TM
 software package tool to identify proteins significantly differentially 
expressed between each condition and were later excised from the gel, treated for LC-
MS identification and ran on an AGILENT Orbi Trap LC-MS to identify the resulting 
peptides. A total of 36 proteins were found to be significantly expressed (P = < 0.05) in 
response to exogenous gliotoxin ranging from 19 kDa to 118.5 kDa (Figure 4.1).  
 The presence of gliotoxin induces a complex global proteomic response with a 
significant decrease in expression of proteins involved in metabolism, transcription, 
translation and protein modification. Interestingly, expression of specific structural 
component associated proteins are modified in the presence of gliotoxin with a 
reduction (1.9 fold) in expression of the actin cytoskeleton protein Vip1p 
(AFUA_2G10030) and an increase (1.3 fold) in an un-characterised ORF 
(AFUA_6G10060) which has a putative ortholog in yeast with F-actin capping activity 
(Teutschbein et al., 2010; Kim et al., 2004). There is also reduction (1.7 fold) in 
AFUA_7G02180 an un-characterised ORF with orthologs in A. nidulans with amino 
acid and nucleotide sugar metabolism as well as UDP-N-acetylglucosamine 
pyrophosphoryase activity that catalyses the formation of UDP-N-acetyl-alpha-D-
glucosamine, an important precursor utilised in the formation of the structural 
polysaccharide chitin (Kanehisa et al., 2004; Groot et al., 2009). 
 Three enzymes were identified to be involved in gluconeogenesis: 
glyceraldehyde 3-phosphate dehydrogenase GpdA (AFUA_5G01970), 
phosphoglycerate mutase, 2,3- bisphosphateglycerate-independant (AFUA_3G09290) 
and a putative enolase (AFUA_6G06770) (Sugui et al., 2008; Teutschbein et al., 2010). 
All three show a significant increase in expression (3, 1.7 and 1.2 fold respectively) in 
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the presence of gliotoxin. Each are also very close together in the gluconeogenesis 
pathway with GpdA catalysing the formation of 3-phospho-D-glycerol phosphate from 
glyceraldehydes 3-phosphate; phosphoglycerate mutase catalysing the formation of 
glycerate 2-phosphate from glycerate-3 phosphate and the putative enolase catalysing 
the formation of phosphoenol-pyruvate from glycerate 2-phosphate. This indicates an 
increase in demand of these products, which feed into L-lactate and acetyl CoA 
biosynthesis, during gliotoxin exposure. 
pH7          pH4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 2D PAGE analysis of AF293 A. fumigatus + 5 µg/ml gliotoxin vs. AF293 A. 
fumigatus + MeOH, separated on pH 4-7 IPG strips on 12 % SDS-PAGE gel.
100 kDa 
20 kDa 
50 kDa 
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The function of each  protein was categorised using the online software package 
FungiFun (https://www.omnifung.hki-jena.de/FungiFun/) which groups each protein 
under different categories giving the total number of proteins involved in each 
individual category (Figure 4.2). The five most abundant categories which can be seen 
include protein with binding function, metabolism, energy, cellular transport and protein 
fate. All 36 proteins identified can be seen in Table 4.1. 
 
 
 
 
 
 
 
 
Figure 4.2 Functional categorisation of proteins differentially expressed in AF293 A. 
fumigatus +/- 5 µg/ml gliotoxin 
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Table 4.1 AF293 A. fumigatus proteins (n=36) identified differentially expressed under 5 µg/ml gliotoxin exposure 
Protein Name 
Fold 
Difference 
AF293 
Sequence 
Coverage 
(%) 
Mascot 
Score 
Molecular 
Mass Da 
CADRE 
 I.D. 
Spot No# 
Proteins Up-regulated       
Molecular chaperone and allergen 
mod-e/hsp90/hsp1 
↑6.6 12 284 80468 AFUA_5G04170 421 
Putative transketolase ↑3.2 4 83 56773 AFUA_2G13240 125 
Translation elongation factor EF-2 
subunit 
↑3.1 10 376 93603 AFUA_2G13530 315 
Glyceraldehyde 3-phosphate 
dehydrogenase GpdA 
↑3 19 309 36466 AFUA_5G01970 378 
Xanthine-guanine phosphoribosyl 
transferase Xpt1 
↑1.9 38 252 19551 AFUA_4G04550 477 
Mitochondrial aconitate hydratase ↑1.8 18 508 85997 AFUA_6G12930 82 
Phosphoglycerate mutase, 2,3 -
bisphosphoglycerate-independent 
↑1.7 7 141 57534 AFUA_3G09290 174 
Woronin body protein HexA ↑1.5 23 415 61485 AFUA_5G08830 470 
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Protein Name 
Fold 
Difference 
AF293 
Sequence 
Coverage 
(%) 
Mascot 
Score 
Molecular 
Mass Da 
CADRE ID Spot No# 
78 kDa glucose-regulated protein 
homolog 
↑1.5 9 129 73414 AFUA_2G04620 109 
Putative choline oxidase ↑1.4 42 767 60727 AFUA_8G04090 176 
Pyruvate kinase ↑1.2 32 525 58812 AFUA_6G07430 205 
Putative enolase ↑1.2 58 1028  AFUA_6G06770 277 
Proteins Down-regulated       
40S ribosomal protein s0 ↓5.3 30 271 32276 AFUA_3G13320 347 
Polyadenylate-binding protein ↓4.6 9 296 81626 AFUA_1G04190 57 
Cell division control protein 48 ↓4.6 21 672 90845 AFUA_2G17110 52 
Transferase Elongation Factor 3 ↓3.6 15 739 118506 AFUA_7G05660 33 
Polyadenylate-binding protein ↓3 18 565 81378 AFUA_1G04190 60 
Ortholog of A. niger CBS 513.88 ↓2.9 4 110 69482 AFUA_4G08030 130 
Hydroxymethylglutaryl-CoA synthase ↓2.5 21 547 52299 AFUA_8G07210 271 
Dipeptidyl peptidase ↓2.5 9 322 87569 AFUA_4G06140 113 
Polyadenylate-binding protein ↓2.4 23 758 81378 AFUA_1G04190 59 
Hsp70 chaperone (HscA) ↓2 5 128 66046 AFUA_8G03930 227 
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Protein Name 
Fold 
Difference 
AF293 
Sequence 
Coverage 
(%) 
Mascot 
Score 
Molecular 
Mass Da 
CADRE ID Spot No# 
Phosphatidylinositol transporter ↓1.9 31 456 37765 AFUA_3G09910 325 
Alanine amino transferase ↓1.9 19 405 55622 AFUA_6G07770 230 
Translation elongation factor EF-1 
alpha subunit 
↓1.9 24 430 54273 AFUA_1G06390 264 
Actin cytoskeleton protein (VIP1) ↓1.9 36 385 28306 AFUA_2G10030 383 
Ubiquitin c-terminal hydrolase ↓1.8 4 63 63414 AFUA_6G02380 146 
Eukaryotic translation initiation factor 
eIF-5A 
↓1.8 34 348 21498 AFUA_1G04070 511 
UDP-N-acetylglucosamine 
pyrophosphorylase 
↓1.7 11 328 57048 AFUA_7G02180 192 
Gamma-glutamyl phosphate reductase ↓1.6 18 341 49016 AFUA_2G07350 278 
Asparagine synthetase Asn2 ↓1.6 13 280 72467 AFUA_4G06900 158 
Putative translation elongation factor 
EF-2 subunit 
↓1.6 7 314 93603 AFUA_2G13530 382 
Hypothetical protein ↓1.5 34 367 20344 AFUA_8G05650 502 
T-complex protein 1 ↓1.5 21 358 59053 AFUA_6G07540 164 
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Protein Name 
Fold 
Difference 
AF293 
Sequence 
Coverage 
(%) 
Mascot 
Score 
Molecular 
Mass Da 
CADRE ID Spot No# 
F-actin capping protein alpha subunit ↓1.3 28 348 30519 AFUA_6G10060 429 
Succinate dehydrogenase ↓1.3 2 65 70422 AFUA_3G07810 243 
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4.2.2 Proteomic response of ΔgliT26933 to 5 µg/ml gliotoxin 
 ΔgliT26933 mycelia were treated as described previously (section 4.2.1). A total 
of 28 proteins were identified to be significantly (P= <0.05), differentially expressed 
between the two treatments, ranging from 18.7 kDa to 129 kDa (figure 4.3). A full list 
of proteins identified can be found in Table 4.2. 
Similar to AF293, the presence of exogenous gliotoxin induces the expression of 
proteins involved in many different functions of the cell such as cell division control, 
amino acid degradation and biosynthesis and RNA degradation. A number of the 
proteins identified are associated with Hsp70. These included mitochondrial Hsp70 
chaperone (AFUA_2G09960), molecular chaperone Hsp70 (AFUA_1G07440), Hsp70 
chaperone Hsp88 (AFUA_1G12610) and the Hsp70 chaperone HscA 
(AFUA_8G03930), all of which had reduced protein expression of 1.9, 1.5, 1.3 and 1.2 
fold respectively (Asif et al., 2010; Teutschbein et al., 2010; Lessing et al., 2007). 
 Two proteins, 3-isopropylmalate dehydrogenase (AFUA_1G15780) and a 
putative branched chain amino acid transferase (AFUA_2G10420), showed increased 
expression of 3.2 fold and 1.3 fold respectively in the presence of gliotoxin 
(Teutschbein et al., 2010; Shimizu et al., 2010). Both these proteins deal with amino 
acid biosynthesis and degradation, namely with valine, iso-leucine and leucine. 3-
isopropylmalate catalyses the formation of 3-isopropylmalate to 2-isopropylmalate, this 
then spontaneously converts to 4-methyl-2-oxopentanoate which is acted upon by the 
branched chain amino acid transferase (AFUA_2G10420) and two other enzymes 
(AFUA_1G101680 and AFUA_4G06160) to from L-leucine (KEGG 
http://www.genome.jp/kegg/; Kanehisa et al., 2004). These enzymes also catalyse the 
formation of L-isoleucine from (S)-3-methyl-2-oxopentanoate, and L-valine from 2 
oxoisovalerate. All three amino acids, L-valine, L-isoleucine and L-leucine, proceed to 
their degradation pathway where they are degraded and converted back to 2-
oxoisovalerate, (S)-3-methyl-2-oxopentanoate and 4-methyl-2-oxopentanoate 
respectively by AFUA_2G10420 (Kenehisa et al., 2004).  
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Figure 4.3 PAGE analysis of ΔgliT26933 A. fumigatus + 5 µg/ml gliotoxin vs. 
ΔgliT26933 A. fumigatus + MeOH, separated on pH 4-7 IPG strips on 12 % SDS-PAGE 
gel 
 
100 kDa 
50 kDa 
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Table 4.2 Proteins differentially expressed in the presence of 5 µg/ml gliotoxin in ΔgliT26933 (n=28) 
Proposed Name 
Fold 
Difference 
AF293 
Sequence 
Coverage 
(%) 
Mascot 
Score 
Molecular 
Mass Da 
CADRE  
ID 
Spot No# 
Proteins Up-regulated       
40S ribosomal protein s4 ↑3.7 31 325 29647 AFUA_3G06840 276 
60S ribosomal protein L10 ↑3.3 20 132 25860 AFUA_2G09210 313 
3-isopropylmalate dehydrogenase ↑3.2 1 35 39048 AFUA_1G15780 336 
Glycolipid transfer protein HET-
C2 
↑3 19 178 22257 AFUA_3G13820 323 
Tropomyosin,  putative ↑2.5 16 117 18758 AFUA_7G04210 338 
Myo-inositol-phosphate synthase ↑1.8 18 381 58809 AFUA_2G01010 118 
Adenosylhomocysteinase ↑1.7 26 615 49039 AFUA_1G10130 177 
GPI-anchored cell wall 
organisation protein 
↑1.5 17 261 41770 AFUA_4G06820 82 
Branched chain amino acid 
transferase, cytosolic 
↑1.3 29 600 44212 AFUA_2G10420 197 
Proteins Downregulated       
Carbomyl-phosphate synthase ↓Infinite 8 308 129714 AFUA_2G10070 8 
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Protein Name 
Fold 
Difference 
AF293 
Sequence 
Coverage 
(%) 
Mascot 
Score 
Molecular 
Mass Da 
CADRE  
ID 
Spot No# 
FAD dependant oxidoreductase ↓3.4 30 685 51468 AFUA_7G05070 155 
60S ribosomal protein P0 ↓2.4 16 185 33532 AFUA_1G05080 248 
Cell division control protein 
Cdc48 
↓2.2 14 538 90510 AFUA_2G17110 25 
Aldehyde reductase (GliO) ↓2.1 63 893 35467 AFUA_5G02020 247 
Mitochondrial Hsp70 chaperone 
(Ssc70), putative 
↓1.9 25 760 71932 AFUA_2G09960 73 
Glutamine 
amidotransferase:cyclamen 
↓1.8 43 847 60558 AFUA_2G06230 127 
Argininosuccinate synthase ↓1.7 22 498 46684 AFUA_2G04310 147 
Phenylalanyl-tRNA synthetase,  
beta subunit 
↓1.6 2 71 68016 AFUA_1G05620 47 
GMP synthase ↓1.6 27 598 61799 AFUA_3G01110 109 
Mitochondrial Hsp70 chaperone 
(Ssc70), putative 
↓1.6 50 1562 71932 AFUA_2G09960 78 
Triosephosphate isomerise ↓1.6 52 736 28283 AFUA_5G13450 303 
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Protein Name 
Fold 
Difference 
AF293 
Sequence 
Coverage 
(%) 
Mascot 
Score 
Molecular 
Mass Da 
CADRE  
ID 
Spot No# 
NADH:flavin 
oxidoreductase/NADH oxidase 
family protein 
↓1.5 24 420 41262 AFUA_2G04060 196 
GABA Permease ↓1.5 2 16 55639 AFUA_1G12310 125 
Molecular chaperone  Hsp70 ↓1.5 16 331 69792 AFUA_1G07440 67 
Adenosylhomocysteinase ↓1.4 49 1207 49039 AFUA_1G10130 181 
C6 finger domain protein ↓1.4 2 19 80854 AFUA_2G05830 134 
Hsp70 chaperone Hsp88 ↓1.3 35 1011 80313 AFUA_1G12610 33 
Hsp70 chaperone (HscA) ↓1.2 19 347 67106 AFUA_8G03930 76 
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In addition, two different proteins, AFUA_2G10070 which encodes a putative 
carbomyl-phosphate synthase and AFUA_2G04310 which encodes argininosuccinate 
synthase; are both down regulated with expression of the carbomyl phosphate synthase 
expression being completely absent in ΔgliT in the presence of gliotoxin and the 
argininosuccinate with a 1.7 fold reduction in expression (Grosse et al., 2008; Vodisch 
et al., 2011). Both these proteins are involved in the alanine, aspartate and glutamine 
biosynthesis pathway with the former utilising L-aspartate  for the biosynthesis of L-
argininosuccinate and the latter utilising L-glutamine for the biosynthesis of carbomyl-
phosphate (Kenehisa et al., 2004). In keeping with this, another protein involved in the 
early stages of L-histidine biosynthesis was found to have reduced expression in the 
presence of gliotoxin (1.8 fold) and later identified as glutamine amidotransferase-
cyclase (AFUA_2G04310) (Vodisch et al., 2011). This enzyme is involved in a 
biochemical crossroads whereby it catalyses the formation of two end products: AICAR 
and imidazole-glycerol-3P. The former is utilised in purine metabolism while the latter 
continues on the L-histidine biosynthesis pathway (Meister & Buchanan, 1978). 
Together, these results highlight a complex response to gliotoxin affecting key amino 
acid biosynthesis and degradation pathways. 
 As seen previously in AF293 (section 4.2.1), proteins with roles in structural 
components of the cell are differentially expressed. Two proteins, a GPI-anchored cell 
wall organisation protein (AFUA_4G06820) and tropomyosin (AFUA_7G04210) 
showed increased expression of 1.5 fold and 2.5 fold respectively (Chabane et al., 2006; 
Asif et al., 2006). Both play a role in cell wall maintenance with the former directly 
involved in cell wall integrity and the latter involved in actin binding and required for 
actin related a key component in the fungal cell wall.  
 Of particular interest, adenosylhomocysteinase (AFUA_1G10130) was found to 
show a 1.7 fold increase in expression. An ortholog of this enzyme in yeast is involved 
in the cysteine and methionine biosynthetic pathway in which it hydrolyses S-adenosyl 
homocysteine to form L-homocysteine which can then be used as a cysteine donor in 
the formation of the radical scavenger glutathione or in the S-adenosyl methionine 
biosynthesis cycle where it is converted to form L-methionine by methionine synthase 
and ultimately s-adenosyl methionine (Kenhisa et al.,, 2004; Tehlivets et al., 2004). 
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 Dysregulated proteins were categorised according to their respective functions 
as described previously in section 4.2. The top five functional categories can be seen in 
Figure 4.4.  
 
 
Figure 4.4 Functional categorisation of proteins differentially expressed in ΔgliT26933 A. 
fumigatus +/- 5 µg/ml gliotoxin 
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4.2.3 Proteomic response of ΔgliZ293 to 5 µg/ml gliotoxin 
 ΔgliZ293 mycelia were treated as described previously (section 4.2.1) for 2D 
PAGE and subsequent LC-MS analysis. In contrast a smaller number of proteins (n= 4) 
were found to be differentially expressed upon gliotoxin addition (Figure 4.5). These 
are listed in Table 4.4 below. Similarly to wild-type and ΔgliT, a heat shock protein was 
found to be differentially expressed in the presence of gliotoxin. Heat shock protein 
Hsp30-like (AFUA_6G06470) had a 3.7 fold increase in expression upon gliotoxin 
addition (Do et al., 2009). Hsp30 is highly up-regulated in the cellular stress response to 
many types of stressors including heat shock and ethanol stress in yeast as well as being 
induced in the presence of hydrogen peroxide in a Yap1 dependant fashion (Seymourt 
& Piper 1999; Piper et al., 1994; Lessing et al., 2007)  . Interestingly there was also an 
increase in expression of a putative transketolase (AFUA_1G13500, 2 fold) which has 
been shown to be up-regulated during heat shock and hydrogen peroxide suggesting the 
cell is under stress (Lessing et al., 2007; Albrecht et al., 2010) . 
 There was also increased expression of a translation elongation factor EF-2 
subunit (AFUA_1G13500, 2 fold) and a conserved hypothetical protein 
(AFUA_1G11480, 1.5 fold) which is as yet, not characterised.  
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Figure 4.5 2D PAGE analysis of ΔgliZ293 A. fumigatus + 5 µg/ml gliotoxin vs. ΔgliZ293 
A. fumigatus + MeOH, separated on pH 4-7 IPG strips on 12 % SDS-PAGE gel 
75 kDa 
25 kDa 
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Table 4.3 Proteins differentially expressed in the presence of 5 µg/ml gliotoxin in ΔgliZ293 
Protein Name 
Fold 
Difference 
AF293 
Sequence 
Coverage 
(%) 
Mascot 
Score 
Molecular 
Mass Da 
CADRE 
 I.D. 
Spot No# 
Heat shock protein Hsp30-like ↑3.7 29 185 21678 AFUA_6G06470 237 
Transketolase, putative ↑2 25 475 75816 AFUA_1G13500 68 
Translation elongation factor EF - 2 subunit ↑1.5 18 607 93603 AFUA_2G13530 225 
Conserved hypothetical protein ↑1.5 11 111 20765 AFUA_1G11480 287 
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 Proteins from Table 4.3 were functionally categorised as described previously 
(section 4.2.1). This can be seen in Figure 4.6 below. As there are only four proteins 
inputted, the percentage is the same amongst all categories for each protein listed.. 
 
 
Figure 4.6 Functional categorisation of proteins differentially expressed in ΔgliZ293A. 
fumigatus +/- 5 µg/ml gliotoxin 
 
4.2.4 Proteomic response of ΔgliTΔgliZ293 to 5 µg/ml gliotoxin 
 ΔgliTΔgliZ293 mycelia were treated as described previously (section 4.2) for 2D 
PAGE and subsequent LC-MS analysis. Similar to ΔgliZ, a total of only five proteins 
were found to be differentially expressed upon gliotoxin addition (Figure 4.7). These 
ranged from30 kDa to 101 kDa and are listed in Table 4.5. Like the last section all the 
proteins identified were shown to have increased expression when challenged with 
gliotoxin exposure with no proteins found to have significant reduced expression in this 
strain in the presence of gliotoxin. 
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Figure 4.7 2D PAGE analysis of ΔgliTΔgliZ293 A. fumigatus + 5 µg/ml gliotoxin vs. 
ΔgliTΔgliZ293 A. fumigatus + MeOH, separated on pH 4-7 IPG strips on 12 % SDS-
PAGE gel        
 
 
100 kDa 
35 kDa 
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 Two enzymes involved in TCA cycle, malate dehydrogenase (AFUA_7G05740) 
and malate dehydrogenase, NAD-dependant (AFUA_6G05210), had a 1.7 fold increase 
in expression in the presence of gliotoxin (Teutschbein et al., 2010; Sugui et al., 2008). 
Both these enzymes are involved in the same process acting on (S)-malate to form 
oxaloacetate or vice versa. Each of these steps lead into some form of carbohydrate 
biosynthesis e.g., malate is later oxidised to form fumarate which is an intermediate of 
the TCA cycle or citrate; while oxaloacetate is hydrated to form citrate (Kanehisa et 
al.,2004).                     
 In contrast to previous results, this comparison shows no differential expression 
of any Hsp related proteins, nor any change in proteins associated with cell structure 
and cell wall integrity. However, similar to AF293, one protein was identified which 
does play a role in septum damage preventing cytoplasm leakage. Woronin body protein 
HexA (AFUA_5G08830) showed a 2.3 fold increase in expression when cells were 
challenged with gliotoxin. As discussed previously, this protein accumulates when the 
septum is damaged acting like a protein plug preventing cytoplasm leakage and 
subsequent damage to the cell (Maruyama et al., 2005). 
 Two other proteins were identified: an outer mitochondrial membrane protein 
porin (AFUA_4G06910) which showed an increase in expression of 1.7 fold, and the 
enzyme C1 tetrahydrofolate (THF) synthase (AFUA_3G08650) which was up-regulated 
1.5 fold (Grosse et al., 2008). The THF synthase catalyses the formation of 5,10 
methylene THF and 5,10 methenyl THF in the folate one carbon pool (Kanehisa et al., 
2004) 
 Proteins and their respective functions are listed in Table 4.4. Their functional 
categories can be seen in Figure 4.8. 
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Table 4.4 Proteins differentially expressed in the presence of 5 µg/ml gliotoxin in ΔgliTΔgliZ293 
Protein Name 
Fold 
Difference 
AF293 
Sequence 
Coverage 
(%) 
Mascot 
Score 
Molecular 
Mass Da 
CADRE  
I.D. 
Spot No# 
C1 tetrahydrofolate synthase ↑1.5 24 778 101040 AFUA_3G08650 30 
Malate dehydrogenase ↑1.7 47 753 35876 AFUA_7G05740 205 
Malate dehydrogenase,  NAD-
dependent 
↑1.7 73 955 34963 AFUA_6G05210 212 
Outer mitochondrial membrane 
protein porin 
↑1.7 32 348 30007 AFUA_4G06910 232 
Woronin body protein HexA ↑2.3 25 494 61485 AFUA_5G08830 237 
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Figure 4.8 Functional categorisation of proteins differentially expressed in 
ΔgliTΔgliZ293A. fumigatus +/- 5 µg/ml gliotoxin 
 
4.3 Discussion 
 This proteomic study reveals that A. fumigatus exposed to gliotoxin induces a 
plethora of effects on the cell response. Structural components of the cell, metabolic 
pathways and the cellular response to stress, show similar differential expression 
amongst all A. fumigatus strains exposed to gliotoxin. Further, many dysregulated 
proteins were found to belong to similar functional categories, suggesting similar 
categories in the cell being affected in each strain. 
 Although there are many similarities in the general aspects of the cell affected 
by gliotoxin exposure amongst each strain, only a number of proteins were identified in 
multiple strains. Cdc48 (AFUA_2G17110), is down regulated in both AF293 +/- 
gliotoxin and ΔgliT26933+/- gliotoxin. (4.6 fold and 2.2 fold respectively). In S. 
cerevisiae, this protein has been shown to be involved in targeting mis-folded proteins 
of the endoplasmic reticulum for ubiquitination and degradation via the proteosome 
(Raasi & Wolf 2007). Interestingly, it has also been found to induce disassembly of the 
sulphur and methionine transcriptional inhibitor Met30 preventing its affect on the 
methionine biosynthesis pathway (Yen et al., 2012). Met30 responds to s-adenosyl 
methionine levels in the cell, inhibiting the transcriptional regulator Met4 (Blaiseau & 
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Thomas 1998; Yen et al., 2012) . In this model, reduced expression of Cdc 48 could 
result in reduced Met30 disassembly and a subsequent increase in Met30 mediated 
inhibition of the methionine biosynthesis pathway in the presence of elevated levels of 
s-adenosyl methionine.  
 As mentioned previously, gliotoxin can be found in a bis-methylated form (Bm-
GT) where it acts as a methyl acceptor for two methyl groups to attach onto its two free 
thiol groups (Amitani et al., 1995). For this to occur it requires a methyl donor, like 
SAM. With the addition of exogenous gliotoxin, there could be a corresponding 
increase in the SAM levels to allow for Bm-GT creation. This suggests that in ΔgliZ and 
ΔgliTΔgliZ, loss of the gli cluster results in an inability to induce this increase in s-
adenosyl methionine, implying some component of the gli cluster mediates Bm-GT 
formation or some step in SAM biosynthesis, and thus no reduction in Cdc48 is seen in 
these strains. 
 HscA (AFUA_8G03930) is also down regulated in AF293 +/- gliotoxin and 
ΔgliT+/- gliotoxin (2 fold and 1.2 fold respectively). As mentioned previously, this is an 
Hsp70 chaperone molecule with proteins orthologous in E. coli involved in iron-sulphur 
cluster assembly (Teutschbein et al., 2010; Silberg et al., 2013). These clusters have a 
myriad of roles including interacting with SAM where they transfer an electron to SAM 
causing reductive cleavage of the S-C (5’) bond resulting in the formation of L-
methionine, 5’deoxyadenosyl radical intermediate and an oxidised protein (Cosper et 
al., 2003). This further strengthens the above point of the s-adenosyl methionine levels 
being altered in the presence of gliotoxin. With reduced expression of HscA and 
subsequent reduction of the Fe-S cluster assembly, there would be a corresponding 
decrease in SAM reduction. In the presence of gliotoxin, this could be a natural 
response to regulate levels of SAM to allow for Bm-GT formation.  
 A translation elongation factor EF-2 subunit (AFUA_2G13530) was identified 
in both AF293 +/- gliotoxin and ΔgliZ293 +/- gliotoxin. Multiple identities of this protein 
were found in the wild type showing both an increase and decrease in expression (3.1 
fold and 1.6 fold respectively) while its expression is increased 1.5 fold in ΔgliZ293. This 
protein has previously been shown to be significantly up-regulated in response to heat 
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stress in A. fumigatus and may imply gliotoxin induction of stress related proteins 
(Albrecht et al., 2010). 
 Woronin body protein Hex A (AFUA_5G08830) is up-regulated (1.5 fold and 
2.3 fold respectively) in both AF293 +/- gliotoxin and ΔgliTΔgliZ +/- gliotoxin. As 
mentioned previously (Section 4.4) this protein acts as a protein plug preventing 
cytoplasmic leakage after septa cross wall damage (Maruyama et al., 2005). This 
suggests gliotoxin presence is increasing septum damage in these two strains resulting 
in the HscA mediated protection. The fact that this protein was not identified in the 
other two mutants i.e. ΔgliT and ΔgliZ implies that either having a completely 
operational gli cluster (AF293) and a completely de-activated gli cluster (ΔgliTΔgliZ) 
potentiates septum damage by gliotoxin presence, or these conditions allow for a 
septum damage response which no longer operates in the other two mutants. This is 
supported in ΔgliT where an increase in tropomyosin (AFUA_7G04210, 2.5 fold) 
involved in actin binding, a crucial component in cell wall and septum formation; and 
the increase of a GPI anchored cell wall organisation protein (AFUA_4G06820, 1.5 
fold) which has been seen to be important in cell wall biogenesis and repair in yeast 
(Terashima et al., 2000), could prove to be an alternate, less efficient, response to this 
type of damage induced by gliotoxin exposure. 
 Of the many differences seen in different proteins being differentially expressed, 
the clearest difference is the number of proteins identified. In both ΔgliZ and 
ΔgliTΔgliZ only a handful of proteins were identified (n= 4 and 5 respectively) to 
significantly differentially expressed. This suggests that the proteomic response to 
gliotoxin exposure is greatly dependent on the presence of a functional gli cluster and 
that the many proteins identified in AF293 and ΔgliT are gli mediated. 
 Contrary to what is seen in the other three strains, AF293 shows an increase in 
gluconeogenesis with the identification of three gluconeogenesis related enzymes: 
glyceraldehyde 3-phosphate dehydrogenase GpdA (AFUA_5G01970), 
phosphoglycerate mutase, 2,3- bisphosphateglycerate-independant (AFUA_3G09290) 
and a putative enolase (AFUA_6G06770). There is also an increase in expression of a 
transketolase (AFUA_2G13240, 3.2 fold), an enzyme involved in the non-oxidative 
pentose phosphate pathway. An increase in expression of both these pathways is 
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indicative of cells grown in an hypoxic environment. Other hypoxic related proteins:  
AFUA_8G07210, AFUA_3G07810, AFUA_6G12930 and AFUA_6G06770, were also 
found to be differentially expressed in a similar fashion as previously seen in other 
hypoxic studies, implying gliotoxin maybe inducing a hypoxic environment (Blatzer et 
al., 2011; Barker et al., 2012; Vodisch et al., 2011).  
 ΔgliT on the other hand does not show any correlation in the expression of the 
proteins identified with those differentially expressed under hypoxic environments. Nor 
does it have any increased expression of gluconeogenesis or any component of the 
pentose phosphate pathway. Instead it shows decreased expression of proteins involved 
in different types of metabolism e.g. AFUA_2G04310 which encodes argininosuccinate 
synthase an enzyme involved in the citric acid cycle, and AFUA_5G13450 which 
encodes triosephosphate isomerise an enzyme involved in glycolysis; are both down 
regulated (1.7 fold and 1.6 fold respectively). Interestingly, similar to AF293 wild-type, 
there appears to be an alteration in the regulation of the SAM cycle. In ΔgliT +/- 
gliotoxin, s-adenosyl homocysteinase a.k.a s-adenosyl homocysteine hydrolase 
(AFUA_1G10130) is both up-regulated 1.7 fold and down regulated 1.4 fold in 
response to gliotoxin. This enzyme catalyses the formation of L-homocysteine from 
SAH, which can then feed back into the SAM cycle to produce more SAM (Tehlivets et 
al., 2004; Kenhisa et al., 2004). An increase in the expression of this protein would 
mean a corresponding increase in L-homocysteine. This amino acid has been shown 
previously to be toxic to cells if it’s allowed to accumulate in the cells, requiring the cell 
to regulate L-homocysteine levels via the formation of L-methionine (McCammon & 
Parks 1981; Fujita et al., 2006). The presence of another s-adenosyl homocysteinase 
isolated from a different spot implies another isoform of this enzyme. As both appear to 
be the same mass, as can be seen on the gel, this suggests some form of post-
translational modification which has been noted for bacterial orthologs for this enzyme 
which explains a difference in their respective iso-electric points (Singhal et al., 2013). 
In the presence of gliotoxin, ΔgliT appears to up-regulate the SAM cycle, most likely to 
form Bm-GT, a process which is hypothesised to be a secondary detoxification pathway 
utilised by A. fumigatus (Li et al., 2012). As this strain no longer possesses the GliT 
mediated detoxification mechanism, one could presume it would rely heavily on this 
Bm-GT alternative to compensate. Due to the hypersensitivity of this mutant to 
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exogenous gliotoxin, this process evidently cannot be used to fully compensate for the 
loss of GliT. 
 ΔgliTΔgliZ293 +/- gliotoxin shows an increase in expression (1.5 fold) of 
AFUA_3G08650 which encodes C1 tetrahydrofolate synthase (THFS) an enzyme 
involved in the folate biosynthesis pathway which catalyses the formation of 10-formyl-
THF, 5,10-methylene-THF and 5,10-methenyl-THF. The 5,10-methenyl-THF is later 
changed to 10-formyl-THF by THFS which can then be utilised in purine biosynthesis 
(Kanehisa et al., 2004). 5,10-methylene-THF is irreversibly converted to 5-methyl THF 
which feeds into the methionine biosynthesis pathway to form methionine along with l-
homocysteine. This could hint at a similar change in the SAM cycle in this strain, 
requiring increased L-methionine production from intermediates derived from the folate 
biosynthesis pathway for Bm-GT production. 
 Contrary to a previous study carried out in ATCC26933 A. fumigatus + 
gliotoxin, AFUA_2G10030 is down regulated in AF293 (1.9 fold). Also, many of the 
proteins identified in that study were not identified here (Carberry et al., 2012). A 
possible explanation for this difference is the concentration of gliotoxin used was far 
greater in the Carberry et al., study (14 µg/ml) compared to 5 µg/ml used in this study, 
suggesting greater gliotoxin concentrations are required to induce differential 
expression of particular proteins (Carberry et al., 2012). 
The major finding from this study is the up-regulation of components of the 
methionine/SAM biosynthetic pathways in the presence of gliotoxin. This suggests 
gliotoxin influences the SAM and methionine cycle by influencing the levels of SAM 
for its own Bm-GT modification.  
 
4.4 gliZ, gliT mutant proteomic response to gliotoxin compared to AF293 
 In the previous section, the protein response to gliotoxin in cells treated with 
gliotoxin was compared with cells treated with a solvent control. This gives an insight 
into the individual response that a particular strain has when challenged with gliotoxin 
compared with a control condition and how this may differ in other strains. In this 
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section, mutant control strains and gliotoxin biosynthesis mutant strains are compared to 
AF293 to see how the proteome differs further between wild-type and mutant, 
something which has not been done before for these gli gene deletions. This allows the 
assessment of key differences at the protein level in wild-type versus mutant and allows 
common trends to emerge which may further elucidate the range in sensitivity seen in 
gliT and gliZ mutants when compared to AF293 to gliotoxin. 
 
4.4.1.1 ΔgliT vs. AF293 
As described in section 4.2.1, mycelia of AF293 and ΔgliT26933 were exposed to either 
MeOH or 5 µg/ml gliotoxin and proteins were extracted. Protein gels were analysed 
using Progenesis
TM
 software package and AF293   MeOH gels (n=3) and ΔgliT + 
MeOH gels (n=3) were compared. Differentially spots were identified and excised from 
the gel. Spots were trypsin digested and resulting peptides identified using LC-MS 
peptide identification. 
 A total of 62 spots were identified between the two treatments (Figure 4.9 A & 
B). 39 spots were isolated from MeOH treated cells (Figure 4.9 A), 23 from gliotoxin 
treated cells (Figure 4.9 B) of which 6 were found to be in both, ranging in size from 24 
kDa to 129.5 kDa. A list of all proteins identified in MeOH treated cells can be found in 
table 4.5. In the MeOH treated cells, four enzymes involved in carbohydrate 
metabolism/biosynthesis were identified. Aldehyde reductase (AFUA_5G02020) had an 
increase of 6.2 fold in ΔgliT + MeOH when compared to AF293 + MeOH. Fructose-
biphosphate aldolase (AFUA_3G11690) was identified twice from two different spots 
indicating two different isoforms also showed increased expression in ΔgliT + MeOH 
compared to AF293 + MeOH of 1.6 and 1.5 fold respectively. Both these enzymes are 
involved in fructose and mannose metabolism. Similarly, glycerol dehydrogenase 
(AFUA_5G02020), which is involved in carbohydrate metabolism and transaldolase 
(AFUA_5G09230), which is involved in the pentose phosphate pathway, showed an 
increase in protein expression in ΔgliT vs. AF293 of 5.8 fold and 1.4 fold respectively.  
 There is also a decrease in expression in two enzymes involved in amino sugar 
and nucleotide sugar metabolism. N-acetylglucosamine-phsophate mutase 
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(AFUA_1G06210) and UDP-N-acetylglucosamine (AFUA_7G02180) showed 3 fold 
and 1.7 fold decrease in expression respectively in ΔgliT vs AF293 + MeOH cells, and 
orthologs of these enzymes have been seen to be involved in chitin formation (Groot et 
al., 2009). 
 
 
 
 pH 7          pH 4 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9 A 2D SDS PAGE analysis of ΔgliT26933 A. fumigatus + MeOH vs. AF293 A. 
fumigatus + MeOH, separated on pH 4-7 IPG strips on 12 % SDS-PAGE gel 
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Figure 4.9 B 2D SDS PAGE analysis of ΔgliT26933 A. fumigatus + 5 µg/ml gliotoxin vs. 
AF293 A. fumigatus + 5 µg/ml gltioxin, separated on pH 4-7 IPG strips on 12 % SDS-
PAGE gel  
75 kDa 
30 kDa 
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Table 4.5 Proteins differentially expressed in the presence in ΔgliT26933 vs AF293 in the presence of MeOH 
Protein Name MeOH 
Sequence 
Coverage 
(%) 
Mascot 
Score 
Molecular 
Mass Da 
CADRE 
I.D. 
Spot No# 
Proteins Up-regulated 
  
 
   
Pyrathiamine resistance gene, thiA ↑16.6 24 351 35309 AO090003000090 352 
Pyrathiamine resistance gene, thiA ↑14.3 17 338 35309 AO090003000090 359 
Aldehyde Reductase (GliO) ↑6.2 40 833 35467 AFUA_5G02020 341 
Pyrathiamine resistance gene, thiA ↑6 18 283 35309 AO090003000090 346 
Pyrathiamine resistance gene, thiA ↑5.9 24 394 35309 AO090003000090 339 
Glycerol dehydrogenase ↑5.8 31 660 37037 AFUA_4G11730 330 
RAS small monomeric GTPase RasA ↑4.5 5 69 24292 AFUA_5G11230 407 
12-oxophytodienate Reductase ↑4.1 22 399 46359 AFUA_5G14330 287 
NADH:flavin oxidoreductase ↑3.5 19 280 41262 AFUA_2G04060 288 
Kelch Repeat Domain ↑3.3 12 130 35955 AFUA_5G12780 320 
Inorganic diphosphatase ↑1.7 9 96 43886 AFUA_3G08380 357 
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Protein Name MeOH 
Sequence 
Coverage 
(%) 
Mascot 
Score 
Molecular 
Mass Da 
CADRE 
 I.D. 
Spot No# 
Mitochondrial Processing Peptidase Beta 
Subunit 
↑1.6 10 336 53295 AFUA_1G14200 252 
Fructose-biphosphate Aldolase ↑1.6 15 461 39952 AFUA_3G11690 329 
Glutamate/Leucine/Valine/Phenylalanine 
dehydrogenase 
↑1.5 35 634 49627 AFUA_4G06620 264 
Fructose-biphosphate Aldolase ↑1.5 7 163 39952 AFUA_3G11690 325 
14-3-3 Family protein ↑1.5 38 430 30201 AFUA_6G06750 345 
Hsp 70 ↑1.4 16 331 69792 AFUA_1G07440 139 
Transaldolase ↑1.4 42 830 35601 AFUA_5G09230 335 
Proteins Down-regulated 
  
 
   
Mycelial catalase, Cat1 ↓9.7 4 106 79925 AFUA_3G02270 110 
Transferase elongation Factor eEF-3 ↓4.8 15 739 118506 AFUA_7G05660 57 
Kelch repeat domain ↓4.5 26 490 35955 AFUA_5G12780 317 
N-acetylglucosamine-phosphate mutase ↓3 18 411 61825 AFUA_1G06210 164 
WW domain protein ↓2.9 23 261 35467 AFUA_5G03750 344 
FAD dependant oxidoreductase ↓2.7 19 462 51468 AFUA_7G05070 246 
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Protein Name MeOH 
Sequence 
Coverage 
(%) 
Mascot 
Score 
Molecular 
Mass Da 
CADRE 
 I.D. 
Spot No# 
Lysophospholipase Plb3 ↓2.6 10 226 67839 AFUA_3G14680 76 
Mannitol-l-phosphate dehydrogenase ↓2.5 12 193 43093 AFUA_2G10660 286 
Hsp90 ↓2 14 259 50550 AFUA_5G04170 108 
Glycerol dehydrogenase ↓1.9 38 660 37037 AFUA_4G11730 328 
Peptidyl-prolyl cis-trans Isomerase Cpr7 ↓1.8 27 374 41956 AFUA_2G02050 291 
UDP-N-acetylglucosamine 
pyrophosphorylase 
↓1.7 11 328 57048 AFUA_7G02180 185 
NADH ubiquinone oxidoreductase ↓1.6 25 193 27525 AFUA_2G10600 351 
Translation elongation factor Ef-2 subunit ↓1.4 39 1372 93603 AFUA_2G13530 89 
Translation elongation factor EF-Tu ↓1.2 21 451 46430 AFUA_1G12170 283 
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Three proteins involved in translation were identified: translation elongation 
factor EF-3 (AFUA_7G05660), translation elongation factor EF-2 subunit 
(AFUA_2G13530) and translation elongation factor EF-Tu (AFUA_1G12170) all had 
decreased protein expression compared to AF293 (4.8, 1.4 & 1.2 fold respectively). 
Each of these subunits and elongation factors are involved in some part of protein 
synthesis, EF-Tu is involved in protein elongations where it binds GTP and aminoacyl-
tRNA; EF-2 and 3 subuints are involved in ribosomal translocation during protein 
synthesis. A list of all proteins identified and their respective fold differences in ΔgliT 
compared to AF293 + MeOH can be seen in Table 4.5. There are also four spots 
isolated as the same protein, the pyrathiamine resistance gene from A. oryzae which was 
used in Schrettl et al., to knock out the gliT gene, which explains why it is so highly up-
regulated. The fact it was isolated numerous times suggests different isoforms of the 
resistance marker being produced in this strain. 
From Table 4.6, gliotoxin treated cells show a decrease in the expression of 
proteins involved in glycolysis and gluconeogensis; SAM cycle and amino acid 
biosynthesis. Aldehyde dehydrogenase (AFUA_4G08600), enolase Asp F22 
(AFUA_6G06770) and triosephosphate isomerase (AFUA_5G13450) are all involved 
in the glycolysis/gluconeogenesis pathway and have reduced expression in ΔgliT 
gliotoxin challenged cells 1.8, 1.8 and 1.5 fold respectively. In addition to this, there is a 
corresponding decrease in expression (4.3 fold) of β-D-glucoside glucohydrolase 
(AFUA_7G06140), an enzyme involved in the biosynthesis of β-D-glucose and α-D-
glucose from starch, suggesting a reduction in the production of simple carbon sugars 
such as glucose from complex carbohydrates in ΔgliT, when compared to AF293. 
Certain amino acid biosynthesis enzymes are also down regulated, with the 
predicted branched chain amino acid amino-transferase (AFUA_2G10420), previously 
described in section 4.2.2, involved in valine/leucine and isoleucine biosynthesis, 
showing a 2.1 fold decrease in expression in ΔgliT + gliotoxin cells (Kispal et al., 
1996). Additionally, there is a corresponding 1.4 fold decrease in iso-valeryl-CoA 
dehydrogenase (AFUA_5G08930) which is involved in valine/leucine and isoleucine.  
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Table 4.6 Proteins differentially expressed in the presence in ΔgliT26933 vs. AF293 in the presence of 5 µg/ml gliotoxin 
Protein Name Gliotoxin 
Sequence 
Coverage 
(%) 
Mascot 
Score 
Molecular 
Mass Da 
CADRE 
 I.D. 
Spot 
No# 
Proteins Up-regulated 
  
 
   
Thiazole synthase ↑4.4 16 287 35309 AFUA_6G08360 404 
Class V Chitinase ↑2.6 11 146 49440 AFUA_3G11280 301 
Argininosuccinate Synthase ↑1.6 32 763 46684 AFUA_2G04310 238 
Outer Mitochondrial Membrane Protein 
Porin 
↑1.5 73 758 30007 AFUA_4G06910 468 
Proteins Down-regulated 
  
 
   
β-D-Glucoside Glucohydrolase ↓4.3 9 202 78738 AFUA_7G06140 76 
Translation Elongation Factor Ef-1 Alpha ↓3.6 16 312 54273 AFUA_1G06390 241 
Protein Disulfide Isomerase PdiI ↓2.9 35 709 56500 AFUA_2G06150 177 
Acyl Co-A Dehydrogenase ↓2.8 18 293 47540 AFUA_1G14850 311 
Branched Chain Amino Acid Amino-
Transferase 
↓2.1 29 600 44212 AFUA_2G10420 302 
Enolase Asp F22 ↓1.8 53 1662 47392 AFUA_6G06770 53 
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Protein Name Gliotoxin 
Sequence 
Coverage 
(%) 
Mascot 
Score 
Molecular 
Mass Da 
CADRE 
 I.D. 
Spot 
No# 
Vacular ATP Synthase Catalytic Subunit A ↓1.8 42 1043 75329 AFUA_5G02370 136 
Aldehyde Dehydrogenase ↓1.8 34 573 60254 AFUA_4G08600 214 
Adenosylhomocysteine ↓1.7 49 1207 49039 AFUA_1G10130 275 
Metallopeptidase, MepB ↓1.6 25 564 82046 AFUA_7G05930 98 
Triosephosphate Isomerase ↓1.5 52 736 28283 AFUA_5G13450 492 
Isovaleryl-CoA Dehydrogenase lvdA ↓1.4 38 936 50784 AFUA_5G08930 296 
Antigenic Mitochondrial Protein Hsp60 ↓1.3 51 1511 62086 AFUA_2G09290 190 
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 The thiazole synthase enzyme, (AFUA_6G08360) was seen to have a 4.4 
increase in expression in ΔgliT cells after addition of gliotoxin when compared to 
AF293. This enzyme is involved in the biosynthesis of the B1 vitamin, thiamine, and has 
been demonstrated to have roles in carbohydrate and amino acid catabolism in yeast 
(Praekalt et al., 1992 & 1994) 
S-adenosyl homocysteinase (AFUA_1G10130) is down regulated in ΔgliT cells 
exposed to gliotoxin 1.7 fold. Previously in section 4.3 table 4.2, this enzyme was 
shown to be dysregulated in ΔgliT   gliotoxin when compared to ΔgliT + MeOH This 
result further illustrates that in ΔgliT, this enzyme is significantly dysregulated in 
response to gliotoxin exposure when compared to ΔgliT + MeOH or wild type + 
gliotoxin cells.  
 
A total of six differentially expressed proteins were found to be shared between 
the two treatments (Table 4.6). Ssc 70 was identified twice in each treatment, isolated 
from different spots indicating multiple isoforms being differentially expressed. 
Multiple isoforms has been described previously in S.cerevisiae for this Hsp70 
chaperone located in the mitochondrion, whereby the functional redundancy among 
such molecules has resulted in single isoforms of this class of chaperone proteins to be 
generalised as the function of others (Sharma & Masison 2008). This protein is up-
regulated in ΔgliT   MeOH vs. AF293  MeOH 2 and 1.9 fold, yet it’s down-regulated 
in ΔgliT + gliotoxin vs. AF293 + gliotoxin 1.3 and 1.9 fold. Ssc 70 is a mitochondrial 
Hsp 70 chaperone, which is involved in many housekeeping roles in the cell including 
protein folding or proof reading of newly synthesised proteins (Mayer & Bukau 2005). 
  
 In both conditions, there is increased expression of Nmt1, a thiamine 
biosynthesis protein, 1.7 fold in MeOH treated cells and 3.6 fold in gliotoxin treated 
cells. As mentioned, thiamine is a B1 vitamin with a role in sugar and amino acid 
catabolism. Added to the thiazole synthesis protein (AFUA_6G08360) which is only 
found to be up-regulated in ΔgliT + gliotoxin vs. AF293 + gliotoxin cells, suggests a 
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greater demand in the biosynthesis of this cofactor in gliotoxin treated cells lacking 
gliT.  
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Table 4.6 Proteins differentially expressed in ΔgliT26933 vs. AF293 in the presence of MeOH and 5 µg/ml gliotoxin  
 
 
 
 
 
 
Protein Name MeOH Gliotoxin 
Sequence 
Coverage 
(%) 
Mascot 
Score 
Molecular 
Mass Da 
CADRE  
I.D. 
Spot 
No# 
Ssc 70 ↑2 ↓1.3 14/50 478/1562 74478 AFUA_2G09960 144/140 
Ssc 70 ↑1.9 ↓1.9 18/43 666/1049 74478 AFUA_2G09960 146/142 
Nmt1 ↑1.7 ↑3.6 16/30 130/455 38588 AFUA_5G02470 315/366 
ATP Citrate Lyase Subunit (ACL) ↑1.2 ↓1.6 37/43 723/952 53001 AFUA_6G10660 224/232 
Carbomyl phosphate synthase, large 
subunit 
↓3.1 ↓7.7 05/11 201/366 129714 AFUA_2G10070 59/21 
Succinyl-CoA:3ketocoid-coenzyme A 
transferase 
↓2 ↓1.7 26/37 488/666 55815 AFUA_6G12250 213/217 
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There is also a corresponding decrease in the expression of carbomyl phosphate 
synthase (AFUA_2G10070) 3.1 fold in MeOH treated cells and 7.7 fold in gliotoxin 
treated cells and succinyl CoA (AFUA_6G12250) 2 fold in MeOH treated cells and 1.7 
fold in gliotoxin treated cells. The former is involved in pyrimidine metabolism, notably 
in the utilisation of l-glutamine to form carbomyl-phosphate, while the latter is involved 
in valine/leucine and isoleucine degradation.  
 
The top five functional categories can be seen in Figure 4.10 A (MeOH) and B 
(gliotoxin) in ΔgliT vs. AF293 +/- gliotoxin treated cells. 
 
 
 
 
 
 
 
 
 
 
Figure 4.10 (A) Functional categorisation of proteins differentially expressed in 
ΔgliT26933A. fumigatus vs. AF293 A. fumigatus + MeOH. 
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Figure 4.10 (B) Functional categorisation of proteins differentially expressed in 
ΔgliT26933A. fumigatus vs. AF293 A. fumigatus + 5 µg/ml gliotoxin. 
 
  
4.4.1.2 Discussion 
 When comparing the proteome of ΔgliT + MeOH and AF293 + MeOH, there are 
many differences highlighting some of the many consequences of gliT loss. Some of the 
most prominent differences seen in this comparison are the changes in the expression of 
metabolic related proteins such as an increase in fructose and carbohydrate metabolism 
with two isoforms of fructose-biphosphate (AFUA_3G11690), aldehyde reductase 
(AFUA_5G02020) and glycerol dehydrogenase (AFUA_4G11730). Coupled with an 
increase in proteins which have orthologs with roles in filamentous growth and putative 
association with actin a major component of cell structure; RasA (AFUA_5G11230) 
and a kelch repeat protein (AFUA_5G12780), there may be a change in the growth rate 
between these two strains, or at least in their response to growth thus a need for 
increased energy creation from certain carbohydrate (Som & Kolaparthit 1994; Arellano 
et al., 2002) . 
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 Proteins typically associated with the cellular response to stress, most notably 
mycelial catalase Cat1 (AFUA_3G02270) which had a 9.7 fold decrease in expression 
and also Hsp90 (AFUA_5G04170). Both these proteins play a role in the cellular 
response to stress, with the former being directly involved in the cellular oxidative 
stress response and the latter involved in cell wall integrity and shown previously to be 
induced in response to H2O2 presence (Calera et al., 1997; Lamoth et al., 2012; Fraczek 
et al., 2010). This suggests that loss of gliT induces represses this particular catalase and 
perhaps Hsp 90. One explanation for this could be due to some reactive intermediates 
being produced in the gli cluster which could be having some form of anti-oxidant 
function. Interestingly, Cat1 was previously shown to have a significant reduction in 
expression (> 40 fold) in A. fumigatus upon gliotoxin challenge, due to gliotoxin anti-
oxidant capability making expression of this catalase redundant (Carberry et al., 2012). 
However in this body of work, this protein is only found to be differentially expressed 
when ΔgliT is compared to AF293 in the absence of gliotoxin. This suggests that the 
levels of this enzyme are un-altered in ΔgliT compared to AF293 in the presence of 
gliotoxin which could imply that in the absence of gliotoxin the need for Cat1 is 
reduced in this strain, perhaps due to some form of redundancy. 
 When exposed to gliotoxin, there is a decrease in the expression of enzymes 
involved in glycolysis/gluconeogenesis (AFUA_5G13450, AFUA_4G08600, 
AFUA_6G06770), as well as proteins involved in translation and protein processing 
(AFUA_1G06390, AFUA_2G06150) and amino acid biosynthesis/degradation 
(AFUA_5G08930, AFUA_2G10420), which is indicative of cell undergoing stress (Sha 
et al., 2013; Harding et al., 2003). The decrease in expression of S-adenosyl 
homocysteinase in the presence of gliotoxin further highlights the relationship of 
gliotoxin and the SAM cycle and suggests a putative role of L-homocysteine 
accumulation and gliotoxin toxicity. 
 
4.4.2.1 ΔgliZ293 vs. AF293 
 Cells from AF293 and ΔgliZ293 were treated as described previously (section 
4.4.1.1). A total of 60 protein spots were identified as being significantly (P = < 0.05) 
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altered in expression between the two comparisons (ΔgliZ + MeOH vs. AF293 + MeOH 
and ΔgliZ + 5 µg/ml gliotoxin vs. AF293 + 5 µg/ml gliotoxin. Of these 61 proteins, 32 
were identified from MeOH treated cells (Figure 4.11 A), 29 from gliotoxin treated cells 
(Figure 4.11 B) with 11 identified to be in common. These ranged from 18 kDa to 106.6 
kDa in size. A list of all identified proteins found in MeOH treated cells can be found in 
Table 4.7. 
   pH 7          pH 4 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 4.11 A 2D PAGE analysis of ΔgliZ293A. fumigatus + MeOH vs. AF293 A. 
fumigatus + MeOH, separated on pH 4-7 IPG strips on a 12 % SDS-PAGE gel 
 
 
 
90 kDa 
30 kDa 
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          pH 7         pH 4   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11 B 2D PAGE analysis of ΔgliZ293A. fumigatus + 5 µg/ml gliotoxin vs. 
AF293 A. fumigatus + 5 µg/ml gliotoxin, separated on pH 4-7 IPG strips on a 12 % 
SDS-PAGE gel 
 
100 kDa 
50 kDa 
30 kDa 
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Table 4.7 Proteins differentially expressed in ΔgliZ293 vs. AF293 in the presence of MeOH 
 
Protein Name MeOH 
Sequence 
Coverage 
% 
Mascot 
Score 
Molecular 
Mass Da 
CADRE 
 I.D. 
Spot No. 
Proteins Up-regulated 
  
 
   
Putative translation elongation factor EF-2 
subunit 
↑2.5 7 315 93603 AFUA_2G13530 293 
Putative WW domain protein ↑2.4 30 235 28374 AFUA_5G03750 295 
Putative outer mitochondrial membrane protein 
porin 
↑2.4 30 372 30007 AFUA_4G06910 332 
Putative triosephosphate isomerase ↑1.9 38 483 28283 AFUA_5G13450 344 
actin cytoskeleton protein (VIP1) ↑1.8 36 385 28306 AFUA_2G10030 292 
Putative class II fructose-bisphosphate aldolase ↑1.7 40 779 39940 AFUA_3G11690 281 
Putative peptidyl-prolyl cis-trans isomerase ↑1.7 29 430 41956 AFUA_2G02050 244 
Putative manganese superoxide dismutase ↑1.6 43 603 23376 AFUA_1G14550 354 
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Protein Name MeOH 
Sequence 
Coverage 
% 
Mascot 
Score 
Molecular 
Mass Da 
CADRE  
I.D. 
Spot No. 
Putative mitochondrial Hsp70 chaperone ↑1.6 38 1161 71932 AFUA_2G09960 97 
Putative choline oxidase ↑1.6 42 767 60727 AFUA_8G04090 131 
Putative glutamate carboxypeptidase ↑1.4 51 794 53272 AFUA_3G05450 164 
Putative enolase ↑1.3 58 1028 43705 AFUA_6G06770 207 
Proteins Down-regulated 
  
 
   
Putative bifunctional tryptophan synthase ↓3.9 34 1104 77777 AFUA_2G13250 76 
Proteasome regulatory particle subunit ↓2.9 27 496 57862 AFUA_5G07050 158 
Putative transaldolase ↓2.3 53 1110 35601 AFUA_5G09230 289 
Putative aminopeptidase P ↓2.3 11 373 72924 AFUA_5G08050 85 
Glutamate/Leucine/Phenylalanine/Valine 
dehydrogenase 
↓1.8 57 1102 49627 AFUA_4G06620 217 
Aspartyl-tRNA synthetase ↓1.8 42 1089 61763 AFUA_2G02590 101 
Ortholog(s) have protein channel activity, role 
in protein import 
↓1.6 30 436 38366 AFUA_6G05110 287 
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Protein Name MeOH 
Sequence 
Coverage 
% 
Mascot 
Score 
Molecular 
Mass Da 
CADRE  
I.D. 
Spot No. 
Putative eukaryotic translation elongation factor 
1 subunit eEF1-beta 
↓1.6 56 397 25230 AFUA_1G11190 306 
UDP-glucose 4-epimerase ↓1.6 45 605 40816 AFUA_5G10780 261 
 177 
 
4.4.2.2 ΔgliZ293 vs. AF293 + MeOH 
Similar to what was described in Section 4.4.1, there is differential expression of 
proteins involved in different metabolic pathways, with an increase in the metabolism of 
simple sugars such as fructose and a corresponding increase in glycolysis and 
gluconeogenesis. This is supported by a 1.9 fold increase in triosephosphate isomerase 
(AFUA_5G13450), 1.8 fold increase in class II fructose-bisphosphate aldolase 
(AFUA_3G11690), both of which are involved in the latter stages of the fructose and 
mannose biosynthetic pathway catalysing the formation of glyceraldehyde-3P; and a 1.3 
fold increase of a putative enolase (AFUA_6G06770) which has a role in glycolysis. A 
full list of proteins identified in ΔgliZ vs AF293 + MeOH can be found in Table 4.7.  
 Interestingly, there is also increased expression of proteins involved in different 
aspects of the cell stress response in ΔgliZ. Manganese superoxide dismutase Sod3 
(AFUA_1G14550) has a 1.6 fold increase in expression. This enzyme is involved in 
super oxide dismutation, which is natural by-product of aerobic respiration, indicating 
that there could be higher amounts of this harmful radical in ΔgliZ cells when compared 
to AF293. An increase in ROS in ΔgliZ cells is further supported by the 1.4 fold 
increase in the expression of a putative glutamate decarboxypeptidase (Dug1; 
AFUA_3G05450), an enzyme involved in the degradation of L-cysteinyl-glycine to L-
glycine and L-cysteine in yeast, which can then used again for the formation of GSH, a 
major component in the ROS response (Ganguli et al., 2007). 
 A 1.7 fold increase in expression of a peptidyl-prolyl cis-trans isomerase 
(AFUA_2G02050) and a 1.6 fold increase of choline oxidase (AFUA_8G04090) may 
support the above point that the cell is undergoing some type of stress as both have been 
demonstrated to be induced under different kinds of stresses, DNA replication stress and 
menadione stress respectively (Sims et al., 2005; Pusztahelyi et al., 2011). 
Certain amino acid biosynthesis is down-regulated in ΔgliZ showing a 1.8 fold 
decrease in glutamate/leucine/phenylalanine/valine dehyrdogenase (AFUA_4G06620) 
as well as other amino acid associated enzymes being down-regulated such as a putative 
aminopeptidase P (AFUA_5G08050) which had a 2.3 fold decrease in expression, and 
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UDP-glucose- 4-epimerase (AFUA_5G10780) which was down regulated 1.6 fold in 
ΔgliZ vs. AF293. 
 
4.4.2.3 ΔgliZ293 vs. AF293 + 5 µg/ml gliotoxin 
Upon gliotoxin addition, there is further evidence which implicates gliotoxin 
dysregulating the SAM cycle. As seen previously in ΔgliT, s-adenosyl homocysteinase 
(AFUA_1G10130) was found to have a 1.7 fold decrease in expression when cells were 
challenged with gliotoxin. Interestingly, another enzyme involved in this pathway was 
seen to be down-regulated. Cobalamin-independant methionine synthase 
(AFUA_4G07360) had a 3.3 fold decrease in its expression in ΔgliZ cells when 
compared to AF293 in the presence of gliotoxin. Orthologs of this enzyme catalyse the 
methylation of L-homocysteine to form L-methionine which can then feed back into the 
SAM cycle (Kacprzak et al., 2003; Suliman et al., 2005) . A full list of all proteins 
identified can be found in Table 4.8. 
 A 4.1 fold decrease in the expression of the putative actin protein 
(AFUA_6G04740) may suggest a reduction in cell growth of ΔgliZ compared to AF293 
due to reduced expression of this structural component (Marui et al., 2010). 
Additionally, there is a decrease in the expression of enzymes involved in complex 
carbohydrate metabolism e.g. a decrease of 2.8 fold of 1,4 β-glucan hydrolase 
(AFUA_7G06140), 3 fold decrease of NAD-dependent malate dehydrogenase 
(AFUA_7G05740) and a 2.3 fold decrease of a transketolase (AFUA_1G13500), all of 
which are involved in different types of carbohydrate metabolism suggest a cell 
undergoing energy conservation, and presumably, stress (Kim et al., 2007; Lu et al., 
2010; Sørensen et al., 2009)  . 
 As in MeOH treated cells, there is a decrease in amino acid biosynthesis. 
Sacchropine dehydrogenase (AFUA_4G11340) which has a 2.4 decrease in its 
expression, is involved in lysine biosynthesis; while AFUA_6G12580 which has 
orthologs in S. cerevisiae (Trp2) involved in tryptophan biosynthesis, is down regulated 
2.5 fold. Similarly phosphoribosyl-AMP (AFUA_1G14570) was infinitely decreased in 
ΔgliZ (Vodisch et al., 2011; Zalkinz et al., 1984; Keesey et al., 1979). Orthologs of this 
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last enzyme are involved in the histidine biosynthesis pathway where it’s involved in 
two key steps in the pathway (Keesey et al., 1979). The first is in catalysing the creation 
of phosphoribosyl-formimo-AICAR-P, and the second being in the biosynthesis of L-
histidine itself (Keesey et al., 1979). Alongside this, a putative amino-peptidase 
(AFUA_4G09030), whose orthologs have been demonstrated to catalyse the cleavage of 
amino acids from proteins and peptide chains, is completely absent from ΔgliZ showing 
an infinite decrease in expression compared to AF293 indicating a reduction in 
protein/amino acid modification in these cells (Basten et al., 2001; Marui & Sawaki 
2012) . 
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Table 4.8 Proteins differentially expressed in ΔgliZ293 vs. AF293 in the presence of 5 µg/ml gliotoxin 
 
Protein Name Gliotoxin 
Sequence 
Coverage 
% 
Mascot 
Score 
Molecular 
Mass Da 
CADRE 
 I.D. 
Spot No. 
Proteins Up-regulated 
  
 
   
Thiamine biosynthesis protein ↑1.7 10 129 38588 AFUA_5G02470 349 
Putative mannitol-1-phosphate 
dehydrogenase 
↑1.4 19 336 43093 AFUA_2G10660 294 
Proteins Down-regulated 
  
 
   
Putative aminopeptidase ↓Infinity 15 533 106624 AFUA_4G09030 63 
Putative phosphoribosyl-AMP 
cyclohydrolase 
↓Infinity 4 59 93404 AFUA_1G14570 59 
Putative translation elongation factor EF-1 
alpha subunit 
↓5.4 28 493 54273 AFUA_1G06390 256 
Putative metallopeptidase with similarity to 
mammalian thimet oligopeptidases 
↓4.2 3 109 82046 AFUA_7G05930 101 
Actin ↓4.1 28 311 41914 AFUA_6G04740 286 
Putative cobalamin-independent methionine 
synthase 
↓3.3 33 917 87073 AFUA_4G07360 96 
Putative NAD-dependent malate 
dehydrogenase 
↓3 28 360 35876 AFUA_7G05740 399 
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Protein Name Gliotoxin 
Sequence 
Coverage 
% 
Mascot 
Score 
Molecular 
Mass Da 
CADRE 
 I.D. 
Spot No. 
Putative secreted 1,4-beta-D-glucan 
glucanhydrolase 
↓2.8 9 341 78738 AFUA_7G06140 88 
Eukaryotic translation initiation factor 
eIF4A; ATP-dependent RNA helicase 
↓2.6 26 454 45981 AFUA_3G08160 269 
Ortholog(s) have anthranilate synthase 
activity, role in cleistothecium development, 
tryptophan biosynthetic process and 
anthranilate synthase complex localization 
↓2.5 18 286 57389 AFUA_6G12580 197 
Saccharopine dehydrogenase ↓2.4 26 446 49940 AFUA_4G11340 257 
14-3-3 family protein ↓2.3 21 166 30201 AFUA_6G06750 385 
Putative transketolase ↓2.3 31 679 75816 AFUA_1G13500 137 
Ortholog(s) have proteasome regulatory 
particle, lid subcomplex, proteasome storage 
granule localization 
↓2.2 31 446 38971 AFUA_1G07540 329 
Putative glutamine synthetase ↓2 25 398 38862 AFUA_4G13120 307 
Putative adenosylhomocysteinase ↓1.7 35 649 49039 AFUA_1G10130 270 
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4.4.2.4 Proteins in common ΔgliZ293 vs. AF293 +/- gliotoxin 
 A total of 11 proteins identified were found to be shared between the two 
comparatives i.e. ΔgliZ293 vs. AF293   MeOH and ΔgliZ293 vs. AF293+ gliotoxin. A 
full list of proteins identified in common between ΔgliZ and AF293 +/- gliotoxin can be 
found in Table 4.9. Of these eleven, only one showed a difference in its expression from 
one treatment compared to the next. Allergen Asp F3 (AFUA_6G02280) was found to 
have increased expression of 2.3 fold in MeOH treated cells but reduced expression of 
1.9 fold in gliotoxin treated cells. This enzyme is a putative thioredoxin peroxidase 
identical to Pmp20, a peroxisomal membrane protein which is involved in tackling ROS 
via the degradation of lipid hydroperoxides within the peroxisomal membrane (Mabey 
et al., 2004). As gliotoxin biosynthesis is abolished in this strain, the addition of 
exogenous gliotoxin does not increase the expression of the entire gli cluster, only gliT. 
This may imply that the lower gliotoxin levels in ΔgliZ, due to the silencing of the 
gliotoxin biosynthetic cluster, may be having an anti-oxidant role resulting in the 
reduced expression of AspF3. 
 In both ΔgliZ and AF293 + gliotoxin comparisons, there is a decrease in the 
expression of 6-phosphogluconate dehydrogenase (AFUA_6G08050); 4.5 fold in 
MeOH and 6.6 in gliotoxin treated cells. This protein is involved in the pentose 
phosphate and glutathione biosynthesis pathways whereby it is one of the controlling 
factors that mediates GSSG reduction to GSH (Teutschbein et al., 2010; Kaneshira et 
al., 2004). The addition of gliotoxin results in an increase in the reduction of this protein 
which suggests that the presence of reduced glutathione is not advantageous to the cell. 
This result further strengthens the hypothesis made throughout this study of the 
relationship between glutathione levels and gliotoxin toxicity whereby low glutathione 
levels are believed to be advantageous to the cell when challenged with gliotoxin 
(Chapter 3). 
 As seen in Section 4.4.2.3 and 4.4.2.4, there is a decrease in the expression of 
different metabolic pathways. Two protein sub-units involved in the pentose phosphate 
pathway; Tublin α-1 subunit (AFUA_1G02550) and tubulin-β subunit 
(AFUA_1G10910) have a decrease in expression of 4.2 and 3.6 fold respectively in 
MeOH treated cells and 2.5 and 2.2 fold respectively in gliotoxin treated cells.
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Table 4.9 Proteins differentially expressed in ΔgliZ293vs. AF293 in the presence of MeOH and 5 µg/ml gliotoxin 
Protein Name MeOH Gliotoxin 
Sequence 
Coverage 
% 
Mascot 
Score 
Molecular 
Mass Da 
CADRE 
 I.D. 
Spot No. 
Proteins Up-regulated 
   
 
   
TCTP family protein ↑2.1 ↑2.3 21/29 209/312 20350 AFUA_1G16840 348/530 
Allergen Asp f 3; peroxiredoxin family 
reductase; 
↑2.3 ↓1.9 50/51 369/382 18557 AFUA_6G02280 371/673 
Proteins Down-regulated 
   
 
   
6-phosphogluconate dehydrogenase ↓4.5 ↓6.6 44/39 849 56228 AFUA_6G08050 215/263 
Tubulin alpha-1 subunit ↓4.2 ↓2.5 47/12 133 50805 AFUA_1G02550 161/206 
Beta-tubulin ↓3.6 ↓2 27/37 /454 52283 AFUA_1G10910 181/229 
Putative glutamine synthetase ↓3.2 ↓2 49/25 /398 38862 AFUA_4G13120 248/307 
Molecular chaperone ↓2.1 ↓1.8 25/30 641/748 67303 AFUA_1G07440 252/140 
Argininosuccinate synthase ↓2 ↓1.7 22/13 498/184 46684 AFUA_2G04310 192/234 
Putative mitochondrial processing peptidase 
beta subunit 
↓2 ↓3.3 33/34 744/767 54981 AFUA_1G14200 206/253 
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Protein Name MeOH Gliotoxin 
Sequence 
Coverage 
% 
Mascot 
Score 
Molecular 
Mass Da 
CADRE 
 I.D. 
Spot No. 
Putative alanine aminotransferase ↓1.8 ↓2.8 50/16 888/321 55622 AFUA_6G07770 175/226 
Argininosuccinate synthase ↓1.7 ↓1.5 39/37 816/512 46684 AFUA_2G04310 195/238 
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Three enzymes identified from four spots, were found to be involved in the 
alanine, aspartate and glutamate metabolic pathway. Argininosuccinate synthase 
(AFUA_2G04310) was identified from two different spot locations under both 
conditions and was found to have reduced expression of 2 and 1.7 fold in MeOH treated 
cells, and 1.7 and 1.5 fold in gliotoxin treated ΔgliZ cells when compared to AF293. 
Glutamine synthetase (AFUA_4G13120) which is involved in the condensation of l-
glutamate and ammonia to form l-glutamine, had a 3.2 fold reduction in expression in 
MeOH treated cells and 2 fold reduction in gliotoxin treated cells. Lastly, alanine 
transferase (AFUA_6G07770) which reversibly converts L-alanine to pyruvate, was 
reduced 1.8 fold in MeOH treated cells and 2.8 fold in gliotoxin treated cells.  
 Dysregulated proteins were categorised according to their respective function as 
described previously in section 4.2.1. The top five categories are given for ΔgliZ vs. 
AF293   MeOH (Figure 4.12 A) and ΔgliZ vs. AF293 + 5 µg/ml gliotoxin (Figure 4.12 
B). Complete list of all proteins identified and their respective functions can be found in 
Table 4.9. 
 
Figure 4.12 (A) Functional categorisation of proteins differentially expressed in 
ΔgliZ293 A. fumigatus vs. AF293 A. fumigatus + MeOH 
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Figure 4.12 (B) Functional categorisation of proteins differentially expressed in 
ΔgliZ293 A. fumigatus vs. AF293 A. fumigatus + 5 µg/ml gliotoxin 
 
 
4.4.2.5 Discussion 
 In the absence of gliZ in A. fumigatus there is a shift in the ROS state of the cell. 
This is supported by the reduced expression of enzymes involved in the OS response, 
most notably the manganese super oxide dismutase (AFUA_1G14550). This enzyme is 
located in the mitochondrion and is involved in dismutating O2
-
 into H2O and H2O2. A 
decrease in this enzyme suggests that when gliotoxin biosynthesis is abolished, it is 
importance is reduced. This could be due to the absence of reactive intermediate steps 
involved in gliotoxin biosynthesis (Forseth et al., 2011). The increased expression of 
Dug1 (AFUA_3G05450), an enzyme involved in the alternate glutamyl cycle which 
degrades L-cysteinyl glycine into L-cysteine and L-glycine, is presumably for 
glutathione biosynthesis. Once challenged with gliotoxin this changes, with no altered 
expression for either of these two enzymes seen, indicating the redundancy of Sod3 is 
no longer present as gliotoxin enters the cell giving way a return to basal levels of this 
enzyme in. AFUA_6G08050 is down regulated in both MeOH treated cells and shows a 
further decrease in gliotoxin treated cells. This enzyme is one component of GSSG 
 187 
 
reduction to GSH and along with the return to basal levels of Dug1 in gliotoxin treated 
cells, implies glutathione levels are being carefully regulated in this strain, more so than 
AF293 re-iterating the point made in the previous chapter about the relationship seen 
between glutathione levels and gliotoxin toxicity. 
 As in previous sections, there is further evidence which supports gliotoxin 
mediated dysregulation of the SAM cycle. This can be seen in the 1.7 fold reduction in 
the expression of s-adenosyl homocysteinase (AFUA_1G10130) and the 3.3 fold 
reduced expression of the cobalamin-independant methionine synthase (Met H/D; 
AFUA_4G07360). As hypothesised earlier, the decrease in s-adenosyl homocysteinase 
could suggest elevated levels of L-homocysteine, which are toxic to the cell, due to an 
increase in SAM mediated S-methylation, presumably due to the formation of Bm-GT. 
The Met H/D is involved in the methylation of L-homocysteine to form L-methionine, a 
key step in maintaining methionine availability for the SAM cycle. A reduction of the 
methionine synthase implies that the cell is trying to further control the production of L-
homocysteine by down-regulating the SAM cycle. Compared to what was seen in 
section 4.4.2 with ΔgliT vs. AF293, no differential expression was found for Met H/D, 
indicating in response to gliotoxin, the SAM cycle is further dysregulated in ΔgliZ than 
in ΔgliT. Met H/D differential expression in ΔgliZ, may suggest that silencing of the gli 
cluster induces repression of this enzyme in gliotoxin exposed. 
 The altered expression of the Asp F 3 peroxiredoxin protein, highlights 
gliotoxin’s potential as an anti-oxidant molecule resulting in its reduced expression. 
This same enzyme was found previously by Carberry et al., (2006) to be significantly 
induced in the presence of 14 µg/ml gliotoxin. One reason for this could be the 
difference in gliotoxin concentration. At 5 µg/ml gliotoxin the anti-oxidant potential of 
gliotoxin is sufficient in preventing major hydrogen peroxide stress from being 
produced. The greater 14 µg/ml gliotoxin appears to overwhelm any benefit seen using 
the lower 5 µg/ml gliotoxin concentrations, inducing OS and a subsequent up-regulation 
of OS proteins.  
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4.4.3.1 ΔgliTΔgliZ293 vs. AF293 
 Cells from AF293 and ΔgliTΔgliZ293 were treated as described previously 
(Section 4.4.1.1). A total of 71 protein spots were identified as being significantly (P = 
< 0.05) expressed between the two comparisons (ΔgliTΔgliZ293 + MeOH vs. AF293 + 
MeOH and ΔgliTΔgliZ293 + 5 µg/ml gliotoxin vs. AF293 + 5 µg/ml gliotoxin. Of a total 
of 68 identified proteins, 27 were identified from MeOH treated cells (Figure 4.13 A), 
34 from gliotoxin treated cells (Figure 4.13 B) with 7 identified to be in common, 
ranging from 18 kDa to 108.7 kDa in size. A full list of proteins identified in 
ΔgliTΔgliZ vs. AF293 + MeOH can be foun in table 4.10. 
 
4.4.3.2  ΔgliTΔgliZ293 vs. AF293 + MeOH 
 As seen in earlier sections, there is an increase in the expression of proteins 
involved in fructose metabolism and glycolysis with a 2.2 fold increase of a protein with 
predicted oxidoreductase properties, a 2.1 fold increase in mannitol-l-phosphate 
dehydrogenase (AFUA_2G10660), a 1.7 fold increase in triosephosphate isomerise 
(AFUA_5G13450), 1.7 fold increase in an aldehyde dehydrogenase (AFUA_4G08600), 
1.5 fold increase in a class II fructose bis-phosphate aldolase (AFUA_3G11690) and a 
1.3 fold increase in enolase (AFUA_6G06770), indicating an increased demand in the 
energy held within these carbohydrates. Opposed to this is the decrease in the 
expression of other carbohydrate metabolic pathways such as the TCA cycle where 
AFUA_4G04520 has a 2.3 fold decrease in its expression. 
 A 1.4 fold increase in glutamate carboxypeptidase Dug 1 (AFUA_3G05450), a 
peptidase involved in the cleavage of L-cysteinyl-glycine to release L-cysteine and L-
glycine, key amino acids required in the formation of the tri-peptide thiol glutathione, 
and a 5.8 fold decrease in the expression of 6-phosphogluconate dehydrogenase 
(AFUA_6G08050), a component responsible for GSSG reduction to GSH, suggest 
altered regulation of the glutathione biosynthesis pathway, and glutathione levels in 
ΔgliTΔgliZ. 
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Figure 4.13 A 2D PAGE analysis of ΔgliTΔgliZ293A. fumigatus + MeOH vs. AF293 A. 
fumigatus + MeOH, separated on pH 4-7 IPG strips on 12 % SDS-PAGE gel 
 
 
  
 
80 kDa 
30 kDa 
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Figure 4.13 B 2D PAGE analysis of ΔgliTΔgliZ293A. fumigatus + 5 µg/ml gliotoxin vs. 
AF293 A. fumigatus + 5 µg/ml gliotoxin, separated on pH 4-7 IPG strips on a 12 % 
SDS-PAGE gel 
100 kDa 
40 kDa 
30 kDa 
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Table 4.10 Proteins differentially expressed in ΔgliTΔgliZ293 vs. AF293 in the presence of MeOH 
Protein Name MeOH 
Sequence 
Coverage 
% 
Mascot 
Score 
Molecular 
Mass 
Da 
CADRE 
 I.D. 
Spot ID 
Proteins Up-regulated 
  
 
   
Allergen Asp f 3 ↑2.5 27 
112 
18453 AFUA_6G02280 422 
Has domain(s) with predicted oxidoreductase 
activity and role in oxidation-reduction process 
↑2.2 4 
13 
32753 AFUA_1G07650 321 
Ortholog(s) have phenylalanine-tRNA ligase 
activity and 
phenylalanine-tRNA ligase complex 
localization 
↑1.8 18 
338 
68325 AFUA_1G05620 65 
Putative triosephosphate isomerase ↑1.7 13 
108 
28068 AFUA_5G13450 381 
Putative aldehyde dehydrogenase (NAD(P)+) ↑1.7 24 
345 
60254 AFUA_4G08600 182 
Putative class II fructose-bisphosphate aldolase ↑1.5 3 
72 
39971 AFUA_3G11690 307 
Thiamine biosynthesis protein, phoB-regulated ↑1.5 4 
39 
38323 AFUA_5G02470 301 
Putative glutamate carboxypeptidase ↑1.4 58 
961 
53272 AFUA_3G05450 186 
Putative Hsp70 chaperone ↑1.3 5 
128 
66973 AFUA_8G03930 118 
Putative enolase ↑1.3 31 
465 
47305 AFUA_6G06770 228 
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Protein Name MeOH 
Sequence 
Coverage 
% 
Mascot 
Score 
Molecular 
Mass 
Da 
CADRE 
 I.D. 
Spot ID 
Putative inorganic diphosphatase ↑1.3 13 
97 
43624 AFUA_3G08380 334 
Proteins Down-regulated 
  
 
   
6-phosphogluconate dehydrogenase ↓5.8 57 
1379 
56228 AFUA_6G08050 234 
Tubulin beta-2 subunit ↓4.4 2 
59 
49892 AFUA_7G00250 188 
Heat shock protein ↓3.9 15 
198 
80640 AFUA_5G04170 67 
Putative V-type ATPase, B subunit ↓2.7 4 
83 
56418 AFUA_2G13240 165 
Ortholog of A. niger CBS 513.88 ↓2.5 19 
275 
61344 AFUA_3G02430 126 
Putative metallopeptidase with similarity to 
mammalian thimet oligopeptidases 
↓2.4 11 
339 
82046 AFUA_7G05930 75 
Has domain(s) with predicted ATP binding, 
ligase activity and role in metabolic process 
↓2.3 5 
83 
48017 AFUA_4G04520 252 
Putative G1/S-specific cyclin ↓2.1 4 
16 
47021 AFUA_2G03920 108 
Putative mannitol-1-phosphate dehydrogenase ↑2.1 20 
93 
43004 AFUA_2G10660 259 
Protein of unknown function identified by mass 
spectrometry 
↓1.9 4 
110 
69525 AFUA_4G08030 102 
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Protein Name MeOH 
Sequence 
Coverage 
% 
Mascot 
Score 
Molecular 
Mass 
Da 
CADRE 
 I.D. 
Spot ID 
Putative glutamine synthetase ↓1.8 6 
63/53 
39900 AFUA_4G13120 264/395 
Argininosuccinate synthase ↓1.8 21 
408 
46684 AFUA_2G04310 209 
Mitochondrial processing peptidase beta-
subunit 
↓1.6 35 
899 
54981 AFUA_1G14200 226 
Ortholog(s) have proteasome regulatory 
particle, lid subcomplex, 
proteasome storage granule localization 
↓1.4 7 
86 
38995 AFUA_1G07540 280 
Putative aminopeptidase P ↓1.4 3 
73 
72680 AFUA_5G08050 97 
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 Similar to a previous result seen in ΔgliZ +MeOH, allergen Asp F3 
(AFUA_6G02280) was found to have a 2.5 fold increase in expression in ΔgliTΔgliZ. 
As mentioned earlier, this belongs to the peroxiredoxin family of proteins, and has a 
putative anti-oxidant function in the liposomal membrane. Unlike ΔgliZ however, this 
same enzyme showed no differential expression in the presence of gliotoxin, implying 
that in ΔgliTΔgliZ this enzyme returns to wild-type levels upon gliotoxin addition. 
 There is also some evidence to suggest an increase in proteins involved in 
protein biosynthesis, as seen in the 1.8 fold increase in a TCTP family protein 
(AFUA_1G16840) with orthologs possessing a role in ribosome interaction and 
apoptosis, and a 1.8 fold increase in the expression of a putative phenylalanine-tRNA 
ligase (AFUA_1G05620) with orthologs involved in phenylalanine, tryptophan and 
tyrosine amino acid biosynthesis (Rinnerthaler et al., 2006; Oh et al., 2013; Roy et al., 
2005). 
 
4.4.3.3 ΔgliTΔgliZ293 vs. AF293 + 5 µg/ml gliotoxin 
 Gliotoxin exposure of ΔgliTΔgliZ strains results in a significant decrease in the 
expression of two proteins involved in protein processing of the endoplasmic reticulum. 
Hsp70 chaperone (AFUA_2G04620), which has a 4.9 fold decrease in expression, and a 
different Hsp70 chaperone Lhs1 (AFUA_1G15050), which is completely absent in 
ΔgliTΔgliZ, have orthologs involved in protein import into the endoplasmic reticulum, 
nucleotide folding and recognition via luminal chaperone (Nishikawa et al., 2001; Sims 
et al., 2005). A full list of proteins identified in ΔgliTΔgliZ vs. AF293 + 5 µg/ml 
gliotoxin can be found in Table 4.11. 
 Differential expression was seen in enzymes involved in valine/leucine and 
isoleucine biosynthesis pathway. A 5.9 fold increase in the expression of 3 
isopropylmalate (AFUA_1G15780) and a 3.4 fold increase in a mitochondrial 
acetolactate synthase (AFUA_4G07210) which catalyse the formation of 2-
oxobutanoate and (S)-2-Aceto-2-hydroxybutanoate sequentially, which leads to 
isoleucine synthesis. There is also a 4.4 fold decrease in the expression of a 
mitochondrial dihydroxy acid dehydratase (AFUA_1G03550) which is involved in the 
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later stages of iosleucine synthesis in the condensation of (R)-2,3-dihydroxy-3-
methylpentanoate to (S)-3-methyl-2-oxopentanoate. 
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Table 4.11 Proteins differentially expressed in ΔgliTΔgliZ293 vs. AF293 + 5 µg/ml gliotoxin 
Protein Name Gliotoxin 
Sequence 
Coverage 
% 
Mascot 
Score 
Molecular 
Mass 
Da 
CADRE  
I.D. 
Spot ID 
Proteins Up-regulated 
  
 
   
3-isopropylmalate dehydrogenase with a 
predicted role in leucine biosynthesis 
↑5.9 12 
228 
39049 AFUA_1G15780 969 
Mitochondrial acetolactate synthase small 
subunit 
↑3.4 5 
36 
35574 AFUA_4G07210 500 
Proteins Down-regulated 
  
 
   
Has domain(s) with predicted ATP 
binding activity 
↓Infinity 7 
306 
108767 AFUA_1G15050 9 
Putative aminopeptidase; conidia-enriched 
protein 
↓8.7 29 
1251 
108707 AFUA_5G04330 95 
Putative cobalamin-independent 
methionine synthase 
↓6.7 2 
43 
86895 AFUA_4G07360 109 
ATP synthase F1, beta subunit ↓5.6 20 
214 
55620 AFUA_5G10550 283 
Hsp70 chaperone ↓4.9 9 
129 
73385 AFUA_2G04620 142 
Putative transketolase ↓4.4 42 
1176 
74828 AFUA_1G13500 163 
Putative mitochondrial dihydroxy acid 
dehydratase 
↓4.4 7 
180 
57877 AFUA_1G03550 163 
Ortholog of A. nidulans FGSC A4 ↓4.3 5 
28 
43201 AFUA_4G03722 308 
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Protein Name Gliotoxin 
Sequence 
Coverage 
% 
Mascot 
Score 
Molecular 
Mass 
Da 
CADRE  
I.D. 
Spot ID 
Molecular chaperone ↓4.2 9 
154 
69660 AFUA_1G07440 165 
Putative hexokinase ↓3.3 15 
229 
54209 AFUA_2G05910 253 
Putative translation elongation factor EF-2 
subunit 
↓2.5 16 
795 
93198 AFUA_2G13530 617 
Secreted dipeptidyl-peptidase ↓2.3 4 
111 
70745 AFUA_2G09030 85 
Putative adenosylhomocysteinase ↓2.3 4 
54 
48490 AFUA_1G10130 345 
Putative secreted lysophospholipase B ↓2.3 5 
79 
67417 AFUA_3G14680 65 
Putative hydroxymethyl glutaryl-
coenzyme A synthase with a predicted role 
in ergosterol biosynthesis 
↓2.1 16 
211 
50797 AFUA_3G10660 290 
Putative transaldolase ↓2.1 4 
36 
35449 AFUA_5G09230 483 
Putative GMP synthase ([glutamine-
hydrolyzing) 
↓1.8 5 
42 
61432 AFUA_3G01110 235 
Putative GABA permease ↓1.7 19 
86 
56640 AFUA_1G12310 688 
Putative proteasome component ↓1.7 13 
233 
28206 AFUA_6G08960 688 
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Hydroxymethyl glutaryl co-enzyme A synthase (AFUA_3G10660) has a 2.1 
fold decrease in expression in ΔgliTΔgliZ cells in the presence of gliotoxin. This 
enzyme is involved in the leucine/valine and isoleucine degradation pathway. Here it 
catalyses the formation of (S)-3-hydroxy-3-methylglutaryl-CoA from acetoacetyl-CoA 
(Kaneshira et al., 2004). Indicating an increase in certain components involved in the 
early stages of iso-leucine biosynthesis, however with the later stages being decreased 
suggesting isoleucine is not the end target. 
 Similar to ΔgliZ, ΔgliTΔgliZ has 2.3 fold decrease in the expression of s-
adenosyl homocysteinase (AFUA_1G10130) and a 6.7 fold decrease in the cobalamin-
independant methionine synthase (AFUA_4G07360). Again, this suggests gliotoxin 
dysregulation of the SAM cycle has become deleterious to the cell thus the need to alter 
its regulation via decreasing the expression of key enzymes. A full list of proteins can 
be seen in Table 4.10.  A full list of proteins identified can be seen in Table 4.11. 
 
4.4.3.4 Proteins in common in ΔgliTΔgliZ293 vs. AF293 +/- gliotoxin 
 As seen in Table 4.12, both MeOH and gliotoxin treated ΔgliTΔgliZ cells, 
display increased expression of 7.9 fold in MeOH treated cells and 3.6 in gliotoxin 
treated cells of the pyrithiamine resistance gene (AO090003000090) from A. oryzae. As 
described earlier, this gene was used to knock out gliT in a ΔgliZ background acting as a 
positive selection marker on pyrithiamine containing plates, and as it is absent from 
AF293, it would be expected to have increased expression.  
 Interestingly, two components of microtubule formation were found to have 
decreased expression in both MeOH and gliotoxin treated cells. β-tubulin 
(AFUA_1G10910) had a 3.8 fold decrease in expression in MeOH treated cells and 4.8 
fold decrease in gliotoxin treated cells. Tubulin α-1 subunit (AFUA_1G02550) was 
identified twice from two different protein spots in gliotoxin treated cells having a 5.8 
and 3.3 respective fold decrease as well as a 2.1 fold decrease in expression in MeOH 
treated cells. 
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Table 4.12 Proteins differentially expressed in ΔgliTΔgliZ293 vs. AF293 in the presence of MeOH and  5 µg/ml gliotoxin 
 
 
Protein Name MeOH Gliotoxin 
Sequence 
Coverage 
% 
Mascot 
Score 
Molecular 
Mass 
Da 
CADRE 
 I.D. 
Spot ID 
Pyrathiamine resistance gene, thiA ↑7.9 ↑3.6 4/16 
36/241 
35492 AO090003000090 313/503 
Eukaryotic translation initiation factor 
eIF4A 
↓5.3 ↓6.2 15/8 
110/73 
45779 AFUA_3G08160 239/338 
Beta-tubulin ↓3.8 ↓4.8 11/29 
190/312 
50024 AFUA_1G10910 198/276 
Putative prolidase ↓3.1 ↓6.1 6/19 
122/410 
51944 AFUA_2G07500 151/221 
Putative ATP citrate lyase subunit ↓2.3 ↓3 50/48 
958/958 
53001 AFUA_6G10660 197/275 
Actin ↓2.2 ↓4.8 18/10 
90/52 
43893 AFUA_6G04740 253/360 
Tubulin alpha-1 subunit ↓2.1 
↓5.8   
↓3.3 
5/33/33 
41/448/4
48 50025 AFUA_1G02550 
178/254/
253 
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As seen in Section 4.4.3.2, there is a 4.4 fold decrease in the expression of a 
different microtubule associated protein, tublin β-2 subunit (AFUA_7G00250). 
Together they form repeating dimers which constitute the structure of microtubules in 
the cell. What is clear, is that once gliotoxin is added there is an increase in the fold 
decrease of these proteins in ΔgliTΔgliZ. With this, there is a decrease in the expression 
of F-actin (AFUA_6G04740) with a 2.2 fold decrease in MeOH treated cells and 4.8 
fold decrease in gliotoxin treated cells. It has been demonstrated that both microtubules 
and F-actin interact for a range of cellular functions.  
 
 Dysregulated proteins were categorised according to their respective function as 
described previously in Section 4.2.1. The top five categories are given for ΔgliTΔgliZ 
vs. AF293   MeOH (Figure 4.14 A) and ΔgliTΔgliZ vs. AF293 + 5 µg/ml gliotoxin 
(Figure 4.14 B).  
 
Figure 4.14 (A) Functional categorisation of proteins differentially expressed in 
ΔgliTΔgliZ293 A. fumigatus vs. AF293 A. fumigatus + MeOH 
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Figure 4.14 (B) Functional categorisation of proteins differentially expressed in 
ΔgliTΔgliZ293 A. fumigatus vs. AF293 A. fumigatus + 5 µg/ml gliotoxin 
 
4.4.3.5 Discussion 
 Proteomic analysis of ΔgliTΔgliZ depicts a very similar response to gliotoxin as 
each of the single mutants. The SAM cycle appears dysregulated via the decrease in the 
expression of S-adenosyl homocysteinase and cobalmin-independant methionine 
synthase upon gliotoxin addition, suggesting that absence of gliZ is necessary for the 
altered expression of cobalmin-independant methionine synthase, as it’s not 
dysregulated in ΔgliT. This dysregulation could help maintain L-homocysteine levels 
below a toxic level  
 Dysregulation of microtubule formation and endoplasmic reticulum 
components, in gliotoxin exposed cells, could suggest a reduction in protein synthesis in 
ΔgliTΔgliZ upon gliotoxin challenge, and a subsequent decrease in the expression of 
certain proteins involved in the endoplasmic reticulum and structures which facilitate 
protein transport such as microtubules (Egan et al., 2012). 
 Microtubules also have a structural role in the cell (Akashi et al., 1994; Horio & 
Oakley 2005). The combined decrease in expression of microtubule components and 
actin may imply reduced cell growth/expansion in ΔgliTΔgliZ when challenged with 
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gliotoxin which may be an attempt to conserve energy to mount a response to gliotoxin. 
Additionally, like ΔgliT and ΔgliZ, there is a down regulation of enzymes involved in 
the TCA cycle (AFUA_6G10660) and pentose phosphate pathway (AFUA_1G13500 
and AFUA_5G09230) which also supports the hypothesis that the cell is conserving 
energy. 
 Similar to ΔgliZ, ΔgliTΔgliZ shows altered expression in enzymes involved in 
glutathione biosynthesis 6-phosphogluconate dehydrogenase (AFUA_6G08050) and 
glutamate carboxypeptidase (AFUA_3G05450) in the absence of gliotoxin, which could 
result in the levels of glutathione to be altered. This suggests that silencing of the gli 
cluster causes dysregulation of glutathione biosynthesis, presumably due to glutathione 
being required in some part of the gliotoxin biosynthetic process which in the absence 
of gliZ is no longer present (Davis et al., 2011). 
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4.5 Summary of the proteomic response to gliotoxin in A. fumigatus, gliT and gliZ 
strains 
 Proteomic results throughout this Chapter depict a very complex cellular 
response to gliotoxin exposure in A. fumigatus. Differentially expressed proteins 
identified in different strains were found to belong to similar functional categories 
suggesting a generic gliotoxin response present in each strain. 
 This study has highlighted the relationship seen between gliotoxin exposure and 
the dysregulation of the SAM cycle, most notably the altered expression of s-adenosyl 
homocysteine. Interestingly this protein was down regulated in all mutant strains in the 
presence of gliotoxin when compared to AF293 wild-type. It was also found to be both 
up-regulated and down-regulated in ΔgliT +/- gliotoxin indicating multiple isoforms of 
this enzyme being present which has some precedence in other organisms (Singhal et 
al., 2013). All spots identified for s-adenosyl homocysteine which showed a decrease in 
protein expression were isolated from the same location on their respective gels. The 
form of S-adenosyl homocysteine which was found to up-regulated was isolated only 
once, with a different, more acidic pI unique to ΔgliT +/- gliotoxin. Demonstrating loss 
of gliT results in further altered expression of this enzyme which is not seen in any of 
the other strains. The altered expression of this enzyme in all mutant strains compared 
to AF293 wild-type in the presence of gliotoxin reveals that gliotoxin dysregulates the 
SAM cycle in these strains. 
 As mentioned previously, L-homocysteine accumulation can be toxic to cells 
(Fujita et al., 2006). Dysregulation of the SAM cycle could result in altered levels of l-
homocysteine as a by-product. The formation of Bm-GT via s-adenosyl methionine 
mediated methylation could induce such a dysregulation and may potentiate gliotoxin 
toxicity. A decrease in the expression of S-adenosyl homocysteinase would result in a 
corresponding reduction in l-homocysteine and prevent its accumulation. Interestingly, 
altered expression of this enzyme is not seen in ΔgliZ and ΔgliTΔgliZ +/- gliotoxin 
indicating there is no change in the levels of this enzyme upon gliotoxin addition. Only 
ΔgliT +/- gliotoxin shows altered expression of S-adenosyl homocysteinase which 
suggests that dysregulation of the SAM cycle in this strain requires components of the 
gli cluster to be active as well as gliotoxin to be present. 
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 Additionally, both ΔgliZ and ΔgliTΔgliZ had altered expression of cobalamin-
independant methionine synthase, another enzyme involved in the SAM cycle, in the 
presence of gliotoxin compared to AF293. This enzyme methylates L-homocysteine to 
form L-methionine which is required for the SAM cycle. Altered expression of both this 
and the S-adenosyl homocysteinase could help regulate L-homocysteine production via 
alteration of the SAM cycle. In contrast, ΔgliT does not show any altered expression of 
this enzyme which could suggest silencing of the gli cluster could be responsible for its 
altered expression in ΔgliZ and ΔgliTΔgliZ in the presence of gliotoxin compared to 
AF293. 
 These results indicate that loss of gliT and gliZ leaves the strain unable to cope 
with gliotoxin exposure with increased sensitivity seen in these strains on gliotoxin 
plates which appears to result in the alteration of the SAM cycle causing these strains to 
dysregulate SAM cycle enzymes in an attempt to reduce gliotoxin toxicity, presumably 
influencing L-homocysteine levels. They also depict gliotoxin toxicity inducing a global 
response resulting in differential expression of proteins involved in metabolism, 
glutathione biosynthesis and the cellular response to stress, further highlighting its 
effects on the cell. 
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Chapter 5:  
A. fumigatus transcriptomic response to 
gliotoxin 
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5.1 Introduction 
Transcriptomics was used to gain a further insight into the global cellular response of A. 
fumigatus to the fungal secondary metabolite gliotoxin. ATCC46645 A. fumigatus and 
ΔgliT46645 were compared to elucidate the subsequent response exogenous gliotoxin 
presence has in these strains and highlight key areas affected by gliotoxin toxicity. 
These strains were utilised as ATCC46645 is a low gliotoxin producer, meaning the 
results seen here are due to the addition of exogenous gliotoxin and not endogenous 
biosynthesis. 
 
5.2 A. fumigatus response to gliotoxin 
 ATCC46645 and ΔgliT46645 A. fumigatus mycelia were treated with either 
MeOH (solvent control) or 5 µg/ml gliotoxin for 3 h. A total concentration of 2 µg/µl of 
extracted total RNA was sequenced employing paired-end sequencing. The mean 
expression values for each gene were calculated from the resulting transcriptome data 
for each strain and treatment and employed to compare the difference in the 
transcriptomic response to gliotoxin for both ATCC46445 and ΔgliT46645. These were 
then compared to each other to calculate the difference in expression levels of particular 
genes between the two strains.  
 
 Genes with ≥ 2 fold expression were deemed to show significant up-regulation 
while genes with ≤ 0.5 fold expression were significantly down-regulated. Table 5.1 
illustrates the total number of genes found to be significantly up and down-regulated in 
response to gliotoxin in both strains. Between each strain comparison there is a major 
difference in the total number of genes differentially expressed suggesting different 
responses between ATCC46645 wild-type and ΔgliT46645, presumably due to the loss of 
gliT. Figure 5.1 illustrates the number of genes shared between ATCC46645 +/- 
gliotoxin and ΔgliT46645 + gliotoxin which are either significantly up (A) or down (B) -
regulated. 
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Table 5.1 Total number of genes significantly up and down regulated in 
ATCC46645 and ΔgliT +/- gliotoxin 
Strain 
WT
1
 glio
2
 / WT 
MeOH
3
 
ΔgliT glio / ΔgliT 
MeOH 
ΔgliT glio / WT 
glio 
Total number of 
genes up-
regulated
4
 
636 1022 437 
Total number of 
genes down-
regulated
5
 
828 2812 2410 
 
1= ATCC46645 A. fumigatus. 2= represents strains treated with 5 µg/ml gliotoxin 
(glio). 3 = strains treated with methanol (MeOH) which served as a solvent control. 4 = 
genes were deemed significantly up-regulated if they had ≥ 2 fold expression 5 = genes 
were deemed significantly down-regulated if they had ≤ 0.5 fold expression. 
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A. Genes with ≥ 2 fold expression 
ATCC46645         ΔgliT 
   399    237  785 
 
 
B. Genes with ≤ 0.5 fold expression 
ATCC46645         ΔgliT 
 
828    534  2278  
 
 
Figure 5.1 Number of significantly expressed genes which overlap in ATCC46645 
and ΔgliT in the presence of gliotoxin. A- represents the number of genes which are 
significantly up-regulated in ATCC46645 and ΔgliT + gliotoxin. B- represents the 
number of genes which are significantly down-regulated in ATCC46645 and ΔgliT + 
gliotoxin 
 
5.3 Pathways up- and down-regulated in response to gliotoxin in ATCC46645 and 
ΔgliT46645 
 Table 5.2 shows the differential expression of genes involved in selected 
pathways which have been previously shown to be involved in gliotoxin toxicity and 
other forms of stress. It also shows various secondary metabolite clusters which are 
differentially regulated in response to gliotoxin in ATCC46645 and ΔgliT46645.
  
 
208 
Table 5.2 Mean expression values of genes differentially expressed in the presence of 5 µg/ml gliotoxin in ATCC46645 and 
ΔgliT46645 A. fumigatus strains 
Gene ID Putative function 
Fold change 
WT + glio/ WT + 
MeOH 
Fold change 
ΔgliT+ glio/ ΔgliT 
+ MeOH 
Fold change 
ΔgliT + glio/ WT 
+ glio 
 
Cysteine and methionine metabolism     
AFUA_1G04160 
Has domain(s) with predicted pyridoxal phosphate 
binding, transaminase activity  
0.261 0.060 0.257 
AFUA_1G05570 Cysteine dioxygenase 0.611 0.452 0.576 
AFUA_1G10130 Putative adenosylhomocysteinase 1.287 3.530 1.682 
AFUA_1G10630 Putative S-adenosylmethionine synthetase 1.011 2.480 1.880 
AFUA_1G15350 
Has domain(s) with predicted O-acetyltransferase 
activity  
0.703 0.093 0.159 
AFUA_3G05480 
Ortholog(s) have cystathionine gamma-synthase 
activity 
1.003 2.415 2.358 
AFUA_3G06830 Aspartate-semialdehyde dehydrogenase 0.983 2.233 2.313 
AFUA_3G11640 Homoserine dehydrogenase 0.801 3.067 2.568 
AFUA_4G03930 Putative cysteine synthase B 0.892 0.095 0.020 
AFUA_4G03950 Ortholog(s) have cystathionine beta-lyase activity 1.273 2.134 1.675 
AFUA_4G07360 Putative cobalamin-independent methionine synthase 0.903 4.112 4.138 
AFUA_5G01500 Homocysteine S-methyltransferase activity 1.082 2.460 1.807 
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AFUA_5G02180 
Cysteine synthase 0.771 2.914 2.957 
AFUA_5G04250 Homocysteine synthase 0.490 0.888 1.880 
AFUA_5G07210 Homoserine O-acetyltransferase 1.341 6.805 2.548 
AFUA_5G08600 Ortholog(s) have serine O-acetyltransferase activity 2.734 2.384 0.783 
AFUA_5G14410 Putative cysteine dioxygenase 1.246 0.205 0.142 
AFUA_6G02490 
Has domain(s) with predicted pyridoxal phosphate 
binding, transaminase activity  
0.963 2.774 2.128 
AFUA_6G03740 Ortholog(s) have role in ascospore formation 0.711 0.281 0.580 
AFUA_6G04430 Ortholog(s) have oxidoreductase activity 0.834 0.492 0.567 
AFUA_7G01370 Ortholog(s) have thiosulfate sulfurtransferase activity 0.452 0.473 0.841 
AFUA_7G01590 
Has domain(s) with predicted catalytic activity, 
pyridoxal phosphate binding activity  
0.824 3.450 3.889 
AFUA_8G04340 Putative cystathionine gamma-lyase 0.756 0.285 0.270 
 
Sulphur metabolism      
AFUA_1G10820 
Ortholog(s) have role in methionine metabolic 
process, sulfate assimilation and intracellular 
localization 
1.734 2.859 1.343 
AFUA_2G15590 Putative sulphite reductase 2.126 4.836 2.378 
AFUA_3G05480 
Ortholog(s) have cystathionine gamma-synthase 
activity 
1.003 2.415 2.358 
AFUA_3G07960 Alpha-ketoglutarate-dependent taurine dioxygenase 3.445 1.852 0.966 
AFUA_4G03930 Putative cysteine synthase B 0.892 0.095 0.020 
AFUA_5G02180 Cysteine synthase (o-acetylserine (thiol)-lyase 0.771 2.914 2.957 
AFUA_5G02190 Has domain(s) with predicted electron carrier activity, 2.354 1.217 0.561 
  
 
210 
molybdenum ion binding, oxidoreductase activity 
AFUA_5G04250 Homocysteine synthase 0.490 0.888 1.880 
AFUA_6G08920 Assimilatory sulfite reductase 0.624 3.474 2.537 
AFUA_7G00350 Putative NAD-dependent dehydrogenase 1.934 3.371 1.483 
AFUA_7G01370 Ortholog(s) have thiosulfate sulfurtransferase activity 0.452 0.473 0.841 
AFUA_7G06030 Alpha-ketoglutarate-dependent taurine dioxygenase;  0.571 0.409 0.331 
AFUA_8G02210 Alpha-ketoglutarate-dependent taurine dioxygenase 2.817 5.496 1.964 
 
Glutathione metabolism     
AFUA_1G01370 Predicted glutathione S transferase 0.624 0.371 0.617 
AFUA_2G00590 Predicted glutathione S transferase 0.447 0.424 0.198 
AFUA_2G08370 Predicted glutathione S transferase 1.646 0.482 0.704 
AFUA_3G05450 Putative glutamate carboxypeptidase 0.755 0.280 0.361 
AFUA_3G08660 
Ortholog of A. nidulans FGSC A4 : AN3028, A. niger 
CBS 513.88  
1.824 2.057 0.955 
AFUA_3G10830 Putative glutathione transferase 0.502 0.462 0.640 
AFUA_4G08010 Putative ornithine decarboxylase 0.582 0.499 0.655 
AFUA_4G13580 Gamma-glutamyltranspeptidase 0.453 0.065 0.109 
AFUA_4G14530 Putative theta class glutathione S-transferase 0.921 0.028 0.055 
AFUA_5G06610 Ortholog(s) have glutathione synthase activity  0.465 0.441 0.659 
AFUA_6G00760 Predicted glutathione S transferase 0.598 0.288 0.571 
AFUA_6G09690 
Glutathione S-transferase encoded in the gliotoxin 
biosynthetic gene cluster 
205.727 151.605 0.183 
AFUA_7G04760 Gamma-glutamyltranspeptidase 0.866 0.292 0.339 
AFUA_7G05500 Putative theta class glutathione transferase 3.849 0.412 0.119 
AFUA_7G08450 Ornithine decarboxylase 0.585 6.754 8.468 
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AFUA_8G06540 
Has domain(s) with predicted catalytic activity and 
role in polyamine biosynthetic process 
2.272 3.544 0.530 
 
 
Oxidative stress related proteins     
AFUA_1G02170 
Ortholog(s) have role in protein refolding and 
mitochondrial matrix localization 
0.640 0.306 0.387 
AFUA_1G14550 Putative manganese superoxide dismutase 0.789 0.037 0.022 
AFUA_2G02050 Putative peptidyL-prolyl ciS-trans isomerase 2.316 2.834 1.035 
AFUA_2G04320 
Has domain(s) with predicted FMN binding, 
oxidoreductase activity and role in oxidation-
reduction process 
1.439 0.161 0.168 
AFUA_2G09290 Putative antigenic mitochondrial protein 2.469 2.768 1.043 
AFUA_2G18030 Putative catalase 0.212 0.836 3.125 
AFUA_3G02270 Mycelial catalase 1.647 0.067 0.439 
AFUA_3G06540 
Ortholog(s) have phosphoadenylyL-sulfate reductase 
(thioredoxin) activity  
0.771 6.841 2.966 
AFUA_3G14970 Putative thioredoxin 0.634 0.443 0.839 
AFUA_4G05950 
Ortholog(s) have disulfide oxidoreductase activity, 
role in cellular response to oxidative stress, response 
to osmotic stress 
1.018 2.034 1.972 
AFUA_4G12990 Putative thioredoxin reductase 2.427 5.076 1.543 
AFUA_5G01440 
Ortholog(s) have thioredoxin peroxidase activity, 
role in cell redox homeostasis, cellular response to 
oxidative stress 
0.580 0.264 0.360 
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AFUA_5G09910 Putative p-nitroreductase family protein 0.583 0.356 0.722 
AFUA_5G10270 Ortholog(s) have mRNA binding 0.375 0.835 1.467 
AFUA_6G07210 Putative copper-zinc superoxide dismutase 1.232 2.206 1.813 
AFUA_7G06420 Ortholog(s) have intracellular localization 1.162 0.406 0.244 
AFUA_8G01090 Putative thioredoxin 0.843 0.033 0.073 
AFUA_8G01670 Putative bifunctional catalase-peroxidase 3.096 1.095 0.215 
 
 
Translation and Ribosomal Biogenesis     
AFUA_1G05080 Putative 60S ribosomal protein P0 2.265 5.292 2.113 
AFUA_1G05500 40S ribosomal protein S12 2.481 6.270 2.174 
AFUA_1G12890 Putative 60S Ribosomal protein L5 2.181 6.717 2.475 
AFUA_1G15730 40S ribosomal protein S22 2.495 5.754 2.327 
AFUA_2G02150 Putative ribosomal protein S10 2.492 5.421 2.205 
AFUA_2G09200 60S ribosomal protein L30 2.036 5.310 2.364 
AFUA_2G10100 Allergen Asp f 8; putative ribosomal protein P2 2.326 7.066 2.448 
AFUA_2G10300 40S ribosomal protein S17 2.404 5.068 2.415 
AFUA_3G05600 60S ribosomal protein L27a 2.065 5.677 2.569 
AFUA_3G06760 Ribosomal protein L37 2.231 5.823 2.831 
AFUA_3G12300 60S ribosomal protein L22 2.637 6.149 2.126 
AFUA_4G07730 60S ribosomal protein L11 2.156 5.449 2.500 
AFUA_5G03020 60S ribosomal protein L4 2.291 5.402 2.013 
AFUA_5G05630 60S ribosomal protein L23 2.209 5.340 2.606 
AFUA_5G06360 60S ribosomal protein L8 2.232 5.715 2.242 
AFUA_6G02440 60s ribosomal protein L24 1.895 5.251 2.594 
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AFUA_6G05200 60S ribosomal protein L28 1.994 5.573 2.476 
AFUA_6G11260 Ribosomal protein L26 2.026 5.199 2.386 
AFUA_6G12660 40S ribosomal protein S10b 2.554 5.563 2.137 
AFUA_6G13250 60S ribosomal protein L31e 2.164 5.294 2.523 
 
Leucine/Valine and Isoleucine degradation     
AFUA_2G10920 
Putative enoyL-CoA hydratase/isomerase family 
protein  
0.603 0.282 0.490 
AFUA_2G12450 Putative hydroxymethylglutaryL-CoA lyase 0.559 0.231 0.335 
AFUA_3G01450 Putative 3-methyL-2-oxobutanoate dehydrogenase 0.314 0.036 0.089 
AFUA_3G09470 
Has domain(s) with predicted coenzyme binding, 
nucleotide binding, phosphogluconate dehydrogenase 
(decarboxylating) activity 
0.709 3.609 1.687 
AFUA_4G12010 Putative 2-oxo acid dehydrogenases acyltransferase 0.267 0.027 0.106 
AFUA_4G12870 
Putative methylmalonate-semialdehyde 
dehydrogenase; transcript up-regulated in conidia 
exposed to neutrophils 
0.636 0.256 0.339 
AFUA_5G01250 
Has domain(s) with predicted coenzyme binding, 
nucleotide binding, phosphogluconate dehydrogenase 
(decarboxylating) activity 
0.283 0.058 0.159 
AFUA_5G08910 
Putative 3-methylcrotonyL-CoA carboxylase subunit 
alpha 
0.419 0.090 0.251 
AFUA_5G08930 Putative isovaleryL-CoA dehydrogenase 0.440 0.076 0.208 
AFUA_5G08940 
Ortholog(s) have methylcrotonoyL-CoA carboxylase 
activity  
0.510 0.150 0.305 
AFUA_5G10280 Has domain(s) with predicted 3-hydroxyisobutyrate 0.359 0.489 0.816 
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dehydrogenase activity 
AFUA_6G08830 
2-oxoisovalerate dehydrogenase complex alpha 
subunit 
0.493 0.068 0.151 
AFUA_6G11020 
Has domain(s) with predicted 3-hydroxyisobutyrate 
dehydrogenase activity 
0.512 0.025 0.072 
AFUA_6G11430 Putative aldehyde dehydrogenase 0.753 0.134 0.135 
AFUA_6G12250 Has domain(s) with predicted CoA-transferase activity 0.249 0.025 0.336 
AFUA_6G14200 Putative acetyL-CoA acetyltransferase 0.451 0.101 0.197 
AFUA_7G01000 
Putative alcohol dehydrogenase involved in ethanol 
metabolism 
0.024 0.399 1.196 
AFUA_7G01720 
Has domain(s) with predicted catalytic activity and 
role in metabolic process 
3.311 2.241 0.578 
AFUA_7G04080 3-ketoacyL-CoA thiolase 0.441 0.587 0.950 
AFUA_8G07210 HydroxymethylglutaryL-CoA synthase 0.731 0.764 2.068 
 
Gliotoxin biosynthetic cluster     
AFUA_6G09630 Zn2Cys6 binuclear transcription factor 7.553 1.722 0.158 
AFUA_6G09640 
Predicted 1-aminocyclopropane-1-carboxylic acid 
synthase 
3.266 0.847 0.296 
AFUA_6G09650 Predicted membrane dipeptidase 4.622 0.119 0.097 
AFUA_6G09660 Non-ribosomal peptide synthetase 69.962 10.582 0.231 
AFUA_6G09670 Predicted cytochrome P450 monooxygenase 29.113 25.645 0.482 
AFUA_6G09680 Predicted O-methyltransferase 3102.029 108.138 0.238 
AFUA_6G09690 Glutathione S-transferase  205.727 151.605 0.183 
AFUA_6G09700 Predicted protein 147.280 84.972 0.248 
AFUA_6G09710 Predicted major facilitator type glioxin transporter 914.854 374.901 0.483 
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AFUA_6G09720 Predicted methyltransferase 25.973 10.363 0.261 
AFUA_6G09730 Predicted cytochrome P450 monooxygenase 103.947 21.798 0.214 
AFUA_6G09740 Gliotoxin sulfhydryl oxidase 534.993 0.159 0.001 
AFUA_6G09745 
Ortholog of N. fischeri NRRL 181 : NFIA_055440, 
NFIA_112700 
33.129 3.294 0.130 
 
 
L-tyrosine degradation     
AFUA_2G04190 Ortholog of A. nidulans FGSC A4 : AN1900 0.401 0.415 0.402 
AFUA_2G04200 4-hydroxyphenylpyruvate dioxygenase 0.351 0.014 0.041 
AFUA_2G04210 
Protein with no conserved domains and no 
similarities to any proteins with known 
function 
0.476 0.025 0.056 
AFUA_2G04220 Homogentisate 1,2-dioxygenase involved  0.120 0.012 0.095 
AFUA_2G04230 Putative fumarylacetoacetate hydrolase 0.087 0.005 0.044 
AFUA_2G04240 Maleylacetoacetate isomerase  0.127 0.016 0.120 
AFUA_2G04262 
Ortholog(s) have nucleic acid binding 
transcription factor activity 
0.292 0.199 0.506 
 
Pigment biosynthesis     
AFUA_2G17530 
Laccase involved in conidial pigment 
biosynthesis 
1.986 0.379 0.230 
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AFUA_2G17540 
Multicopper oxidase involved in conidial 
pigment biosynthesis 
7.984 0.000 0.000 
AFUA_2G17550 
Conidial pigment biosynthesis protein with a 
role in polyketide shortening 
5.936 0.346 0.244 
AFUA_2G17560 
1,3,6,8-tetrahydroxynaphthalene reductase 
involved in conidial pigment biosynthesis 
1.209 0.512 0.264 
AFUA_2G17580 
Scytalone dehydratase involved in conidial 
pigment biosynthesis 
0.935 0.423 0.319 
AFUA_2G17600 
Polyketide synthase involved in biosynthesis 
of the conidial pigment 
1.063 0.863 0.395 
 
Fumitremorgin B Biosynthesis     
AFUA_8G00170 
Putative non-ribosomal peptide synthetase 
(NRPS) 
0.133 0.031 0.157 
AFUA_8G00190 Putative cytochrome P450 0.376 0.065 0.321 
AFUA_8G00200 Putative O-methyltransferase 0.385 0.047 0.275 
AFUA_8G00210 Putative brevianamide F prenyltransferase 0.363 0.009 0.139 
AFUA_8G00220 Cytochrome P450 0.642 0.000 0.000 
AFUA_8G00230 
Non-heme Fe(II) and alpha-ketoglutarate-
dependent dioxygenase 
0.708 0.005 0.026 
AFUA_8G00240 Putative cytochrome P450 1.402 0.051 0.097 
AFUA_8G00250 Putative prenyltransferase 1.410 0.033 0.065 
AFUA_8G00260 Putative ankyrin repeat protein 0.963 0.466 0.561 
 
 
  
 
217 
5.3.1 Gliotoxin alters cysteine and methionine biosynthesis 
 Previously, proteomic results indicated that the L-cysteine and L-methionine 
metabolic pathway was dysregulated when challenged with gliotoxin. Transcriptomic 
results were identified within this pathway to help corroborate what was seen at the 
protein level, and further elucidate gliotoxins’ affect on this pathway. Gliotoxin 
presence induces differential expression of genes involved in the L-cysteine and L-
methionine biosynthetic pathway. Interestingly in ATCC46445, only four genes show 
significantly altered expression after gliotoxin challenge. These include genes which 
encode an L-homocysteine synthase (AFUA_5G04250), a putative transaminase 
(AFUA_1G04160), a putative thiosulfate sulfurtransferase (AFUA_7G01370) and a 
putative serine O-acetyltransferase (AFUA_5G08600) (Sugui et al., 2008; Noma et al., 
2009). Interestingly in ΔgliT +/- gliotoxin, a significant number of genes differentially 
expressed. Gliotoxin induces significant altered expression of genes involved in L-
cysteine and L-methionine biosynthesis, 14 of which showed a > 2.2 fold increase in 
expression. All genes which have increased expression encode enzymes involved in L-
cysteine, L-cystathionine, L-methionine, L-homocysteine and S-adenosyl methionine 
biosynthesis (Kanehisa et al., 2004). This suggests exogenous gliotoxin increases the 
need for increased expression of components which feed into the SAM cycle and the 
SAM cycle itself. The S-adenosyl homocysteinase gene (AFUA_1G10130) shows a 3.5 
fold increase in expression, which is similar to what was seen in the proteomics results 
for the same condition used here whereby S-adenosyl homocysteinase was seen to be 
differentially expressed (both up and down-regulated), indicating dysregulation of this 
gene induced by gliotoxin, is continuing on to the protein level.  
Genes with decreased expression encode enzymes involved in the methionine 
salvage pathway and in SAM de-methylation and subsequent S-adenosyl-L-
homocysteine production, which could result in a corresponding decrease in S-
adenosyl-L-homocysteine being produced in the cell. 
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5.3.2 Sulphur metabolism 
 Section 5.3.1 depicts gliotoxin mediated dysregulation of the cysteine and 
methionine metabolic pathway. Enzymes involved in L-homocysteine biosynthesis were 
significantly up-regulated in ΔgliT +/- gliotoxin. This amino acid can also be produced 
via the sulphur metabolic pathway acting as another source of L-homocysteine for the 
cell. In wild-type cells challenged with gliotoxin, five genes which encode enzymes 
involved in sulphite, sulphate and sulphide biosynthesis showed a significant increase in 
expression. Interestingly, only two genes showed a decrease in their expression, a 
putative thiosulfate sulphur-transferase (AFUA_7G01370) and homocysteine synthase 
(AFUA_5G04250).   
 In ΔgliT +/- gliotoxin, three genes have a decrease in their expression. Similar to 
wild-type, one of these genes encodes an enzyme involved in thiosulfate to sulphite 
conversion. A total of 8 genes with increased gene expression were found to encode 
enzymes involved in sulphite, sulphide, L-cysteine and L-homocysteine biosynthesis. 
This is at odds with the wild-type which shows reduced expression in homocysteine 
synthase, highlighting two very different responses in these two A. fumigatus strains to 
gliotoxin.  
 
5.3.3 Glutathione metabolism 
 Previous results have illustrated how glutathione levels play an important role in 
gliotoxin toxicity. The aforementioned pathways are also linked to the glutathione 
metabolic pathway with L-homocysteine, L-cysteine and L-cystathionine being utilised 
to form glutathione. In ATCC46645 +/- gliotoxin, a total of three genes have a 
significant increase in their expression, two of which are glutathione transferases 
(AFUA_6G09690 and AFUA_7G05500). The former is gliG, a component of the gli 
biosynthetic cluster. Prior work by Schrettl et al.,, has shown that gliotoxin induces 
expression of certain components of the gli cluster, and the increase in expression seen 
here could be due to this self regulatory effect (Schrettl et al., 2010). Also, there are a 
total of ten putative glutathione transferases involved in the same function in this 
pathway indicating some redundancy. 
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 Interestingly, genes involved in glutathione biosynthesis, and glutathione 
processing, have a significant decrease in expression upon gliotoxin addition in these 
cells. This could suggest glutathione biosynthesis is not advantageous during gliotoxin 
exposure thus genes such as glutathione synthase (AFUA_5G06610) and γ-glutamyl 
trans-peptidase (AFUA_4G13580) show reduced expression. Similar to previous 
results, ΔgliT shows a dramatic change in its response to gliotoxin. As in wild-type, 
there is an increase in the expression of genes which encode enzymes involved in 
glutathione S-transferase activity (AFUA_6G09690), glutathione reduction 
(AFUA_3G08660), polyamine biosynthesis (AFUA_8G06540) and ornithine de-
carboxylation (AFUA_7G08450). gliG showed the highest increase in expression, and 
could be due to gliotoxin influence on the gli cluster as mentioned earlier. Unlike 
ATCC46645, which showed three genes with decreased expression, ΔgliT has twelve 
genes with a significant decrease in expression, seven of which encode glutathione 
transferases. The remaining are involved in glutathione synthesis (AFUA_5G06610) 
and glutathione degradation (AFUA_3G05450, AFUA_4G13580 and 
AFUA_7G04760). These results suggest glutathione biosynthesis genes are 
dysregulated in response to gliotoxin with genes involved in glutathione salvage and 
glutathione synthesis being equally affected in ΔgliT and to a lesser extent wild type 
cells. 
 
5.3.4 Oxidative stress related proteins 
 Previous results from this study have shown gliotoxin induces oxidative stress in 
A. fumigatus. Results presented in section 5.3.3 have shown that gliotoxin alters the 
expression of genes involved in glutathione biosynthesis, a radical scavenger and key 
component of the OS response (Alton Meister 1988; Izawa et al., 1995) . One key 
difference between wild-type and ΔgliT +/- gliotoxin, is the altered expression of genes 
which are involved in the OS response. An increase in the expression of relatively few 
OS related genes is seen in ATCC46645 +/- gliotoxin with catalase-peroxidase 
(AFUA_8G01670), thioredoxin reductase (AFUA_4G12990), a putative peptidyl-prolyl 
cis-trans isomerise (AFUA_2G02050) which has orthologs seen to accumulate during 
DNA replication stress and Hsp 60 (AFUA_2G09290) all showing a significant increase 
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in their expression upon gliotoxin addition. Two genes had a decrease in their respective 
expressions: a putative catalase (AFUA_2g18030) and AFUA_5G10270 which has 
orthologs with mRNA binding and stress response functions. 
 Unlike ATCC46645, ΔgliT shows a decrease in the expression of manganese 
super oxide dismutase (AFUA_1G14550) and a simultaneous increase in the expression 
of a copper-zinc superoxide dismutase (AFUA_6G07210), both are involved in 
hydrogen peroxide dis-mutation and are located in different parts of the cell. A decrease 
in the expression of a mycelia catalase (AFUA_3G02270), two thioredoxins 
(AFUA_3G14970 and AFUA_8G01090), thioredoxin-peroxidase (AFUA_5G01440), 
oxido-reductase (AFUA_2G04320), p-nitroreductase (AFUA_5G09910) and 
AFUA_7G06420 which has orthologs with NADPH oxid-oreductase activity, were all 
seen in ΔgliT +/- gliotoxin. Similar to wild type, there is increased expression of the 
thioredoxin reductase (AFUA_4G12990), peptidyl-prolyl cis-trans isomerise 
(AFUA_2G02050) and Hsp60 (AFUA_2G09290). Contrary to this, there is a significant 
increase in the expression of a sulphate reductase with thioredoxin activity 
(AFUA_3G06540) and a disulphide oxido-reductase (AFUA_4G05950) which may 
have increased expression to compensate for gliT loss fulfilling its oxido-reductase 
activity, albeit less efficiently. 
 
5.3.5 Ribosomal biogenesis 
 Chapter 5 highlighted the dysregulation of certain protein biosynthesis and 
processing components had in the presence of gliotoxin. At the transcriptomic level this 
is still the case, with Table 5.2 showing the top 20 genes to be differentially regulated 
out of a total number of 62. The majority of genes listed in Table 5.3 have a significant 
increase in their expression indicating gliotoxin induces a comprehensive response in 
this pathway. Although most of the genes are up-regulated in both ATCC46645 and 
ΔgliT +/- gliotoxin, only in ΔgliT are all ribosomal related genes up-regulated. 
Secondly, the level of up-regulation is significantly higher in ΔgliT when compared to 
ATCC46645 + gliotoxin, suggesting in the absence of gliT there is a greater demand for 
the expression of these genes than in wild-type cells.  
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5.3.6 Leucine/valine and isoleucine degradation 
 Different enzymes involved in the leucine/valine and isoleucine degradation 
pathway were found to be differentially expressed in protein lysates extracted from cells 
treated with gliotoxin. As seen in Table 5.3, gliotoxin appears to induce a decrease in 
the expression of the majority of genes involved in this pathway. There are some 
exceptions, such as AFUA_7G01720 which shows increased expression in both 
ATCC46645 and ΔgliT +/- gliotoxin. This encodes an enzyme which catalyses the 
formation of acetyl-acetate and acetyl CoA which is utilised in the citrate cycle. 
There is also significantly increased expression of the hydroxymethylglutaryL-
CoA synthase (AFUA_8G07210) in ΔgliT + gliotoxin when compared to ATCC46645 
+ gliotoxin, suggesting an increased need for acetyL-CoA biosynthesis related genes to 
be up-regulated in the presence of gliotoxin once gliT is no longer present. The 
reduction of so many genes involved in this pathway could result in an increased 
availability of these amino acids for subsequent translation. This is further supported by 
the fact two enzymes involved in leucine/valine and isoleucine biosynthesis 
(AFUA_1G15780 and AFUA_2G10420) were found to be up-regulated in ΔgliT in 
response to gliotoxin. 
 
5.3.7 Gliotoxin biosynthetic cluster 
 Schrettl et al.,, showed addition of gliotoxin induced increased expression of 
genes involved in gliotoxin biosynthesis (Schrettl et al., 2010). Gliotoxin exposure has 
also been demonstrated to induce an up-regulation of gliotoxin specific proteins in A. 
fumigatus (Schrettl et al., 2010). Un-surprisingly, there is a significant increase in the 
regulation of genes of the gli cluster, ranging from 3-3102 fold. The dramatic increase 
in expression of gliM (AFUA_6G09680) may suggest a role in the detoxification of 
gliotoxin, explaining why it is so highly up-regulated. Interestingly, the corresponding 
expression levels in ΔgliT +/- gliotoxin are relatively low when compared to 
ATCC46645 +/- gliotoxin, and are significantly decreased when ΔgliT + gliotoxin is 
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compared to ATCC46645 + gliotoxin. This could suggest gliT presence is necessary for 
such high amounts of expression of the gli cluster. Unlike ATCC46645 +/- gliotoxin, 
ΔgliT +/- gliotoxin shows no increase in the expression of the clusters’ transcriptional 
regulator gliZ (AFUA_6G09630), or of the L-amino-cyclopropane-1-carboxylic acid 
gliI (AFUA_6G09640). Surprisingly, there is a significant decrease in the expression of 
the dipeptidase gliJ (AFUA_6G09650). 
 
5.3.8 L-tyrosine degradation 
 Addition of gliotoxin alters expression of different gene clusters in A. fumigatus 
as seen in Section 5.3.7. The L-tyrosine degradation pathway consists of a six gene 
cluster of (Schmaler-ripcke et al., 2009). In both ATCC46645 +/- gliotoxin and ΔgliT 
+/- gliotoxin all six of these genes have a significant decrease in their expression. 
Interestingly, these same genes are significantly lower in ΔgliT + gliotoxin when 
compared to ATCC46645 + gliotoxin. These genes encode enzymes involved in the 
degradation of L-tyrosine into acetoacetate and fumarate, components of the citrate 
cycle. These same genes have been identified in encoding enzymes involved in an 
alternative melanin, pyomelanin, biosynthetic process in A. fumigatus (Schmaler-Ripcke 
et al., 2009). Melanin and pyomelanin are two types of pigments produced in 
abundance in conidia and also possess a role in the oxidative stress response 
(Nosanchuk & Casadevall 2003). 
 
5.3.9 DHN-melanin biosynthesis 
 Biosynthesis of dihyroxynaphthalene (DHN)-melanin is carried out via a six 
gene cluster located on chromosome 2. DHN-melanin is an important pigment utilised 
in conidia in its cell wall. It has also been demonstrated to be important in virulence 
acting as a defence mechanism against host reactive oxygen species and adherence to 
epithelial cells. Both a multi-copper oxidase (AFUA_2G17540), also known as abr1, 
and conidial pigment biosynthesis protein (AFUA_2G17550) also known as ayg1, 
showed a significant increase in their respective expression in ATCC46645 +/- 
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gliotoxin. These two genes encode enzymes involved in the initial steps of DHN-
melanin biosynthesis. 
 Contrary to this, ΔgliT +/- gliotoxin, shows a decrease in the expression of three 
genes in this pathway: a laccase (AFUA_2G17530) abr2, ayg1 and scytalone 
dehydratase (AFUA_2G17580) arp1. Interestingly, no transcripts of abr1 in ΔgliT + 
gliotoxin were found, which could be due to the gene being expressed but at levels too 
low to be detected. Bar abr1, all other genes in this cluster were significantly lower in 
ΔgliT + gliotoxin when compared to ATCC46645 + gliotoxin indicating the entire 
cluster is being down-regulated in ΔgliT in the presence of gliotoxin compared to wild-
type. 
 
5.3.10 Fumitremorgin B biosynthesis 
 Fumitremorgin B is a secondary metabolite produced in A. fumigatus and other 
filamentous fungi. It acts as a mycotoxin, which can inhibit microtubule formation and 
is an increasing problem in the food industry, encoded by a nine gene cluster located on 
chromosome 8 (Grundmann et al., 2008). Both ATCC46645 +/- gliotoxin and ΔgliT +/- 
gliotoxin have a decrease in the expression of certain parts of this cluster. 
 In ATCC46645 +/- gliotoxin, four of the nine genes show a decrease in their 
expression. These include the clusters putative non-ribosmal peptide synthase 
(AFUA_8G00170) ftmA, cytochrome P450 (AFUA_8G00190) ftmC, o-
methyltransferase (AFUA_8G0020) ftmD and brevianamide F prenyL-transferase 
(AFUA_8G00210) ftmPT1. These same genes are also decreased in ΔgliT +/- gliotoxin, 
however so are the non-heme F (II) and α-ketoglutarate-dependant dioxygenase 
(AFUA_8G00230) ftmF, putative cytochrome P450 (AFUA_8G00240) ftmG, putative 
prenyL-transferase (AFUA_8G00250) ftmPT2 and a putative ankyrin repeat protein 
(AFUA_8G00260) ftml. Similar to abr1 in section 5.3.10, another cytochrome P450 
(AFUA_8G00220) ftmE, had no detectable levels of transcript in ΔgliT + gliotoxin 
which could mean that the levels are reduced to such a low level in this strain that they 
cannot be detected or that addition of gliotoxin in ΔgliT completely switches off this 
gene.  
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5.4. Quantitative PCR (qPCR) of A. fumigatus gliT and gliZ strains 
 Results shown in the previous section further highlight key pathways involved in 
the response to gliotoxin. Some of these results corroborate what has discussed in 
Chapter 4, with genes involved in glutathione metabolism and the SAM cycle being 
significantly dysregulated when challenged with gliotoxin. To supplement these results 
and verify the trends of gene expression seen here, qPCR was carried out on selected 
genes which showed altered expression in response to gliotoxin and/or strain 
background. Utilising cDNA from the mRNA extracted from mycelia of A. fumigatus 
strains exposed to 5 µg/ml gliotoxin, it is possible to quantify the number of transcripts 
of a given gene using specific primers and a fluorescent agent. The amount of 
fluorescence will be proportional to the amount of that transcript present in that sample. 
 Additionally, cDNA was also constructed from ΔgliZ293 and 
ΔgliTΔgliZ293exposed cells, to investigate how the expression of these genes may be 
affected in these strains compared to each other and ATCC46645 and ΔgliT46645 with 
the aim of further elucidating the difference in their respective response to gliotoxin 
exposure. GliM (AFUA_6G09680) and AFUA_2G11120 were two of the four genes 
selected as firstly both had relatively high increases in expression in the presence of 
gliotoxin, with gliM being the most up-regulated gene and AFUA_2G11120 being the 
fourth highest. Secondly both have been annotated with predicted methyltransferase 
activity and could be involved in bis-methylating gliotoxin thus their large expression 
values. GliJ (AFUA_6G09650) was also chosen as it had differential expression 
between ATCC46645 +/- gliotoxin and ΔgliT +/- gliotoxin, showing an increase in its 
expression in wild-type cells in the presence of gliotoxin, but a decrease in ΔgliT. This 
may imply gliT requirement for its regulation in this gliotoxin mediated response, which 
the other strains could help elucidate.  
Lastly laeA (AFUA_1G14660) was chosen due to the fact it has a decrease in its 
expression in ΔgliT +/- gliotoxin. Also, its involvement as a transcriptional regulator of 
secondary metabolite biosynthesis could indicate if there is a similar response in the 
other mutant strains to gliotoxin and down-regulation of particular secondary metabolite 
clusters regulated by laeA. Each of these genes would help strengthen the results seen in 
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the transcriptomic data from section 5.3, while also illustrating if the same response is 
happening in the other gli mutants. 
 
5.4.1 GliM and AFUA_2G11120 relative expression 
 Both GliM and AFUA_2G11120 are predicted methyL-transferases which are 
also highly up-regulated in response to gliotoxin. As seen in Figure 5.2 A (GliM) and B 
(AFUA_2G11120), the relative gene expression can be seen when compared to the 
household keeping gene calm to ensure that any rise is due to that strain and condition 
and not simply a rise in general transcription. Interestingly, no analysis could be carried 
out for gliM in MeOH treated cells. One reason for this could be that this method is not 
as accurate as RNA Seq and is unable to detect low levels of transcripts, which further 
suggests as it can be detected in gliotoxin treated cells that gliM is induced under 
gliotoxin presence and in its absence gliM expression is very low. 
 
Figure 5.2 A Relative gliM expression in A. fumigatus strains ATCC46645, 
ΔgliT46645, ΔgliZ293 and ΔgliTΔgliZ293 in the presence of 5 µg/ml gliotoxin.  
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Figure 5.2 B Relative AFUA_2G11120 expression in A. fumigatus strains 
ATCC46645, ΔgliT46645, ΔgliZ293 and ΔgliTΔgliZ293 in the presence of methanol 
(MeOH) and 5 µg/ml gliotoxin (GLIO). The figures show mean ratio values of GliM 
and AFUA_2G11120 expression compared to the household keeping gene calm 
(reference ratio). 
 
 ΔgliTΔgliZ293 has the highest expression of both gliM and AFUA_2G11120. 
Unlike gliM, AFUA_2G11120 is expressed under basal conditions and similar to what 
is seen in the transcriptomic results from Section 5.3, gliotoxin presence induces a 
significant increase in the expression of AFUA_2G11120. 
 
5.4.2 gliJ relative expression 
 gliJ encodes a dipeptidase involved in gliotoxin structure formation. This could 
suggest gliT is necessary for the gliotoxin regulated increase in expression of all gli 
cluster genes. gliJ relative expression in A. fumigatus strains can be seen in Figure 5.3. 
 
  
 
227 
 
Figure 5.2 Relative gliJ expression in A. fumigatus strains ATCC46645, ΔgliT46645, 
ΔgliZ293 and ΔgliTΔgliZ293 in the presence of methanol (MeOH) and 5 µg/ml 
gliotoxin (GLIO). The figure shows mean ratio values of gliJ expression compared to 
the household keeping gene calM (reference ratio). 
 Contrary to what was seen in section 5.3, gliJ expression in ΔgliT is not lowered 
in response to gliotoxin exposure here. However, both the decrease in gliJ expression in 
ΔgliT + gliotoxin when compared to ATCC46645 + gliotoxin and the increase in its 
expression in ATCC46645 +/- gliotoxin are the same as what was described earlier, 
corroborating what was seen in the RNA Seq data. 
 
5.4.3 LaeA relative expression 
 The control of secondary metabolites in cells is very important as many can be 
highly reactive and have adverese effects on the organism if not kept in check. One such 
way to do this is via various transcriptional regulators such as laeA which respond to 
various external and internal stimuli and responds accordingly in the regulation of their 
metabolites. The presence of gliotoxin appears to dysregulate secondary metabolites and 
gene clusters as shown in Section 5.3. As laeA is itself dysregulated in ΔgliT and has 
been described in previous work to influence many different secondary metabolites, its 
expression was examined here (Figure 5.4). 
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Figure 5.3 Relative laeA expression in A. fumigatus strains ATCC46645, ΔgliT46645, 
ΔgliZ293 and ΔgliTΔgliZ293 in the presence of methanol (MeOH) and 5 µg/ml 
gliotoxin (GLIO). The figure shows mean ratio values of laeA expression compared to 
the household keeping gene calM (reference ratio). 
 In Figure 5.3 it is hard to see if ΔgliT shows reduced expression of laeA 
as seen in the transcriptomics. This is common between MeOH vs gliotoxin treated 
samples, however any difference between individual strains is clear. 
 
5.5. RNA Seq comparision of A. fumigatus ΔgliT and S. cerevisiae G600 
 To further elucidate gliotoxins mode of toxicity, the transcriptome response of 
ΔgliT was compared to a similar transcriptome study carried out in yeast (O’Brien, 
2011). S. cerevisiae shows relative phenotypic sensitivity > 8 µg/ml gliotoxin (chapter 
6), similar to ΔgliT. This work used two different concentrations of gliotoxin. 16 and 64 
µg/ml to induce a response in the yeast compared to a methanol control. Selected 
pathways which were differentially regulated in ΔgliT were compared with orthologous 
pathways in S. cerevisiae cells treated with the lower, 16 µg/ml gliotoxin in order to 
uncover some similarities between these two gliotoxin sensitive strains. 
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 Orthologs of genes from the different pathways listed in Table 5.2 were checked 
for significant up- and down- regulation (≥ 2 fold or ≤ 0.5 fold expression) in S. 
cerevisiae cells where applicable. In certain cases no orthology could be found due to 
certain genes not having been identified in yeast suggesting these evolved at a later time 
point. 
 Interestingly there are some similarities between the two fungi. Looking at the 
various genes differentially regulated in response to gliotoxin, the yeast transcriptome 
response appears to be more like ΔgliT than A. fumigatus wild-type. Table 5.4 lists 
genes differentially regulated in selected pathways in A. fumigatus ATCC46645, ΔgliT 
and S. cerevisiae in the presence of gliotoxin. Like ΔgliT, genes involved in L-cysteine, 
L-cystathionine, L-methionine and S-adenosyl methionine show significant increase in 
their expression in S. cerevisiae upon gliotoxin addition. There is also one gene found to 
have a significant decrease in expression in all three strains (YOR251c/TOM1) which 
encodes an enzyme involved in catalysing the formation of thio-sulfate and pyruvate 
from sulphite. Unlike ΔgliT, S. cerevisiae does not have an increase in the expression of 
S-adenosyl homocysteinase, presumably increased in ΔgliT to regulate the SAM cycle, 
suggesting this gene does not need to be significantly altered to maintain the SAM cycle 
in S. cerevisiae. 
 Similarly, genes involved in sulphur metabolism are also affected by gliotoxin 
presence in S. cerevisiae with significant expression of certain genes in the yeast which 
are also significantly altered in ΔgliT, and to a lesser extent ATCC46645, in a 
comparable fashion. In all three organisms, there is an increase in genes which encode 
enzymes involved in sulphide biosynthesis as well as a decrease in one gene involved in 
sulphite biosynthesis. Analogous to the L-cysteine and L-methionine metabolic 
pathway, S. cerevisae’s transcriptomic response to gliotoxin within the sulphur 
metabolic pathway is more akin to ΔgliT than ATCC46645 wild-type, with genes 
involved in L-cysteine and L-homocysteine having significant up-regulation. 
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Table 5.4 Mean expression values of genes differentially expressed in the presence of 5 µg/ml gliotoxin in ATCC46645 and 
ΔgliT46645 A. fumigatus strains and 16 µg/ml S. cerevisiae  
Gene ID Putative function 
Fold change 
WT + glio/ WT + 
MeOH 
Fold change 
ΔgliT + glio/ ΔgliT 
+ MeOH 
Fold change 
S. cerevisae + 
glio/ S.cerevisae + 
MeOH 
 
Cysteine and methionine metabolism     
AFUA_5G02180/YLR303w 
Cysteine synthase 0.771 2.914 5.5 
AFUA_4G03950/YGL184c Ortholog(s) have cystathionine beta-lyase activity 1.273 2.134 2 
AFUA_7G01590/YFR055w 
Has domain(s) with predicted catalytic activity, 
pyridoxal phosphate binding activity  
0.824 3.450 4 
AFUA_8G04340/YAL012w Putative cystathionine gamma-lyase 0.756 0.285 4.06 
AFUA_6G02490/AAT1 
Has domain(s) with predicted pyridoxal phosphate 
binding, transaminase activity  
0.963 2.774 2.65 
AFUA_7G01370/YOR251c 
Ortholog(s) have thiosulfate sulfurtransferase 
activity 
0.452 0.473 0.48 
AFUA_1G04160/AAT1 
Has domain(s) with predicted pyridoxal phosphate 
binding, transaminase activity  
0.261 0.060 2.65 
AFUA_1G10130/YER Putative adenosylhomocysteinase 1.287 3.530 2.75 
AFUA_5G01500/YPL273w Homocysteine S-methyltransferase activity 1.082 2.460 2.54 
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AFUA_4G07360/YER091c 
Putative cobalamin-independent methionine 
synthase 
0.903 4.112 2.87 
AFUA_1G10630/YDR502c Putative S-adenosylmethionine synthetase 1.011 2.480 3.8 
AFUA_2G13630/YGL202w 
Putative amino transferase 0.579 0.224 
2 
 
Sulphur metabolism      
AFUA_2G15590/YFR030w Putative sulphite reductase 2.126 4.836 4.3 
AFUA_6G08920/YJR137c Assimilatory sulfite reductase 0.624 3.474 3.95 
AFUA_4G03930/YLR303W Putative cysteine synthase B 0.892 0.095 5.5 
AFUA_5G02180YLR303W Cysteine synthase (o-acetylserine (thiol)-lyase 0.771 2.914 5.5 
AFUA_5G04250/YLR303W Homocysteine synthase 0.490 0.888 5.5 
AFUA_1G10820/YKL001c 
Ortholog(s) have role in methionine metabolic 
process, sulfate assimilation and intracellular 
localization 
1.734 2.859 7.44 
 
Oxidative stress related proteins     
AFUA_1G14550/YHR008c Putative manganese superoxide dismutase 0.789 0.037 0.36 
AFUA_3G02270/YDR256c Mycelial catalase 1.647 0.067 0.16 
AFUA_2G18030/YDR256c Putative catalase 0.212 0.836 0.16 
AFUA_3G06540/YPR167C 
Ortholog(s) have phosphoadenylyL-sulfate 
reductase (thioredoxin) activity  
0.771 6.841 4.63 
AFUA_5G01440/YLR109W 
Ortholog(s) have thioredoxin peroxidase 
activity, role in cell redox homeostasis, cellular 
response to oxidative stress 
0.580 0.264 2.29 
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AFUA_8G01670/YKR066C Putative bifunctional catalase-peroxidase 3.096 1.095 0.319 
AFUA_4G05950/YPLO59W 
Ortholog(s) have disulfide oxidoreductase 
activity, role in cellular response to oxidative 
stress, response to osmotic stress 
1.018 2.034 0.476 
AFUA_2G04320/YHR179W 
Has domain(s) with predicted FMN binding, 
oxidoreductase activity and role in oxidation-
reduction process 
1.439 0.161 2.92 
AFUA_7G06420/YHR179W Ortholog(s) have intracellular localization 1.162 0.406 2.92 
AFUA_5G09910/YCL026C Putative p-nitroreductase family protein 0.583 0.356 3.93 
 
Translation and Ribosomal Biogenesis     
AFUA_1G05080/YLR340W Putative 60S ribosomal protein P0 2.265 5.292 3.9 
AFUA_1G05500/YOR369C 40S ribosomal protein S12 2.481 6.270 2.12 
AFUA_1G12890/YPL131W Putative 60S Ribosomal protein L5 2.181 6.717 4.16 
AFUA_1G15730/YJL190C 40S ribosomal protein S22 2.495 5.754 4.06 
AFUA_2G02150/YHL015W Putative ribosomal protein S10 2.492 5.421 2.75 
AFUA_2G09200/YGL030W 60S ribosomal protein L30 2.036 5.310 3.4 
AFUA_2G10100/YDR382W Allergen Asp f 8; putative ribosomal protein P2 2.326 7.066 2.22 
AFUA_2G10300/YDR447C/ 
YML024W 40S ribosomal protein S17 
2.404 5.068 3.03/3.19 
AFUA_3G05600/YGL103W 60S ribosomal protein L27a 2.065 5.677 6.64 
AFUA_3G06760/YDR500C Ribosomal protein L37 2.231 5.823 3.05 
AFUA_4G07730/YGR085C/ 
YPR102C 60S ribosomal protein L11 
2.156 5.449 3.56/3.19 
AFUA_5G03020/YBR031W 60S ribosomal protein L4 2.291 5.402 3.06 
AFUA_5G05630/YOL127W 60S ribosomal protein L23 2.209 5.340 3.9 
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AFUA_5G06360/YFR031C/ 
YIL018W 60S ribosomal protein L8 
2.232 5.715 4.67/5.67 
AFUA_6G02440/YGL031C/ 
YGR148C 60s ribosomal protein L24 
1.895 5.251 3.91/3.15 
AFUA_6G11260/YGR034W Ribosomal protein L26 2.026 5.199 4.66 
AFUA_6G12660/YOR293W 40S ribosomal protein S10b 2.554 5.563 4.6 
AFUA_6G13250/YLR406C 60S ribosomal protein L31e 2.164 5.294 5.12 
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5.6 Discussion 
 Gliotoxin induces a complex, global response affecting a large array of genes 
and pathways in A. fumigatus. This study focused on key pathways and genes which 
have been previously shown to be altered in response to gliotoxin either at the 
protein level or from different cell responses seen to be affected by gliotoxin. One 
such pathway is the cysteine and methionine metabolic pathway. This pathway is 
involved in the biosynthesis of key amino acids such as L-cysteine, L-methionine 
and L-homocysteine. It also feeds into other key pathways which appear to have 
some role in gliotoxin toxicity such as sulphur metabolism and glutathione 
metabolism. ATCC46645 appears to have a very different transcriptomic response 
when compared to ΔgliT, especially in the pathways listed in Table 5.3. The key 
difference between ATCC46645 wild-type and ΔgliTs’ transcriptomic response to 
gliotoxin is seen in the cysteine and methionine metabolic pathway and the sulphur 
metabolic pathway where expression of genes involved in S-adenosyl methionine 
biosynthesis are altered. There is an increase in genes involved in L-homocysteine, 
L-cysteine and L-methionine biosynthesis, each required for the SAM cycle and 
subsequent S-adenoysl methionine biosynthesis. Interestingly, one of the few genes 
which have a decrease in its expression (AFUA_6G03740) is involved in S-adenosyl 
homocysteine biosynthesis (Kinehisa et al.,, 2004). Similarly, there is an increase in 
the expression in S-adenosyl homocysteine hydrolase (AFUA_1G10130) which 
encodes an enzyme which breaks down S-adenosyl homocysteine to L-homocysteine 
(Tehlivets et al., 2004). It has been previously mentioned here that gliotoxin may 
induce an accumulation of L-homocysteine which can be toxic to cells when not kept 
in check (Fujita et al., 2006). Alternatively, the regulation of S-adenosyl 
homocysteine levels could also be paramount, as this product has been shown to 
inhibit S-adenosyl methionine mediated S-methylation (Deguchi & Barchas 1971). If 
there is a corresponding increase in the translation of these enzymes, this altered 
expression of genes which maintain S-adenoysl homocysteine levels could be a 
method of preventing it inhibiting S-adenosyl methionine methylation, either of 
gliotoxin or other reactive intermediates which are produced in ΔgliT + gliotoxin. 
Additionally, when the S. cerevisiae transcriptome is compared to this, there is a 
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comparable trend in the altered expression of genes, suggesting a link between 
sensitivity to gliotoxin and these two strains.  
 This could imply that the ability to convert gliotoxin to the bis-methylated 
form is present in the yeast, however later in Chapter 6 this was found not to be the 
case. De-carboxylated S-adenosyl methionine acts as an aminopropyl donor in the 
biosynthesis of polyamines. In both ATCC46645 and ΔgliT + gliotoxin, 
AFUA_8G06540, a gene which encodes an enzyme involved in putrescine 
biosynthesis, a polyamine which, along with spermine and spermidine, has been 
demonstrated to be involved in sporulation and cell differentiation in A. fumigatus 
shows a significant increase in its expression (Guevara-Olvera et al., 1993; López et 
al., 1997).  
The majority of genes involved in glutathione metabolism show a decrease in 
their expression in ΔgliT in response to gliotoxin. In both ATCC46645 and ΔgliT + 
gliotoxin, there is a common decrease in the expression of genes involved in 
glutathione biosynthesis and the γ-glutamyl cycle. Due to glutathiones’ role in the 
oxidative stress response, it may have been hypothesised to have increased 
expression due to the production of super oxide radicals seen in chapter 3. However, 
Bernardo et al.,, demonstrated that gliotoxin influx occurred in a glutathione 
dependent manner suggesting higher levels of glutathione could result in greater 
gliotoxin influx into the cell (Bernardo et al., 2003). In this case, reducing the 
expression of genes involved in glutathione biosynthesis and their subsequent 
enzymes would be advantageous to the cell. Interestingly, S. cerevisiae + gliotoxin 
does not show similar dysregulation of glutathione biosynthesis. A total of five genes 
were shown to be dysregulated in this pathway when the yeast is challenged with 
gliotoxin, four of which are involved in the oxidation/reduction of glutathione to its 
oxidised and reduced isoforms (Grant 2001). Three of these four genes show a 
significant decrease in their respective expression suggesting that in yeast, like A. 
fumigatus, the presence of gliotoxin alters genes involved in the regulation of 
glutathione biosynthesis, albeit in a different manner.  
 Both ATCC46645 and ΔgliT show high expression values for 
glutathione S-transferase, particularly gliG. In Schrettl et al., exogenous gliotoxin 
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has been shown to up-regulate the expression of the genes in the gliotoxin 
biosynthetic cluster gli (Schrettl et al., 2010). This significant increase in expression 
of gliG, is presumably due to this effect and not related, directly to the glutathione 
metabolic pathway. This is further supported by various S-transferases with 
significant decreases in their expression in response to gliotoxin. 
One key difference between ATCC46645 and ΔgliT is the decrease in the 
expression of a DUG1 ortholog, which is a key component of the γ-glutamyl cycle 
and glutathione degradation pathway (Ganguli et al., 2007; Kaur et al., 2009). A 
corresponding decrease in the expression of this enzyme would reduce the L-glycine 
and L-cysteine levels in the cell as they would still be contained within any 
glutathione being produced, this would impact further on glutathione biosynthesis 
and the levels of glutathione in ΔgliT. These results could imply that in the presence 
of gliotoxin, glutathione levels in the cell could be further reduced in ΔgliT, 
something which was seen in Schrettl et al., in which the addition of exogenous 
glutathione (20 mM) to agarose plates containing gliotoxin (10 µg/ml) completely 
abolished the hypersensitive phenotype of the ΔgliT strain indicating a relationship 
between gliT and glutathione biosynthesis. 
This proposed gliotoxin mediated reduction of glutathione in A. fumigatus 
was demonstrated in Carberry et al.,, in which they illustrated that addition of 
exogenous gliotoxin (5 µg/ml) resulted in a significant decrease in the glutathione 
levels in both ATCC26933 and ΔgliT26933 (Carberry et al., 2012). Secondly, the 
glutathione levels were far lower in ΔgliT than the wild type upon gliotoxin addition, 
corroborating the above transcriptomic data. Together, these results demonstrate 
gliotoxin mediated reduction of de novo glutathione, presumably due to redox action 
with its disulphide bridge, as well as altering the expression of glutathione 
biosynthetic genes in A. fumigatus resulting in a further loss of glutathione.  
As mentioned previously, glutathiones’ primary role in the cell is acting as a 
radical scavenger in the oxidative stress response (Izawa et al., 1995; Lee et al., 
2001). The expression of other oxidative stress related genes were also found to be 
altered in the presence of exogenous gliotoxin. Analogous to previous results, there 
is a clear difference in the expression of these genes between ATCC46645 and ΔgliT 
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+ gliotoxin. In ATCC46645, only six genes are differentially expressed, four of 
which are up-regulated. Most notable among these are a putative catalase 
(AFUA_2G18030), thioredoxin reductase (AFUA_4G12990) and a bi-functional 
catalase-peroxidase (AFUA_8G01670) (Goetz et al., 2011; Abadio et al., 2011; 
Paris et al., 2003). Reduced expression of catalase may imply gliotoxin carrying out 
an anti-oxidant role as illustrated in Chapter 3.  
 An increase in the expression of the thioredoxin reductase could be to due to 
an increase in disulphide formation requiring further reduction to maintain the redox 
balance inside the cell. In ΔgliT there is a similar increase in the expression of this 
thioredoxin reductase indicating its expression is independent of gliT loss. 
Interestingly there is differential expression of two superoxide dismutases, 
AFUA_1G14550 (Sod3) and AFUA_6G07210 (Sod4) (Lambou et al., 2010). The 
decrease in the expression of sod3 which encodes a cytoplasmic superoxide 
dismutase and the contrasting increase in the expression of sod4 a putative 
mitochondrial super-oxide dismutase suggests gliotoxin toxicity affecting these two 
locations in differing ways (Lambou et al., 2010). The first could be due to 
gliotoxins’ anti-oxidant potential while located in the cytoplasm while the second 
highlighting its affect on the redox status of the mitochondrion. 
Contrary to this, S. cerevisiae shows no real comparison in the expression of 
orthologous genes, of which only three show a similar trend in expression compared 
to ΔgliT and none with ATCC46645. Instead it shows an increase in different 
oxidative stress related genes such as those with functions in oxidative/reduction 
reactions (AFUA_2G04320/YHR179W) and response to oxidative stress 
(AFUA_5G01440/YLR109W) (Niino et al., 1995; Lee et al., 1999). This indicates a 
difference in components of the OS response being affected in all three organisms, 
implying that although there are some clear similarities between both gliotoxin 
sensitive strains ΔgliT and S. cerevisiae, not all responses are affected in the same 
fashion. This could be due to the presence of un-related genes which are not present 
in the yeast, for example ΔgliK shows hypersensitivity when challenged with H2O2 
implying some role in OS and could explain why genes which are differentially 
regulated in the yeast are not in A. fumigatus or ΔgliT (Gallagher et al., 2012) 
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 One clear result which shows similarity in its response to gliotoxin in all 
three strains is translation and ribosomal biogenesis genes which show a significant 
increase in expression. The expression levels of S. cerevisiae orthologs are similar to 
ATCC46645, while ΔgliT shows > 2 fold more expression than both. Gliotoxin 
presence induces an increase in genes involved in the synthesis of the ribosome, 
suggesting an increase in general translation. In Chapter 4 both 40 S ribosomal 
protein S4 (AFUA_3G06840) and 60S ribosomal protein L10 (AFUA_2G09210) 
show > 3 fold up-regulation in ΔgliT, while AF293 shows a 3.1 fold up-regulation of 
a translation elongation factor 2 subunit (AFUA_2G13530) corroborating an 
increase in the translational machinery in the cell upon gliotoxin addition (Grosse et 
al., 2008; Asif et al., 2010; Teutschbein et al., 2010). This increase in translation 
could be due to various reasons, one could be the dysregulation of the L-cysteine and 
L-methionine biosynthetic pathways or any of the other pathways which are altered 
by gliotoxin altering the level of translation in the cell. This is further supported in A. 
fumigatus strains with concurrent decrease in the expression of the leucine/ valine 
and isoleucine degradation pathway. Increased translation would require an increase 
in amino acid biosynthesis and a corresponding decrease in amino acid degradation, 
the latter of which is seen in both ATCC46445 and ΔgliT in the presence of 
gliotoxin.  
 Gliotoxin increases the expression of genes within its own biosynthetic 
cluster gli (Schrettl et al., 2010). This was demonstrated by Schrettl et al., where 
addition of gliotoxin to ATCC46645 increased the expression of gliT, A and G. This 
is similar to what is seen here in table 5.3 with significant up-regulation of all genes 
of the gli cluster in ATCC46645 when challenged with gliotoxin. Interestingly this is 
not seen in ΔgliT. Four of thirteen genes show no increase in their expression, with 
two having decreased expression in the presence of gliotoxin. This would suggest 
that gliT is necessary for gliotoxin mediated expression of the gli cluster, as the 
transcriptional activator, gliZ (AFUA_6G09630) is un-altered compared to the 
control samples of ΔgliT when gliotoxin is added. Also, its expression is 
significantly decreased when ΔgliT + gliotoxin is compared to ATCC46445 + 
gliotoxin. Surprisingly all of the gli cluster genes are significantly decreased in ΔgliT 
in response to gliotoxin when compared with ATCC46645 + gliotoxin. This could 
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explain why no gliotoxin could be detected by Schrettl et al.,, as gliotoxin 
biosynthesis in this strain would be predicted, based on these results, to be much 
lower than wild-type cells. Other components of the gli cluster have been proposed 
as gliotoxin detoxification mechanisms such as gliA (AFUA_6G09710) and gliM 
(AFUA_6G09680), however there could be others source. As ΔgliT has a significant 
decrease in the expression of all gli cluster genes, any alternative gliotoxin 
detoxification mechanism which relies on other gli genes would be subsequently 
reduced and could be another explanation for ΔgliT hypersensitivity to gliotoxin. 
 Conidial pigmentation is controlled by the biosynthesis of different types of 
melanin: DHN melanin or the alternative pyomelanin (Schmaler-ripcke et al., 2009; 
Valiante et al., 2009). The former is synthesised via a seven gene cluster located on 
chromosome 2 while the latter is an alternative melanin used in conidial 
pigmentation first discovered by source et al.,, wherein a six gene cluster also 
located on chromosome 2 was found to alter the pigmentation of the fungus and also 
its sensitivity to different stressors. Melanins are high molecular weight pigment 
molecules, which also have a role in the OS response with DHN melanin shown to 
protect the cell from reactive oxygen species produced by host immune cells during 
infection source (Nosanchuk & Casadevall 2003). ATCC46645 and ΔgliT show a 
significant decrease in the expression of genes involved in pyomelanin biosynthesis 
when grown in the presence of gliotoxin. However, only ATCC46645 shows a 
simultaneous increase in the expression of two genes involved in the biosynthesis of 
DHN-melanin indicating that in the presence of gliotoxin, wild-type cells favour the 
biosynthesis of one type of melanin over the other. ΔgliT + gliotoxin shows a 
significant decrease in the expression of three of the six genes involved in this cluster 
meaning genes involved in the biosynthesis of both types of melanin are reduced 
which could result in lower concentrations of each being produced which could have 
a direct affect on ΔgliTs’ ability to cope with reactive oxygen species. 
 Fumitremorgin B is a secondary metabolite which acts as a mycotoxin 
(Maiya et al., 2006). Both ATCC46645 and ΔgliT show a significant decrease in the 
expression of components of this cluster, with all genes having a significant decrease 
in their expression in ΔgliT + gliotoxin. This could simply be a stress response, 
enabling the cell to conserve energy as biosynthesis of this secondary metabolite has 
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no direct advantage when the cell is undergoing gliotoxin induced stress. It could 
also imply gliotoxin has a regulatory role in the cell, altering the expression of 
certain metabolites at different time points which may interfere or which are no 
longer required after gliotoxin biosynthesis has occurred, usually 48 h after growth.  
 
Gliotoxin induces a complex response in both A. fumigatus strains. It also has 
similar affects on the yeast S. cerevisiae which was seen to possess a similar 
response to gliotoxin as ΔgliT. This is particularly seen in the alteration of the 
cysteine and methionine metabolic pathway, notably the SAM cycle. Gliotoxin 
appears to affect this and some other metabolic pathways in a similar fashion in 
sensitive strains highlighting the importance of the role gliT has in A. fumigatus 
gliotoxin detoxification. This is further supported by the resistance which can be 
induced in S. cerevisiae when A. fumigatus gliT is transformed into yeast under a 
constitutive promoter as demonstrated by Schrettl et al., (2010) The dysregulation of 
the SAM cycle could imply a role of this pathway in gliotoxin detoxification which 
is only beneficial in the presence of gliT, thus why ΔgliT and S. cerevisiaes 
sensitivity to gliotoxin is abolished when gliT is being expressed.  
 Loss of gliT has a dramatic affect on the transcriptomic response to gliotoxin 
in this strain, particularly in the regulation of gli cluster genes (Schrettl et al., 2010). 
The significant decrease in their respective expression may further highlight why 
ΔgliT is so sensitive to gliotoxin as other components of the cluster could be 
necessary along with gliT for complete gliotoxin detoxification. One such gene is 
gliA which is the putative gliotoxin transporter (Gardiner & Howlett 2005). Reduced 
expression of this gene and the membrane protein it encodes would result in a 
corresponding decrease or complete abolishment of gliotoxin efflux from the cell 
which may then accumulate in the cell. If this was the case any alternative gliotoxin 
detoxification mechanisms, such as gliotoxin methylation, would naturally be up-
regulated which is suggested here by the increased expression of the SAM cycle 
related genes and SAM cycle related enzymes as demonstrated in Chapter 4.
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Chapter 6 
Phenotypic response of Saccharomyces 
cerevisiae to gliotoxin 
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6.1. Oxidative Stress Response in Saccharomyces cerevisiae 
 The production of harmful reactive oxygen species (ROS) is a by-product of 
respiration and can cause damage to important cell components (Storz, et al., 1987). To 
protect against these various ROS, organisms can employ both enzymatic and non-
enzymatic means to help defend against increasing oxidative stress (OS) conditions 
(Kugel & Jones 1994). Eukaryotes can employ many types of cell responses to tackle 
the potential harm caused by different types of OS such as the biosynthesis of 
superoxide dismutases, and glutathione which help attenuate oxidative stress (Finkel & 
Holbrook 2000; Izawa et al., 1995; Jamieson 1998). 
  Superoxide dismutases are required by the cell to aid in the OS response 
in dismutating O2
-
 into molecular oxygen and hydrogen peroxide (Steinman 1980). 
There are two superoxide dismutases in yeast: Sod1p which is located in the cytosol and 
Sod2 which is located in the mitochondrion (Culotta et al., 1995). In cells lacking 
SOD1, they exhibit increased sensitivity to OS inducers including H2O2, and diamide 
highlighting its role in the OS response (Jamieson 1998; Muller 1996). 
 The tri-peptide glutathione is the most abundant thiol found in the cell (Meister 
& Anderson 1983) and has been found to be instrumental in the OS response (Grant et 
al., 1996). It can exist in one of two natural forms, a mono-thiol form commonly 
referred to as GSH or reduced glutathione, and a disulphide form whereby the two 
sulphur moieties covalently bind to each other via the formation of a disulphide bridge 
commonly referred to GSSG or oxidised glutathione (Meister 1988; Grant et al., 1996; 
Lee et al., 2001), only reverting back to the reduced form via a NADPH-dependent 
reaction requiring the glutathione specific reductase Glr1 (Grant et al., 1996).  
The importance of these two molecules can be seen in the regulation of the 
intracellular ratio of GSH:GSSG which  is maintained de novo with a higher percentage 
of GSH to GSSG (Muller, 1996). In cells where the GSSG form is more abundant than 
the reduced form, is indicative of oxidative stress and an indicator of the oxidative state 
of the cell (Muller 1996; Garcia et al., 2011). While increased levels of GSH 
predisposes cells to become more sensitive to reducing stress e.g. when exposed to 
reducing agents like dithiothreitol (Grant et al., 1997). 
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 Glutathione is produced in yeast via two ATP-dependent steps. The first is 
carried out by γ-glutamylcysteine synthetase (GSH1), forming the dipeptide γ-
glutamylcysteine from glutamate and cysteine. In the last step glycine is added via 
glutathione synthetase (GSH2) producing glutathione (Lee et al., 2001; Grant et al., 
1997). Glutathione biosynthesis is heavily regulated in order to maintain the 
GSH:GSSG ratio as seen by GSH1 being negatively regulated by increasing levels of 
glutathione (Huang et al., 1988, Meister et al., 1988). 
Glutathione acts as a radical scavenger of the cell via the oxidising of its free 
thiol found within its sulphydryl moiety (Meister 1988; Izawa et al., 1995). Δgsh1 
strains show subsequent auxotrophy on non-glutathione containing media, however this 
is not the case in Δgsh2 strains which can still grow in the absence of glutathione due to 
an accumulation of the γ-glutamylcysteine (Wheeler et al.,2002). These strains also 
showed increased susceptibility to oxidative stress inducers such as H2O2 (Lee et al., 
2001; Izawa et al., 1995), dipyridyl disulphide (López-Mirabel et al., 2007) and heavy 
metal stress (Gales et al., 2008). This is mainly caused by an inability to deal with 
mitochondrial dysregulation and a build up of endogenous ROS (Meister and Anderson 
1983, Grant and Dawes 1996). 
During OS there is an increase in the oxidised form of GSSG (Grant et al., 
1996). This can be due to interaction of the reduced form with ROS, via interactions 
with glutathione peroxidases (Izawa et al., 1995) or via protein modification in the form 
of glutathionylation (Garcia et al., 2011). In the mitochondrion, H2O2 is scavenged by 
glutathione peroxidases where it is reduced to H2O and O2, with GSH acting as an 
electron donor (Garcia et al., 2011). Glutathione also modifies proteins via their free 
thiols, as seen in the mitochondrion where proteins are reversibly bound to GSH 
protecting the protein from oxidative damage (Garcia et al., 2011). This is achieved by 
GSSG migrating to the mitochondrion during OS, as glutathione is not produced in the 
mitochondrion, and is then reduced via thioredoxin, glutathione reductase and NADPH 
presence (Garcia et al., 2011; Yang et al., 2010). 
 There are two key transcription factors associated with glutathione biosynthesis 
and regulation: yap1and met4 (Wheeler et al.,2002 & 2003). Yap1 is a transcription 
factor which is up-regulated during OS, particularly H2O2 presence (Agnés et al., 2000). 
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Yap1 has two key domains which are required for its regulatory function: an N-terminus 
Nuclear Localisation Signal which tags it for nuclear import, and a C-terminus Nuclear 
Export Signal (Kuge & Jones 1997). Yap1 migrates to and from the nucleus under non-
stress conditions, however during OS induced by the presence of H2O2 or the thiol 
oxidant diamide, the protein accumulates within the nucleus after forming a di-sulphide 
bridge via a glutathione peroxidase, Gpx3, preventing its export via the exportin Crm1 
(Kuge et al., 2001; Delauney et al., 2002; Kuge et al., 1998). However, Yap1 
accumulation has also been seen under different OS without the necessity of this 
conformational change which was shown to be dispensable in the presence of diamide 
(Lee et al., 2013). Once accumulated in the nucleus Yap1 has been found to increase the 
regulation of key cell response genes such as GLR1 (glutathione reductase), TRR1 
(thioredoxin reductase) and GSH1(γ-glutamylcysteine synthetase) to name a few (Grant 
et al., 1996; Wu & Moye-Rowley 1994). 
 Δyap1 strains demonstrate increased sensitivity to OS, especially H2O2 induced 
stress (Schnell et al., 1992) due to its role as the transcriptional regulator of a regulon 
consisting of 32 H2O2 inducible proteins alone (Lee et al., 2013). 
 Met4 on the other hand is involved in the regulation of genes involved in the 
biosynthesis of amino acids which contain sulphur, heavy metal response and 
glutathione metabolism (Thomas & Surdin-kerjan 1997; Wheeler et al., 2003). Δmet4 
strains are auxotrophic for L-methionine, SAM and L-homocysteine (Wheeler et al., 
2002; Wheeler et al., 2003). Interestingly in Δgsh2 strains, Met4 has been demonstrated 
to induce the gsh1 promoter, a process which can be later inhibited by the presence of 
GSH, or in the case of a Δgsh1 where no GSH is produced, the addition of exogenous 
GSH (Wheeler et al., 2002). 
 The non-ribosomal peptide, fungal secondary metabolite gliotoxin, produced in 
certain fungi namely Aspergilli spp. and Gliocladium spp. (Scharf et al., 2011), has 
been shown previously to have anti-fungal and cytotoxic properties towards both fungi 
and animal cells respectively (Herrick 1945; Sutton et al., 1994). Due to the presence of 
a trans-molecular di-sulphide bridge, gliotoxin is a redox active molecule, cycling 
between an oxidised and reduced form, instilling it the ability to alter the oxidative state 
of cells and inducing toxicity (Waring et al., 1995; Cramer et al., 2006; Gardiner & 
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Howlett 2005). A genome-wide yeast deletion screen carried out by Chamilos et al., 
identified important gene components of the oxidative stress response and other key 
cellular pathways to be affected by gliotoxin challenge (Chamilos et al., 2008). 
However, as demonstrated in this study, additional strains with altered phenotypic 
responses to gliotoxin were identified which were originally overlooked. 
A gene targeted approach was utilised here to further assess the response of S. 
cerevisiae to gliotoxin. With the aim to identify key targets of gliotoxin toxicity and to 
elucidate how gliotoxin induces its toxicity in this model organism. 
 
6.2 Growth response of S. cerevisiae mutants to gliotoxin 
 Many studies have implicated gliotoxins’ toxicity with the induction of OS and 
production of ROS (Waring 1990; Waring et al., 1995; Carberry et al., 2012). Being 
able to cycle between an oxidised and reduced form makes this highly likely, as would 
its ability to interact with the free thiols of proteins in the cell (Waring et al., 1995). 
Previous work on the proteomic response to gliotoxin in A. fumigatus has identified an 
increase in protein expression of Sod1p in response to gliotoxin and a reduced 
expression of Ctt1p implicating gliotoxin induced alteration of the OS response 
(Carberry et al., 2012).  Results from previous chapters have illustrated gliotoxin does 
induce a significant increase in the levels of superoxide production, as well as 
dysregulating genes and proteins involved in the OS response (Chapters 3-5). 
In a genome wide study carried out by Chamilos et al., (2008) using S. 
cerevisiae mutants exposed to exogenous gliotoxin, identified 3 strains which exhibited 
increased sensitivity to gliotoxin and 10 with increased resistance (Chamilos et al., 
2008). Of these strains one was found to also be involved in the sulphur and methionine 
biosynthesis pathway, CYS3. CYS3 encodes cystathionine γ-lyase, an enzyme involved 
in catalysing the formation of L-cysteine from L-homocysteine (Figure 6.1) (Hiraishi & 
Miyake 2008). 
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Figure 6.1 Cystathionine γ-lyase activity 
 
Previous results demonstrated that gliotoxin exposure induces oxidative stress 
on the cell. Causing dysregulation to parts of the L-cysteine and L-methionine 
metabolic pathway and sulphur pathways (Chapter 5), as well as affecting glutathione 
biosynthesis and the SAM cycle (Chapter 4 and 5). Using a gene targeted approach, S. 
cerevisiae deletion strains were screened on gliotoxin Figure. 6.2 A and B. 
 Gliotoxin exposure (8 µg/ml) elicits a sensitive phenotype in both Δsod1 and 
Δyap1 on SC media. Both are involved in the OS response further corroborating 
gliotoxin induction of OS on the cell. However, when this is compared to other strains 
lacking important OS response genes such as Δctt1 (Figure 6.2 A and B), gliotoxin 
exposure elicits a wild-type phenotype. Similarly, the response of other OS response 
mutant strains such as Δtrx2, which encodes thioredoxin an important OS repair protein 
and sulphur metabolism regulator (Kugel & Jones 1994), Δgsh2 which encodes 
glutathione synthetase the last enzyme involved in glutathione biosynthesis (Grant et 
al., 1997), Δglr1 which encodes a glutathione reductase which is important in the 
reduction of oxidised glutathione (GSSG) to form GSH and helps maintain the de novo 
GSH levels (Grant et al., 1996; Muller 1996; Østergaard et al., 2004) and Δskn7 which 
encodes an important transcription factor involved in the OS response (Jamieson 1998; 
Auesukaree et al., 2009) educe a wild-type phenotype when exposed to gliotoxin 
(O’Brien 2011). 
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 Δgsh1 shows increased resistance to gliotoxin (Figure 6.2 B). GSH1 encodes the 
rate limiting step in the formation of GSH and loss of this gene has been demonstrated 
to have a corresponding abolishment of GSH biosynthesis (Greenberg & Demple 1986; 
Lee et al., 2001)  Due to the role in the OS response, loss of GSH may be expected to 
induce sensitivity when the cell is exposed to gliotoxin, yet the opposite was seen here. 
This suggests low to null levels of GSH is advantageous when exposed to gliotoxin. 
  
 
 
 
Figure 6.2 A and B Growth analysis of S. cerevisiae strains grown on synthetic 
complete media (SC) with or without gliotoxin. Comparative growth analysis assay 
using strains BY4741a, Δgsh1, Δyap1 and Δctt1. (A) Strains grown on SC media. (B) 
Strains grown on SC media with 8 µg/ml gliotoxin added.  
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When the growth response of Δgsh1 is compared with strains lacking genes 
involved in glutathione biosynthesis Δgsh2 elicits a wild-type response (Figure 6.3 C 
and D) while Δcys3 elicits a sensitive growth response (Figure 6.3 A and B).  
  
 
 
 
 
 
 
 
 
 
 
Figure 6.3 A-D Growth analysis of S. cerevisiae strains grown on synthetic 
complete media (SC) with or without gliotoxin. Comparative growth analysis assay 
using strains BY4741a, Δcys3, Δgsh1, and Δgsh2. (A) Strains BY4741a, Δcys3 and 
Δgsh1 grown on SC media. (B) Strains BY4741a, Δcys3 and Δgsh1 with 8 µg/ml 
gliotoxin added. (C) Strains BY4741a, and Δgsh2 grown on SC media. (D) Strains 
BY4741a, and Δgsh2 grown on SC media with 8 µg/ml gliotoxin added 
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In Figure 6.4, each of the key genes involved in glutathione biosynthesis is illustrated. 
Cys3p is involved in the enzymatic breakdown of l-homocysteine to l-cysteine which 
later becomes part of the tri-peptide of glutathione. 
 
 
Figure 6.4 Glutathione biosynthesis pathway 
 
 Δcys3 is sensitive to gliotoxin however Δcys4 elicits a wild-type phenotype 
(Figure 6.5 A and B). Loss of CYS3 may cause an alteration in the L-cysteine levels 
which in itself could induce stress via the alteration of GSH levels in vivo. As Δgsh1 is 
resistant to gliotoxin, it is un-likely that an alteration to glutathione biosynthesis due to 
the absence of CYS3 is responsible for this sensitivity. Previously it has been 
demonstrated that loss of CYS3 results in subsequent auxotrophy for L-cysteine (Cherest 
et al., 1993) requiring cysteine to be present in the media for optimum growth. This 
could explain the weaker growth of this strain seen on SC media plates without 
gliotoxin, presumably due to low L-cysteine levels in the media (Figure 6.5 A). 
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Figure 6.5 A and B Growth analysis of S. cerevisiae strains grown on synthetic 
complete media (SC) with or without gliotoxin. Comparative growth analysis assay 
using strains BY4741a, Δcys3 and Δcys4. (A) Strains BY4741a, Δcys3 and Δcys4 grown 
on SC media. (B) Strains BY4741a, Δcys3 and Δcys4 with 8 µg/ml gliotoxin added.  
 
As seen in Figure 6.3 D, Δgsh2 elicits a wild-type phenotype when challenged 
with gliotoxin. Gsh2p catalyses the last step in glutathione formation. Strains lacking 
GSH2 have been shown to possess low to null levels of glutathione yet can compensate 
by over expressing GSH1 and the biosynthesis of γ-glutamyl cysteine (Jamieson 1998; 
Wheeler et al., 2002). As Δgsh2 cells possess naturally lower levels of glutathione than 
wild-type cells, loss of glutathione biosynthesis alone may not necessarily confer 
resistance to gliotoxin. All other strains used and tested on gliotoxin not mentioned here 
elicited a wild-type phenotype. 
 
6.3 Oxidative stress response in S. cerevisiae 
As seen in Chapter 3, gliotoxin induces an increase in the production of ROS. 
This is further corroborated in Chapters 4 and 5 where gliotoxin challenge results in 
subsequent dysregulation of OS related genes and proteins. To further elucidate the 
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affect gliotoxin has on the OS response, yeast deletion strains lacking genes involved in 
the OS response were exposed to H2O2 and gliotoxin. S. cerevisiae was employed due 
to the ready availability of mutants in this model organism, a well characterised OS 
response and a fully sequenced genome. Mid-exponential cells were serially diluted 
before being transferred onto minimal media agarose plates containing different 
concentrations of H2O2 (0-3 mM). Results for 0 (A), 2 (B) and 3 (C) mM H2O2 can be 
seen in figure 6.7 A-C, 1 mM not included as it is very similar to what is seen on 2 mM 
plates. 
In Figure 6.6, all strains elicit a wild-type response when grown on SC media. 
However this changes once H2O2 is added whereby a dramatic change can be seen. On 2 
mM H2O2 (Figure 6.6 B) SC plates, Δyap1 becomes hypersensitive with very little 
growth seen and no growth visible on 3 mM H2O2 (Figure 6.6 C). As mentioned 
previously, Yap1pis a transcription factor which regulates the expression of many OS 
response genes (Agnés et al., 2000; Kugel & Jones 1994) . In Δyap1 this would no 
longer be occurring and once exposed to H2O2, lack of this Yap1 mediated OS response 
would result in the cells being vulnerable to ROS and oxidative damage. This has been 
demonstrated in other studies in which Δyap1 was seen to be highly sensitive to ROS 
generated by different OS inducing compounds e.g. H2O2 (Draculic et al., 2000; 
Auesukaree et al., 2009; López-Mirabel et al., 2007) . 
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Figure 6.6 A-C Growth analysis of S. cerevisiae strains grown on synthetic 
complete media (SC) with or without H2O2. Comparative growth analysis assay using 
strains BY4741a, Δgsh1, Δyap1 and Δctt1. (A) Strains grown on SC media. (B) Strains 
grown on SC media with 2 mM H2O2 added. (C) Strains grown on SC media with 3 
mM H2O2 added. 
 
 SOD1, GSH1 and CTT1 are also involved in the OS response (Bermingham-
McDonogh et al., 1988; Jamieson 1998; Drakulic et al., 2005). Sod1 is a superoxide 
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dismutase involved in the dismutating the superoxide radical and hydroxyl radical to 
molecular oxygen and hydrogen peroxide. The latter of which can serve as a signalling 
molecule activating Yap1 nuclear accumulation and subsequent transcriptional 
activation of OS response genes (Agnés et al., 2000; Kuge et al., 2001). Sensitivity to 
H2O2 is not seen until 3 mM H2O2 (Figure 6.6 C) in Δsod1, indicating loss of this gene 
is not paramount in the OS response to H2O2. In yeast there are many forms of 
enzymatic and non-enzymatic means to alleviate ROS and OS (Finkel & Holbrook 
2000; Jamieson 1998). In a Δsod1 strain these other defence mechanisms could be 
compensating for the loss of Sod1 helping to tackle the OS until the concentration of 
H2O2 becomes too much and begins to overwhelm them ultimately resulting in the 
strains eliciting a sensitive phenotype. 
GSH is involved in scavenging free radicals inside the cell which can cause OS 
and facilitates their removal from the cell (Izawa et al., 1995). It also has many other 
roles in metal stress tolerance and S-glutathionylation of proteins (Wheeler et al., 2003; 
Yang et al., 2010) . In Figure 6.6 B, Δgsh1 is somewhat sensitive to 2 mM H2O2, 
showing greater sensitivity to the highest concentration of 3 mM H2O2 (Figure 6.6 C). 
In other works, Δgsh1 has been demonstrated to have increased sensitivity to a variety 
of compounds such as nickel, menadione plumagin and ethanol (Bishop et al., 2007; 
Stephen & Jamieson 1996; Yoshikawa et al., 2009) presumably due to the loss of GSH 
and its role in the OS response. GSH1 encodes the rate limiting enzyme involved in the 
biosynthesis of the tri-peptide glutathione. Glutathione cycles between a reduced GSH 
form and an oxidised GSSG form, with the former being the most abundant in the cell, 
which aids in maintain the redox state of the cell (Grant 2001; Wheeler et al., 2003) . 
Loss of GSH1 would result in the loss of glutathione biosynthesis, its free radical 
scavenging ability and its ability to maintain the redox state of the cell. However, like a 
Δsod1 strain, other OS response mechanisms could be compensating for the loss of 
GSH1 and helping to attenuate ROS production de novo.  
CTT1, encodes a catalase which catalyses the breakdown of H2O2 into water and 
molecular oxygen (Jamieson 1998). Loss of CTT1 does not elicit sensitivity in Δctt1 on 
3 mM H2O2 (Figure. 6.6 C) suggesting other mechanisms may be compensating for its 
absence e.g. presence of another catalase Cta1 (Petrova et al., 2004). 
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 In Δsod1 and Δctt1 H2O2 could be detoxified via other OS response 
mechanisms such as glutathione peroxidases e.g. Gpx1 and Gpx2, which catalyse the 
breakdown of H2O2 to water via the reduction of oxidised GPX proteins in the presence 
of H2O2 and GSH resulting the formation of GSSG (Figure 6.7) (Inoue et al., 1999) . 
 
Figure 6.7 Breakdown of H2O2 by glutathione and glutathione peroxidases 
 
6.4 Gliotoxin and H2O2 growth comparison  
 H2O2 is a known OS inducer, causing a rise in the production of ROS and 
oxidative damage in the cell (Collinson & Dawes 1992; Davies et al., 1994; Finkel & 
Holbrook 2000). It also acts as a signalling molecule in the cell inducing an OS 
response (Agnés et al., 2000; Dantas et al., 2010)  via activation of Yap1 nuclear 
localisation and subsequent transcriptional activation of OS response genes. This is 
enabled by the aforementioned di-sulphide formation in Yap1 inducing transcriptional 
function and activation of OS response genes (Kugel & Jones 1994; Agnés et al., 2000; 
Kuge et al., 2001). 
As seen in Section 6.2, gliotoxin affects some major components of the OS 
response but not all as certain strain are un-perturbed by H2O2 presence. H2O2 appears 
to have a similar effect on yeast mutant strains as gliotoxin exposure, implying both 
H2O2 and gliotoxin could be having a similar effect on the cell, or at least effecting 
similar components of the OS response.  
 H2O2 has been implemented as a pre-treatment in many studies experimenting 
with its effect in alleviating chemically induced cellular stress (Collinson & Dawes 
1992; Davies et al., 1995; Park et al., 1997). Davies et al., demonstrated that 0.4 mM 
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H2O2 was sufficient in inhibiting growth of S. cerevisiae cells, yet when cells were pre-
exposed to lower H2O2 concentrations and then re-exposed to the higher concentration, 
growth response significantly improved (Davies et al., 1995). Similarly, pre-treatment 
with other toxins have been shown to help induce resistance in S. cerevisiae to hydrogen 
peroxide whereby 50 µg/ml cyclo-hexamide pre-exposure increased growth on a lethal 
dose of H2O2 (Collinson & Dawes 1992) underlining the potential signalling roles 
certain toxins have in inducing particular stress responses. 
 Co-addition of gliotoxin and H2O2 was seen to alleviate H2O2 toxicity in a 
gliotoxin concentration dependent manner in A. fumigatus strains (Gallagher et al., 
2012). Gliotoxin mediated attenuation of H2O2 was tested in S. cerevisiae strains grown 
on SC agarose plates containing similar concentrations of H2O2, gliotoxin and a 
combination of both (Figure 6.8 A-D). 
 Both 1 mM H2O2 (Figure. 6.8 B) and 8 µg/ml gliotoxin (Figure 6.8 C) elicit 
different degrees of sensitivity in certain yeast strains further supporting gliotoxin 
affecting similar biological pathways as H2O2. Contrary to this, H2O2 challenge induces 
sensitivity in Δgsh1 while this same strain is resistant to gliotoxin, highlighting how 
glutathione is necessary in the H2O2 stress response, but its absence is advantageous 
during gliotoxin exposure. 
 When both chemicals are added together, the attenuation of gliotoxin toxicity is 
not seen (Figure 6.8 D) as seen in A. fumigatus (chapter 3). Instead, addition of H2O2 
has a synergistic effect, potentiating gliotoxin toxicity and resulting in inhibiting growth 
of all strains including the wild-type. This dramatic decrease in cell growth could be 
caused by an inability to respond to both H2O2 and gliotoxin. As can be seen in Figure 
6.9 B, growth is relatively un-perturbed in the wild-type in the presence of 1 mM H2O2, 
less so in the presence of gliotoxin (Figure 6.8 C). On co-addition plates wild-type cells 
are unable to tolerate the toxicity of both H2O2 and gliotoxin eliciting a sensitive 
phenotype. H2O2 has been noted to reduce the thiol content as part of the OS response to 
peroxide stress via oxidation of free thiols (Winterbourn & Metodiewa, 1999). 
Gliotoxin has also been shown to lower the de novo glutathione pool, (Bernardo et al., 
2001). With the addition of these two, there would be an increasing oxidative state 
inside the cell due to the oxidation of different thiols found in the cell via H2O2 and 
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gliotoxin as well as increased formation of ROS which may explain this increased 
sensitivity. 
The apparent inability of gliotoxin to alleviate H2O2 toxicity in S. cerevisiae 
could be due to the presence of different or more complex defensive mechanisms 
present in A. fumigatus which are absent in yeast such as gliotoxin induction of the gli 
biosynthetic cluster etc. In S. cerevisiae, any increase in the OS response induced by 
gliotoxin exposure does not outweigh the combinatory toxic effect of both chemicals.  
  
 
 
 
 
 
 
Figure 6.8 A-D Growth analysis of S. cerevisiae strains grown on synthetic 
complete media (SC) with or without gliotoxin and/or H2O2. Comparative growth 
analysis assay using strains BY4741a, Δsod1, Δgsh1, Δyap1 and Δctt1. (A) Strains 
grown on SC media. (B) Strains grown on SC media with 1 mM H2O2 added. (C) 
Strains grown on SC media with 8 µg/ml gliotoxin added. (D) Strains grown on SC 
media with 1 mM H2O2 and 8 µg/ml gliotoxin added. 
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6.5 Influence of glutathione on S. cerevisiae response to gliotoxin 
 Glutathione has been shown to be important in facilitating gliotoxin transport 
into the cell (Bernardo et al., 2003). It acts as an important anti-oxidant in the OS 
response for a variety of different stresses, with depletion of de novo glutathione pools 
being lethal to the cell (Lee et al., 2001; Cameron & Pakrasi 2010) . However, from 
Section 6.2 loss of GSH1 elicits resistance to gliotoxin exposure indicating that 
glutathione or some related product may be exacerbating gliotoxin toxicity potentially 
through the facilitation of gliotoxin influx into the cell. With this in mind yeast strains 
were exposed to glutathione depleting conditions via the addition of the thiol-reductant 
diamide and CDNB. 
 
6.5.1 Influence of diamide on S. cerevisiae and gliotoxin exposure 
 Diamide is a cell permeable thiol oxidant which has been shown to oxidise 
cysteine residues within Yap1 nuclear export domain disabling its ability to interact 
with Crm1p and subsequently its efflux from the nucleus facilitating Yap1 mediated 
regulation of OS response genes (Gulshan et al., 2011). It also acts as a GSH scavenger, 
oxidising GSH to its oxidised isoform GSSG, reducing the in vivo GSH pool (Kower 
and Kower 1995; Sato et al., 1995; Carberry et al., 2012). Cells with reduced levels of 
GSH are naturally resistant to diamide as GSH presence is a pre-requisite for diamide 
toxicity, thus preventing alteration of the oxidative state of the cell due to rising GSSG 
levels (Kower and Kower, 1995). To examine the relationship between glutathione 
levels and the growth response of S. cerevisiae to gliotoxin, cells were exposed to a 
range of diamide concentrations (Figure 6.9 A-C) to identify S. cerevisiae strains which 
were resistant and thus possessed naturally lower levels of glutathione. These were then 
exposed to gliotoxin (Figure 6.9 D) and a combination of both gliotoxin and diamide 
(Figure 6.9 E and F) to examine if diamide mediated alteration of the in vivo glutathione 
levels subsequently improved yeast growth response to gliotoxin. 
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Figure 6.9 A-F Growth analysis of S. cerevisiae strains grown on synthetic 
complete media (SC) with or without gliotoxin and or diamide. Comparative growth 
analysis assay using strains BY4741a, Δsod1, Δgsh1, Δyap1 and Δcys31. (A) Strains 
grown on SC media. (B) Strains grown on SC media with 1 mM diamide added. (C) 
Strains grown on SC media with 2 mM diamide added. (D) Strains grown on SC media 
with 8 µg/ml gliotoxin added. (E) Strains grown on SC media with 1 mM diamide and 8 
µg/ml gliotoxin added. (F) Strains grown on SC media with 2 mM diamide and 8 µg/ml 
gliotoxin added. 
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In Figure 6.9 B, 2 mM diamide elicits a sensitive phenotype in both Δsod1 and 
Δyap1. As both are involved in OS response, any increase in OS by diamide toxicity 
would be potentiated by the loss of each respective gene. Δyap1s’ augmented sensitivity 
when compared to Δsod1 could be due to Yap1 transcriptional positive regulation of OS 
response genes. One such gene, GLR1 could alleviate diamide stress via its glutathione 
reductase role maintaining GSSG and GSH levels and subsequently the oxidative state 
of the cell (Lee et al., 2001; Muller 1996) 
 Gsh1 and Cys3 are both involved in glutathione biosynthesis. Loss of these 
genes educes a resistant phenotype when exposed to diamide, indicating they may 
possess low levels of glutathione (Grant et al., 1997; Bernardo et al., 2003; Piccirillo et 
al., 2009). Lower levels of glutathione, reduces the risk of diamide mediated oxidisation 
of GSH to GSSG and subsequent OS. When Δgsh1 and Δcys3 growth on 8 µg/ml 
gliotoxin is compared to this, Δcys3 has an increased sensitive phenotype while Δgsh1 
shows an increased resistant phenotype compared to the wild type BY4741. This altered 
response seen in the phenotype of Δcys3 on diamide versus gliotoxin suggests that low 
glutathione levels, presumably responsible for its resistance to diamide, is insufficient to 
aid with its growth in the presence of gliotoxin. 
 When these same cells are exposed to a combination of both 1 mM diamide and 
8 µg/ml gliotoxin (Figure. 6.9 E) there is some improvement in growth when compared 
to gliotoxin alone, however only in strains Δyap1 and Δcys3. Wild-type, Δsod1, and 
Δgsh1 show no significant difference in their respective growth response in the presence 
of both diamide and gliotoxin when compared to gliotoxin alone  demonstrating 
addition of diamide is not advantageous in these strains; while in Δyap1, and to a lesser 
extent Δcys3, it does. Any benefit caused by diamide presence must not out-weigh 
gliotoxin toxicity in wild-type, Δsod1 or Δgsh1 strains.  
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6.5.2 Influence of 1-Chloro-2,4 di-nitro benzene on S. cerevisiae growth response 
on gliotoxin. 
 CDNB is a benzene derivative which has been shown to reduce the in vivo 
glutathione pools by conjugating to the free thiol of GSH (Izawa et al., 1995) and 
inhibiting thioredoxin reductase and glutathione reductase which are both required in 
protecting against oxidative stress and re-formation of GSH from GSSG (Holmgren 
1989; Grant 2001). CDNB is non-toxic to S. cerevisiae as seen in Figure 6.10 A with no 
change in the growth when compared to un-exposed cells (Izawa et al., 1995; Trotter & 
Grant 2002a). Inoculated cultures were incubated with CDNB prior to transferral to 
minimal media plates in an attempt, to artificially reduce the intra-cellular levels of 
GSH in S. cerevisiae strains to examine if their respective growth could be improved to 
gliotoxin exposure once GSH was depleted (Figure 6.10 A-C). 
 
In Figure 6.10 A, the addition of CDNB (0.08 M) had no adverse effects on cells 
when grown on minimal media. When exposed to 8 µg/ml gliotoxin (Figure. 6.10 B), 
this was not the case for Δsod1 + CDNB, where pre-incubation with CDNB potentiated 
gliotoxin toxicity increasing Δsod1   CDNB sensitivity. Δsod1 has a hypersensitive 
phenotype when exposed to gliotoxin, presumably due to the loss of an important OS 
response gene. When there is a simultaneous reduction in glutathione due to CDNB pre-
exposure, gliotoxin toxicity is exacerbated in the Δsod1 +CDNB strain, as two key OS 
responses no longer exist and its inability to tackle OS stress inflicted by gliotoxin 
presence is intensified. 
 In Figure 6.10 B, BY4741   CDNB and Δyap1 + CDNB show an improvement 
in growth when compared to wild type and Δyap1 un-exposed cells respectively. This 
CDNB required augmentation of growth, improves growth on higher concentrations of 
gliotoxin (16 µg/ml) (Figure 6.10 C). Very little growth of the Δyap1 +CDNB can be 
seen while none is visible for Δyap1. This along with the increased resistance of the 
BY4741   CDNB demonstrates CDNBs’ ability to improve growth of certain strains 
when exposed to gliotoxin via the reduction of glutathione levels inside the cell, further 
corroborating a relationship between glutathione presence and gliotoxin toxicity. 
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Figure 6.10 A-C Growth analysis of S. cerevisiae strains exposed with or without 
CDNB and grown on synthetic complete media (SC) with or without gliotoxin. 
Comparative growth analysis assay using strains BY4741a, BY4741a   CDNB Δsod1, 
Δsod1   CDNB, Δyap1 and Δyap1 + CDNB. (A) Strains grown on SC media. (B) 
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Strains grown on SC media with 8 µg/ml gliotoxin added. (C) Strains grown on SC 
media with 16 µg/ml gliotoxin added. 
6.6 Glutathione quantification in S. cerevisiae 
 From the previous sections glutathione appears to play some role in the cells 
response to gliotoxin toxicity, with diminished levels of glutathione providing resistance 
to gliotoxin exposure. To verify this, S. cerevisiae lysates were created from minimal 
media and used to quantify the glutathione content of specific strains. As glutathione 
exists in two forms, a reduced GSH and oxidised GSSG, it’s important to measure both 
to ascertain the redox state of the cell (Meister 1988; Drakulic et al., 2005; Østergaard 
et al., 2004).  
 The ratio of GSH:GSSG is pushed in favour of the reduced form (Meister 1988; 
Grant et al., 1996) with a proportional increase in both indicative of increased redox 
stress in that cell (Trotter & Grant 2002a; Gales et al., 2008). As can be seen in Figure 
6.11, there is clear difference in the glutathione content of S. cerevisiae strains which 
may explain their different growth responses to gliotoxin exposure. The wild-type strain 
BY4741a exhibits almost equal levels of GSH:GSSG suggesting some form of OS is 
occurring, perhaps due to being grown on minimal media. Δsod1 shows negligible 
levels of glutathione under these same conditions with its GSSG content being slightly 
less than BY4741a. Indicating all GSH being produced is being oxidised into the GSSG 
form presumably due to its anti ROS role in the cell and at this time point (24 hours) 
and has not yet been reduced back to GSH. Δyap1 possess significantly greater (P = 
0.002) GSSG:GSH levels, when compared to wild-type. This reduced glutathione level 
could be due to reduced expression of GLR1 and GSH, both of which are 
transcriptionally regulated by Yap1 which is no longer present in this strain (Lee et al., 
2013). 
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Figure 6.11 Glutathione quantification in S. cerevisiae strains Net GSH and GSSG 
levels were quantified using protein lysates of S. cerevisiae strains BY4741a, Δsod1, 
Δyap1, Δcys3 and Δgsh1 grown in minimal media.  
 
 Δcys3 shows GSH levels comparable to those of BY4741a, however the levels 
of GSSG are significantly higher (p = 0.004). As the GSH levels are not altered 
compared to wild type, loss of Δcys3 does not appear to be vital in the formation of 
glutathione, presumably due to the availability of l-cysteine in the media which can be 
taken up by the cell and used to synthesise glutathione. Its increased GSSG levels 
suggest increase in GSH oxidation as part of its role in the OS response. Although loss 
of Δcys3 may not significantly alter the glutathione levels inside the cell, this increase in 
GSSG could be caused by loss of other CYS3 activity such as a subsequent rise in l-
cystathionine which has been seen to result in homocysteine accumulation which can be 
toxic to cells (Fujita et al., 2006). 
 No measurable quantities of GSH or GSSG could be detected in the Δgsh1 
strain, confirming its pivotal role in glutathione biosynthesis. Since all gliotoxin plate 
assays were carried out on similar media, the glutathione levels shown in figure 6.11, 
depict the cells glutathione level prior to being exposed to gliotoxin. 
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In cells where GSH and GSSG are absent i.e. Δgsh1, we see resistance in the 
presence of gliotoxin highlighting that complete absence of glutathione is advantageous 
when exposed to gliotoxin. Δcys3 sensitivity to gliotoxin could be due to its 
significantly higher levels of GSSG seen Figure 6.11. Alongside this, gliotoxin redox 
cycling would further dysregulate the oxidative state of the cell inducing stress. 
Similarly in Δyap1 and Δsod1, which show high GSSG:GSH levels, gliotoxin could 
increase the GSSG levels in the cell by its own mediated by GSH. However the 
sensitivity seen in Δsod1 and Δyap1 is more likely a combination of the altered 
glutathione levels in these strains and the role their respective genes play in the OS 
response. 
 
6.7 Metformins’ influence on S. cerevisiae growth in response to gliotoxin exposure 
 Metformin is a compound primarily used in the treatment of type-2 diabetes 
whereby it reduces plasma concentrations of glucose helping reduce hypoglycaemia and 
promote less weight gain when compared to similar treatments (Nosadini et al., 1987; 
Li et al., 1999; Mäkimattila et al., 1999). Although the exact mechanism of its 
functionality is not yet fully elucidated, it has been found to be important in other 
treatments such as reducing cancer (Dowling et al., 2011) and in delaying the ageing of 
rodents and nematodes (Anisimov et al., 2011; Onken & Driscoll 2010; Cabreiro et al., 
2013).   
In a most recent study, Cabreiro et al., (2013) found that C. elegans feeding on 
E. coli which were pre-exposed to metformin (100 mM), helped increase lifespan by 36 
%. They found this increase in lifespan was specific to E. coli exposed to metformin and 
was not seen in C. elegans plus metformin alone, indicating it was due to some 
modification of the E. coli themselves which was affecting the C. elegans ageing 
(Cabreiro et al., 2013). Looking closer into the metabolic affects after metformin 
exposure, it was found metformin exposure disrupted folate metabolism by inhibiting 
methionine synthase causing a subsequent accumulation of 5-methyl tetrahydrofolate, 
reduction in homocysteine and an increase in the s-adenosyl homocysteine levels (33%) 
and s-adenosylmethionine (86%) (Cabreiro et al., 2013). 
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 From previous results in S. cerevisiae, the accumulation of L-homocysteine due 
to gliotoxin exposure could explain the sensitivity of certain strains. Using metformin, 
L-homocysteine levels could be artificially reduced in these strains and thus help 
promote growth on gliotoxin. However as seen in Figure 6.12 B, exposure to 100 mM 
metformin increases sensitivity of Δsod1 and Δgsh1 when compared to plates with no 
metformin added (Figure 6.12 A) suggesting an alteration of the SAM cycle potentiates 
gliotoxin toxicity in these strains. When grown on minimal media plates containing 8 
µg/ml gliotoxin and 100 mM metformin (Figure. 6.12 D) the growth of all strains is 
reduced when compared to 8 µg/ml gliotoxin alone (Figure. 6.12 C) indicating presence 
of metformin does not help promote growth in the presence of gliotoxin, but potentiates 
it due to some alteration of methionine biosynthesis. 
 
 
 
 
 
 
 
 
 
Figure 6.12 A-D Growth analysis of S. cerevisiae strains grown on synthetic 
complete media (SC) with or without gliotoxin and/or 100 mM metformin. 
Comparative growth analysis assay using strains BY4741a, Δyap1, Δsod1 and Δgsh1. 
(A) Strains grown on SC media. (B) Strains grown on SC media with 100 mM 
metformin added. (C) Strains grown on SC media with 8 µg/ml gliotoxin added. (D)  
Strains grown on SC media with 100 mM metformin and 8 µg/ml gliotoxin added 
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6.8 Comparison of RNA Sequence analysis and phenotypic response to gliotoxin in 
S. cerevisiae 
 RNA sequence analysis is one form of investigative study which can highlight 
key areas which are differentially regulated at the transcript level in response to a 
specific stimulus. Using the S. cerevisiae strain G600 exposed to two concentrations of 
gliotoxin (16 µg/ml and 64 µg/ml respectively were chosen in this study to compare a 
concentration which inhibited the growth of 50 % of a population and a higher 
concentration which causes >90 % inhibtion of S. cerevisiae growth) O’Brien (2011) 
carried a full transcriptomic study on the yeasts response to gliotoxin exposure. In the 
presence of gliotoxin, it was found ribosome biogenesis, protein biosynthesis and stress 
response genes were found to be the most common biological processes which were 
found to have >2 fold up-regulation, while carbohydrate metabolism, transport and 
mitochondrion organisation were found to be the most common biological processes 
with > 2 fold down-regulation (O’Brien 2011). 
 This data allowed for further examination of genes involved in gliotoxin 
tolerance at the transcript level. From this work it was clear that gliotoxin exposure 
caused a subsequent up-regulation of genes involved in methionine biosynthesis. In 
table 6.2, genes involved in methionine biosynthesis, glutathione biosynthesis and 
oxidative stress are differentially regulated when exposed to gliotoxin 
 
Table 6.1 Transcript Up and Down regulation in response to 16 µg/ml gliotoxin 
exposure in S. cerevisiae vs. S. cerevisiae control 
Gene Name >1.5 fold up-regulation >1.5 fold down-regulation 
GSH1 ø Ø 
GSH2 ø Ø 
CYS3 4 - 
CYS4 1.55 - 
STR3 4 - 
STR2 - 1.8 
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SOD1 ø Ø 
YAP1 ø ø 
CTT1 - 3.55 
GPX1 - 5.85 
GPX2 - 1.55 
MET6 2.89 - 
SAM2 3.88 - 
SAM1 1.82 - 
ø= no significant up/down regulation 
  
Genes involved in the OS response i.e. YAP1, SOD1 show no differential 
regulation in response to gliotoxin exposure, indicating any OS stress induced by 
gliotoxin exposure does not affect these genes at the transcript level, perhaps due to an 
‘intact’ OS stress response. However, there is a significant down-regulation of genes 
involved in hydrogen peroxide stress i.e. CTT1, GPX1 and GPX2, corroborating results 
seen in plate assays using mutant strains exposed to gliotoxin whereby they showed no 
significant change in their growth response demonstrating how these genes are 
dispensable in the presence of gliotoxin and gliotoxin stress. This result further depicts 
gliotoxin acting as an anti-oxidant in vivo explaining why these and other OS response 
genes are significantly down-regulated when compared to the control condition. 
Similar to gliotoxin plate assays, CYS3 is significantly up-regulated in response 
to gliotoxin. Loss of CYS3 results in a sensitive phenotype when challenged with 
gliotoxin. The significant up-regulation of CYS3 and CYS4 would suggest there is a 
demand for an increase in the transcription of genes which encode enzymes that 
catalyse the formation of L-cysteine a precursor of GSH biosynthesis. However, as a 
corresponding increase in gsh1 and gsh2 was not seen during these conditions, 
suggesting this significant increase in the expression of cys3 and cys4 may not be 
directly linked to glutathione biosynthesis. 
 Additionally, there appears to be a simultaneous dysregulation of genes which 
are involved in different parts in the SAM biosynthesis cycle as seen in Figure 6.13. 
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Figure 6.13 Representation of S-adenosyl Biosynthesis in S. cerevisiae Figure gives, 
genes italicised in their respective positions in this pathway. Red arrows depict 
significant transcript up-regulation, and blue depicting significant transcript down-
regulation in response to 16 µg/ml gliotoxin exposure. 
 
 From Figure 6.13, there is significant up-regulation in genes which encode 
enzymes that catalyse the key preceding steps in SAM biosynthesis suggesting its role 
in gliotoxin stress. As mentioned previously, SAM is an essential molecule found in all 
cells, with SAM1 and SAM2 type genes being highly conserved eukaryotes (Lu 2000). 
SAM acts as a methyl donor in transulfuration reactions whereby it donates its methyl 
group to a methyl acceptor and is transformed into SAH (Mato et al., 1997). This type 
of reaction is important in the OS response (Luo & Levine 2009) via the methylation of 
key OS response proteins which is a requirement of their function, and in the 
biosynthesis of polyamines which themselves play an important role in the stress 
response both directly via their interaction with ROS and in protecting important 
molecular components of the cell such as DNA and RNA (Finkelstein 1990). With the 
large increase in expression of genes in the SAM biosynthesis pathway, a corresponding 
increase in translation of the respective proteins may be of benefit in this regard i.e. 
SAMs role in the cellular  stress response. 
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 As mentioned previously, gliotoxin has an analogue in the form of Bis methyl 
gliotoxin which has been isolated from patients suffering from IA and found to more 
abundant than gliotoxin (Domingo et al., 2012). It was hypothesised that this form of 
gliotoxin was actually a product of gliotoxin de-toxification, with each of the two 
methyl moieties being donated via SAM dependant methylation. However, this 
metabolite wasn’t discovered in S. cerevisiae (section 6.9). 
 
6.9 Bis-methyl-gliotoxin detection in S. cerevisiae 
  In section 6.8, transcriptomic evidence highlighted dysregulation of the SAM 
cycle, similar to what was seen in A. fumigatus (Chapter 5). This may indicate a role for 
this pathway in tackling gliotoxin toxicity, presumably via its role in the OS response or 
by modifying gliotoxin. As mentioned previously, any modification of gliotoxins 
disulphide bridge would be advantageous in attenuating gliotoxin toxicity. Similarly 
Bm-GT has been hypothesised as a product of gliotoxin detoxification and would 
require the SAM cycle in its biosynthesis. S. cerevisiae culture supernatants from cells 
exposed to gliotoxin showed no Bis methyl gliotoxin (m/z 357) to be produced 
indicating this mechanism of gliotoxin modification is not present in yeast and could go 
towards in explain its sensitivity (Figure. 6.14).  
A 
 
 
 
 
Figure 6.14 LC-MS detection of gliotoxin exposed S. cerevisiae culture 
supernatants Two un-associated peaks are found where the 357 Bm-GT should be 
detected if present 
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6.10 Discussion 
Gliotoxin is a potent anti-fungal and cytotoxic toxin (Herrick 1945; Waring et al., 1995; 
Sutton & Waring 1996). Gliotoxin toxicity is facilitated by the presence of an intra-
molecular di-sulphide bridge which has been attributed to inactivating proteins via 
conjugation of their free thiols, resulting in the formation of ROS and subsequent OS 
and the disruption of the NADPH oxidase complex important in neutrophilic oxidase 
burst killing (Waring et al., 1995; Carberry et al., 2012; Tsunawaki et al., 2004). 
To further elucidate the effects gliotoxin toxicity has on a eukaryotic cell, the 
tractable yeast model S. cerevisiae was employed. The growth of S. cerevisiae strains 
were assessed on known oxidative stress inducers such as H2O2 and diamide and 
compared to their respective growth on gliotoxin. 
In Figure 6.6 B, 2 mM H2O2 elicits a hypersensitive phenotype in Δyap1 
presumably due to the loss of Yap1p transcriptional regulation of key OS response 
genes (Kugel & Jones 1994; Agnés et al., 2000; Kuge et al., 2001). On 3 mM H2O2 
(Figure. 6.6 C) Δgsh1 and Δsod1 possess a sensitive phenotype indicating at these 
higher concentrations loss of either Δgsh1 or Δsod1 leaves the cell vulnerable to H2O2 
induced stress.  
 When challenged with gliotoxin (Figure.6.2 B) Δsod1& Δyap1 possess a 
sensitivity suggesting gliotoxin is inducing some kind of OS on the cell, as illustrated 
previously (Chapter 3, Section 4.5.3). Interestingly, no difference in growth could be 
seen in other strains involved in the OS response such as Δgsh2, Δctt1 or Δglr1 
suggesting these genes are either not involved in detoxifying the ROS induced by 
gliotoxin exposure or are not imperative in that response due to some form of 
compensatory mechanism. 
In a genome wide screen of various S. cerevisiae mutants lacking particular 
genes by Chamilos et al., (2008), Δcys3 was found to be sensitive to gliotoxin exposure, 
which was corroborated in this work. However, the sensitivity of Δyap1 and Δsod1 or 
the resistance repeatedly seen of the Δgsh1 strain were not identified. As Δgsh1 is 
lacking in glutathione (Lee et al., 2001) this result implies reduced glutathione levels 
helps protect S. cerevisiae from gliotoxin toxicity.  
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Glutathione is synthesised via two enzymes: γ-glutamyl cysteine synthetase 
(GSH1) and glutathione synthetase (GSH2) whereby GSH1 is the rate limiting step 
(Ohtake et al., 1990; Jamieson 1998; Wheeler et al., 2002). Δgsh2 has been shown to 
have reduced glutathione levels yet resulting in the over expression of GSH1 via Met4p 
positive regulation (Wheeler et al., 2002). Once challenged with gliotoxin Δgsh2 shows 
no inhibition in growth demonstrating that low levels of glutathione in Δgsh2 does not 
elicit gliotoxin resistance. This may suggest that only null levels of glutathione are 
advantageous when exposed to gliotoxin or that absence of γ-glutamyl cysteine could 
induce the resistance seen Δgsh1. 
 Both Δyap1 and Δsod1 are sensitive to 2 mM diamide (Figure. 6.9 C) 
presumably due to the induction of OS. Δcys3 and Δgsh1 are resistant to diamide 
exposure (Figure. 6.9 C) as is Δgsh2 (Trotter & Grant 2002b). Resistance to diamide 
suggests low levels of glutathione in the cell. As each of these are involved in different 
stages of glutathione biosynthesis, their resistance could be due to altered glutathione 
levels in vivo and subsequent reduction in diamides’ ability to oxidise glutathione thus 
attenuating stress (Boyland & Chasseaud 1967; Lee et al., 2001; Wheeler et al., 2002). 
This result further suggests that low glutathione levels are not sufficient to instil 
resistance to gliotoxin as Δcys3 is sensitive to gliotoxin, yet has low glutathione levels. 
When challenged with both gliotoxin (8 µg/ml) and diamide (1 mM) (Figure 6.9 E) only 
Δyap1 shows improved growth while in remaining strains co-addition of diamide and 
gliotoxin elicits a wild-type phenotype (Figure 6.9 E).  
 Pre-exposure to CDNB educes improved growth of wild-type and Δyap1 
resulting in growth on higher gliotoxin concentrations (16 µg/ml, Figure 6.10 C). 
CDNB specifically scavenges glutathione, depleting intracellular levels (Izawa et al., 
1995; Wheeler et al., 2003) further supporting the hypothesis that loss of glutathione is 
important in gliotoxin toxicity. The increased sensitivity seen in Δsod1 + CDNB would 
suggest that loss of Sod1p and depleted levels of glutathione only exacerbate gliotoxin 
toxicity. Addition of CDNB and loss of SOD1 potentiates the sensitivity seen in Δsod1 
upon exposure to gliotoxin. This could suggest loss of both glutathione and SOD1 
leaves the cell vulnerable to OS induced by gliotoxin toxicity. 
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 The GSH:GSSG ratio is highly regulated in order to maintain the redox state of 
the cell, with the reduced form found in greater amounts (50:1) creating a reduced 
environment inside the cell (Meister 1988; Drakulic et al., 2005). During the course of 
this work, it was hypothesised that glutathione levels influenced gliotoxin toxicity with 
null levels of glutathione resulting in resistance. This can be seen in Δgsh1 which 
showed no measurable levels of GSH or GSSG due to the loss of the γ-glutamyl 
cysteine synthetase gene, and is subsequently, highly resistant to gliotoxin exposure. 
This is further supported by the sensitivity seen in Δcys3 when challenged with 
gliotoxin exposure and its corresponding altered levels of GSSG which might lead to 
this sensitivity. Loss of Δsod1 and Δyap1 respectively, results in a reduction in GSH 
and GSSG levels when compared to BY4741a wild type. Each possesses higher levels 
of GSSG compared to their respective GSH levels which is indicative of some 
underlying OS occurring. This increase in endogenous stress, in combination with 
gliotoxin toxicity would result in increase in ROS subsequently inhibiting growth, as 
seen in figure 6.2 B. The GSH:GSSG ratio seen in Figure 6.11 for BY4741a wild-type 
is almost equal and not what would be expected as a higher level of reduced glutathione 
is maintained within the cell (Muller 1996; Drakulic et al., 2005). This could be 
attributed to growth on minimal media and the availability of resources inducing 
nutritional stress already inside the cell.  
 
 Metformin has been shown previously to influence the methionine biosynthesis 
cycle which in turn can influence the glutathione biosynthesis pathway due to L-
cysteine availability from homocysteine (Cabreiro et al., 2013; Ohtake et al., 1990). 
Interestingly addition of metformin (Figure 6.12 B) increases the sensitivity of all 
strains, notably Δgsh1 and Δyap1. Once added in combination with gliotoxin, the 
sensitivity induced by metformin is still present in Δgsh1 halting the resistance seen 
when grown on gliotoxin alone (Figure 6.12 C). This does not necessarily imply that 
metformin addition induces sensitivity of Δgsh1 to gliotoxin, as Δgsh1 does not show 
further sensitivity on metformin and gliotoxin when compared to metformin alone.  
From this body of work a key role for glutathione absence has been identified 
which instils resistance to gliotoxin exposure in Δgsh1. Altered levels of glutathione 
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and the loss of OS response genes also underlie sensitivity seen in different S. cerevisiae 
strains once challenged with gliotoxin, highlighting gliotoxins’ ability to induce some 
form of ROS, presumably in the form of the superoxide radical due to its redox cycling 
ability and its transport facilitated by reduced glutathione (Bernardo et al., 2003; Sutton 
& Waring 1996) . The absence of Bm-GT in S. cerevisiae culture supernatants may 
explain its sensitivity to this fungal secondary metabolite and may also support its role 
as a detoxification mechanism of gliotoxin in A. fumigatus which is not present in yeast. 
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Chapter 7 
Discussion 
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7.1 Thesis Discussion 
Gliotoxin is an important secondary metabolite which further mediates invasive 
aspergillosis in immuno-compromised individuals (Sutton & Waring 1996). Although 
gliotoxins’ chemical structure and biosynthetic cluster have been characterised, a lot has 
yet to be elucidated about the genes involved in its biosynthesis. This work depicts the 
characterisation of two genes, gliT and gliZ, found within the gliotoxin biosynthetic 
cluster gli, in the human opportunistic pathogen Aspergillus fumigatus. It describes the 
dysregulation of two key cellular pathways which appear to have separate roles in 
gliotoxin toxicity and gliotoxin detoxification, highlighting a novel relationship between 
gliotoxin and two molecules found within these different pathways. A secondary role 
for gliotoxin is also demonstrated, suggesting gliotoxin may in fact be an accidental 
toxin possessing an additional role as an anti-oxidant in A. fumigatus 
 
 GliZ encodes a Zn2Cys6 bi-nuclear transcriptional regulator of the gli cluster 
(Bok et al., 2006). In ΔgliZ gliotoxin biosynthesis is completely abolished, however 
gliT has been shown to be expressed (Bok et al., 2006; Schrettl et al., 2010). ΔgliZ 
shows no sensitivity to gliotoxin, presumably due to the independent regulation of gliT 
which, along with other gli cluster genes, has been noted to increase in the presence of 
exogenous gliotoxin (Cramer et al., 2006), further highlighting its role in self protection 
against gliotoxin presence (Bok et al., 2006). As mentioned, gliT is involved in self 
protection against gliotoxin toxicity acting as a gliotoxin oxido-reductase reducing the 
trans-molecular di-sulphide bridge which is imperative in gliotoxin toxicity. Loss of 
gliT results in hypersensitivity to relatively low levels of gliotoxin (Schrettl et al., 
2010). Similar to ΔgliZ, no gliotoxin could be detected in ΔgliT culture supernatants, 
suggesting gliotoxin biosynthesis is abolished, or that gliotoxin efflux is inhibited.  
 ΔgliTΔgliZ was created to characterise the phenotypic response in A. fumigatus 
when the gli cluster was completely silenced. Interestingly, exposure to gliotoxin 
elicited a sensitive phenotype, however this response was not as sensitive as ΔgliT. This 
led to the hypothesis that some gliotoxin biosynthesis may be occurring in ΔgliT 
eliciting a hypersensitive phenotype to exogenous gliotoxin. Evidence can be found in 
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the transcriptome response to gliotoxin in ΔgliT. A significant increase in expression of 
almost all gli genes could result in the formation of endogenous gliotoxin, or gliotoxin 
related intermediates, may have the potential to potentiate exogenous gliotoxin toxicity 
and subsequent ΔgliT sensitivity. An intermediate with a mass of 279.076 m/z was 
found to be unique to ΔgliT supernatants (Schrettl et al., 2010). Although this was later 
found to not induce any sensitivity, this suggests different metabolites are being 
produced in this strain which may be deleterious. Secondly, ΔgliTΔgliZ is not as 
sensitive as ΔgliT presumably due to the absence of these intermediates as the gli cluster 
is completely silenced. Instead, ΔgliTΔgliZ sensitivity to exogenous gliotoxin, is due to 
the loss of the gliT self protective mechanism, explaining why it’s more sensitive than 
ΔgliZ which still expresses gliT. Accumulation of endogenous gli related products and 
other factors which will be discussed later, can be attributed to the hyper-sensitivity 
seen in ΔgliT. 
Gliotoxin exists in either a di-sulphide oxidised form or a reduced di-thiol form. 
This di-thiol form has been demonstrated to be methylated to form bismethyl gliotoxin 
(bm-gt) which has previously been shown to exist at either greater or equi-molar 
concentrations than gliotoxin (Domingo et al., 2012). Bm-gt is a more stable compound 
than gliotoxin, and due to its non-reactive nature, has been hypothesised as a product of 
gliotoxin detoxification (Waring & Beaver 1996). Bm-gt synthesis may be differentially 
regulated in the absence of gliT and gliZ in an attempt to reduce gliotoxin toxicity. This 
hypothesis is supported by the many observations made in chapters 3, 4 and 5. In 
summary, s-adenosyl-L-methionine acts as the primary methyl donor in methylation 
reactions, presumably in bm-gt formation. Genes and enzymes involved in the s-
adenosyl-l-methionine biosynthesis cycle (SAM) were found to be dysregulated in 
response to gliotoxin, most probably in an attempt to influence bm-gt biosynthesis. This 
suggests that bm-gt biosynthesis may be up-regulated in these strains which could 
potentially be deleterious if not properly maintained. 
Accumulation of by-products, namely l-homocysteine, has been demonstrated to 
be toxic if allowed to accumulate within the cell. This suggests an increase in the 
regulation of the SAM cycle brings with it the risk of these products accumulating if not 
properly regulated. Evidence for this occurring can be found in chapter 4 with the 
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identification of s-adenosyl homocysteinease in gliT and gliZ mutants exposed to 
gliotoxin compared to wild-type. This enzyme was found to have decreased expression 
in all gliT and gliZ mutant strains suggesting the L-homocysteine levels are being 
altered in response to gliotoxin. Two isoforms of this same enzyme was later identified 
in ΔgliT +/- gliotoxin, one which was down-regulated, same location as previous 
identifications, and the other which was up-regulated which was unique to this 
comparison, further suggesting l-homocysteine levels are significantly altered in this 
mutant compared to the other two. Alongside the aforementioned factors affecting ΔgliT 
sensitivity, this work provides evidence that l-homocysteine levels could also be a major 
factor facilitating its sensitivity to gliotoxin. 
 Additionally, Met H/D cobalamin L-methionine synthase was identified to be 
differentially regulated in ΔgliZ and ΔgliTΔgliZ when compared to wild-type cells 
exposed to gliotoxin. Similarly to s-adenosyl homocysteinase, this enzyme is also 
involved in the SAM cycle utilised in the biosynthesis of L-methionine. Altered 
expression of both these enzymes may suggest that components of the SAM cycle may 
be induced by components of the gli cluster which are now silenced in these strains thus 
this enzyme is now being repressed. This is supported by the fact this enzyme was not 
identified in ΔgliT as it can still express these gli genes. Furthermore, it may also 
explain why only identify the up-regulated s-adenoysl homocysteinease isoform in 
ΔgliT protein lysates and not ΔgliZ or ΔgliTΔgliZ +/- gliotoxin.  
 The dysregulation in the SAM cycle could also be a mechanism linked to 
gliotoxin toxicity. This is supported by the observations made in chapter 6 wherein 
cellular pathways, notably the SAM cycle, were altered in a similar fashion in both the 
yeast S. cerevisiae and ΔgliT when exposed to gliotoxin. Additionally, S. cerevisiae was 
shown to be unable to bis methylate gliotoxin suggesting this pathway is naturally up-
regulated in fungi sensitive to gliotoxin and its role in modifying gliotoxin could be a 
later adaptation evolved by the fungus.  
 
 Throughout this work, glutathione levels have been hypothesised to be linked 
with gliotoxin susceptibility. This is supported by the fact that gliotoxin has been shown 
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to transport freely into mammalian cells in a glutathione dependent manner (Bernardo et 
al., 2003) highlighting the relationship between gliotoxin and glutathione. Additionally 
in S. cerevisiae, complete absence of glutathione confers resistance to gliotoxin 
exposure in Δgsh1 (chapter 6). This suggests that the absence of glutathione is 
advantageous to cells and that high glutathione levels may be deleterious. This was 
demonstrated in Carberry et al., where ΔgliT was found to have significantly higher 
GSH levels when grown in AMM media and subsequent sensitivity to gliotoxin 
exposure (Carberry et al., 2012).  
 In yeast low to null levels of glutathione may reduce the influx of gliotoxin into 
the cell thus preventing it from having an effect. While in A. fumigatus this may not be 
the case due to the presence of a putative gliotoxin transporter protein gliA. Which may 
actively pump gliotoxin in and out of the cell regardless of the glutathione levels in the 
cell. 
  Gliotoxin has been previously demonstrated to be a potent anti-fungal agent 
inhibiting growth of many different fungi (Waring et al., 1995). However, based on 
results shown here, it is unclear if this is its only role in the cell and whether it may in 
fact be an anti-oxidant molecule in A. fumigatus. Support for this can be seen in chapter 
3 where co-addition of 15 µg/ml gliotoxin attenuates ROS production in cells 
challenged with 5 mM H2O2. Also Choi et al., noted that gliotoxin actively targeted the 
thioredoxin system, accelerating the oxidation of NADPH and subsequent reduction of 
H2O2 to water and molecular oxygen (Choi et al., 2007). This suggests gliotoxin has a 
dual function in the cell or that its toxic affect on other fungal cells is serendipitous.  
 Interestingly, co-addition of gliotoxin and H2O2 in agarose plates was found to 
elicit a wild-type phenotype in ΔgliT, with the hypersensitivity to gliotoxin previously 
seen on gliotoxin only plates completely disappearing. This indicates H2O2 chemically 
substitutes for gliT loss, presumably through the reaction found in Choi et al., whereby 
gliotoxin is oxidised facilitating its efflux from the cell. 
 
 The findings presented here highlight many key issues involved in gliotoxin 
biosynthesis and gliotoxin toxicity. As described by Schrettl et al., gliT is essential in 
  
 
277 
the self protection against gliotoxin. However, silencing of the gli cluster, including 
gliT, does not elicit a similarly sensitive phenotype. This suggests loss of gliT alone 
may not explicate ΔgliTs’ sensitivity to gliotoxin but the involvement of various other 
factors such as biosynthesis and subsequent accumulation of reduced gliotoxin, inability 
to produce bm-gt, accumulation of gli cluster intermediates and accumulation of L-
homocysteine. This highlights some of the effects gliotoxin may be inducing in non 
gliotoxin producing cells as illustrated in S. cerevisiae with exogenous gliotoxin 
addition inducing a similar dysregulation of the SAM cycle as in ΔgliT.  
 The identification of S-adenosyl homocysteinase common to all gliT and gliZ 
mutants responding to gliotoxin implies that the alteration of the gli cluster results in the 
dysregulation of components of the SAM cycle which may potentiate gliotoxin toxicity 
within these strains and could help explain particular phenotypes seen in these 
respective strain genotypic backgrounds.  
This work has contributed to the characterisation of gli cluster mutants, 
highlighting key cellular pathways involved in gliotoxin tolerance and toxicity. 
Additionally, this work stresses the need for further work in elucidating the mechanisms 
involved in gliotoxin biosynthesis and the endogenous machinery utilised for its 
detoxification which could be employed as potential cellular targets.  
From this body of work, the components of secondary metabolite regulation and 
biosynthesis, particularly in the case of gliotoxin, can be seen to not always be linear but 
can in fact be quite complex. This may also be the case in other secondary metabolite 
clusters, especially those with clustered genes orthologous to those of the A. fumigatus 
gli cluster. Secondly, gliotoxin and similar ETP molecules could fulfil multiple 
functions within a particular organsims, as demonstrated here with gliotoxin performing 
an anti-oxidant role in the presence of H2O2, and it may be the case that these other 
secondary metabolites could have a similar dual function which has yet to be 
characterised. 
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7.2 Future Work 
 Work presented here has raised many key questions with regard to gliotoxin 
biosynthesis and means of gliotoxin toxicity in A. fumigatus and S. cerevisiae. These 
include the LC-MS identification of Bm-GT production in gliT, gliZ mutants. The 
ability to produce Bm-GT may be a by-product of gliotoxin detoxification and could be 
impaired in A. fumigatus strains which exhibit a sensitive phenotype to gliotoxin. Based 
on the similarities of A. fumigatus ΔgliT and S. cerevisiae transcriptome and phenotypic 
response to exogenous gliotoxin, Bm-GT may be abolished in ΔgliT. 
 Secondly, the quantification of L-homocysteine and SAH from A. fumigatus 
lysates could help corroborate the hypothesis made throughout this body of work that 
gliotoxin dysregulates the SAM cycle inducing toxicity by inducing accumulation of 
one or both of these molecules which are toxic at high levels in the cell. A. fumigatus 
lysates exposed and un-exposed to gliotoxin could illustrate a rise in the level of L-
homocysteine or SAH and could be expected to have a greater affect in A. fumigatus 
and yeast strain which elicit a sensitive phenotype. 
 Glutathione levels have been demonstrated to play an important factor in the 
response to gliotoxin in S. cerevisiae and A. fumigatus. Low to null levels of GSH has 
been illustrated to be advantageous to S. cerevisiae Δgsh1 eliciting a resistant phenotype 
to gliotoxin. Similarly the addition of GSH reducing chemicals, i.e. CDNB, was shown 
to significantly improve growth of certain S. cerevisiae strains when challenged with 
exogenous gliotoxin. Additionally, the GSH levels in A. fumigatus were found to be 
altered un unstressed gliT, gliZ mutant strains and was suggested to be a factor in their 
respective sensitivities to exogenous gliotoxin exposure. To further corroborate this, A. 
fumigatus gene deletions of gene involved in GSH biosynthesis should be examined to 
test if low to null GSH levels are as vital in A. fumigatus as they are in S. cerevisiae. 
 Lastly, proteomic analysis of the A. fumigatus response to exogenous gliotoxin 
identified one key enzyme found to be shared in all A. fumigatus gliT, gliZ mutant 
strains. S-adenosyl homocysteinease is involved in the hydration of SAH to form L-
homocysteine, and its expression is significantly decreased in ΔgliT, ΔgliZ and 
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ΔgliTΔgliZ when compared to A. fumigatus AF293 wild type. This is further evidence 
of gliotoxin alteration of the SAM cycle and suggests accumulation of L-homocysteine. 
It may be of interest to influence the levels of L-homocysteine by either addition of L-
homocysteine or other product which will be used to produce L-homocysteine, e.g., L-
cystathionine, directly into the media. Or by creating a gene deletion of methionine 
synthase which methylates L-homocysteine to produce L-methionine, thus reducing the 
L-homocysteine levels. Either could increase L-homocysteine levels inside the cell and 
potentially augment gliotoxin toxicity.  
 This work highlights key areas for future studies which will help further 
elucidate the means of gliotoxin toxicity and biosynthesis in A. fumigatus and its effects 
on other fungi. 
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